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EXECUTIVE SUMMARY 
 
This report aims to provide an overview of patients’ rights in all EU Member States, 
Norway and Iceland by mapping national patients’ rights legislation, soft-law, 
structures and enforcement procedures ensuring the rights of patients. The mapping 
exercise was performed from January to September 2015 providing a cross-sectional 
view of the patients’ rights situation in the 30 countries under study. 
The mapping exercise included a literature review, a review of activities funded by the 
EU Health programme, the Research and Innovation Framework Programme and by 
the European Partnership on Active and Healthy Ageing (EIP-AHA). Furthermore, 
qualitative assessment of the patients’ rights situation was undertaken by national 
patients’ rights experts by means of a survey. Preliminary results were presented and 
discussed with a wide range of relevant stakeholders at a workshop on September 10th 
and 11th 2015 in Brussels. 
A conceptual model for this comparative mapping of patients’ rights was developed as 
a starting point for the assessment. The three domains of patients’ rights assessed 
cover (1) basic individual rights, (2) consumer- based rights and (3) 
procedural rights. Basic individual rights cover the right to informed consent; to 
privacy and dignity; to access to the medical file; and to information on one’s health. 
Consumer based rights entail the right to choose one’s provider, to a second opinion, 
to safe and timely treatment (patient safety and quality of care) and to information 
concerning care options. Procedural rights include the right to complain, to 
compensation, and to participate in decision-making. However, these different 
patients’ rights subjects cannot be totally separated from each other. 
The survey tool assessed the following patients’ rights subjects: (I) the formal 
recognition of the right and/or the way it is embedded in broader national laws; (II) 
the implementation of the right in practice; (III) the application of the right in the 
cross-border context; (IV) the use of the right in practice; and (V) available remedies 
and procedures when the right is not respected. Furthermore, broader positioning of 
patients’ rights within the health system and the impact of the Council of Europe’s 
work on the situation of patients’ rights was assessed.  
In the area of basic individual rights all Member States, as well as Norway and 
Iceland, are developing a legal approach to defining and implementing patients’ rights 
to self-determination and confidentiality (rights to consent and information; privacy; 
accessing records). This is not a surprise because these rights are embedded in 
several individual human rights frameworks. While most Member States are 
developing a legal and more unified approach for basic patients’ rights, their actual 
enforcement remains an issue. Low sensitivity and poor knowledge among citizens, 
professionals and policy makers are reported as main stumbling blocks for the 
development of patients’ rights, together with the paternalistic model of the doctor-
patient relationship that still subsists in several countries. 
The right to self-determination, as expressed in the rights to informed consent, the 
closely related right to information, and the right to privacy and confidentiality, is 
strongly protected in the vast majority of countries. In many countries, privacy is 
actually more protected than the right to self-determination due to strong data 
protection legislation. The right to access one’s medical file is also provided for in most 
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Member States, although many respondents reported that some hospitals try to limit 
access in practice. Many countries charge a small fee for a copy of the medical record. 
With regard to the more consumer-oriented rights, the results of the mapping 
exercise are more diverse. These rights represent a more recent trend inspired by an 
increased emphasis on ensuring quality and safety in the health sector, but also more 
generally on responsiveness and efficiency in public service provision. At least in some 
cases, the development of a body of more consumer-oriented patients’ rights seems to 
be directly inspired by the transposition process of Directive 2011/24/EU on the 
application of patients’ rights in cross-border health care. These rights are not yet 
well-established in many countries. Although the right to freely choose one’s 
healthcare provider is increasingly acknowledged as a patient right, it is still often 
restricted by regulation and reality. Geographical restrictions in provider choice are 
increasingly lifted, and in some cases openings are even created to private or non-
contracted care if access cannot be guaranteed with public or contracted providers 
(e.g. Denmark). Nonetheless, provider choice can be an important source of inequity, 
especially for people living in rural and remote areas as well as for people who cannot 
afford private healthcare provision.  
Furthermore, the information required to enable provider choice is often not 
sufficiently available. Various countries have invested substantially in centralized 
information points (e.g. call centers, web sites) providing information to citizens about 
healthcare providers. Initiative “1177” (a 24/7 phone line and web site), which is a 
collaborative project between all county councils and regions in Sweden, is a good 
example. Many countries have also instituted an obligation for providers to inform 
citizens about various aspects that can be instrumental to making a choice. However, 
reliable information on performance, which is the most sought out type of information, 
is generally the least available. In some (7) countries legal requirements exist for 
providing clear and objective information about provider performance (outcomes, 
quality indicators, safety standards, rights/fitness to practice). However, the required 
level varies between countries. No specific legal requirements in this regard exist in 
the other countries. 
The right to a second opinion is closely linked to the right to freely choose one’s 
provider. A small majority of countries formally recognize the right to a second 
opinion. In other countries it is subsumed in the right to freely choose a provider. In 
several countries the right to a second opinion (and the assumption of related costs) is 
subject to strict rules and conditions. Sometimes the right will be limited to certain 
(mostly life-threatening) conditions. Sometimes the second opinion must come from a 
provider in the same hospital or region. Sometimes only one referral is allowed per 
treatment or care process. However, most disturbing is the high level of discretion 
given to the treating physician to “allow” the patient to exercise the right to a second 
opinion. 
In contrast to the concept of a right to safe and quality treatment, many respondents 
refer to the obligation of the provider, sometimes framed as a patients’ right to 
receive a certain standard of care. This obligation/right remains very broad and is not 
further specified. In addition, from a process perspective, a majority of countries 
operate professional standards and clinical guidelines whereas the use of protocols is 
practiced to a lesser extent. Outcomes are reported publicly in Scandinavian countries 
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(Denmark, Finland, Iceland, Norway) but this practice is not common in many other 
countries. 
Mechanisms for the enforcement of patient rights are very varied country-by-
country. Within countries, most jurisdictions have a wide range of mechanisms for 
investigating and responding to complaints. These range from very traditional, court-
based inquiries in Civil, Criminal and Administrative Law, and particularly in the Law of 
medical liability or personal injury, through established alternative dispute resolution 
fora, particularly Ombudsmen, to mediation. 
There is a degree of required cultural orientation in negotiating the range of 
mechanisms. Even where similar mechanisms are used, different jurisdictions have 
different rules and expectations about the different roles of various stakeholders in the 
enforcement processes. This is seen at many levels: for example, timescales for 
making complaints differ widely, as do methods of making complaints; Ombudsmen 
may be available, but the extent of their power and where they are situated in the 
system differ.  
Establishing fault remains the main criteria for compensation. In the majority of 
jurisdictions, compensation is only available where fault (negligence) can be 
established. In some jurisdictions no fault compensation has been established, and in 
a very small number, a hybrid exists where fault is the required route for 
compensation at Law, but schemes have been developed to address where patients 
with damages will not be compensated. 
Alternative Dispute Mechanisms do not tend to produce compensation or rectification 
for a patient. Where Ombudsmen or other non-court complaint schemes are provided, 
the range of resolution tools available to these mechanisms is limited, often to issuing 
an opinion about the case or to administrative Law remedies (specific 
performance).Apology and explanation are not often mentioned as goals or outcomes 
in dispute resolution. Country experts do not point to many parts of systems that are 
designed to explain to patients what actually happened and to give apologies to 
patients. This could be implied where an internal procedure is undertaken by the 
health care provider or institution and a report has to be given to the patient. 
However, the idea of apologizing to the patient does not appear. This could relate to 
the use of fault-based compensation schemes that are in place, and that are separate 
from the internal reviews. 
In some jurisdictions, patients who wish to complain are given assistance. The 
processes are very complex, and in some jurisdictions there are duties on different 
stakeholders to assist the patient in making a complaint (and in some this extends to 
assisting in negotiating settlements). Insiders (Member States’ own citizens) will have 
knowledge of how to negotiate the processes - or at least where to go to seek help in 
that negotiation. Outsiders will need strong guidance and help in accessing the 
underpinning ‘unconscious knowledge’ of citizens - the background knowledge of the 
legal and normative culture of one’s own community - and it is not clear that National 
Contact Points have been created with a duty to provide at least signposts to this 
information. 
From the Country Expert Survey it is clear that Council of Europe activities are not 
reported to have a great influence on individual States. Decisions of the European 
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Court of Human Rights are followed in the countries, but there are few decisions that 
directly bite on patient rights without leaving scope for a margin of appreciation.  
The impact of Directive 2011/24/EU on the application of patients’ rights in cross-
border health care on the development of patients’ rights varies between individual 
Member States. While for some countries it may have been mainly indirect, in several 
Member States (such as Austria, Belgium, Luxembourg, Finland, Hungary, Latvia, 
Malta, Norway, Poland, Spain) the Directive has been indeed a driver for the 
development of patients’ rights, especially those that are more consumer-oriented. 
The basic mode of operation is that the Directive pushes Member States to be more 
transparent about rights patients have. While no specific provisions exist for cross-
border patients in many Member States, existing laws regarding informed consent, 
privacy and access to the medical record equally apply to all health care provided in 
their territory. However, language and technical support (e.g. translation services, e-
copy of medical record, common single consent model, common patient and discharge 
summaries) may help cross-border patients to enforce basic patients’ rights. 
However, there is a need to clarify the very notion of patients’ rights in the context of 
the Directive by providing accurate information to the Member States. The rights 
contained in this Directive are not the basic patients’ rights in the sense of a sick 
individual but rights of a patient in his capacity as a recipient - and even more a 
potential recipient - of health services. The answers of the respondents make it clear 
that policy makers in many countries regard patients’ rights in the traditional way. As 
this could hamper the implementation of the Directive in daily life, a broader concept 
of patients’ rights, including the various dimensions as covered in this mapping 
exercise, could be promoted. Examples of good practice in this regard are Norway, 
where the Patients’ Rights Act was revised in 2011 and now also includes “users” of 
care services; and the Netherlands, where the Act of 9 December 2014 on long-term 
care contains rules on the participation and co-decision making of the client. 
The obligations that Article 4 of the Directive imposed on Member States clearly 
inspired some countries to push forward some of the more consumer-oriented 
patients’ rights. As a principle, Directive 2011/24/EU extends patients’ choice to 
healthcare providers in another Member State irrespective of whether or not they are 
contracted by the statutory health system in that Member State. This raises two 
particular and related issues: Firstly, several Member States signalled that in the 
context of the transposition of the Directive private non-contracted providers were 
claiming “equal treatment” with foreign providers whose services would be reimbursed 
under the Directive even without being contracted by the cross-border patients’ health 
insurer. Second, in countries (e.g. in Austria, Netherlands) with differential 
reimbursement rates for contracted and non-contracted providers, the application of 
lower reimbursement levels to non-contracted cross-border providers could be 
regarded as a disincentive for patient mobility. 
Finally, it must be acknowledged that the aim of this study was to provide a mapping 
of national patients’ rights. Rights related to social coverage for health care or linked 
ethical questions were not considered. Moreover, the review of literature has only 
included English language sources. The assessment of each national situation is based 
on a single country expert review (backed up with other available source). In this 
regard the mapping aimed at providing a comparative overview of patients’ rights 
currently in place in EU Member States, Norway and Iceland. 
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RÉSUMÉ EXÉCUTIF 
 
Ce rapport a comme but de fournir un aperçu sur les droits du patients dans les États 
Membres de l’Union Européenne, y compris la Norvège et l’Islande en réalisant une 
modélisation des législations nationales des droits des patients, des stratégies, des 
structures ainsi que les procédures de mise en vigueur des droits des patients. Cet 
exercice de modélisation a été réalisé de janvier à septembre 2015 en apportant une 
vision transversale sur la situation des droits des patients dans les 30 pays étudiés.  
Cet exercice de modélisation inclut une analyse bibliographique, une révision des 
activités financées par le Programme Santé de l’UE, Programme-cadre pour la 
recherche et le développement technologique et par le Partenariat européen 
d’innovation pour un vieillissement actif et en bonne santé (EIP-AHA). De plus, une 
évaluation qualitative de la situation des droits des patients a été menée via une 
enquête réalisée auprès d’experts des droits des patients au niveau national. Les 
résultats préliminaires ont été présentés et débattus avec un large spectre 
d’importants acteurs pendant un atelier ayant eu lieu le 10 et 11 Septembre 2015 à 
Bruxelles.  
Un modèle conceptuel pour cette modélisation comparative des droits des patients a 
été développé comme point de départ pour l’évaluation. Trois domaines des droits des 
patients ont été évalués (1) droits individuel de base (2) droits des 
consommateurs (3) droits procéduraux.  Les droits individuels de base couvrent 
le droit au consentement éclairé; droit au respect de la vie privée et à la dignité ; droit 
d’accès au dossier médical ; droit à l’information sur son état de santé. Les droits des 
consommateurs comportent le droit au libre choix du prestataire, droit d’obtenir un 
deuxième avis, droit au traitement sécurisé et en temps opportun (sécurité des 
patients et qualité des soins) et droit aux informations concernant les différentes 
options de traitements. Les droits procéduraux incluent le droit de porter plainte, de 
recevoir une compensation et de participer à la prise de décision. Toutefois, ces 
différents sujets/thèmes des droits des patients ne sont pas totalement indissociables.  
L’outil d’enquête a permis d’évaluer chacun de ces sujets des droits des patients : (I) 
la reconnaissance formelle du droit et / ou la manière dont il est intégré dans les lois 
nationales au sens large, (II) la mise en œuvre pratique de ce  droit, (III) l’application 
du droit dans le contexte transfrontalier, (IV) l’utilisation pratique du droit, (V) les 
voies de recours et les procédures disponibles dans le cas du non-respect de droit. En 
outre, la position au sens large des droits des patients dans le système de santé et 
l’impact de l’action du Conseil de l’Europe sur la situation des droits des patients ont 
été évalués.  
Dans le domaine des droits individuels de base, tous les Etats Membres ainsi que la 
Norvège et l’Islande, développent une approche juridique pour définir et mettre en 
œuvre des droits des patients à l’autodétermination et à la confidentialité (droits de 
consentement éclairé; vie privée ; accès au dossier médicale). C’est sans surprise car 
ces droits sont repris dans plusieurs cadres de droits de l’Homme. Alors que la plupart 
des Etats Membres développent une approche juridique plus unifiée des droits de 
patients de base, leur mise en application reste problématique. Une sensibilité limitée 
et de pauvres connaissances parmi les citoyens, les professionnels et les décideurs 
politiques sont signalées comme étant un frein majeur pour le développement des 
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droits des patients, conjointement avec le modèle paternaliste de la relation médecin-
patient qui subsiste encore dans plusieurs pays.   
Le droit à l’autodétermination, tel qu’il est exprimé dans le droit au consentement 
éclairé, étroitement lié au droit à l’information, et du droit à la vie privée et à la 
confidentialité, est fortement protégé dans la grande majorité des pays. Dans de 
nombreux pays, le droit à la vie privée est en fait mieux protégé que le droit à 
l’autodétermination en raison des solides législations en matière de protection des 
données. Le droit d’accès au dossier médical est également assuré dans la plupart des 
Etats Membres, bien que de nombreux correspondants ont signalé qu’en pratique 
certains hôpitaux tentent de limiter l’accès. De nombreux pays réclament une petite 
redevance pour obtenir une copie du dossier médical.    
En ce qui concerne les droits axés sur les consommateurs, les résultats de l’exercice 
de modélisation sont plus variés. Ces droits représentent aussi une tendance plus 
récente qui porte l’attention sur la l’assurance de qualité et de sécurité dans le secteur 
de la santé, mais aussi plus généralement sur la réactivité et sur l’efficacité dans la 
prestation des services publics. Au moins, dans certains cas, le développement d’un 
ensemble de droits de patients plus orientés sur le consommateur semble être 
directement inspiré par le processus de transposition de la Directive 2011/24/UE sur 
l’application des droits des patients en matière de soins de santé transfrontaliers. Ces 
droits restent encore à être mis en place dans beaucoup de pays. Bien que le droit de 
choisir librement son prestataire de soins est de plus en plus reconnu comme un droit 
du patient, il est souvent encore limité par la réglementation ou la réalité. Des 
restrictions géographiques sont de moins en moins fréquentes lors du choix du 
prestataire de soins. Dans certains cas l’ouverture aux prestataires privés ou non-
conventionnés est même crée au cas où l’accès ne peut être garanti par des 
prestataires publics ou conventionnés (par exemple : Danemark). Néanmoins, le choix 
du fournisseur peut être une important source d’inégalité, particulièrement pour les 
habitants de zones rurales et désertes, de même que pour les personnes ne pouvant 
pas se permettre la fourniture de soins privés.  
Par ailleurs, souvent l’information requise pour opérationnaliser le libre choix du 
prestataire n’est pas suffisamment disponible. Divers pays ont investi 
considérablement dans des points d’informations centralisés (ex : centres d’appel, site 
web), qui fournissent d’information aux citoyens sur les prestataires de soins. Un bon 
exemple est l’initiative « 1177 » (une ligne de téléphone disponible 24h/24h et 7j/7 et 
un site web) qui est un projet collaboratif entre toutes les autorités de santé et les 
régions en Suède. Plusieurs pays ont aussi institué une obligation pour les prestataires 
de soins d’informer les citoyens concernant les divers aspects pouvant être essentiels 
pour faire un choix. Cependant, le type d’information le plus recherché mais le moins 
disponible concerne la performance. Dans certains (7) pays, des dispositions 
juridiques ont été mise en place pour fournir d’information claire et objective à propos 
de la performance des prestataires (résultats, indicateurs de qualité, standards de 
sécurité, agrément/aptitude à pratiquer). Toutefois, le niveau requis diffère selon le 
pays. Il n’y a pas de dispositions juridiques à ce sujet dans les autres pays.  
Le droit d’obtenir un deuxième avis est étroitement lié au droit de libre choix du 
prestataire de soins. Une faible majorité des pays a formellement reconnu ce droit au 
deuxième avis. Dans certains pays, il est dérivé implicitement du droit au libre choix 
du prestataire. Dans plusieurs pays, le droit au deuxième avis (et la couverture des 
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frais liés) est sujet à des règles et des conditions strictes. Parfois, ce droit sera limité à 
certaines conditions (principalement mortelles). Parfois, un deuxième avis devra venir 
d’un autre prestataire du même hôpital ou de la même région. Parfois, une seule 
référence sera autorisée pour chaque traitement ou processus de soins. Toutefois, le 
plus inquiétant est le niveau très élevé de discrétion du médecin traitant à 
« autoriser » le patient d’exercer ce droit à un deuxième avis.  
Contrairement au concept de droit à un traitement sécurisé et de bonne qualité, la 
plupart des correspondants à l’enquête se réfèrent à l’obligation du prestataire, parfois 
formulé comme un droit du patient à recevoir un certain standard de soins. Cette 
obligation/ce droit reste très large et n’est pas plus spécifié. De plus, à partir d’une 
perspective de processus, une majorité de pays opère avec les standards 
professionnels et les lignes directrices cliniques alors que l’utilisation des protocoles 
est pratiquée dans une moindre mesure. Les résultats sont rapportés publiquement 
dans les pays Scandinaves (Danemark, Finlande, Islande, Norvège) mais cette 
pratique n’est pas coutume dans bon nombre de pays.  
Les mécanismes de mise en application des droits de patients sont assez variés pays 
par pays. Au sein de certains pays, la plupart des juridictions ont un grand éventail de 
mécanismes pour examiner et répondre aux plaintes. Ceux-ci comprennent aussi bien 
des enquêtes judiciaires traditionnelles relevant des tribunaux en matière de droit 
civil, pénal et administratif, et particulièrement du droit de responsabilité médicale ou 
de dommages et intérêts, que des plateformes de résolution de dispute ou de 
médiation extrajudiciaire, comme le Ombudsman.   
Un degré d’orientation culturel est requis dans la négociation de l’ensemble des 
mécanismes. Même là où des mécanismes similaires sont utilisés, les différentes 
juridictions ont des règles et des attentes différentes en ce qui concerne les différents 
rôles des multiples acteurs dans les processus de mise en application. Cela se voit à 
plusieurs niveaux : par exemple, les délais de dépôt de plaintes diffèrent 
considérablement, tout comme les procédés de formulation des plaintes; les 
médiateurs (Ombudsmen) peuvent être disponibles, mais l’étendue de leur pouvoir et 
leur position dans le système différent.   
Le principal critère pour l’indemnisation reste la détermination d’une faute commise. 
Dans la majorité des juridictions, une compensation est uniquement disponible lorsque 
la faute (négligence) peut être établie. Dans certaines juridictions, aucun système de 
compensation n’a été établi, et dans un très petit nombre, un système hybride existe 
lorsque la faute est la voie nécessaire pour une compensation au niveau légal, mais 
des systèmes ont été développés pour traiter les cas où des patients avec des 
dommages et intérêts ne seront pas compensés.  
En général, des mécanismes extrajudiciaires de règlement de disputes ne produisent 
pas d’indemnisation ou de rectification pour le patient. Là où des médiateurs ou 
d’autres systèmes de plainte extrajudiciaires sont prévus, l’éventail d’outils de 
résolution mise à disposition de ces mécanismes est limité, souvent des avis 
consultatifs sur l’affaire ou le recours aux remèdes de droit administratif 
(performances spécifiques). Des excuses et des explications sont rarement 
mentionnées comme objectifs ou résultats dans la résolution de disputes. Les 
correspondants nationaux ne mentionnent pas souvent des parties du système 
conçues pour expliquer aux patients ce qui est arrivé et de présenter des excuses aux 
patients. Cela pourrait être implicite lorsque une procédure interne est entreprise par 
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le prestataire ou un établissement de soins de santé et où un rapport doit être remis 
au patient. Cependant, l’idée de présenter des excuses aux patients n’y apparaît pas. 
Cela pourrait être lié aux régimes de compensation en place, et qui sont séparés des 
examens internes.  
Dans certaines juridictions, les patients qui souhaitent se plaindre reçoivent de 
l’assistance. Les processus sont très complexes, et dans certaines juridictions, les 
différents acteurs ont l’obligation d’aider le patient à déposer plainte (voire à aider à la 
négociation d’un compromis). Les citoyens des Etats Membres auront souvent une 
certaine connaissance comment naviguer ces processus – ou en tous cas savoir où 
obtenir de l’aide dans cette négociation - tandis que les étrangers auront davantage 
besoin d’assistance plus solide et de l’aide pour accéder aux « savoir inconscient » 
sous-jacent des citoyens – les connaissances de base de la culture juridique et 
normative de sa propre communauté. Il n’est pas clair si les Points de contact 
nationaux ont été crées avec l’obligation de fournir au moins des indications à cette 
information.  
D’après l’enquête d’experts nationaux il apparaît que les activités du Conseil de 
l’Europe n’ont pas de grande influence sur les Etats individuels. Les décisions de la 
Court Européenne des Droits de l’Homme sont respectées dans les pays, mais il y a 
peu de décisions qui sont directement liés aux droits de patients sans laisser de marge 
d’appréciation.  
L’impact de la Directive 2011/24/UE sur l’application  des droits des patients en 
matière de soins de santé transfrontaliers sur le développement des droits des 
patients varie entre les Etats membres. Alors que pour certains pays cet impact a été 
jusqu’ici principalement indirect, pour d’autres États Membres (comme l’Autriche, la 
Belgique, le Luxembourg, la Finlande, la Hongrie, la Lettonie, Malte, la Norvège, la 
Pologne, l’Espagne) la Directive a été effectivement un moteur pour le développement 
des droits de patients, surtout ceux qui sont plus axés vers le consommateur. Le 
principe de base est que la Directive force les États Membres à être plus transparents 
en matière de droits des patients. Alors qu’aucune disposition spécifique n’existe pour 
les patients transfrontaliers dans de nombreux Etats Membres, les lois existantes 
concernant le consentement éclairé, la confidentialité et l’accès au dossier médical 
s’appliquent également à tous les soins de santé dispensés sur le territoire. 
Cependant, la connaissance de la langue et un soutien technique (ex: service de 
traduction, copie électronique du dossier médical, un modèle unique et commun de 
consentement, un registre d’entrée et sortie de patients commun) peuvent aider les 
patients transfrontaliers à faire respecter leurs droits fondamentaux des patients.  
Néanmoins, il est nécessaire de clarifier la notion même des droits des patients dans 
le cadre de la Directive en fournissant des informations précises aux Etats Membres. 
Les droits énoncés dans la Directive ne sont pas les droits des patients de base au 
sens d’une personne malade, mais les droits d’un patient en sa qualité de bénéficiaire 
– voir même un bénéficiaire potentiel – de services de soins de santé. Les réponses 
des correspondants indiquent clairement que dans de nombreux pays les 
décisionnaires considèrent les droits des patients de manière traditionnelle. Comme 
cela pourrait entraver la mise en œuvre de la Directive au quotidien, un concept plus 
large des droits des patients, y compris les différentes dimensions couvertes dans cet 
exercice de modélisation, pourrait être favorisé. Des exemples de bonnes pratiques à 
cet égard sont la Norvège, où l’Acte sur les Droits des Patients a été révisé en 2011 et 
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inclus désormais également les « utilisateurs » de services de soins; et les Pays-Bas, 
où la Loi du 9 Décembre 2014 sur les soins de longue durée contient des règles 
concernant la participation et la codécision du client. 
Les obligations de l’article 4 de la Directive imposée aux États Membres a clairement 
inspiré certains pays à faire avancer certains droits des patients à caractère plus 
consommateur. En principe, la Directive 2011/24/UE étend le choix des patients 
concernant les prestataires de soins dans un autre Etat Membre, indépendamment de 
savoir si oui ou non ils sont contractés par le système de santé de cet Etat Membre. 
Des questions spécifiques et liées se soulèvent. Premièrement, plusieurs États 
Membres ont signalé que dans le contexte de la transposition de la Directive des 
prestataires privés et non conventionnés, est réclamé un traitement égal par rapport 
aux prestataires étrangers, dont les prestations seraient remboursées dans le cadre de 
la Directive sans même être conventionnées par l’organisme d’assurance du patient 
transfrontalier. Deuxièmement, certains pays (ex: Autriche, Pays-Bas) appliquant 
traditionnellement un remboursement différentiel pour différents types de prestataires 
contractés ou non, l’application des niveaux de remboursement plus bas pour les 
prestataires de soins transfrontaliers non contractés pourrait être perçue comme un 
frein pour la mobilité des patients. 
Enfin, il faut reconnaître que le but de cette étude était de fournir une modélisation 
des droits des patients nationaux. Les droits liés à la couverture sociale pour les soins 
de santé ou liées à des questions d’éthiques n’ont pas été considérés. En outre, la 
revue bibliographique a seulement inclus les sources en Anglais. L’évaluation de 
chaque situation nationale est basée sur un examen d’expert unique (sauvegardé avec 
une autre source disponible). À cet égard, la modélisation vise à fournir un aperçu 
comparatif des droits des patients en place dans les Etats Membres de l’UE, la Norvège 
et l’Islande.  
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ZUSAMMENFASSUNG 
 
Dieser Bericht zielt darauf ab, eine Übersicht der Patientenrechte in allen EU 
Mitgliedsstaaten, Norwegen und Island zu geben. Hierzu wurden nationale 
Patientenrechtsgesetzgebungen, rechtlich nicht bindende Regelungen (Soft-Law), 
Strukturen und Durchsetzungsverfahren, die die Rechte von Patienten sicherstellen, 
zusammengetragen. Die Bestandsaufnahme erfolgte zwischen Januar und September 
2015 und gibt eine Querschnittssicht auf die Situation von Patientenrechten in den 30 
berücksichtigten Ländern. 
Die Bestandsaufnahme schließt eine Literaturrecherche, eine Bewertung von 
Aktivitäten, die durch das EU Gesundheitsprogramm, durch das Forschungs- und 
Innovationsrahmenprogramm und durch die Europäische Innovationspartnerschaft 
„Aktives und gesundes Altern“ gefördert sind, ein. Darüber hinaus wurde eine 
qualitative Bewertung der Patientenrechtesituation von nationalen Experten auf dem 
Gebiet der Patientenrechte mittels eines Surveys durchgeführt. Erste Ergebnisse 
wurden auf einem Workshop am 10. und 11. September 2015 in Brüssel präsentiert 
und mit einer großen Auswahl von relevanten Vertretern besprochen. 
Ein Konzeptmodel für die vergleichende Analyse von Patientenrechten wurde bei 
Beginn entwickelt. Die drei Bereiche von Patientenrechten umfassen (1) die 
Grundrechte des Einzelnen, (2) Rechte gestützt auf den Verbraucherschutz 
und (3) Verfahrensrechte. Grundrechte des Einzelnen beinhalten das Recht auf 
Einwilligung nach erfolgter Aufklärung, auf Schutz der Privatsphäre und Würde, auf 
Einsicht in die Patientenakte und auf Informationen zur eignen Diagnose. Rechte 
gestützt auf den Verbraucherschutz umfassen das Recht auf freie Arztwahl, auf eine 
Zweitmeinung und auf eine sichere und zeitnahe Behandlung (Patientensicherheit und 
Versorgungsqualität) und auf Informationen zu Behandlungsoptionen. 
Verfahrensrechte schließen das Recht auf Beschwerde, auf Schadenersatz und auf 
Teilnahme am Entscheidungsfindungsprozess ein. Letztlich können diese 
verschiedenen Aspekte von Patientenrechten nicht gänzlich voneinander getrennt 
werden 
Das Befragungsinstrument hat alle Aspekte von Patientenrechten hin untersucht auf: 
(I) die formale Anerkennung des Rechts und/ oder die Art und Weise wie es in 
übergeordnetes nationales Recht eingebunden ist, (II) die Durchsetzung des Rechts in 
der Praxis, (III) die Anwendung des Rechts im grenzüberschreitenden Kontext, (IV) 
den Gebrauch des Rechts in der Praxis und (V) die Rechtsmittel und Verfahren falls 
das Recht nicht geachtet wird. Darüber hinaus wurden die allgemeine Stellung von 
Patientenrechten im jeweiligen Gesundheitssystem und der Einfluss von Aktivitäten 
des Europarats auf die Situation von Patientenrechten untersucht. 
Im Bereich der Grundrechte des Einzelnen haben alle Mitgliedstaaten sowie 
Norwegen und Island eine rechtliche Herangehensweise entwickelt, um das Recht auf 
Selbstbestimmtheit und Vertraulichkeit (Rechte auf Zustimmung und Information, 
Schutz der Privatsphäre, Akteneinsicht) zu definieren und durchzusetzen. Dies ist nicht 
überraschend, da diese Rechte Bestandteil von verschiedenen Konventionen zu 
Menschenrechten sind. Während die meisten Mitgliedsstaaten rechtliche 
Herangehensweisen entwickeln und vereinheitlichen, bleibt ihre tatsächliche 
Geltendmachung weiterhin eine Aufgabe. Eine niedrige Sensibilisierung und 
Kenntnisstand unter Bürgern, medizinischem Personal und politischen Entscheidern 
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werden als einer der wichtigsten Hemmschuhe für die Weiterentwicklung von 
Patientenrechten angeführt, zusammen mit der paternalistischen Haltung im Arzt–
Patienten Verhältnis, welches in einigen Ländern noch fortbesteht. 
Das Recht auf Selbstbestimmung, ausgedrückt durch das Recht auf Einwilligung nach 
erfolgter Aufklärung, das verwandte Recht auf Information und das Recht auf Schutz 
der Privatsphäre und auf Vertraulichkeit, ist stark geschützt in einer großen Mehrheit 
der Länder. In vielen Ländern ist das Recht zum Schutz der Privatsphäre stärker 
geschützt als das Recht auf Selbstbestimmung aufgrund einer rigiden 
Datenschutzgesetzgebung.  
Im Hinblick auf die Rechte gestützt auf den Verbraucherschutz gehen die 
Ergebnisse unserer Bestandsaufnahme weiter auseinander. Diese Rechte stehen für 
einen jüngeren Trend, angestoßen durch eine gesteigerte Betonung von Qualität und 
Sicherheit im Gesundheitswesen, zielen aber auch auf allgemeine 
Reaktionsverbesserung und Effizienz bei der Erbringung öffentlicher Dienstleistungen. 
Zumindest in ein paar Fällen ist die Entwicklung eines Grundgerüstes von auf 
Verbraucherschutz gestützten Patientenrechten augenscheinlich direkt angeregt durch 
den Umsetzungsprozess der Richtlinie 2011/24/EU über die Ausübung der 
Patientenrechte in der grenzüberschreitenden Gesundheitsversorgung. Diese Rechte 
sind in vielen Ländern noch nicht voll etabliert. Obwohl das Recht auf freie Arztwahl in 
zunehmendem Maße als Patientenrecht anerkannt wird, ist es oft beschränkt durch 
Vorschriften und der Realität. Geographische Restriktionen bei der Auswahl der 
Behandlung werden mehr und mehr weggenommen und in manchen Fällen wird eine 
Öffnung hin zu privaten und nicht-vertraglich gebundenen Behandlungen ermöglicht, 
wenn eine Versorgung durch öffentliche und Vertragsanbieter (z.B. Dänemark) nicht 
gewährleistet werden kann. Gleichwohl, die freie Arztwahl kann eine wichtige Quelle 
für Ungleichheiten sein, insbesondere für Menschen in ländlichen und abgelegenen 
Gegenden und für Menschen, die sich eine private Behandlung nicht leisten können. 
Des Weiteren sind Informationen, die eine freie Arztwahl ermöglichen, oft nicht 
hinreichend vorhanden. Verschiedene Länder haben deutlich in zentrale 
Informationsstellen (z.B. Callcenter, Internetseiten) investiert, die Informationen über 
Gesundheitsdienstleister für Bürger bereitstellen. Ein gutes Beispiel ist die Initiative 
“1177” (eine Rund-um-die Uhr Telefonleitung und Internetseite), ein 
gemeinschaftliches Projekt zwischen Kreisverwaltungen und Regionen in Schweden. 
Viele Länder haben eine Verpflichtung für Dienstleister institutionalisiert, um ihre 
Bürger über verschiedene Aspekte, die für eine Entscheidung über die Auswahl 
dienlich sind, zu informieren. Aber verlässliche Informationen über die 
Leistungsfähigkeit sind im Allgemeinen kaum vorhanden, wenngleich diese die am 
meisten nachgefragte Art der Information ist. In einigen (7) Ländern bestehen 
rechtliche Verpflichtungen, um klare und objektive Informationen über die 
Anbieterleistungen (Behandlungsresultate, Qualitätsindikatoren, Sicherheitsstandards, 
Recht/ Tauglichkeit zur Berufsausübung) zu veröffentlichen. Aber das 
Anforderungsniveau unterscheidet sich zwischen den Ländern. In anderen Ländern 
gibt es keine spezifischen rechtlichen Verpflichtungen in dieser Hinsicht. 
Das Recht auf eine Zweitmeinung ist eng verbunden mit dem Recht auf freie Arztwahl. 
In einer kleinen Mehrheit der Länder gibt es eine formelle Anerkennung des Rechts auf 
eine Zweitmeinung. In anderen Ländern wird dieses Recht mit dem Recht auf freie 
Arztwahl zusammengefasst. In mehreren Ländern ist das Recht auf eine Zweitmeinung 
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(und die Übernahme verbundener Kosten) vorbehaltlich strenger Regeln und 
Voraussetzungen. Manchmal ist dieses Recht auf bestimmte (meistens 
lebensbedrohliche) Erkrankungen beschränkt. Zuweilen ist nur eine Überweisung pro 
Behandlung oder Versorgungsepisode erlaubt. Aber sehr beunruhigend ist das hohe 
Maß an Ermessen, das dem behandelnden Arzt zugestanden wird, um dem Patienten 
das Recht auf eine Zweitmeinung zu “erlauben”.  
Im Gegensatz zum Konzept eines Rechts auf eine sichere und qualitativ hochwertige 
Behandlung, verweisen viele befragte Experten hier auf die Verpflichtung der 
Behandelnden, zuweilen formuliert als Patientenrecht auf einen bestimmten Standard 
der Behandlung. Diese Verpflichtung/ dieses Recht bleibt oft sehr allgemein und wird 
nicht weiter definiert. Ferner, aus Verfahrenssicht, handhaben eine Mehrheit der 
Länder Ausbildungsstandards und klinische Behandlungsleitlinien wohingegen 
Ablaufprotokolle in einem geringeren Umfang genutzt werden. Behandlungsresultate 
werden in skandinavischen Ländern (Dänemark, Finnland, Island, Norwegen) öffentlich 
gemacht, aber diese Praxis ist in vielen anderen Ländern nicht verbreitet. 
Mechanismen zur Durchsetzung von Patientenrechten unterscheiden sich von 
Land zu Land. In den Ländern haben die meisten Rechtssysteme eine Fülle von 
Mechanismen, um Beschwerden zu untersuchen und darauf einzugehen. Diese gehen 
von sehr traditionellen bei den Gerichten angesiedelten Beweisaufnahmeverfahren im 
Zivil-, Straf- und Verwaltungsrecht, und insbesondere gestützt auf das 
Arzthaftungsrecht oder Personenschaden, über alternative Streitschlichtungsstellen, 
insbesondere Ombudsmännern, bis hin zur Mediation. 
Es gibt einen Grad an kultureller Verbundenheit, die benötigt wird, um die 
verschiedenen Mechanismen einzuschätzen. Auch wo ähnliche Mechanismen benutzt 
werden, haben verschiedene Rechtssysteme verschiedene Regelungen und 
Erwartungen an die unterschiedlichen Rollen von Akteuren im Durchsetzungsprozess. 
Das kann man an vielen Stellen beobachten: zum Beispiel unterscheiden sich Fristen 
und die Art und Weise, wie Beschwerden einzureichen sind, deutlich. Ombudsmänner 
können vorhanden sein, aber der Grad ihrer Einflussnahme und wo sie im System 
verortet sind, unterscheiden sich. 
Die Feststellung der Schuld bleibt das wichtigste Kriterium für eine Entschädigung. In 
der Mehrzahl der Rechtssysteme kann ein Schadenersatz nur erfolgen, wenn eine 
Schuld (Fahrlässigkeit) festgestellt wird. In einigen Rechtssystemen gibt es keine 
Schadenersatzregelung, und in einer sehr geringen Anzahl existieren Mischformen, wo 
für ein Recht auf Entschädigung die Schuld gerichtlich festgestellt werden muss, aber 
daneben wurden Institutionen aufgebaut, um Patienten ohne gerichtlich-festgestelltes 
Recht auf Entschädigung finanziell zu helfen. 
Alternative Streitschlichtungs-Mechanismen neigen dazu, keine Entschädigung oder 
Mangelbeseitigung für den Patienten herbeizuführen. Wo Ombudsmänner oder andere 
außer-gerichtliche Beschwerdesystem etabliert sind, ist die Wahl der Konfliktlösungs-
Instrumente für diese Mechanismen begrenzt, oft um eine Stellungnahme zu dem Fall 
oder den Rechtsmitteln abgegeben. Eine Entschuldigung oder Erklärung wird als Ziel 
oder Ergebnis der Streitschlichtung nicht oft genannt. Die Länderexperten weisen nicht 
auf viele Teile des Rechtssystems hin, die so konstruiert sind, dass Patienten erklärt 
bekommen, was eigentlich passiert ist oder durch die Patienten eine Entschuldigung 
erhalten. Dies könnte einbezogen werden bei einer internen Überprüfung durch den 
behandelnden Arzt oder die Einrichtung und wenn ein Bericht an den Patienten 
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gegeben werden würde. Aber die Vorstellung, sich bei Patienten zu entschuldigen, 
taucht hier nicht auf. Dies könnte mit den Schadenersatz-Systemen, die auf eine 
Feststellung der Schuld basieren, zusammenhängen, welche zurzeit etabliert sind und 
welche getrennt sind von internen Überprüfungen. 
In einigen Rechtssystemen, in denen Patienten sich beschweren wollen, wird ihnen 
Hilfestellung gegeben. Die Abläufe sind komplex. In einigen Rechtssystemen besteht 
die Verpflichtung für verschiedene Akteure dem Patient zu helfen, eine Beschwerde 
einzureichen (und in einigen geht dies soweit, dass bei der Aushandlung eines 
Vergleichs unterstützt wird). Eingeweihte (die eigenen Bürgers eines Mitgliedsstaats) 
werden das Wissen haben, um diese Abläufe zu bewältigen – oder zumindest wo sie 
Hilfe erhalten können. Nicht-Eingeweihte werden eine ausgedehnte Beratung 
benötigen, um sich das grundlegende unbewusste Wissen von Bürgern anzueignen – 
das Wissen um die rechtliche und normative Kultur der eigenen Gesellschaft – dabei 
ist nicht klar, ob die nationalen Kontaktstellen geschaffen wurden mit der 
Verpflichtung, um wenigstens den Weg zu diesem Wissen zu weisen. 
Es wird deutlich durch die Expertenbefragung, dass die Aktivitäten des Europarats 
keinen großen Einfluss auf individuelle Staaten haben. Entscheidungen des 
Europäischen Gerichthofes für Menschenrechte werden in Ländern befolgt bzw. 
nachvollzogen, aber nur wenige Entscheidungen sind so griffig in Bezug auf 
Patientenrechte ohne dabei die Möglichkeit für einen Ermessensspielraum zu lassen.  
Der Einfluss der Richtlinie 2011/24/EU über die Ausübung der Patientenrechte in der 
grenzüberschreitenden Gesundheitsversorgung auf die Entwicklung von 
Patientenrechten variiert in den individuellen Mitgliedsstaaten. Während der Einfluss in 
einigen Ländern indirekter Natur gewesen sein dürfte, war die Richtlinie in 
verschiedenen Mitgliedsländern (z.B. in Österreich, Belgien, Luxemburg, Finnland, 
Ungarn, Lettland, Malta, Norwegen, Polen, Spanien) in der Tat eine Triebkraft für die 
Entwicklung von Patientenrechten. Die grundlegende Wirkungsweise der Richtlinie ist 
dabei, Mitgliedsländer zu einer größeren Transparenz bezüglich der Rechte, die 
Patienten haben, zu drängen. Während es keine besonderen Vorschriften für 
grenzüberschreitende Patienten in vielen Ländern gibt, so sind die bestehenden 
Gesetze in Bezug auf Einwilligung nach erfolgter Aufklärung, auf Schutz der 
Privatsphäre und auf Einsicht in die Patientenakte gleichermaßen anwendbar auf alle 
erbrachten Gesundheitsleistungen im jeweiligen Staatsgebiet. Jedoch würden Sprach- 
und technische Unterstützungen (z.B. Übersetzungsdienst, elektronische Auszüge aus 
der Patientenakte, ein vereinheitlichtes Einwilligungsmodel, einheitliche Patienten-
Kurzakten und Entlassbriefe) vermutlich grenzüberschreitenden Patienten helfen, ihre 
grundlegenden Patientenrechte durchzusetzen. 
Jedoch besteht Bedarf, das Verständnis von Patientenrechten im Kontext der Richtlinie 
zu klären, indem genauere Informationen an die Mitgliedsstaaten gegeben werden. 
Die Rechte, die die Richtlinie beinhaltet, sind nicht die grundlegenden Patientenrechte 
im Sinne eines kranken Einzelnen sondern die Rechte eines Patienten in seiner 
Eigenschaft als Empfänger – und viel mehr als potenzieller Empfänger - von 
Gesundheitsdienstleistungen. Die Antworten der Befragten machen deutlich, dass 
politische Entscheider in vielen Ländern Patientenrechte in traditioneller Weise 
auffassen. Da dies aber die Umsetzung der Richtlinie in der täglichen Praxis behindern 
könnte, könnte demgegenüber ein breiteres Verständnis von Patientenrechten 
gefördert werden, eingeschlossen der verschiedenen Dimensionen, die diese 
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Bestandsaufnahme abgedeckt hat. Beispiele guter Praxis sind in dieser Hinsicht 
Norwegen, wo das Patientenrechte- Gesetz überarbeitet in 2011 wurde und nun die 
„Benutzer“ von Gesundheitsdienstleistungen beinhalten und die Niederlande, in denen 
das Gesetz zur Langzeitpflege (9.Dez. 2014) Regelungen zur Teilnahme und 
Mitentscheidung des Klienten beinhaltet. 
Die Verpflichtungen, die Artikel 4 der Richtlinie Mitgliedsstaaten auferlegt, sind 
deutlich inspiriert durch ein Bemühen hin zu einigen der am Verbraucherschutz 
orientierten Patientenrechten. Zum Beispiel erweitert die Richtlinie 2011/24/EU die 
Wahlmöglichkeiten von Patienten auf Gesundheitsanbieter in anderen Mitgliedsländern 
unabhängig davon, ob mit diesen Verträge mit dem Gesetzlichen Gesundheitssystem 
im Mitgliedsstaat bestehen oder nicht. Das wirft zwei besondere und verwandte Punkte 
auf: Erstens, verschiedene Mitgliedsstaaten gaben an, dass im Zusammenhang mit 
der Umsetzung der Richtlinie private nicht-vertragsgebundene Anbieter eine 
„Gleichbehandlung“ forderten im Hinblick auf ausländische Anbieter, deren Leistungen 
über die Richtlinie erstattet würden, ohne vertragliche Grundlage mit dem 
Krankenversicherer des grenzüberschreitenden Patienten. Zweitens: in Ländern (z.B. 
Österreich, die Niederlande) mit unterschiedlichen Erstattungssätzen für Vertrags- und 
nicht-vertraglich gebunden Anbieter kann die Anwendung von niedrigeren 
Erstattungssätzen auf nicht-vertragliche, grenzüberschreitende Anbieter als 
Hinderungsfaktor für Patientenmobilität gesehen werden. 
Letztlich sollte nicht unerwähnt bleiben, dass es das Ziel dieser Studie war, eine 
Bestandsaufnahme von nationalen Patientenrechten zu geben. Rechte bezüglich der 
sozialen Absicherung oder verbundene ethische Fragestellungen wurden hier nicht 
berücksichtigt. Auch hat die Literaturrecherche lediglich englischsprachige Quellen 
berücksichtigt. Die Beurteilung der jeweiligen nationalen Situation basiert auf einer 
einzelnen Expertenbewertung (gestützt auf andere vorhandene Quellen). In dieser 
Hinsicht verfolgte die Bestandsaufnahme das Ziel, einen vergleichenden Überblick 
zugeben, welche Patientenrechte in EU Mitgliedsstaaten, Norwegen und Island 
vorhanden sind. 
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1. INTRODUCTION 
 
Patients’ rights play an important role in health system development. Initially based 
on fundamental human rights of integrity and self-determination, they are especially 
critical in the intimate context of medical care and are particularly relevant safeguards 
given the information asymmetry between patients and medical professionals. From 
the individual rights as a patient, the concept has gradually expanded to also 
incorporate the rights to become a patient (i.e. social patients’ rights) addressing 
issues of coverage, access and entitlements. More recently, we observe a further 
expansion towards “consumer” patients’ rights, which are more focused on issues of 
information, quality and choice. All in all, these various patients’ rights reflect and 
support a broader trend of patient empowerment, which aims to emancipate citizens 
who are receiving, or are about to receive, medical care, and to give them a more 
active role in decisions regarding their own care and care process1. It can even extend 
to trends of involving patients – or their patient organizations – more closely in policy 
making. 
Patient empowerment in its various forms is essentially determined at national level 
and to some extent reflects different local cultural contexts, especially when it relates 
to ethical questions, for example, related to the beginning- and end-of-life. However, 
an international dimension cannot be denied, especially because of the imperative of 
human rights, enshrined in international agreements and expectations, such as the 
Universal Declaration of Human Rights (1948) and the European Convention of Human 
Rights (1950). Through the adoption in 2000 of the Charter of Fundamental Rights of 
the European Union these fundamental patients’ rights have not only been officially 
reaffirmed and recognized as part of the universal values shared by all EU Member 
States but they must be observed in the development and application of EU law2.  
The relevance of patients’ rights for the EU, and the call for a more explicit 
endorsement of patients’ rights at that level, followed indirectly from the application of 
EU integration principles to the health sector. As early as 1984, the European 
Parliament adopted a Resolution inviting the European Commission to submit a 
proposal for a “European Charter on the Rights of Patients”, taking into account the 
freedom of establishment for doctors and practitioners of paramedical professions. In 
2002, Active Citizenship Network promoted the idea of a European Charter of patients’ 
rights in the context of increasing citizen and patient mobility and the enlargement of 
the EU. Also the further developments in EU consumer policy, and the increased 
attention to patient safety and medical liability, have stirred the debate on patients’ 
rights. With the EU’s increased focus on innovation in the fields of medicine (e.g. 
personalised medicine) and of ICT (e.g. e-health), new implications and challenges for 
patients’ rights will certainly arise, especially with regard to privacy issues. 
Developments in these areas are already seen in the recent legislative revision of the 
EU Clinical Trials regime and the on-going attempts to revise the Data Protection 
regime. However, Member States have used different routes to protect patients’ 
rights: some have chosen to express it in terms of the rights of patients; others in 
                                                 
1 See also A. Coulter, S. Parsons and J. Askham, Where are the patients in decision-making about their own 
care?, HEN-OBS Policy Brief, 2008 
2 The accession of the EU as individual party to the European Convention of Human Rights was adopted in 
2013 but still needs to undergo a long process of scrutiny and ratification.  
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terms of the obligations of health care providers. Enforcement is also carried out 
differently: in some Member States it is through the courts, in others through boards, 
ombudsmen, etc. 
With the adoption of the Directive 2011/24/EU on the application of patients’ rights in 
cross-border healthcare it may seem that patients’ rights are now fully incorporated in 
EU law. However, the Directive essentially focuses on the social and consumer 
patients’ rights in the context of cross-border health care. With the exception of the 
right to reimbursement of cross-border care, it doesn’t specify particular rights for 
patients but rather ensures that procedures and structures are in place in Member 
States to guarantee common operating principles that all EU citizens would expect to 
find (…) in a health system anywhere in the EU. For ensuring quality and safety this 
only relates to information on existing standards and guidelines3.  
On the other hand, the national contact points are expected to increase information 
flows and awareness on patients’ rights in all their facets. To increase transparency 
around patients’ rights, not only reimbursement rights but also the more classical 
patients’ rights is key. In the preparatory phase prior to the Directive, the public 
consultation clearly showed that it was not only legal uncertainty about the statutory 
coverage that prevented patients from seeking health care in another Member State 
than their own. Also the uncertainty about the non-financial conditions within which 
healthcare is provided, was considered a significant obstacle. This is why the European 
Commission in 2007 decided to take an integrated approach, also addressing the 
wider “flanking” measures and conditions necessary for citizens to have confidence 
regarding the care they would receive throughout the EU, including information, 
quality and safety, continuity of care, as well as mechanisms to ensure appropriate 
remedies and compensation in the case of harm4. 
Beyond the scope of cross-border care, Member States are facing a number of 
common challenges, which require them to pay increasing attention to the issue of 
patients’ rights: for example, the growing complexity of healthcare interventions and 
the rise in ethical questions, demographic changes with an ageing population and a 
rising burden of chronic conditions (including mental health problems), the 
prioritization of quality and safety of health care, the empowerment of citizens and the 
increased attention of cultural preferences. These elements require Member States to 
develop a coherent strategy around citizens’ and patients’ rights with respect to health 
care. 
Within this context the mapping exercise of existing patients’ rights in 30 countries 
(including the 28 EU Member States, Norway and Iceland) provides an overview of the 
various legal frameworks as well as other policy tools and mechanisms in place (or in 
the making) to define, implement and enforce patients’ rights. More particularly, the 
study has 
                                                 
3
 W. Palm and R. Baeten, The quality and safety paradox in the patients’ rights Directive, European Journal 
of Public Health, 2011, 272-274 
4 Palm W, Wismar M, Van Ginneken E, Busse R, Ernst K, Figueras J. Towards a renewed community frame-
work for safe, high quality and efficient cross-border healthcare within the European Union. In: Wismar 
M, Palm W, Figueras J,Ernst K, Van Ginneken E (eds). Cross-Border Healthcare: Mapping and Analysing 
Health Systems Diversity. World Health Organization on behalf of the European Observatory on Health 
Systems and Policies. Copenhagen, 2011: 32. 
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 Identified, analyzed and mapped national laws and other policy instruments 
(strategies, charters, etc.) that guarantee patients’ rights in all 30 countries; 
 Described and assessed structures, procedures and mechanisms that have 
been set up to enforce the patients’ rights that have been defined by the 
above-mentioned legislation (including soft-law); 
 Mapped patients’ rights that are drawn from relevant Council of Europe 
instruments and documents as well as from its institutions’ activities (incl. the 
European Court of Human Rights); 
 Drawn conclusions from a workshop discussion with experts and Commission 
officials to develop a minimum set of patients’ rights that could be defined and 
implemented at EU level.  
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2. METHODOLOGY 
 
2.1 General approach 
Before all, international comparisons and mapping exercises require a sound and solid 
conceptual framework to map and categorise various approaches and national 
strategies. This has been a first priority in this project. An exercise to map national 
approaches according to their enforceable character and type of legislation was 
already undertaken by Nys and Goffin (2011)5. This has been the basis to develop a 
more specific conceptual framework for this project, laying out the various dimensions 
in defining, enshrining and implementing patients’ rights. We discerned various 
patients’ rights aspects according to three domains: 
 Basic individual rights, such as the right to informed consent; to privacy and 
dignity; to access to the medical file 
 Social rights, such as access to health care; reimbursement; equal treatment 
 Consumer-based rights, such as to choose one’s provider, to second opinion, to 
safe and timely treatment (patient safety and quality of care) 
 
In addition, two sets of cross-cutting rights can be distinguished: 
 Procedural patients’ rights, such as the right to complain, to compensation, and 
to participate in decision-making are integrated in each of the domains because 
they help to enforce various patient’s rights 
 Informational patients’ rights, such as the right to information about one’s 
health, about treatment options, about rights and entitlements, including the 
basket of care and information about providers. 
  
 
                                                 
5 H. Nys and T. Goffin, Mapping national practices and strategies relating to patients’ rights, in Wismar M, 
Palm W, Figueras J,Ernst K, Van Ginneken E (eds). Cross-Border Healthcare: Mapping and Analysing 
Health Systems Diversity. World Health Organization on behalf of the European Observatory on Health 
Systems and Policies. Copenhagen, 2011: 159-216 
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Clearly, these different patients’ rights could not be totally separated from each other. 
Some could even be considered as ‘derived’ rights that help to implement and enforce 
other rights. For example, the right to informed consent has obvious links with the 
right to information. This right to information includes different kinds of information: 
about one’s health, about one’s rights and entitlements, about treatment options. The 
right to information in its turn is related to the procedural right of access to the 
medical file as it is an important lever to ‘enforce’ the right to informed consent. Also 
the other procedural rights to complain and compensation to some extent depend on 
the access to the medical file to prove any harm or errors. Also the right to second 
opinion can be considered as a ‘derived’ or ‘connected’ right of the right to choose 
one’s provider.   
For the sake of this mapping exercise we have focused on the patients’ rights domains 
of basic individual rights and, consumer-based rights (indicated with *), including the 
linked procedural rights that help to enforce them. The social patients’ rights related to 
coverage for health care have been left out due to the scope of this mapping exercise. 
Also patients’ rights in relation to ethical questions are not addressed in this study.  
The patients’ rights subjects under study have been clustered in the following way: 
 Self-determination 
a) The right to informed consent 
i) The right to information about one’s health 
ii) The right to participate in (clinical) decision-making /to choice of 
treatment options (*) 
 Confidentiality 
b) The right to privacy 
c) The right to access one’s medical record 
 Choice 
d) The right to choice of healthcare provider (incl. ...) (*) 
i) The right to second opinion (*) 
ii) The right to information about the healthcare provider (*) 
 Quality and safety 
e) The right to safe and high-quality treatment received in a timely manner 
(*) 
 Procedural rights 
f) The right to complain 
g) The right to compensation 
h) The right to information about rights and entitlements (*) 
 
Please find the final version of the survey template in the Annex 1. 
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2.2 Literature review and review of funded actions 
The mapping exercise included a literature review. The aim was to locate published 
information (studies, reports etc.) on areas that would benefit from greater formal 
cross-border co-operation and collaboration in healthcare provision, or information 
that would assist in developing a methodology to investigate this. 
The term cross border was included in searches in relation to quality of care; these 
only produced 8 relevant hits. For this work a search was carried out using PubMed 
and the terms health care and cross-border. Health care is used as a MESH term in 
PubMed, and includes delivery of health care, as well as the three words individually. 
Cross-border also includes “cross border” as two separate words. This search 
produced 498 hits, all of which were reviewed. In addition, searching was also carried 
out using Google Scholar and Google. These searches began with the four words 
cross, border, health and care. The types of documents included in the search results 
are peer-reviewed articles, journal entries and book chapters. The results are provided 
as tables of bibliographic information for the identified references, combining the 
results from the PubMed and Google searches. The results have been grouped into the 
following categories.  
Cross-border and inter-regional projects and studies 32 results 
Health care “tourism” – reproduction   32 results 
Health care “tourism” – other, non-specific  16 results 
Patients’ rights and legal issues    42 results 
Telemedicine, E-health, information exchange  19 results 
Trade in health services     5 results 
Other        20 results 
 
The term health “tourism” was used as it appears in a number of the results, but it 
intended to cover any travel for treatment. 
In addition, more detailed information on the state of patients’ rights in Member 
States was also made available through the Observatory’s HiT health system reviews, 
which include a special section on patient empowerment.  
The review of activities funded by the EU Health programme, the Research and 
Innovation Framework Programme and by the European Partnership on Active and 
Healthy Ageing (EIP-AHA) intended to identify funded projects and other mechanisms 
relevant to patient rights (patient rights laws, enforcement procedures and Council of 
Europe activities). Eligible activities needed to be funded in the last ten years (cut-off 
year 2005). The used search terms include “patient rights”, “quality of care”, “patient 
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safety”, “choice”, “provider”, “privacy”, “consent”, “health record”, “consumer right”, 
“indicators” and “guidelines”. The respective databases of the above mentioned 
funding mechanisms were used: 
 The Projects and Results service of FP7. FP6, FP5 linked to CORDIS 
 http://cordis.europa.eu/guidance/about-projects_en.html 
 The Project database of the Health programmes administered by CHAFEA 
 http://ec.europa.eu/chafea/projects/database.html 
 The Search form of the EIP- Active and Healthy Ageing tapping into Resources 
and Projects specifically 
 https://webgate.ec.europa.eu/eipaha/index/search 
 
2.3 Survey among national experts 
The qualitative assessment of the patients’ rights domestic situation was undertaken 
by national patients’ rights experts by means of a survey. The survey combined the 
data collection for (1) the review of legislation, (2) enforcement procedures and (3) 
the ratification status for the relevant treaties of the Council of Europe. The 
combination of the review in one survey tool has been useful, since the definition, 
promulgation and enforcement6 of patients’ rights are closely interrelated.  
The project drew on previous experience and research in this field, including the work 
done as part of the EU-funded EuroGentest project on Harmonizing Genetic Testing 
across Europe (see http://europatientrights.eu/). The network of country experts that 
was established under this project, consisting of legal experts mainly in the field of 
health law, has been reactivated successfully to respond to the new survey. Based on 
that past experience an effective exchange with the country correspondents and follow 
up has been organised. Since this type of information and the level of detail on all 
countries have not been readily available in international literature, it has been 
important for this project to rely on such a network to get the latest developments in 
the country. 
The collected data has been analysed, systematised and included in a country-by- 
country matrix, together with information drawn from other sources including 
available information and knowledge drawn from previous projects and existing 
international literature.  
 
2.4 Review of Council of Europe activities 
This review was undertaken in two ways. The Council of Europe publishes its treaties 
and conventions, extensive literature about the formal acceptance of its activities by 
its Member States, and other reports and working documents. The Activities of the 
European Court of Human Rights have similar official reports and statistics. A review 
of these official sources was the first part of this review. The second part was of the 
                                                 
6
 Some procedures of enforcement have been the object of research e.g. Mackenney and Fallberg, 
Protecting Patient’s Rights, A comparative study of the ombudsman in healthcare, 2004. 
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perceived impact of Council of Europe activities in the Member States, and this was 
surveyed by including questions in the survey among national experts about the 
impact of Council Europe and European Court of Human Rights activities in their 
countries. 
 
2.5 Workshop 
Preliminary results have been presented and discussed with a wide range of relevant 
stakeholders during a workshop on September 10th and 11th 2015 in Brussels. The 
workshop has been the occasion to test and discuss the evidence produced in the 
Tender’s work with a group of national and European stakeholders. The generated 
insights supported the definition of a minimum set of patients’ rights and their 
implementation at both national and European level. Furthermore, a number of new 
questions in connection to the mapping exercise have been raised. In order to prepare 
the discussion at the workshop a discussion paper has been prepared which 
participants have received in advance. This paper and the programme of the workshop 
are included in Annex 5 and 6. 
 
2.6 Limitations of the study 
The mapping exercise of national patients’ rights relied on a key-expert‘s review of the 
national situation with one expert providing the assessment of patients’ rights for her / 
his country. This has been refined and validated with the help of literature, if available, 
and added by a discussion of overall findings during the workshop. Nevertheless, the 
subjectivity of single answers -their attitude towards the situation of patients’ rights in 
her/ his country – cannot be disregarded and should be considered in the findings of 
the study.  
Furthermore, the rights related to social coverage for health care or linked ethical 
questions were not considered. Moreover, the review of literature included only 
English language sources.  In this regard the mapping aimed at providing a first 
comparative overview what patients’ rights are in place in EU Member States, Norway 
and Iceland. 
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3. RESULTS 
 
3.1 Patients’ rights law and enforcement –an overview 
In the following sections the findings of the mapping exercise on patients’ right in all 
Member States of the EU, Norway and Iceland are presented first – in this section per 
patient rights domain – basic individual, consumer based and procedural rights. In the 
following subsection combined findings per country are displayed. 
 
3.1.1 General context 
Gradually all Member States are developing a legal approach to defining and 
implementing patients’ rights. Only a few Members States are lacking a special law on 
patients’ rights (Austria, Bulgaria, Ireland, Italy, and Malta). However, the legal 
framework on patients’ rights usually extends beyond the scope of a single patients’ 
rights law. Other specific legal acts or governmental decisions addressing specific 
issues or aspects, the application of general principles derived from civil, criminal or 
administrative law, or even direct reference to the Constitution will complete the 
picture. Even if in most cases the adoption of a patients’ rights law meant an 
important shift towards a more patient-oriented approach, still in many cases laws 
defining the obligations of health professionals or deontological codes continue to be 
an important source for patients’ rights.  
Clearly, countries like Finland, the Netherlands and Hungary belong to the patients’ 
rights pioneers. They also represent a different approach in terms of legally defining 
and implementing patients’ rights: the nominate contract model (Netherlands), a 
special patients’ rights law with legally enforceable rights (Hungary) and the vertical or 
public model (Finland). These pioneers were followed by a next group of countries in 
the late 1990s and early 2000s, which often were inspired by the adoption and 
ratification process of the Council of Europe’s Biomedicine Convention. Among the 
most recent group of countries introducing special patients’ rights legislation, some 
actually consolidated or coordinated their existing framework (e.g. Germany, 
Denmark) while others were pushed by increased public interest (e.g. Portugal) or 
inspired by patients’ rights law in neighbouring countries (Luxembourg). 
The driving force often was the fundamental rights movements that generated from 
the societal awakening in the 1970s. This was sometimes also supported by the 
development of health law as a separate legal discipline. In some Central European 
countries the political transition in the early 1990s created a boost for patients’ rights. 
Civil society, especially patients’ organisations, played an important role in many 
countries to put patients’ rights on the political agenda (e.g. France, Romania). More 
recently, media coverage of patients’ rights violations have helped to increase 
awareness around this issue. Low sensitivity and poor knowledge among citizens, 
professionals and policy makers are reported to be one of the main stumbling blocks 
for the development of patients’ rights, together with the paternalistic model of the 
doctor- patient relationship that still subsists in several countries.  
Whereas fundamental patients’ rights seem to have become well-established in most 
Member States, this seems to be less the case for the more consumer-oriented rights. 
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They also represent a more recent trend that is inspired by an increased attention for 
ensuring quality and safety in the health sector, but also more generally for 
responsiveness and efficiency in public service provision. At least in some cases the 
development of body of more consumer-oriented patients’ rights seems to be directly 
inspired by the transposition process of the Directive 2011/24/EU on the application of 
patients’ rights in cross-border health care. 
For all types of patients’ rights alike the main problem remains the actual enforcement 
of patients’ rights. At least for six countries weak enforcement was explicitly 
mentioned as one of the main challenges (Croatia, Cyprus, Greece, Poland, Romania, 
and Slovenia). On the other hand, it seems that courts are increasingly engaging in 
this field. Also a lot of alternative enforcement mechanisms are emerging, ranging 
from monitoring bodies (Bulgaria), patients’ rights advocates (Hungary) and 
ombudspersons (Poland) to legal representation of individuals by patient associations 
(France). 
 
Impact of Directive 2011/24/EU on the situation of patients’ rights in EU 
Member States, Norway and Iceland 
The impact of Directive 2011/24/EU on the application of patients’ rights in cross-
border health care on the development of patients’ rights varies between individual 
Member States. While for some countries it may have been mainly indirect, in several 
Member States (such as Austria, Belgium, Luxembourg, Finland, Hungary, Latvia, 
Malta, Norway, Poland, Spain) the Directive has been indeed a driver for the 
development of patients’ rights, especially those that are more consumer-oriented. In 
Latvia, for instance, due to responsibilities provided by the transposition on the 
Directive, the operation of the Treatment Risk Foundation was started in October 
2013. The basic mode of operation is that the Directive pushes Member States to be 
more transparent about rights patients have. Some of the specific issues reported by 
respondents related to the application of patients’ rights in the context of cross-border 
patients are highlighted here. These cover for example informed consent and access 
to medical record possibly impeded by language problems, choice of provider and 
information for cross-border patients, procedural rights and continuity of care. 
While in many member states no specific provisions exist for cross-border patients, 
the existing laws regarding informed consent, privacy or access to the medical 
record equally apply to all health care provided on their territory. However, for some 
country respondents it is clear that the cross-border situation may require some 
special attention. Some highlight the possibility to receive an e-copy of the medical file 
for cross-border patients (Estonia, Luxembourg, Romania, Slovenia). In France and 
Norway, mandatory translating services are covered by law with regard to domestic 
and cross-border patients not able to communicate in the official language of the 
country. In the UK, NHS trusts offer on the of basis the NHS Constitution, section 3a 
on the patients’ right to information 7 either translated patient information (leaflets) or 
translation services upon request to non-native speakers. The latter often 
                                                 
7 NHS Constitution for England (2013), available at 
http://www.nhs.uk/choiceintheNHS/Rightsandpledges/NHSConstitution/Documents/2013/the-nhs-
constitution-for-england-2013.pdf 
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implemented as a telephone translation service.8 Finally, the EXPAND cross-border 
project (among others in Luxembourg) aims to make cross-border patient data 
sharing more efficient. 
Many countries foresee as a general condition to grant prior authorization for cross-
border care that the service is part of the statutory benefit basket but cannot be 
provided within medically necessary time limits. Although in principle prior 
authorization cannot be granted on the basis of quality and patient safety reasons, 
this seems to be a strong motivation for cross-border care. Although the Directive 
2011/24/EU provides for the possibility of member states to require and refuse prior 
authorization for treatment by providers who would raise quality and safety concerns, 
none of the countries except Romania seems to have actually implemented specific 
regulations in that respect. In that later respect, Romain Government Degree No 
304/2014 requests Romain citizens to obtain a document on the quality of the health 
care professional from the national contact point of the intended country of treatment 
as pre-condition to grant prior authorization. 
As a principle Directive 2011/24/EU extends patients’ choice options to healthcare 
providers in another Member State irrespective of whether or not they are contracted 
by the statutory health system in that Member State. This raises two particular and 
related questions:  
First, to what extent does this put pressure on member states to extend choice 
options and also allow reimbursement for non-contracted providers domestically? 
Indeed, several Member States signalled that in the context of the transposition of the 
cross-border care Directive private non-contracted providers were claiming “equal 
treatment” with foreign providers whose services would be reimbursed under the 
Directive even without being contracted by the cross-border patients’ health insurer. 
In Estonia an amendment to the legislation was pushed in 2013 by private providers 
that would allow patients to obtain specialist day care and inpatient care without 
waiting time from any provider while receiving full reimbursement from the statutory 
health insurance fund at a later date. Even if from a legal perspective this could not be 
sustained, the political argument was that in this way no public health insurance 
money would be exported, as otherwise patients would get the treatment in Latvia or 
Finland.  
Secondly, to what extent are member states allowed to limit reimbursement for cross-
border care to rates that are applicable to non-contracted providers? Indeed, some 
countries traditionally apply differential reimbursement for different types of providers. 
For instance, in Austria a patient who seeks treatment with a non-contracted provider, 
will obtain a lower reimbursement of 80% of the fee that would have been paid 
directly to a contracted physician performing the same service. Also in the Netherlands 
patients with an in-kind policy, which guarantees them free-of-charge health services 
from providers who have been contracted by their health insurer, can only obtain 
reimbursement at a lower level if they seek treatment from a non-contracted provider 
(Article 13 of the Dutch Health Insurance Act). Based on the so-called “hindrance 
criterium” this level should be “substantial” so that it treatment from a non-contracted 
                                                 
8 Gan, S (2012)  LOST IN TRANSLATION:HOW MUCH IS TRANSLATION COSTING THE NHS, AND HOW CAN 
WE BOTH CUT COSTS AND IMPROVE SERVICE PROVISION? Health2020.org, available at 
http://www.2020health.org/2020health/Publications/publications-2012/Translation-Services.html 
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provider remains a financially feasible option for the patient. In a written to a question 
from Dutch MEP Ria Oomen-Ruyten in September 2013 (E-010662/13) Health 
Commissioner Borg made clear that this lower reimbursement could not automatically 
apply to cross-border health services: “the application of reimbursement tariffs or 
amounts lower than those used for care received from contracted providers in the 
Netherlands would amount to a disincentive for patients to use their rights to cross-
border healthcare. It would therefore constitute an obstacle to the exercise of free 
movement, and would need to be justified with reference to overriding reasons of 
general interest. It would also need to be demonstrated that this obstacle was both 
proportionate and necessary with regard to the desired objective.” The Dutch 
government proposed to abolish the insurers’ obligation to reimburse non-contracted 
care, at least for secondary care, which would reduce free choice of provider in the 
Netherlands. In an advice to the First Chamber the highest administrative court has 
found this proposal consistent with European law, i.e. the Directive 2011/24. However, 
the amendment was not adopted in Parliament. 
Another issue is whether the absence of choice options domestically because the 
specific care or expertise is not available in the country (e.g. rare diseases) could 
justify to getting care and/or second opinion in another member state. Also the 
applicability of conditions that actually limit choice need to be questioned as to their 
conformity with EU rules, such as referrals by a domestic provider or the requirement 
that first all domestic treatment options have to be exhausted.  
The Country Expert reports show that in the area of enforcement the Directive has 
produced little specific impact. Countries all had complaint and compensation schemes 
in place, and individuals coming from outside the country are not given special routes 
to complaint or compensation. In line with the Directive, individuals seeking to use 
their cross-border rights are simply treated as ‘insiders’ for the purposes of 
enforcement.  
National Contact Points are charged with providing information to those who 
enquire about the processes of enforcement. It is clear from the country experts’ 
reports that the processes of enforcement are extremely complex in each Member 
State. In some jurisdictions, National Contact Points will be able to point to particular 
institutions within the system who have duties to assist any individual (including those 
from outside the jurisdiction) who are making complaints. This is not uniform across 
the system. It remains to be seen how far National Contact Points themselves will see 
their role in providing information as providing information not only about the specific 
enforcement rights and processes, but about the more general legal landscape that it 
is essential to know and understand to make effective complaints. For example, where 
compensation is within the general civil Law, it is necessary to understand the way in 
which the general tort of negligence operates. It remains to be seen how far individual 
National Contact Points go in providing this broad information about the national legal 
processes. 
 
3.1.2 Basic individual rights 
Self-determination and confidentiality 
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All Member States are developing a legal approach to defining and implementing the 
basic fundamental or classic patient rights to self-determination and confidentiality 
(including the rights to consent; privacy; and accessing medical records). These rights 
are embedded in several individual human rights frameworks (for example the 
Biomedicine Convention). In a way this mapping exercise concludes that we will arrive 
at a minimum set of patient rights in all 30 States. 
Despite a common base for basic individual rights, the rights to consent, privacy and 
accessing medical records are protected by multiple mechanisms in each Member 
State. The right to privacy is perhaps the most heavily protected, with strong 
penalties in many states for breaches of confidentiality and data protection. Most 
countries also have strong protections for the right to consent, with some notable 
exceptions such as Latvia. The right to access one’s medical record is also provided for 
strongly in most member states, although many respondents reported that some 
hospitals do try to limit access in practice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Despite most countries have a strong legislative basis for patients’ right to self-
determination, in some countries remain some processes which could impede the 
right to informed consent. For example, in one of the countries under study, several 
hospitals require patients to sign a “general consent form” before they can be seen 
by a doctor. Such “basic consents” actually take the form of a contractual obligation, 
meaning that a patient cannot even be admitted to a hospital without consenting in 
advance to whatever a doctor may recommend. These procedures appear to be 
incompatible with informed consent as it is normally understood. In the same 
country, patients do not have a right to different treatment options, but rather to 
“the professional choice of the physician”. Given that consent is a prerequisite to 
seeing a doctor, it is perhaps unsurprising that limits are also placed on choosing 
different options, but these facts suggest that greater emphasis on self-
determination is required in a few member states. 
 
The right to privacy is even more strongly protected than the right to self-
determination in most European countries, with various civil, criminal and 
constitutional protections in place and clear complaint and redress mechanisms, 
often via Data Protection Directorates/Inspectorates. However, there are a few 
exceptions; in some cases, an “old-fashioned” attitude to privacy still dominates 
despite new legal safeguards. In one country, there appear to be few procedures for 
safe data processing, and patients are sometimes examined in front of other 
patients, violating their right to privacy. This situation may be largely due to the fact 
that healthcare professionals remain relatively unaware of the importance of privacy 
and confidentiality. In another country, details of celebrity’s medical records are 
occasionally leaked to news media, but this represents an illegal transgression 
rather than widespread practice due to weak regulation or ignorance of the 
importance of confidentiality. 
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3.1.3 Consumer based rights 
Choice 
Choice in health care is a complex issue. It can relate to various aspects (e.g. 
provider, insurer, insurance plans). It can be modified in various ways (e.g. 
gatekeeping, financial incentives, etc.). In some countries choice is an intrinsic value 
of the health systems, in others it is more regarded as a tool to increase efficiency and 
improve quality. Countries have put in place different mechanisms to enable choice. 
The right to participate in clinical decision-making/to choice of treatment options is 
only formally recognised in Finland, the Netherlands and Norway. For the other 
Member States many respondents answer yes, but on closer look they are referring to 
the right to give or refuse informed consent. 
The right to second opinion is closely linked to the right to choose one’s provider. A 
small majority of Member States has formally recognized this right to a second 
opinion. In other Member States it is subsumed under the right to freely choose a 
physician. 
Information is key to making an informed choice about what healthcare provider to 
consult. Specific legal requirements for providing clear and objective information about 
providers regarding their performance (outcomes, quality indicators, safety standards, 
rights/fitness to practice are established in Belgium, Denmark, Ireland, Luxembourg, 
Netherlands, Norway and Slovenia but the level is varying between them. No specific 
legal requirements in the other Member States. 
 
 
  
Enabling choice through reporting on outcomes of quality of care and 
patient safety 
In order to operate provider choice patients are increasingly looking for information 
on the quality of healthcare providers. Reliable and systematic sources of 
information are still lacking in many countries. However, a number of Member 
States are starting to organise public reporting on the status of quality of care and 
patient safety to support transparency in domestic health systems. The quality 
indicators and outcomes used differ as well as the institutions that publish these 
reports. Providing transparent and reliable information on quality outcomes of 
providers is in the first place seen as a responsibility of the state. In the first place 
many countries have instituted a duty on the individual providers to inform their 
patients on their performance or aspects of it (e.g. patient safety, waiting lists). For 
instance, since 2007 all German hospitals are required to publish results on 27 
selected indicators collected by Bonus Quality System (BQS).  
But governments also invest in producing centralised and comparative information. 
In England quality outcome information is published on the NHS Choices website 
(http://www.nhs.uk/pages/home.aspx). Also the Care Quality Commission, the 
independent regulator of all health and adult social care services provided by the 
National Health Service, local authorities, and the independent sector in England, 
rates performance for every provider on the basis of 5 questions 
(http://www.cqc.org.uk/search/services/hospitals). 
         Continued on next page 
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In the Netherlands the governmental National Health Care Institute guides patients 
in their choices by providing information on quality indicators on delivery care, 
rehabilitation and hospital services (http://www.kiesbeter.nl/). Also the Norwegian 
Health Directorate takes a leading role in publishing quality indicators 
(https://helsenorge.no/kvalitetsindikatorer) and providing up-to-date relevant 
information (patient’s rights, waiting times and quality information) to patients 
about the different hospitals through the information service Free Hospital Choice 
Norway. In Sweden the National Board of Health and Welfare and the association of 
local health authorities and regions (SALAR) collaborate to develop an annual 
comparison and ranking across county councils (Öppna jämförelser), including a 
comparison of hospitals based on a composite of some 50 indicators. In Romania 
the Ministry of Health started to develop a performance ranking of hospitals in 
2011, which can be consulted on its web site. In Estonia the health insurance fund 
publishes reports on selected indicators for the main 19 acute hospitals as part of 
the Hospital Network Development Plan (HNDP) and provides information on family 
physicians’ performance. In France the National Health Authority (Haute Autorité de 
Santé – HAS) publishes a mix of yearly collected performance indicators based on 
the accreditation process (www.scopesante.fr). In Italy based on the set of 
indicators collected since 2009 by the National Health Outcomes Programme a 
public reporting system was developed late 2013 (www.doveecomemicuro.it). In 
Germany the new Institute for Quality Assurance and Transparency in Health Care 
(IQTiG) is also required to publish results of the quality assurance measures in an 
appropriate manner and in a form understandable to the general public. The 
German association of health insurance funds developed a rating system for long-
term care providers (www.pflegenoten.de).  
Despite of the progress made many of the quality reports are not updated on a 
regular basis. Furthermore, the information is not systematically available for all 
providers. This is also why the state effort is in many countries complemented by 
private initiatives. These can be in the first place patient associations or consumer 
organizations. Examples are the Belgian consumer organisation Test-Achats, which 
publishes comparative information on hospital quality (Belgium http://www.test-
aankoop.be/gezondheid/hospitalisatie) or the Dutch Patients’ and Consumers’ 
Federation which developed a patient reporting system to rate individual healthcare 
providers (www.zorgkaartnederland.nl). In Germany the private non-profit 
Bertelsmann Foundation together with the main patients and consumer 
organisation developed a healthcare provider search engine based on patient 
reporting (https://www.weisse-liste.de). Also media like newspapers and 
magazines increasingly publish comparative information on hospitals The French 
magazine Le Point (http://www.lepoint.fr/) publishes an annual ranking of hospitals 
and private clinics covers 64 medical specialties including activities such as 
psychiatry, depression or schizophrenia. Le Point’s ranking is jointly based on the 
PMSI, the Health Information System in French hospitals and a questionnaire. In 
Sweden even the Confederation of Swedish Enterprises initiated comparative 
information about providers (www.omvard.se), which is partly based on information 
collected through National Patient Surveys that are conducted every two years. 
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Second opinion 
Although patients are always free to consult another doctor to receive a second 
opinion the question whether this right should be formally recognized and covered 
under the statutory health system is less universally accepted. While in certain 
countries the right to second opinion is implicitly included in the right to choose one’s 
provider, in countries which apply some kind of gatekeeping mechanisms it requires a 
more explicit form of recognition and regulation.  In several countries the right to 
second opinion (and the assumption of related costs) is subject to strict rules and 
conditions. In general it will be subject to referral, hence the explicit approval of the 
treating physician. Sometimes it will be limited to only one referral per treatment or 
care process (Estonia, Norway, Slovenia, Spain). Certain countries limit second opinion 
to certain providers, most often public or contracted providers but sometimes even 
more restricted to providers in the same hospital (Slovenia), or specific ones listed per 
pathology (as in some Italian regions) or chosen by the treating physician (Poland). In 
some cases the second opinion can be also provided by a non-contracted provider or 
even a foreign provider (Estonia, Italy). Some countries limit the right to second 
opinion to certain conditions (Denmark, Italy, Spain, Sweden). In Denmark where 
second opinion is not formally recognized a special second opinion panel is set up by 
the Health and Medicines Authority for severely sick patients who have been given up 
by their provider. This panel will assess whether the patient may benefit from 
experimental treatment at a private hospital in Denmark or a hospital abroad. The 
decision to refer the patient to this panel is in the hands of the treating physician. In 
Italy for patients suffering from a rare disease (or for whom a suspected diagnosis of 
rare disease was made) a clinical evaluation by experts of the National Network for 
Rare Diseases is possible. If no experts can be found within the national territory - or 
if the expert’s opinion is inconclusive - scientific advice can be asked to foreign expert 
centres. 
What is the most disturbing is the high level of discretion of the treating physician in 
“allowing” the patient to exercise the right to second opinion.  In Poland the right to 
second opinion was framed as a right to appeal to a medical opinion or a medical 
decision. This medical appeal is to be filed to a Medical Commission operated by the 
Patient Rights Ombudsman office. The Commission takes a decision on the basis of the 
medical records and any necessary examination. In 2013, 28 objections were filed but 
only 2 met the formal requirements and were proceeded to the Commission. 
 
Quality and patient safety 
In contrast to the concept of a right to safe and quality treatment many respondents 
refer here to the obligation of the physician, sometimes framed as a patient right, to 
adhere to a standard of care. In many countries ‘the standard of care patients/clients 
are entitled to expect' is very broadly described in various legal acts as "meeting 
certain patients' expectation and or "adhering to the current scientific medical 
knowledge". The right is embedded in the contractual relationship between provider 
and patient (e.g. Austria), in dedicated patient rights acts (e.g. Finland, Iceland) or 
can be recognized in a set of different laws (e.g. Italy) However, this remains often 
very broad and not further specified. 
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The obligation of professionals to adhere to a certain standard of care is structurally 
ensured by the formal recognition via licensing and accreditation of healthcare 
professionals in almost all countries and to a lesser degree - but increasingly - of 
healthcare institutions (e.g. hospitals) providing care. Poland is an exception here only 
providing voluntary system of accreditation. To ensure a defined standard of care, 
continuous professional development (CPD) is mandatory in approximately half of EU 
countries for a number of healthcare professions. For physicians, mandatory CPD 
schemes have been implemented in 12 countries (UK, IRL, DE, GR, HU, IT, NL, NO, 
PL, SK, SL) and voluntary schemes in four countries (AU, BE, ES, SW).9 For the 
nursing profession found CPD is compulsory in 14 EU countries (UK, BE, CY, CZ, EST, 
FR, IT, LV, LIT, RO, SK).10 For medical specialties CPD is compulsory in 18 EU member 
states and voluntary in 13 countries. For dentists, 14 countries reported a compulsory 
CPD scheme11. None of the EU countries reported mandatory CPD schemes for 
midwives. However, the number of countries that have link the compliance with 
compulsory CPD schemes directly with the revalidation of licenses or accreditation is 
considerably lower. In many instances, the impact or sanctions following non-
compliance remain unclear. Moreover, countries differ regarding the requirements on 
CPD (number of study days/ credits in a certain period) and the specificity of 
established guidelines for CPD.12  
In addition – from a process perspective, a majority of countries operate professional 
standards and clinical guidelines whereas the use of protocols is practiced to a lesser 
extent. Reporting publicly about outcomes is practiced in Scandinavian countries 
(Denmark, Finland, Iceland, Norway, ) but not common in many other countries. 
Countries which have not stipulated patient safety and quality formally include Ireland 
and Malta.  
Implementation of patient safety and quality policies is a task often spread over 
various institutions in the healthcare sector including typically the Ministry of Health, 
professional chambers and a dedicated institute for quality. The recognition of the 
right to treatment in a timely manner, hence provisions on waiting times and list are 
to a lesser degree – compared to quality and safety - formally recognized in the 30 
countries. Among the countries addressing waiting time, some have set maximum 
waiting times whereas others only have established criteria how waiting lists need to 
be established without specifying limits.  
 
 
 
                                                 
9
 Murgatroyd, G. (2011) ‘Continuing professional development: the international perspective’ General 
Medical Council Research paper. 
10 European Federation of Nurses (EFN) (2012) ‘EFN country report on continuing professional development 
in nursing’, available at http://www.efnweb.be/wp-content/uploads/2012/11/EFN-Report-on-CPD-June-
2006-Final-rev-22-10-2012.pdf 
11 Bullock, A., Bailey, S., Cowpe, J., Barnes, E., Thomas, H., Thomas, R., Phillips, S., Kavadella, A., Kossioni, 
A., Tsiklakis, K., Karaharju-Suvanto, T.,Suomalainen, K., Kersten, H., Povel, E., Giles, M., Walmsley, A., 
Soboleva, U., Liepa, A. and Akota, I. (2013) ‘Continuing professional development systems and 
requirements for graduate dentists in the EU: survey results from the DentCPD project’ European 
Journal of Dental Education 17(sup 1) pp. 18-22. 
12 European Commission (2013). EAHC/2013/Health/07 Study concerning the review and mapping of 
continuous professional development and lifelong learning for health professionals in the EU – Final 
Report, available at http://ec.europa.eu/health/workforce/docs/cpd_mapping_annex3a_en.pdf 
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3.1.4 Enforcement and Redress 
Enforcement and redress in relation to patient rights pose a number of interesting 
questions, which emerge from the country expert reports.  
The information can be considered around three issues:  
 The legal basis for the claim. Here there is a range within the Member States. 
The range that is clear is: disciplinary action from professional regulatory 
bodies or practice licensing authorities; administrative breaches (separating 
breaches of constitutional or Human Rights Law from explicitly ‘patient rights 
Law’ breaches); civil Law issues (separating breaches of contract issues from 
tortious liability); and overtly European Union-generated rights and duties 
(separating general Law, e.g. data protection, from the specificities of Cross-
border Patient Rights as defined in the Directive.  
 The forum in which the enforcement or redress issues are addressed. The 
range here is from formal courts (including appeals to courts from more 
informal fora); Ombudsmen (both general ombudsmen and healthcare specific 
ombudsmen); Mediation councils and practices; out-of-court settlements where 
a lawyer or lawyers operate to manage settlements; Complaint procedures 
within the healthcare provider’s administrative system; Professional bodies’ 
complaints procedures; Complaint to a non-medical tribunal or authority; other 
mechanism. 
Blame free reporting system - Denmark 
The implementation of an incident reporting system in Denmark started in 2004, 
since then health personnel in hospitals can report incidents. The successful 
implementation required a change in culture among healthcare professionals seeing 
the reporting as learning opportunity rather than for victim blaming. Moreover, the 
success of the system was dependent on ensuring a blame-free environment in 
which incidents could be reported. The incident reporting system has been opened 
up to all providers in the healthcare system in 2010. From 2011 onwards even 
patients, their relatives and municipalities are now eligible to report incidents as 
well. 182 000 incidents reports from the healthcare system were entered into the 
database in 2013, of which approximately 1.5% was reported by patients and their 
families. However, because of the successful implementation of the reporting 
systems the reported number of incidents reported has increased. It is now a 
challenge to follow-up and act upon all incidents received. Furthermore, it has 
caused currently political pressure because of the perceived increased safety 
problems in Danish health care institutions putting politicians in a difficult position. 
Therefore, politicians are questioning the success of the system as numbers are not 
going down. 
European Commission (2014). Key findings and recommendations on Reporting and learning systems for 
patient safety incidents across Europe. European Commission, Patient Safety and Quality of Care working 
group. 
Torben Mogensen (2014), Reporting and learning systems, Contribution to panel discussion at Cluster 
Meeting Rome, 3rd December 2014 
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 Outcome range. Here we are concerned with the actions taken to redress 
breaches. The range here is: criminal (imprisonment and fines); professional 
disciplinary action (removal or suspension of license to practice); financial 
compensation (either based on a fault system or a no-fault system); ‘specific 
performance’ (e.g. rectification of records, corrective therapy); apology (with 
or without admission of liability); explanation; and, effectiveness measures or 
reports. 
 
Legal basis for the claim 
The biggest difference between Member States is in the basis of civil liability in tort 
Law. In the majority, the traditional basis for medical injury compensation is 
negligence, which requires the breach of a duty of care based on fault (i.e. an 
unacceptable act by the health carer or provider, an act that, for example, no 
reasonable practitioner would have done) and the establishing of a causal link 
between the action and the damages. In many jurisdictions this remains the basis of 
an action - indeed, even when alternative dispute resolution is available, in most 
jurisdictions “fault-based” negligence remains as a back-stop for determining 
compensation when other elements of the claim have been addressed. However, in 
some jurisdictions, there has been a move to compensation through “no-fault” 
systems. Here, the requirement to prove that the cause of the harm was 
unconscionable, or beyond normal or reasonable practice, is removed. The schemes 
are underwritten by insurance schemes and the only matter to be proved is the 
evidential question, ‘what happened?’ In terms of cross-border patient rights, this 
difference could be significant (especially patients coming from an expectation of no-
fault systems to a fault-based approach). 
There are a number of jurisdictions where the ‘breach of statutory duty’ is used in 
relation to the more consumer-based patient rights (e.g. rights in relation to choice) 
where the outcome is not a matter of negligence, but rather a more ‘procedural’ 
breach. These breaches are also, in some jurisdictions, addressed through breaches of 
contract Law, either between the patient and the health provider, or the patient and 
the insurer, or through Administrative Law. 
Experts did not, in the vast majority, refer to criminal sanctions (but they did not 
indicate that criminal sanctions were not available, for example, in the case of gross 
misconduct or of assault (unjustified treatment without consent). Where there is a 
general set of duties imposed by European Law without the possibility of exemption 
for breach (for example, where the MS is subject to a European Directive as is the 
case in data protection), then these can be presumed. We have rather taken the view 
in this study that criminal sanctions, unless the experts indicate to the contrary, are, 
like fitness to practice and other professional standards mechanisms, rather unrelated 
to the enforcement of patient rights for the individual patient in question. His or her 
dispute seems, in those situations, to be more the vehicle for a different journey; 
sanctions are not, except in a few cases, about helping the patient, except in the 
abstract. This leads to something that is missing in the Country reports: apology and 
explanation. It might be implied in the nature of the internal inquiries, but where there 
is fault-based compensation, it is unlikely that an apology will be quick in coming in 
the process.  
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Fora 
Again, here the back-stop position of the formal courts is not always articulated, but in 
the vast majority of the reports Civil and Administrative Courts are large players in the 
process of enforcement and compensation - particularly in relation to compensation. 
That said, it is striking how many jurisdictions use Ombudsmen for dispute resolution 
in breaches of patient rights. Ombudsmen are designed to redress something of the 
imbalance of power in a formal court setting, by ensuring that the weaker party (and 
here we assume that is the patient) is not disadvantaged by the formality of 
approaching Law and making a complaint. Whilst an Ombudsman operates within 
strict processes of administrative justice, their interaction with the patient (in this 
case) is more informal. Many jurisdictions rather limit the contribution that 
Ombudsmen make to the process, perhaps limiting them to administrative Law issues 
with administrative Law, process-based remedies. Mediation is available in some 
jurisdictions, but it does not seem to be widely employed.  
Many jurisdictions start the complaint process with an informal complaint between the 
patient and the health carer (the person or institution that has caused the alleged 
breach of duty). Then there are duties to disclose information on the carer, and there 
are duties to inform the patient, in some jurisdictions, about alternative measures. 
What is clear is that the range of fora for addressing patient rights is broad, with some 
jurisdictions opting for more patient-accessible mechanisms than others (judging from 
the comments of the experts on the effectiveness of the system). The procedures 
operated by professional bodies in their complaints fora are an issue in this aspect. 
In a large number of jurisdictions, some participant in the process is charged with a 
statutory duty to assist the complainant in his or her negotiation of the process. This 
can range from assistance with funds to pay for legal advice, to a duty on the health 
care provider to give clear information about the complaints procedures. In many 
jurisdictions, some participant has a strong duty to assist. However, it is not clear how 
this is perceived by the patient; if the assistance-giver is sufficiently independent of 
other parties in the process to allow the patient to trust the assistance. This requires 
further study, especially as the National Contact Points will be seen, it could be 
imagined, as places where at least clear explanations of the way that the system 
works can be found. A final point is that the Country Reports show that there are 
many gaps in the narratives; understandably, there are whole areas where individuals 
have simple background, cultural knowledge of the way that systems work - the 
expectations that one can have about the system, where information really can be 
found, etc. This can be described as the local dialect of the Law and patient rights, and 
it is not immediately apparent to outsiders; insiders will know the normative language 
and its context, outsiders will be lost to a very large extent.  
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Compensation and redress 
We have some details in the expert reports on financial compensation. However, this 
is an area where more detail is needed. For example, very few experts refer to 
imprisonment or fines, but we know (for example, in data protection Law) that both 
are required for some breaches. What is striking is that none of the experts referred to 
apology or explanation in their reports, but at the same time, this is often reported to 
be what patients who have suffered breaches of their rights seek from the process of 
complaint. 
Under the Convention on Human Rights and Biomedicine there are three components: 
judicial protection (including injunctive relief) (Article 23); compensation for ‘undue 
damage’ from a procedure (Article 24); and, sanctions for breaches of the Convention 
rights (Article 25). From the survey, it is clear that enforcement of rights produces a 
very broad spectrum of processes, not all of which are available in each Member 
State. 
Within this part we are concerned with Procedural Rights – the ways by which patient 
rights are protected and enforced in the Member States. We have considered this in 
two dimensions: we asked the Country Experts about the specific enforcement of the 
traditional and modern rights, and about general issues of the right to complain, to 
receive compensation, and to receive information about rights and entitlements; we 
National Agency for Patients’ Rights and Complaints - Denmark 
It is apparent from the study that there is an enormous range of mechanisms for 
patients to negotiate in seeking to enforce one’s rights or seek redress for breach of 
those rights (particularly mistake or negligence). Assistance in negotiating this wide 
range of procedures must be valuable for patients. In Denmark, the National Agency 
for Patients’ Rights and Complaints provides this level of service. 
It has four principle responsibilities: 
 to provide “a single point of access for patients who wish to complain about 
the professional treatment in the Danish health service”; 
 to deal “with complaints about the disregard of patient rights and complaints 
about the Patient Insurance Association’s decisions over compensation”; 
 to provide “for the administration of the system for reporting inadvertent 
incidents within the health service, and helps to make sure that the 
knowledge gained from these incidents and patient and liability suits is used 
preventatively”; and, 
 to offer “guidance on rights to healthcare in other countries in accordance 
with Danish legislation, EU regulations and other international agreements”. 
(from homepage of website) 
 
http://www.patientombuddet.dk/?sc_lang=en 
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have then considered these issues within an analytical framework of the legal basis of 
the mechanism, the fora within which they operate, and the range of redress that is 
available. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
General Context 
This mapping exercise considers the enforcement mechanisms in the abstract – i.e. 
not how they are applied in practice (how discretions are used or the standards of 
evidence that are required for a successful complaint or action, or whether the system 
is adequately funded to make it available to patients) but the range of possibilities 
that are available in the Law. In this General Context section, it must be stressed that 
not all the mechanisms described occur in each jurisdiction.  
Legal bases range from sanctions in the Civil or tortious liability for compensation is 
seen through either a no-fault approach, or a fault- or negligence-based system. 
Administrative or constitutional Law (including human rights Law) is also used as the 
basis for an action, with redress being available either through the formal court 
structure or through more informal ‘ombudsmen’ or other tribunals. It is interesting 
that the Directive on Cross-border Patient Rights does not of itself create legal bases 
for redress, although in a number of jurisdictions the National Contact Point is 
indicated as a procedural route. The fora that are available to address breaches of 
patient rights are from the formal to the informal. Criminal, civil, administrative and 
constitutional courts are possible forums for complaint, as are professional ‘courts’, 
ombudsmen and tribunals. In the first instance, however, a complaint will be made to 
the health care provider, be that the professional directly dealing with the treatment 
A new model for redress: separating redress and professional liability - 
Austria 
Since 2001 an additional redress model for patients has been in introduced in 
Austria. On the background that the legal practice shows that the enforcement of 
indemnity claims may take years of court proceedings and is often difficult for 
patients because the burden of proof lies with the patient. 
In cases where redress linked to the liability of professionals and providers is not 
possible, because evidence for the harm caused by a provider is hard to establish, a 
fund for redress of harm has been established. The fund is financed by patient fee 
per day of hospital stay and is administered by the regional patient advocacy and an 
independent commission decides on redress for individual cases. There is an overall 
limit of approx. 22000€ for redress from the fund in individual cases.  
The new model is an addition to the existing system and patients are supposed to 
investigate if the existing civil law measures for redress are deemed to be 
successful. Only, in cases where this seems not promising, a petition to the fund 
may be successful. However, a redress from the fund does not bar patients from a 
civil law process. There is no legal claim to redress from the fund. 
NÖ Patienten-und Pflegeanwaltschaft (2001). Rechtliche Informationen 2001-06-29 - Entschaedigung 
nach Behandlungsschaden. St Poelten, Austria: NÖ Patienten-und Pflegeanwaltschaft 
Study on Patients’ Rights in the European Union - MApping eXercise 
40 | P a g e  
 
or the institution within which the care is provided. Here, a range of dispute resolution 
mechanisms is used, again with varying degrees of formality. At this general level, 
however, it is very interesting to see that two of the key elements that patients 
making a complaint might want to see are not present in the patient rights legal 
landscape: explanation and apology. 
Sources of the Law differ between jurisdictions. A large number of Member States 
have specific patient rights legislation containing the right to complain. Equally, many 
use general Laws relating to compensation, or the general tort Law system to find a 
solution to the complaint. This relates most obviously to quality of care issues, and the 
long-established area of medical negligence – areas that have a physical or 
psychological damage. What is not as well established is redress for a breach of a right 
per se. This diversity in approaches to procedural rights within each jurisdiction that 
ensure the patient’s ability to complain and ‘manage’ any adverse effects of their 
treatment, and that could make complaint difficult and unpredictable, is amplified in 
the cross-border situation. Take for example, the enforcement of the right to informed 
consent. 
From the Country Correspondent reports, there are many Member States where the 
full range of legal remedies and mechanisms is available to a patient, i.e. the patient 
can pursue his or her complaint through the criminal Law, the civil Law of Tort 
(medical liability), through a parliamentary or health Ombudsman, and/or through a 
professional hearing (or that their complaint could initiate a professional action as 
well), and that this process might be started through an informal complain made to 
the health carer or the institution, or to other bodies (Austria, Hungary, Italy, 
Netherlands, Portugal and the UK). In other jurisdictions, the expert reports that there 
are no specific procedures for informed consent, but that the general Law applies, 
which could mean that all the above actions are available (Iceland, Latvia, Lithuania, 
Luxembourg, and Slovenia). In Germany, only the criminal liability was mentioned, 
whereas in other jurisdictions, the criminal Law was not mentioned, only the general 
civil Law (Belgium, Croatia, France, Norway, and Poland). It should be noted that 
there are variations within this civil liability. For example, the experts from Belgium 
and Sweden pointed to the difficulty in making a medical negligence claim for breach 
of informed consent regulations, and Estonia indicated that the burden of proof was on 
the patient. Some experts indicated the role of a National Agency for Patients’ Rights 
And Complaints (Denmark), an Office of Patient Rights (Greece), Malpractice 
Commission (Romania), or Health Care Surveillance Authority (Slovakia). What was 
particularly interesting in the context of the survey being about Directive and cross-
border patient rights, no expert mentioned the role of the National Contact Points in 
this context. Further, no expert discussed how rules of which Law and which forum 
would apply in the international context. 
What is clear is that a patient coming from outside a Member State will have a 
complicated and culturally different (often almost opaque) system to consider. It is 
unclear how far this will act as a barrier to deciding to use rights to cross-border 
treatment under the Directive, but it certainly raises the question of how far 
harmonization of processes, or at least a strengthening of the role of the National 
Contact Point.  
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Dissemination and Communication of Patient Rights: The NHS Constitution 
and Handbook – the UK 
The National Health Service has been an iconic feature of UK life since its inception 
in 1948. However, its universal, free at the point of use, approach perhaps did not 
articulate the underpinning rights of patients. This was to a very large extent 
remedied with the publication of the “NHS Constitution” with the accompanying 
“Handbook to the NHS Constitution”. First published in 2012 and revised in 2015, 
the Constitution is designed with the following in mind: “The aim of the Constitution 
is to safeguard the enduring principles and values of the NHS… It is intended to 
empower the public, patients and staff by setting out existing legal rights and 
pledges in one place and in clear and simple language” (Handbook, p. 3) It outlines 
“rights”, “pledges” and “responsibilities”; the “legal obligations” that patients (and 
staff) have, the “ambition” of the NHS beyond the legal obligations, and the 
“expectations of how patients, the public and staff can help the NHS work effectively 
and ensure that finite resources are used fairly” (Handbook, p. 4). 
This is can be seen as an important change in the NHS. The Constitution is written 
in plain English, and covers in 16 pages only, all aspects of NHS Patient Rights. It 
starts with the guiding principles of the NHS, particularly the expectations of 
professionalism and patient-centricity; the values that underpin the conduct of the 
NHS, including partnership with the patients, respect and dignity, equality, empathy 
and the commitment to “improving lives”. Thereafter, it outlines access, privacy, 
choice, patients’ responsibilities, and the rights and pledges (and expectations) 
relating to NHS staff. It includes aspects of enforcement. It concerns both the 
traditional rights and the modern rights. 
Alongside the NHS Constitution is the Handbook. This articulates in much greater 
detail the legal bases of the rights, pledges and responsibilities - in some 156 pages. 
It gives the principles that are clear in the Law, and discusses where they are more 
aspirational or not fully clear. It articulates policy, and it seeks to flesh out the areas 
that are issues of practice, discretion or debate. 
http://www.nhs.uk/choiceintheNHS/Rightsandpledges/NHSConstitution/Pages/Overview.aspx 
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Lay summaries of patients’ rights law – the Netherlands 
Dutch patients’ organisations such as the Patient federation NPCF 
(https://www.npcf.nl/) and Zorgbelang Nederland (www.zorgbelang-nederland.nl) 
publish on their websites lay summaries on patients’ rights in the Dutch context. The 
summaries include easy understandable information using short and practical 
relevant information – sometimes with the help of examples - on a number of 
patients’ rights domains such as: 
 rights of information 
 informed consent 
 right to free choice of provider 
 right to confidentiality  
 right to privacy 
 right to access the medical file 
 right to complain 
 right to second opinion 
 duties of patients 
In addition to the short information provided on the websites the NPCF produces 
downloadable brochures with more extensive information. More information (in 
Dutch) can be found at the organisations websites. 
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3.2 Patients’ rights law – a country-by-country review 
 
AUSTRIA 
General context 
A comprehensive patients’ rights law is lacking in Austria. The general approach taken 
is rather a political one. Non-binding Patients’ Rights Charters are established through 
agreements between the Federation and individual Federal States. Nine Federal States 
have so far concluded such agreements: Burgenland, Carinthia, Lower Austria, Upper 
Austria, Salzburg, Styria, Tyrol, Vorarlberg and Vienna. Enforceable patients’ rights 
arise from several other legal provisions: constitutional, civil, criminal or 
administrative laws, including laws regulating different professions in the healthcare 
sector. Also court decisions play an important role, especially national supreme court 
decisions relating to rights and duties arising from the treatment contract (specifically 
relating to informed consent). Together with the international movement on patients’ 
rights, they have been a major driver for their development. On the more-consumer 
oriented patients’ rights, the high degree of fragmentation (including the division of 
powers between the Federal and State level) as well as the lack of transparency has 
hampered its development and enforcement. It also doesn’t fit with the more 
traditional approach to health care.  
Self-determination & confidentiality 
The right to consent is recognized in the Austrian constitution and specific provisions 
in civil and criminal law, and is also regulated by administrative laws. The duty to 
inform has been further specified in several Supreme Court decisions. Written consent 
is not required except in specific cases (such as IVF treatment). Consent to a 
treatment contract and consent to treatment are treated separately.  
Patients have a right to information on different treatment options and can choose not 
to be informed about certain information. There are no specific duties to cross-border 
patients. In terms of enforcement, criminal, civil and administrative court proceedings 
can be initiated. 
The right to privacy recognized in the constitution and Data Protection Act, and 
specific provisions in civil and criminal law; it is also regulated by administrative laws. 
Exceptions to this right apply in certain cases (such as public interest). The Health 
Telematic Act imposes strict provisions on exchange of electronic data, which also 
apply to cross-border patients. Criminal, civil and administrative court proceedings can 
be initiated if right is not respected. 
The right to access records is well-established and recognized in constitutional, 
administrative and civil law. Rights in this area were strengthened via the Electronic 
Health Record Act (2012). Enforcement of this right is via a breach of contract claim.  
Quality & safety 
The right to safe and quality treatment in a timely manner is part of the treatment 
contract and as such implemented in civil law. Healthcare professionals have the 
obligation to provide treatment in compliance with the current international state of 
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science. Limitations on treatment to be provided are implemented in social security 
law. Treatment of patients has to be adequate and appropriate, but shall not exceed 
what is necessary. This right is content of the treatment contract and as such can be 
legally pursued in case of any breach quality assurance responsibilities in the 
healthcare sector. 
Besides, there are public funding and private activities aiming at increasing patient 
safety in practice. E.g.: the Austrian Platform for Patient Safety 
There is no regulation regarding acceptable waiting times. However, federal states 
have to implement transparent waiting list regimes for elective operations and 
invasive diagnostics in case of waiting times of more than four weeks. Patients have 
the possibility to address Patient Ombudsmen or in case of damages patients can 
initiate court proceedings. 
Prior authorization for cross-border healthcare in order to receive the (full) amount of 
domestic treatment costs (not only 80 %) has to be granted, if the person is entitled 
to domestic social security coverage and if treatment in Austria cannot be provided in 
due time. Prior Authorization can then still be rejected, if this treatment abroad would 
mean a significant risk to the patient or to public health or if there are severe concerns 
for patient safety due to a low standard and quality of treatment. 
Choice 
Free choice of providers and unrestricted access to all care levels (general 
practitioners, specialist physicians and hospitals) are characteristic features of the 
Austrian health care system. This right is part of the general rules regulating the 
treatment contract. Every patient has the right to choose his or her treating physician 
or hospital, provided there is free capacity. According to § 145 (1) Social Security Act 
patients’ preferences have to be respected to the extent this is in line with the 
patient’s specific condition and as long as this choice does not cause any additional 
social security costs. If the patient chooses a non-contracted provider reimbursement 
will be lower (80% of the fee that would have been paid for a contracted physician 
performing the same service). Within public hospitals only first-class patients or 
patients with additional private insurance can choose their treating physician, although 
the Constitutional Court started this would be against the constitutional principle of 
equality (Art. 7 B-VG - Austrian Constitution).  
To choose a healthcare provider patients can rely on various sources, such as a 
hospital directory developed by Gesundheit Österreich GmbH (GÖG) 
(www.spitalskompass.at), the Arbitration Boards of the Medical Chambers of the 
Federal States (http://www.aerztekammer.at/) or patients’ ombudsmen or 
representatives (“Patientenvertretungen”), organized by Federal States. There are no 
systematically produced quality reports available to assist patients in their choice of a 
physician. A specific legal requirement for providing transparent information about 
quality of care or performance of individual healthcare providers is lacking. The Health 
Ministry’s Health Portal or the Hospitals Directory only report on minimum numbers of 
interventions in particular specialties or publish quality reports by individual hospital 
operators. Hospitals also don’t systematically publish their waiting lists. Since 2011 
the Federal Hospital Act obliges federal states to implement transparent waiting list 
regimes for elective operations and invasive diagnostics in case of waiting times of 
more than four weeks. In some federal states only patients on waiting lists are entitled 
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to receive this information. As to prices, hospitals have to provide transparent 
information only if there is uncertainty about social security coverage. The Federal 
Hospital Act and Physicians Act were amended as a result of the implementation of the 
Patients’ Rights Directive.  
There is no formal legal right to second opinion but all contracted physicians (GPs and 
specialists) can be accessed by patients free of charge without needing a referral. 
Referral is only required to receive radiological examination or laboratory diagnosis. 
 
BELGIUM 
General context 
With the law of 22 August 2002 on the rights of the patients a legal approach has 
been taken in Belgium, based on a contractual relation between the patient and 
provider. It is mainly focused on traditional patients’ rights as it generated from the 
discussion on the ratification of the Biomedicine Convention in the 1990s. Only in 2014 
a right to receive limited information about the healthcare provider (insurance and 
registration status) was included, also under impulse of the patients’ rights directive. 
For its enforcement, patients are referred to the classical liability procedures (civil; 
criminal, disciplinary).  
Self-determination & confidentiality 
The right to consent is stipulated in Article 8 of the Patient Rights Law. Written 
consent not usually required, and presumed consent is permitted in emergency 
situations. The Patient Rights Law makes a distinction between info concerning 
patient’s health status and information given in order to gain consent, but in practice 
this distinction is not often made. Information on alternative treatment options must 
be provided and a right not to know exists, with some exceptions. There is no formal 
entitlement to shared decision-making, and there are no provisions for cross-border 
patients. The main current issues are a move from ‘normal and foreseeable’ risks to 
‘relevant risk’ theory. In terms of enforcement, the PRL provides no sanctions when 
the right to consent is not respected, meaning that medical liability is the only avenue. 
The right to privacy is also protected in Patient Rights Law, as is a right to protection 
of intimacy. There is a very important legal obligation to protect privacy, which is 
enshrined in Criminal Code (with exceptions). There are no specific duties to cross-
border patients, and no particular evidence of use of this right in practice. 
Patients have a right to access medical record within 15 days, which is also provided 
for via the Patient Rights Law. This right is not intended to satisfy information needs, 
but only to facilitate access in order to protect privacy. No provisions for cross-border 
patients. 
Quality & safety 
The patient has the right to receive high-quality health care that meets his or her 
needs, with respect for his or her human dignity and his or her self-determination, and 
without any discrimination on any grounds whatsoever. The precise implication of the 
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expression ‘high-quality health care’ is further explained in the explanatory 
memorandum, requiring a physician to act according to ‘the applicable standards and 
the current state of scientific knowledge’. The applicable standards refer, among 
others, to guidelines and protocols set up by the medical profession.  
Article 20 of the Hospital Law requires that the quality of the medical activity in a 
hospital be evaluated. The medical department heads are required to cooperate with 
the medical director in carrying out quality assurance activities. Each health care 
institution in Flanders (general hospital, psychiatric hospital, rest and nursing home, 
and centre for mental health care) must implement a quality policy by establishing a 
quality manual and quality plan. The quality manual describes the vision and objective 
of the internal quality policy. This manual is translated into a quality plan that includes 
a description of the existing situation and operational objectives concerning specific 
areas imposed by the government.  
The law regulating the practice of the main health care professions (the so called 
Royal Decree n°78) only allows the practice of these professions to persons who have 
obtained a given university degree together with a registration of this degree (visum) 
by the ministry of health. In 2007 the federal ministry of health launched a first multi-
year plan on quality and safety. The current multi-year plan came into effect in 2013 
and will run until 2017. This plan encourages hospitals to introduce improvement 
measures in four areas: ‘high risk’ medication; safe surgery; identity vigilance and 
transmural care.  
Neither legal rules nor guidelines in Belgium exit on timely treatment. 
The prior authorization has to be refused by the advisory physician of the competent 
sickness fund when after a clinical evaluation it appears with reasonable certitude that 
the patient would be exposed to a patient-safety (including healthcare provider) risk 
that can be considered as unacceptable, given the possible benefits of the cross-
border treatment. 
Choice 
Article 6 of the Patients’ Rights Law (PRL) states that a patient has the right to freely 
choose and change his or her healthcare professional, except for some restrictions in 
cases determined under the law (e.g. prisoners, mentally ill patients admitted against 
their will etc.). It applies to all types of providers. No referral is needed to see a 
specialist. However, since 1999, financial incentives have been introduced to 
strengthen the position of the GP as the preferred entrance point. For consultations 
with the GP who holds the global medical file, the patient’s co-insurance is reduced by 
30%. Also an increased reimbursement applies for the first visit to a specialist if 
referred by a GP (up to the preferential reimbursement rate). In hospitals, the choice 
may be limited in practice (in some specialties). Also the choice for certain doctors 
may entail higher user fees. The right to second opinion follows naturally from the 
freedom of choice. 
Information to patients about providers mainly comes from sickness funds and 
patients’ associations. Based on the right to informed consent contained in Article 8 
PRL patients have to be informed about the financial consequences of any decision. 
Following the implementation of the Patients’ Rights Directive providers also have to 
inform patients about personal or collective protection with regard to professional 
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liability (Art. 8/1) as well as on their authorization or registration status (Art. 8/2). 
Too little information about the quality of care is available to the patients to help them 
in their choice. Based on the Flemish Indicators project hospitals can on voluntary 
basis post information on five relevant quality criteria on their website. No specific 
obligation exists about information on waiting times. 
 
BULGARIA 
General context 
Patients’ rights in Bulgaria are still rather in the stage of awareness raising. There is 
no special law on patients` rights. However, in 2009 the Public Council on the Rights 
of the Patient was established, an advisory and monitoring body that is to monitor and 
analyse all activities related to patient rights and support the development of patients’ 
rights legislation.  
Self-determination & confidentiality 
The right to consent is protected by Article 88 of the 2004 Health Act. Consent is 
normally verbal, and patients have right not to know, with some exceptions. Patients 
have a right to information on planned treatment and alternatives. No cross-border 
patient provisions. In terms of enforcement, the Medical Audit Agency imposes fines 
and guilds have competencies. 
The Health Act recognizes a right to privacy, which is also enshrined in Art 145 of the 
Criminal Code. Information can only be shared where treatment is continuing at 
another hospital, where there is a threat to the health of another person, of for 
various forensic, statistical or public health reasons. No specific cross-border patient 
provisions exist. Enforcement works via obligations and contracts act. 
Patients can access records via medical personnel; there are no electronic records, 
though lab results can be obtained over the internet. There are no cross-border 
patient provisions, and enforcement is via the Administrative Law. 
Quality & safety 
The Bulgarian Constitution guarantees availability of medical help by right of health 
insurance and free medical aid, regulated governmental control over health-care 
activities, the production of pharmaceuticals, bio materials and medical devices. The 
implementation of the constitutionally stated governmental control are regulated by 
special laws introducing licensing and registration regimes for carrying out medical 
activities, retail and wholesale of drugs  
There is a licensing regime on medical institutions under Medical Institutions Act 1999. 
The act defines the types of hospitals in the country and their commercial and 
administrative law status.  
An example how the right to safe and quality treatment received in a timely manner is 
exercised in practice is challenged provides a judicial decision of the Court of EU. Case 
C-173/09, Georgi Elchinov v. National Health Insurance Fund. 
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Choice 
Bulgarian citizens have are free to choose their general practitioner, specialist, 
diagnostic laboratory and hospital without territorial restrictions. However, in order to 
benefit from social coverage, the provider needs to be contracted. Also referral from 
their GP or a specialist contracted by the National Health +Insurance Fund (NHIF) is 
required to access specialized outpatient or inpatient care. Only mothers are free to 
choose a paediatrician for their children and a gynaecologist for themselves without 
GP referral. In hospital patients can only choose their treating physician if they are 
willing to pay extra. Similarly, the right to second opinion only exists for patient who 
can afford to pay out of pocket.  
Information about health providers’ accreditation assessment is available on the 
Ministry of Health web page. The NHIF is obliged by law to provide information to the 
insured about contracted health care providers and pharmacies. Citizens can receive 
up-to-date information through their regional offices as well as municipal offices. 
However, the information policies of both the Health Ministry and the NHIF have been 
assessed as insufficient, especially on the scope and quality of health services. 
 
CROATIA 
General context 
Croatia has long tradition of medical and law science favouring a human approach of 
physicians towards patients (cf. Andrija Štampar). It developed a comprehensive legal 
framework for the protection of patients’ rights. Next to a special patients’ rights 
Protection Act (2004), various other acts guarantee patients’ rights, including 
regulations regarding the medical profession, e.g. the Medical Practice Act and Act of 
nursery, the Code of medical ethics and deontology. Apart from the criminal act that 
contains provisions about malpractice, enforcement is a weak point. The Patients’ 
Rights Protection Act is foreseeing the establishment of a commission for the 
protection of patients` rights. Within civil society the Croatian Association for the 
Promotion of patients’ rights is pushing for the further improvement of patients’ rights.  
Self-determination & confidentiality 
Rights to consent, to information and to participation in decision-making are all 
enshrined in the Patients` Rights Protection Act. Law stipulates that written consent 
should be given, but in practice it can be given verbally and lack of written consent is 
does not prove that consent was not given. Information should cover the following: 
“health condition, including medical evaluation of income of certain diagnostic or 
therapeutic procedure, recommended medical examination and procedure and date 
when they can be done, possible advantages or risks of performing or avoiding certain 
medical examination or procedure, right to decide on certain medical examination or 
procedure, possible alternatives on recommended medical procedures, course of 
health care proceeding, further health care proceeding, the recommended way of life, 
[and] rights and procedure for exercising their rights from health insurance.” No 
specific duties for cross-border patients exist but Croatia has implemented Directive 
2011/14 EU, meaning that discrimination against foreigners is forbidden. Enforcement 
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or rights is via the Civil Obligations Act and the Patients` Rights Protection Act. 
Physicians can also be brought before the Croatian Medical Chamber. 
The right to privacy is stipulated in Articles 4, 25 and 28 of the Patients` Rights 
Protection Act, Article 1 of the Law on Protection of Personal Data No specific duties 
for cross-border patients, Article 21 of the Medical Practice Act, and Article 2 of the 
Code of Medical Ethics and Deontology. 
Right to access record protected by Article 23 of Patients` Rights Protection Act as 
well as in Article 23 of Medical Practice Act and Article 29 of Dental Practice Act. 
Access via help of staff. No specific cross-border provisions exist for patients. 
Quality & safety 
Every patient has an equal right to quality and continuous health care appropriate to 
his state of health in accordance with generally accepted professional standards and 
ethical principles (Article 2 of Patients` Rights Protection Act). The Inspectorate of the 
Ministry of Health is the main body responsible for implementation of patients` safety 
and quality policies. Waiting lists and waiting times are defined by Ministry of Health; 
maximum waiting times vary. Also there is a system of prioritization for specific 
treatments.  
Choice 
The patients’ right to choose freely their healthcare provider (medical doctor and 
dentist) is formally recognized by Article 22 of the Health Protection Act. There are no 
restrictions in terms of geographical area or financial status. However, patients need a 
referral from a GP to access specialized care either in- or outpatient, except for 
gynaecologists and paediatrician. Also the right to second opinion is recognized and 
stipulated in Article 10 of Patients` Rights Protection Act.  
Various actors provide information about available providers and treatments, including 
the Croatian Institute on Public Health, the Health Insurance Fund, the Ministry of 
Health as well as patients’ associations. Each health care provider is responsible for 
providing information about performance, waiting lists and prices. The introduction of 
a new performance-based payment system and the development of an e-health 
information system (including e-waiting lists) since 2012 is expected to improve the 
situation and even provide comparative information on providers.  
 
CYPRUS 
General context 
The legal framework on patients’ rights in Cyprus consists of a law on the 
safeguarding and the protection of the rights of patients (2005). It includes 17 
patients’ rights and a mechanism for monitoring and resolving patients’ complaints 
about patients’ rights violations. In addition, other guarantees are found in other legal 
provisions contained in the Constitution, the personal data protection law, etc. 
Although patients’ rights are considered an essential element for ensuring the quality 
of health care, there are no special provisions on more consumer-oriented patients’ 
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rights, but Contract Law provision could be used for that purpose. Respect and 
enforcement of patients’ rights still remains an important challenge. This is also 
related to the subsisting patriarchal doctor-patient relationship in Cyprus that 
translates into relatively low awareness and sensitiveness levels among citizens. 
However, the 2001 “Charter on the Rights of Patients” that was produced by a 
Patients’ Rights Movement NGO (KIDDA) and the ratification of the Biomedicine 
Convention in 2002 contributed to the development of patients’ rights legislation.  
Self-determination & confidentiality 
The right to consent is recognized in Article 11 (1) of the Patient Rights Act. The 
Processing of Personal Data (Protection of the Individual) Law of 2001 
(138(I)/2001)13and The Law about the Removal and Transplantation of Organs of 
Human Origin 2012 are also relevant. Consent can only be given orally if thereafter 
provided in writing as soon as possible, and can be presumed in cases of incapacity. 
Patients must also be given information in written form, also concerning specific risk 
information on different treatment options. Patients have a right not to know. No 
specific right to participation, but the role of the patient has been enhanced under the 
Patients’ Rights Act. No specific cross-border patient provisions, but the Patient Rights 
Act provisions can be seen as covering these. The Cross-Border Health Care Law also 
protects the right to information. 
The right to privacy recognized in Article 16 of the Patients’ Rights Act, which states 
that “no intrusion is permitted on the private and family life of the patient without the 
patient's consent unless, this is necessary for diagnosis, treatment or care.” (This is a 
rather wide exception.)  The right to privacy and family life is embedded as a broader 
right under Article 15 of the Constitution of the Republic of Cyprus. The right to 
medical secrecy also protected by the Patient Rights Act, with some exceptions. Data 
is protected by the Processing of Personal Data Act. The Cross-Border Health Care Law 
protects the privacy of cross-border patients. The Patients’ Right Act (Articles 17 and 
18) protects the right to access records “within a reasonable time”, with no specific 
cross-border patient provisions. 
Quality & safety 
Every patient in Cyprus shall have the right to health care, appropriate to the needs of 
his health to be provided within a reasonable time according to those needs: Provided 
that, in the case of a medical emergency the patient shall have the right to receive 
urgent health care unconditionally. Also Article 4(2) stipulates that the patient shall 
have the right to receive good quality health care, characterized by high technical 
standards as well as human relations between the patient and the health care services 
provider. 
With regard to health care providers each group/type has their own regulations 
regarding the process of application, qualifications and renewal of their license. The 
Ministry of Health has launched a plan on quality assurance and within that framework 
of quality assurance programme each hospital introduces its own procedures and 
policies. The plan on quality assurance aims to identify areas for improvement, 
formulate guidelines for best practice and evaluate the delivery of care. The Ministry of 
                                                 
13 http://www.cylaw.org/nomoi/enop/non-ind/2001_1_138/index.html 
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Health has established a quality assurance committee, the National Committee for 
Quality Assurance and Risk Management, which includes representatives from all 
branches of the Ministry of Health. It envisages a process whereby all hospitals in 
Cyprus would be accredited with an international body, and has developed an action 
plan to strengthen quality assurance in all health facilities. In the private sector almost 
all Private Hospitals/clinics have acquired ISO 9001:2008 which concerns the Quality 
and Safety of Services for patients.  
Choice 
According to Article 4.5.a Patients’ Rights Act The patient shall have an inalienable 
right to choose and to change the medical institution or health care services provider, 
provided that this is compatible with the functioning of the health care system. Choice 
under the public system is limited to providers employed under the public sector14. 
There is no strict gate-keeping or referral system but in practice, long waiting lists 
implicitly limit public sector access, even though the law stipulates that health care is 
to be provided within reasonable time (Article 4.1). Private patients can access any 
doctor at any time but their private health insurance may impose specific conditions.  
The right to choice is supported by both the right to information (Article 10) and the 
right to second opinion (Article 10.7). Providers are obliged to respect this right and 
provide any reasonable assistance, such as providing a copy of the patient’s medical 
record. Upon admission patients have to be informed about the identity and 
professional position of every person providing health care to him, as well as the 
regulations regarding the conditions and procedures of stay and provision of health 
care in the institution (Article 8.a). Also the Pancyprian Medical Association 
(http://www.cyma.org.cy/) provides information about the specializations of each 
doctor and whether they have renewed their professional license, including 
information about CME status. Information about performance is not kept 
systematically and not officially available. Also information on waiting times is lacking. 
Prices applicable in the private sector are at the discretion of each doctor (Art. 16-18 
Regulations of Medical Profession Deontology).  
 
CZECH REPUBLIC 
General context 
The main source for patients’ rights in the Czech Republic is the Special Act no. 
372/2011 Coll. on Health Care Services. Other specific patients´ rights are included in 
special laws like the Act no. 373/2011 Coll. on Specific Health Care Services. The legal 
approach is the result of a process that started after transition in the early 1990s. 
Judicial decisions as well as the adoption of the Oviedo Convention have contributed to 
strengthening patients’ rights. 
 
                                                 
14 According to plans for the future introduction of the universal General Health System (GHS) patients 
eligible for low cost health services will be allowed to choose their own doctor no matter if the doctor is 
employed by the public or private sector. 
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Self-determination & confidentiality 
The right to consent is enshrined in Oviedo Convention and also in the Act no. 
372/2011 Coll. on Health Care Services. Verbal and implied consent are sufficient 
legally, but written consent is normally sought by providers. Civil Code states that in 
situations where written consent is not prescribed, “it is presumed that consent was 
given.” Information should be provided regarding diagnosis, prognosis, risks and 
benefits of proposed treatment, information of alternative treatments. There is right 
not to know, with exceptions. No provisions for cross-border patients. Enforcement 
operates via claims for moral damages. 
Right to privacy also protected by the Act on Health Care services, as well as the 
Oviedo Convention and also in the Ethical Code and Disciplinary Code of the Czech 
Medical Chamber. Enforcement is ensured via civil, administrative, criminal and 
disciplinary laws. No specific CBP provisions. 
Right to records also protected by Convention and the Act on Health Care services. 
Access is free and should take place in presence of staff. No cross-border patient 
provisions. Enforcement ensured by the Office for Personal Data Protection. 
Quality & safety 
Right to safe and quality treatment received in a timely manner is formally recognized 
partly in the Oviedo Convention. There is a mix of approaches to ensure patient safety 
in the Czech Republic. Some of them are formal and obligatory: the process of 
authorization to provide health care services by Regional Offices and MoH; the control 
of providing health care services provided by Regional Offices and MoH or the special 
administrative control in specific areas e.g. by State Institute for Drug Control. Some 
of approaches are not obligatory but can be formal, i.e. certification (e.g. ISO) and 
accreditation by accreditation agencies. And some of approaches are informal like 
publishing of guidelines adopted by professional associations.  
Accessibility of medical care in time and in region is regulated by Governmental Order 
no. 307/2012 Coll., on Regional and Time Accessibility of Medical Care. The 
government can, in the form of Governmental Order, define paid cross-border services 
which need previous authorization. Patients can take civil action, can complain to 
administrative bodies, when there is serious breach of duties, also penal proceeding 
can be applied. 
Choice 
The rights to free choice and to second opinion are both formally recognised in §28 Act 
n° 372/2011 Coll. on Health Care Services. In principle, Patients can freely contact 
any health care provider, GP, specialist, hospital etc., although some limitations exist 
for seeing a provider not contracted by the patient’s health insurance fund. Patients 
register with a primary care physician of their choice, but can switch to a new one 
every three months without restriction. Patients are free to obtain care directly from a 
specialist of their choice without referral, even though it is not recommended that they 
do so. In contrast, a patient is admitted to inpatient care only and exclusively upon 
referral from a physician (except in cases of medical emergency). 
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There is no central point for patients to obtain information in order to choose a 
provider. Information comes mainly from the Ministry of Health and Regional Offices. 
Providers have a duty to publicly inform about identification of health care facility, 
working time, prices, etc. A unified system to assess the performance of various 
providers and quality of health services is still lacking. There is, however, some 
advancement in this area. For example, a registry managed by the Czech Institute of 
Health Information and Statistics gathers information on adverse events. So far 40% 
of inpatient providers (measured in bed capacity) participate in this project which aims 
at supporting best practices by information sharing. Several other projects are 
spearheaded by the state or regional governments, whereas others are run by 
professional or civic organizations, such as the National Reference Centre (Národní 
Referenční Centrum, NRC) or the Czech Oncological Society (ČLS JEP). 
 
DENMARK 
General context 
Denmark has a comprehensive and legal framework protecting patients’ rights that 
encompasses both fundamental and more consumer oriented rights. The Health Act 
(Consolidating Act no.1202 of 14 November 2014) is complemented by a series of 
more specific laws (e.g. Consolidating Act no. 1113 of 7 November 2011 on 
Complaints and Compensation within the Health Care Services; Consolidating Act no. 
877 of 4 August 2011 on Authorization of Health Care Professionals and on Health 
Care Services) and the application of general legal provisions (e.g. administrative and 
criminal law). This is the result of a steady development process in Danish health law 
over the last 30 years that started in 1988 with the the establishment of a special 
Patients Complaints Board. Next to the ratification process of the Biomedicine 
Convention, changes in the general Danish data protection regulation also contributed 
in strengthening rights of patients by ensuring their right to access their medical file. 
More consumer-oriented rights, such as access to treatment, waiting time and free 
choice of provider, become more prominent partly through general policies promoting 
more efficiency in the public sector.  
Self-determination & confidentiality 
The right to consent is recognized in the Health Act (and the Act on Artificial 
Reproduction). Consent to research is regulated by the Act on Research Ethics Review 
on Health Research Projects. Verbal consent is normally required, though written 
consent is sometimes necessary for comprehensive interventions. Presumed consent is 
only possible for “ordinary treatment”. Patients must be told of all possible options. No 
cross-border patient provisions, but there is an obligation to provide interpretation 
(article 50 of the Health Act). A comprehensive body of case law exists. Enforcement 
is via complaints to The National Agency for Patients’ Rights and Complaints. 
The right to privacy is recognized in the Health Act and the Act on Processing of 
Personal Data, with the former affording more protections to patients. There are also 
provisions in the Penal Code: “general rules on confidentiality are laid down in the 
penal code for public employees (article 152), licensed health care professionals 
(article 152 b) and the assistants of licensed health care professionals (article 152 c).” 
No special rules for cross-border patients. A comprehensive body of case law also 
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exists for privacy. Enforcement via the National Agency for Patients’ Rights and 
Complaints. 
The right to access records is provided in the Health Act. For information gathered 
outside the clinical context, administrative law applies. Records are available online via 
sundhed.dk within 7 days of request for no fee. Parents normally allowed to access 
children’s (under 18) records. Data cannot be added and cannot be erased within ten 
years of last data registration. No specific cross-border patient rules. Again, a there is 
a comprehensive body of case law. Enforcement is also via the National Agency for 
Patients’ Rights and Complaints. 
Quality & safety 
The general aim of the Health Act is to ensure that patients’ needs may be fulfilled in 
regards to easy and equal access to the health care services, treatment of high 
quality, comprehensive treatment, free choice, easy access to information, 
transparent health care services and short waiting time for treatment. 
Quality assurance aspects with regard to health care professionals’ performance are 
primarily monitored through the licensing, inspection and control system which is 
monitored by the Danish Health and Medicines Authority. A number of health care 
professionals need to have a license to use specific titles and to perform specific 
procedures/services. Regions and the Municipalities are responsible to ensure quality 
development of the services. In addition, the Act also lay down obligations to report 
information to national databases to ensure collection of reliable data for quality 
assessment and development. As a special initiative the Danish Health Care Quality 
Program (DDKM) has been developed and the Danish Institute for Quality and 
Accreditation in Health (IKAS) has been established. According to the Health Act – a 
legal obligation exists for health care professionals to report adverse events to the 
Regions or the municipalities. Patients may also report adverse events. The Danish 
Health and Medicines Authority continuously develops and revises clinical guidelines, 
which are available at the Authorities website. 
Article 88 of the Health Act Regions allows the patient to have extended free choice of 
hospitals, if the Regions cannot meet the maximum waiting times. In general, the 
maximum waiting time is two month for hospital treatment. However, if the patient is 
suffering from a very serious condition, the maximum waiting time is instead one 
month.  
Prior authorization for XBC may be refused if the patient would be exposed to an 
unacceptable patient-safety risk (including healthcare provider if treated at a hospital 
in another Member State. The patient can issue a complaint to The National Agency 
for Patients’ Rights and Complaints. 
Choice 
The right to free choice of provider is recognized in the Health Act, both for hospital 
care (Art. 86 and 87) and GPs (article 59.5; and Executive Order no. 966 of 29 August 
2014 on Choice and Change of General Practitioner and Treatment by Practicing 
Doctors). For primary care, Danish citizens can either choose for a permanent or 
family-doctor model (Group 1) or a complete freedom of choice (Group 2). Group 1 
patients are required to register with a particular GP, subject to some geographical 
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restrictions, who will have to provide a referral whenever specialist care is needed. 
Health care provided is free of charge and patients can change their GP at all times. 
Group 2-patients are free to consult any GP and any specialist without referral. They 
will receive reimbursement for the same amount as for Group 1 patients but providers 
can charge higher fees. The large majority of Danish citizens belong to group 1. Even 
with referral patients can freely choose the specialist. Patient can also seek treatment 
in any public hospital in all five Danish Regions as well as in a few listed specialized, 
private hospitals. However, hospitals may limit access to treatment for patients from 
outside the Region if treatment capacity is limited. When treatment cannot be 
provided in the Region within stipulated maximum waiting times (1 or 2 months 
depending on the severity of the condition), patients can choose a private hospital or 
even a hospital abroad, provided this hospital has an agreement with the Regions for 
this (extended right of free choice). 
The patient is entitled to receive information about both the general and the extended 
right of free choice to hospital treatment (see article 90 of the Health Act). Regions 
and hospitals have a legal obligation to inform patient within 8 weekdays about 
possible date for treatment and waiting times at other hospitals (in the Region as well 
as in other Regions). Information about waiting times for hospital and specialist 
treatment may also be available at the official national health website 
(www.sundhed.dk). The website of the Danish Medicines and Health Authority 
provides information about providers’ fitness to practice (article 13 of Consolidating 
Act no. 877 of 4 August 2011 on Authorisation of Health Care Professionals and on 
Health Care Services). The National Agency for Patients’ Complaints and 
Compensation sometimes published decisions of the Disciplinary Board with the name 
of the providers (in case of severe or continuous criticism) for a period of two years 
(see article 17 in Act on Complaints and Compensation within the Health Care Services 
(Consolidating Act no. 1113 of 7 November 2011). There is no legal obligation for 
providers to provide information about fees and price for group 2 patients. 
There is no general right to second opinion. However, severely sick patients who have 
been given up by their provider may request an assessment by a special second 
opinion panel, which is set up by the Danish Health and Medicines Authority. This 
panel will assess whether the patient may benefit from experimental treatment at a 
private hospital in Denmark or a hospital abroad. The patient needs to be referred to 
the panel by the doctor treating him/her. Detailed rules are laid down in article 30 in 
Executive Order no. 958 of 29 August 2014 on Right to Hospital Treatment. 
 
ESTONIA 
General context 
The main instrument regulating patients’ rights in Estonia is the Law of Obligations 
Act, which includes a special chapter on the Contract for Provision of Health Care 
Services. However, many other relevant legal provisions are scattered over a number 
of other laws and regulations. Estonia is still in the early phase of developing a 
comprehensive framework on patients’ rights. The main driver for its development is 
Estonia’s membership of international institutions such as the EU, Council of Europe, 
WHO etc. 
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Self-determination & confidentiality 
Provisions concerning right to consent in various specific Acts governing different 
areas of healthcare, the main one being the Law of Obligations Act. Others include: 
the Human Genes Research Act, the Medical Devices Act § 212,  the Communicable 
Diseases Prevention and Control Act, the Artificial Insemination and Embryo Protection 
Act, the Termination of Pregnancy and Sterilisation Act, and the Procurement, 
Handling and Transplantation of Cells, Tissues and Organ Act. The Mental Health Act § 
2 defines “informed consent”. Consent is assumed and rarely written, although it is 
required by law for surgery. Requirements for providing information vary between 
providers. There are guidelines concerning rights of cross-border patients. In 
enforcement, the burden of proof lies with the patient. 
The Law of Obligation act guarantees the right to privacy; the Health Services 
Organization Act covers data protection and enforcement via Estonian Data Protection 
Inspectorate. Patients have the right to restrict access to their records to particular 
healthcare providers.  
The right to access records is covered by the Law of Obligation Act and also stipulated 
in the Personal Data Protection Act and Public Information Act. Access to records is 
facilitated with assistance of practitioner, and the first 20 pages of copied data are 
free. The Health Services Organization Act (section 505) guarantees the same rights 
to cross-border patients: “Patients who wish to receive or who receive cross-border 
health services shall have remote access to their treatment documents or have the 
possibility to receive copies thereof.” 
Quality & safety 
Health care services shall at the very least conform to the general level of medical 
science at the time the services are provided and the services shall be provided with 
the care which can normally be expected of providers of health care services. The 
regulation of minister of social affairs on availability and timeline of health services is 
the sub-regulation relating to the issue. The health care providers have their own 
structural norms, process protocols, outcome indicators.  However the big health care 
providers (hospitals, etc.) are working in the close cooperation and contest with 
providers of other regions to have good quality management. The institution in charge 
of health care providers is the Health Board who is working with close interactions of 
the Estonian Health Insurance Fund and coordinated by Ministry of Social Affairs. To 
the date there is no revoked license of physician. The problem is related to the 
physician describing the addiction medicines (i.e. narcotic medicines) to the patients 
(mostly from not indicated to the medication). After the criminal investigation the 
legal body is ended up but the physician will establish the new one. 
The waiting times are defined by health care provider and depend upon funding of the 
Health Insurance Fund. The practice on how the right to safe and quality treatment 
received in a timely manner (incl. the specific procedures or remedies) is incipient. 
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Choice 
Since 2006 citizens in Estonia can freely choose their doctor or hospital, provided they 
are contracted with the Estonian Health Insurance Fund (EHIF). At the primary care 
level they have to register in the practice list of a family physician (Health Care 
Services Organization Act § 8. (3)). They have the right to change their family 
physician on the basis of a written application and the transfer will become effective as 
of the first day of the following calendar month. Patients need a family doctor’s 
referral to see most specialists and to be admitted as a non-emergency inpatient. 
Since 2012, only patients with severe conditions needing special monitoring may 
continue visiting the specialist without a new referral.  
Information about available providers and treatments can be retrieved from health 
practitioners as well as from specific non-profit unions or associations. Healthcare 
providers are legally obliged to provide information on availability, accessibility and 
prices (Health Services Organization Act § 505). This is done mostly through web 
sites. The EHIF provides information through its web site, local service desks, call 
center and other channels, including a list of contracted providers, information on 
entitlements and prices etc. The Health Board, which is coordinated by the Ministry of 
Social Affairs and works in close interaction with the EHIF, also produces information, 
but this is mainly health care statistics and reports on economic activities in the field 
of health care. Public information on performance and quality is still limited. Since 
2012 the EHIF has started to publish reports on selected indicators for the main 19 
acute hospitals (part of the Hospital Network Development Plan – HNDP) and also 
provides information on family physicians’ performance. Waiting times are closely 
monitored by the EHIF and maximum waiting time targets were introduced in 2001. 
The right to second opinion is recognized by the Health Insurance Act (Division 3, § 
40) but it is subject to strict rules and conditions. The EHIF will only assume the 
related costs of the second opinion once per treatment event to the extent specified in 
the list of the health services. If the second opinion is sought with a non-contracted 
provider in Estonia a written contract needs to be concluded between the insured 
person and the health insurance fund. Also providers abroad can be consulted. The 
treating physician must provide the insured person with a referral letter and transmit 
all documents regarding health services rendered or copies thereof to the provider of 
the second opinion.  
 
FINLAND 
General context 
The development of patient rights in Finland stems from the general societal 
awakening to strengthening respect for fundamental rights and self-determination 
since the 1970s. Finland was one of the pioneers in terms of legally defining and 
implementing patients’ rights through the Patient Rights Act 785/1992 (1992) and 
Patient Injury Act (1986). The legal framework is completed by a series of other 
relevant legislation, including a set of legal obligations imposed on healthcare 
professionals to respect the patient’s rights to self-determination and confidentiality. 
Patients’ rights are seen essential to protecting the confidential relationship between 
patient and healthcare provider. 
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Self-determination & confidentiality 
The Patient Rights Act guarantees the right to consent and dictates the types of 
information to which patients are entitled: “A patient shall be given information about 
his/her state of health, the significance of the treatment, various alternative forms of 
treatment and their effects and about other factors related to his/her treatment that 
are significant when decisions are made on the treatment given to him/her.” Written 
consent is not normally used and there is a right not to know. The Act guarantees that 
decisions are made with the “mutual understanding” of the patient. There is no direct 
support for cross-border patients, and only official languages are used, though citizens 
from other Nordic countries receive translation services free of charge. There are no 
specific enforcement pathways. Right seems to work in practice, but “self-
determination is a particular challenge in longitudinal care of older people, disabled 
and mentally ill patients” – work continues on a measure to “enhance self-
determination of social care customers and patients, and to set conditions for 
personally restrictive measures in social and health care.” 
The right to privacy is a fundamental right protected by the Constitution and the 
Patient Rights Act. The Act on National Electronic Health and Social Care Archives, the 
Data Protection Act and the Act on Healthcare also impose obligations. Public health 
care professionals are also subject to legislation governing civil servants (specific 
criminal liability). There are no specific cross-border patient provisions. There is a 
large body of reports, surveys and case law. Privacy enforcement is via Patient Rights 
Act 14 § (offence) and Data Protection Act, and also potentially via the Penal Code.  
The right to access records is protected by Patient Rights Act 5 § para 3; Data 
Protection Act 26 §; Act on Openness of governmental activities (621/1999) 10 – 12 
§, Act on Electronic, Social and Health Care Records. No specific cross-border patient 
provisions. An online service is currently being developed. 
Quality & safety 
The Finish Patient Rights law defines the right to good health and medical care and 
related treatments and Access to treatment. Timeframes for access are determined in 
Health Care Act Health care actors must have plans on quality and patient safety. 
There is a magnitude of provisions concerning accreditation, reporting requirements, 
best practice-guidelines etc. Health professionals must be licensed and registered in a 
publicly available register. Harmonised Principles of Care find their basis now in Health 
Care Act 7 §, but they were initiated already in 2005. They concern criteria on non-
urgent care. MoH has also issued a decree on criteria of urgent care and conditions for 
specialised emergency rooms. The aim of the decree is to make sure that equality, 
safety and quality of patient care is met throughout the country. Current Care 
Guidelines are independent, national, evidence-based clinical practice guidelines. They 
are intended as a basis for treatment decisions. The National Institute for Health and 
Welfare has published a Patient safety manual in 2011. National and regional 
authorities monitor the performance of health care services. Health care act 50-53 §§ 
dictate the times for urgent and non-urgent care. The assessment of needs for 
treatment shall be based on harmonized principles (prioritization). 
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Reimbursement of cross-border services require that the treatment belongs to the 
national service selection refer ref to in Health Care Act 7 a §. This service selection is 
based on quality and safety of treatments.  
National Institute for Health and Welfare (THL) monitor the performance and reports 
to the National Supervisory Authority for Health and Social Affairs (Valvira). The 
National Supervisory Authority for Health and Social Affairs has posed threat or fines 
on health care providers because they have not been able to deliver on time.  
The general Patient rights Act provisions regarding objection and complaint, etc. are 
applicable. Also, the National Authorities may pose sanctions for non-compliance of 
time-lines. To appeal of decisions made by the Social Security Institution can be 
appealed to administrative court or to the appeal board of social security, depending 
on the decision to which of these. 
Choice 
With the Health Care Act N° 1326/2010, which has entered into force in 2014, the 
right to free choice of health care provider has been formerly recognized (47 § and 48 
§). However, choice is limited and regulated. People can choose to register with one of 
the different primary health centre units operating in their municipality. They can 
exceptionally be treated in another health centre in case of emergency or during 
temporary stay in another region. They can also choose to register outside their 
municipality of residence (extended choice). Transfer to another health centre is only 
possible once a year upon written notification. Within the health centre the patient can 
choose his or her attending professional, subject to restrictions arising from the 
expediency of the service provision. Access to specialized care requires a referral from 
a licensed physician. Any secondary health care provider in the country can be chosen. 
Next to the public healthcare system citizens can also opt to seek treatment with a 
private provider (partial coverage by the National Health Insurance) or in occupational 
health care (provider chosen by the employer).  
Basic information about access and legal rights is found on web sites of healthcare 
providers, municipalities as well as the single access point to public services in Finland 
(http://www.suomi.fi). There are no legal requirements to publish indicators on quality 
and safety. However, the National Institute for Health and Welfare (THL) has a specific 
programme to improve and monitor quality and safety in health care and provide 
information to patients. Decree 341/2011 requires that patients are informed about 
the safety plan of individual healthcare providers. Local authorities and joint municipal 
authorities for hospital districts must publish waiting times at 4 months intervals 
(Health care act 55 §).  
There are no specific provisions on the right to second opinion.  
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FRANCE 
General context 
France has a law on patient rights (2002-303) since 2002. Before that the deontology 
code since 1995 defined physicians’ duties towards patients. Patients’ associations 
have played an important role in the development of patients’ rights, especially in the 
aftermath of the scandal of blood contaminated by HIV. As a result a compensation 
scheme was introduced for all infections contracted through medical activities. Patients 
associations also participate in hospital administrative committees and in research 
ethics committees. They can represent individual patients in court and seize the 
Commission for indemnification. 
Self-determination & confidentiality 
The 1994 law on respect for the human body makes informed consent necessary. The 
Code of Medical Ethics provides further stipulations, stating that "The physician must 
provide a fairly clear and appropriate information to the person that he examines 
cares or advises about his health condition, the investigations and treatment offered; 
throughout the disease, the physician respects the personality of the patient in his 
explanations and make sure of their understanding.” Generally consent is oral, except 
in certain circumstances. Information should be provided in written form, and there is 
a right not to know. The law on patient rights regards the patient as a partner in 
decision-making. Cross-border patients have the same rights as those living in the 
country, and provision of translators is mandatory. Enforcement is via general 
procedures and disciplinary sanctions. 
Privacy is protected by both the civil and the criminal codes and the public health 
code. A breach can be punished by a penalty of one year in prison and a fine of up to 
15,000 euros. Data protection law regulates e-records and the commission for 
freedom and electronic data controls and protects data.  
Patients can directly access their file; each hospital has a special service to this end. 
There is a right to correct data in the record. Cross-border patients have the same 
rights. 
Quality & safety 
The Public Health code states: Everyone has, given his condition and the urgency of 
the interventions that he or she requires, the right to receive the most appropriate 
care and benefit from the therapeutic efficacy of which is acknowledged and that 
guarantee the best security health, in light of medical knowledge proved. All the 
professionals must have a license to practice. Conditions are defined par the public 
health code for professionals coming from other EU member states. The public health 
code defines the criteria. Safety and quality of health care by: 1) binding measures of 
activity authorizations or implantation of equipment, organization of public and private 
health facilities, technical operating conditions in high-risk areas, monitoring the use 
of health of products) 2) vigilance systems which allow the detection of adverse 
events 3) health facilities certification system Good practice recommendations for 
professionals are developed at national level by the High Health Authority. Health 
facilities have an obligation present to the public their indicators of quality and safety 
of care. Recommendations and guidelines are provided to professionals by the HAS 
Study on Patients’ Rights in the European Union - MApping eXercise 
61 | P a g e  
 
and by scientific societies of professionals. They describe the state of the art for the 
specialists. The social security verifies the quality of care or medical products 
delivered. 
Better conditions for oocyte donation when access is quicker in another state because 
the waiting list in France is too long so the patients are allowed to go abroad and the 
social security reimburses a large part of the expenses.  
The French law (social security recommendations) respects the provisions of the 
Directive 2011/24/EU, e.g. refusal when there could be an unacceptable risk, or when 
the quality of care is not guaranteed.  
Choice 
The patients’ right of free choice of provider (practitioner and health facility) is one of 
the fundamental principles of the French health system that is recognized by law 
(Article L. 1110-8.1 Public Health Code, Article 6 Deontology Code). This also 
supposes a right to second opinion (Articles R 4127-60-62 of the Public Health Code). 
The statutory health insurance reimburses health services provided by all licensed 
providers without geographical restrictions. However, some physicians (so-called 
sector 2 providers) are not applying the national agreement tariffs and have the right 
to practise extra-billing. No referral is needed to access specialist doctors or hospital 
care. However, with the 2004 health care reform a soft form of gatekeeping was 
introduced. Under the voluntary ‘preferred doctor scheme’ (médecin referent), 
patients are asked to register with a preferred doctor of their choice, whom they 
should visit before accessing another doctor. They can opt out of this pathway and 
have direct access to specialists or other GPs for an additional out-of-pocket payment 
that is 40% of the SHI tariff. The preferred doctor is most often a GP, but people can 
also choose a specialist of any kind working in the private or public sector. Also linked 
to the generalised application of user charges and the extra-billing, some concern has 
been expressed about the actual ability of patients living in remote areas or with 
limited financial capacity to choose their provider (HCAAM 2006). 
Information on healthcare providers is not systematically organised. Providers are not 
allowed to advertise their services. They only provide general information. However, 
increasingly information on quality and performance is publicly made available. Based 
on the accreditation process by the National Health Authority (Haute Autorité de Santé 
– HAS) a mix of yearly collected performance indicators are published 
(www.scopesante.fr). Physicians who underwent a practice appraisal can disseminate 
this information. Also patients’ associations are very active in generating information 
for patients (www.leciss.org). Newspapers and magazines publish a yearly star 
ranking of public and private hospital services (e.g. http://hopitaux.lepoint.fr).  
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GERMANY 
General context 
Germany has a well-developed and historically reasoned strong implementation of 
fundamental patients’ rights as well as more consumer-oriented patients’ rights. Based 
on jurisprudence they were dispersed over various sources, mainly the general civil 
code (BGB) and the social code (SGB V). To increase their transparency and 
consistency they were re-edited in the special Patients’ rights Act (2013). Choice (of 
doctor and of therapies) and proper information are seen as elemental elements to 
ensure the right of physical integrity, which requires the patient’s consent to every 
action of the doctor. A very strong national reform strategy involving a whole range of 
institutions (e.g. German Medical Association, ethics commissions, sickness funds, 
medical faculties) and the media are considered important drivers for the further 
development of patients’ rights. 
Self-determination & confidentiality 
In Germany the general civil code and criminal law ensure protection of the  right to 
consent. Verbal consent is sufficient, but written consent is often used for evidentiary 
purposes. There is a broad duty to inform patients orally or in writing, including 
information about different treatment options. The duty to inform entails the duty to 
help cross-border patients to understand via translation. The right not to know is not 
defined directly in law but is widely seen as part of the “allgemeines 
Persönlichkeitsrecht” (Art. 2 I i.V.m. 1 I GG) and the “Recht auf informationelle 
Selbstbestimmung”. In 2003 the Oberlandesgericht Celle defined it as the “reversed 
manifestation of the right to informational self-determination (NJW 2004, 449-451). 
The right to privacy is regulated “in § 203 I 1 StGB and also in § 9 
Musterberufsordnung der Ärztekammern.” The German criminal code stipulates the 
consequences of a violation of the obligation to secrecy in §203 StGB with a maximum 
sentence of one year in jail. 
The right to access records is recognized in § 630g BGB, which provides a right to 
immediate and comprehensive access to and electronic duplicates of records (on a 
paid basis) “to the extent that there are no considerable therapeutic grounds or third-
party rights at stake to warrant objections to inspection.” The right to access records 
passes to heirs after death, and there is no right to alter/erase records. No specific 
cross-border patient provisions. In practice it is easy to access data but almost 
impossible to check whether it is being kept confidential.  
Quality & safety 
There is a right to be accepted by a statutory insurance company which grants access 
to adequate medical health care, while its quality standard is guaranteed by legal 
regulations as the requirement of approbation to be a practicing physician as well as 
regularly enforced quality management for hospitals and the pharmacy. This, in 
association with the IQWIG, ensures the safety and quality of treatment. A specific law 
guaranteeing treatment in a timely manner is not given. The IQWiG is an independent 
scientific institute that evaluates the quality and efficiency of health care. The institute 
investigates what therapeutic and diagnostic services are feasible and valuable and 
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communicates its findings to the health care professions, patient and the general 
public.  
There is no right to timely treatment. It’s a well-known problem in Germany that there 
are not enough specialized physicians in rural areas. Also, some professions generally 
have very long waiting times (e.g. psychotherapeutics).  
Choice 
Patients in Germany enjoy the right to free choice of provider (SGB V § 76). In the 
statutory health insurance (SHI) this is limited to SHI-accredited physicians and 
hospitals contracted by the sickness funds. However this covers the majority of them, 
respectively 98% of ambulatory physicians and 99% of hospital beds. Patients select 
their own family physician but can only change once every quarter. However, they 
don’t act as gatekeepers and patients frequently choose office-based specialists 
directly. Since 2004 measures were introduced to strengthen the coordinating role of 
family physicians, including a quarterly co-payment for physician visits (Praxisgebühr) 
to enhance gate-keeping that was abolished again in 2013. Sickness funds were 
required to offer the option to enrol in a “family physician care model”, potentially with 
a bonus for complying with the gate-keeping rules. For patients participating in 
disease management programmes (DMP) or integrated care contracts choice is 
confined to participating providers and access to specialist care is subject to referral 
by the patient’s coordinating family physician. Private patients are in principle not 
restricted in their choice.  
There is no central administrative authority to provide information about providers and 
availability of services but various actors are actively engage in this, including sickness 
funds, professional chambers and provider federations, patient organizations. Web 
sites such as the German hospital directory (www.german-hospital-directory.com) or 
health navigator sites set up by individual sickness funds help patients to find the 
appropriate provider. The Citizens Advice Bureaus, which are operational in all sixteen 
States, evaluate the quality and cost of medical services. Hospitals included in the 
state-level hospital requirement plans are obliged by law (SGB V § 137) to publish 
quality reports every two years. Since 2007, all hospitals have been required to 
publish results on 27 selected indicators collected by Bonus Quality System (BQS). 
The new Institute for Quality Assurance and Transparency in Health Care (IQTiG) that 
was established in 2014 is also required to publish results of the quality assurance 
measures in an appropriate manner and in a form understandable to the general 
public. Based on these risk-adjusted comparative overviews or benchmarks of quality 
in key areas of hospital services are created and published on the internet. Finally, 
Germany also has developed a rating system for long-term care providers 
(www.pflegenoten.de).  
The right to second opinion is derived from the formal right to free choice of provider. 
It is also explicitly mentioned in the Patient Charter that was published in 2002. 
Sickness funds also actively provide support for their members looking for second 
opinion.  
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GREECE 
General context 
Although already the first reference to “rights of hospitalized patients” was found in 
1992, the legal approach to patients’ rights in Greece is still in its early stages of 
development. A long tradition of medical paternalism and a lack of public awareness 
(among medical professionals and patients) could only be turned by the open-minded 
approach of a small group of legal experts and policy-makers, working mostly in the 
field of fundamental rights. Next to references in the Constitution and specific laws 
(e.g. on transplantation, assisted reproduction) the most important source for 
patients’ rights is the law on Medical Ethics (l. 3418/2005), which develops the 
patients’ rights in more detail. Even if non-binding, the opinions and recommendations 
of the Hellenic National Bioethics Commission are also considered influential to fill any 
gaps in the legislation. The status of enforcement still remains weak but very recently 
case-law before the courts started to emerge. Also control mechanisms and 
institutions were created to support patients’ rights implementation, e.g. the 
Ombudsman’s office, the Office of Patient Rights in the Ministry of Health.  
Self-determination & confidentiality 
The right to consent is recognized in the law ratifying the Oviedo Convention and the 
Law on Medical Ethics, as well as several more specific laws: article 1 of Law 
3089/2002 (on assisted reproduction, 1456 CC), article 5 of law 3305/2005 (also on 
assisted reproduction); article 7 of Law 3984/2011 (on transplantation); article 47 of 
the Law 2071/1992 (on the National Health Service); and articles 205 of Ministerial 
Decision ΔΥΓ 3/89292/2003 (on clinical trials – Dir. 2001/20). In the vast majority of 
cases consent is presumed, but younger doctors ask for verbal consent. Written 
consent is used by some hospitals for surgery, and is essential for clinical trials. 
Information provided to patients must be comprehensive and there is a right not to 
know. There are specific provisions for cross-border patients. There have been only a 
few court cases. Enforcement is via the Ministry’s Office for Patient Rights, at the 
hospital level, or at the Ombudsman’s office. 
The right to privacy is formally recognized in various instruments: “Constitution: 
article 9 para 1 sec. b, article 9 A (on data protection); Law decree 54/1974 
(ratification of the ECHR): article 8; Law 2619/1998 (ratification of the Oviedo 
Convention): article 10 para 1; Law 2472/1997 (on data protection – Dir. 46/95); Law 
decree 1565/1939 (on medical profession): article 23 a; Law 3418/2005 (on Medical 
Ethics): articles 8 para 2, 3, 5 (confidential relationships as a physician’s duty), 13 
(medical secrecy), 14 (data protection in medical registries); Civil Code (as amended 
by Law 3089/2002 on assisted reproduction): article 1460 (donor anonymity); Law 
3305/2005 (on assisted reproduction): article 8 para 6 (confidentiality of donors’ 
data); Law 3984/2011 (on transplantations): article 10 (anonymity of deceased donor 
and organ recipient); and Ministerial Decision ΔΥΓ 3/89292/2003 (on clinical trials – 
Dir. 2001/20): article 5 (confidentiality of participants’ data). Processing of data 
requires written consent. The law on cross-border patients mentions the rights to 
privacy and data protection. The national data protection authority is highly active in 
enforcement. 
The right to access records is recognized explicitly, with copies on request via 
application to hospital authorities. After death, heirs exercise rights of access. Cross-
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border patients have the same rights. Data Protection Authority can impose 
administrative sanctions following reports of violations. The ombmudsman’s office has 
issued several decisions on refusal of access. Consent implied, verbally or written.  
Quality & safety 
The Greek Law 3418/2005 makes an explicit reference to “quality, safety and 
efficiency” in its Article 4, stating in particular a physician’s duty a) to cooperate with 
colleagues and health practitioners, in order to avoid medical malpractice, to ensure 
patients’ safety, to minimize the unnecessary costs, and to maximize efficient health 
care; b) to provide prescriptions, as necessary for ensuring the quality, safety and 
efficiency of health care or treatment; and c) to contribute to the creation and 
implementation of mechanisms and methods aimed to improve the intending to the 
quality of health care. The same law provides, also, for a number of clear criteria for 
ensuring a standard level of quality services, repeatedly making reference to the need 
for each physician to act only: a) in accordance with evidence-based medicine. 
However, no reference to time considerations exists.  
The NOH has a responsibility to ensure that the services provided by its affiliated 
private healthcare providers meet certain quality and safety standards. According to a 
recent ministerial decision medical protocols and guidelines should be issued under the 
responsibility of the Central Health Council and the medical scientific societies, with 
the aim to cover all medical acts related to the e-prescribing system but there is no 
evidence about their implementation in practice. The Ministry and the NOH control the 
outcomes on a permanent basis, by receiving relevant data from hospitals and other 
healthcare services and by performing inspections. The central organ for inspections of 
the Ministry is the Health Inspectors’ Body, which has general competence of coercive 
control, backed with administrative sanctions 
In general, public healthcare services follow priority schedules, for receiving patients. 
This is decided by the service administration, on the doctors’ proposals.  
Case-law in administrative courts regarding collaborations of the NHS with private 
laboratories and clinics, or administrative inspections (regarding, for example, 
licensing, or quality standards), exists. The Ombudsman’s office also has addressed 
cases of patient complaints.  
At present the preparation of protocols to be implemented generally, and the issue of 
the ministerial decision on cross-border care are expected. 
A person may report a relevant case to the Ombudsman’s office (applicable to public 
health services only). A patient can also refer to the courts, in the context of medical 
liability, or in the context of administrative law, asking for compensation – if, for 
example, doctors or administrative organs have violated formally existing prioritization 
rules. 
Choice 
The right to free choice of provider is not formally recognized in Greece but it is 
presupposed in the organic law creating the national health service (ESY Law 
2071/1992) and the Law regarding the rights and duties of the physician (l. 
3418/2005). In practice, choice options differ according to the health funds citizens 
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are affiliated to and their financial capacity to afford private health care. Several 
funds, such as those of bank employees, self-employed, civil servants offer freedom of 
choice between a private and a public doctor. In addition many funds operate own or 
contract with health centres, mainly in urban areas. Patients can choose any primary 
healthcare center that is either public or contracted by their specific health fund. Since 
there is no formal gatekeeping and referral system, they can also go directly to any 
public hospital (also for outpatient consultations) and can opt for a second opinion in 
another one. Within the hospital patients usually cannot choose their treating 
specialist doctor and have to accept substitute care from assistants working under his 
supervision. Since 2002 doctors working in public hospitals can attend patients 
privately in afternoon outpatient visits. The increasing waiting lists and regional 
variations in availability of health care are adding to the inequalities in accessibility. 
The Greek Ministry of Health has a general responsibility regarding providing 
information to citizens. A central telephone line of the ESY informs about the 
availability, waiting times and prices at public hospitals. Also the various social 
insurance funds, medical associations or medical scientific societies as well as patients’ 
organizations and specialized state organizations provide information about providers 
in different specialty fields (e.g. transplants, diabetes). However, information on costs 
and quality of services is generally lacking. 
Patients have an explicit right to ask for a second opinion in an ongoing treatment (so-
called medical consultancy). In that case the patient can freely choose one or more 
“advisory physicians” (Article 22 para 1 of l. 3418/2005). The caring physician can 
also suggest one. He remains responsible for the treatment but can disclaim any 
responsibility or decide to withdraw.  
 
HUNGARY 
General context 
Hungary was among the first countries in Europe where patients’ rights were codified 
in statutory law. Spurred by the Szószóló Foundation, an NGO established in 1994 to 
represent patients' interests, the Health Care Act was adopted in 1997 that introduced 
a patient-oriented approach, which is applicable in all health care institutions, both 
state and private. Upon acceptance into the institution and before treatment, the 
health care provider has to inform the patient about his patients’ rights, the 
possibilities for their enforcement and the internal rules of the institution. Violations of 
patients’ rights are sanctioned by various legal norms, including the Criminal and Civil 
Code. The law also provides for non-litigious resolution of disputes between patients 
and healthcare providers through a Mediation Council. The Commissioner for 
Fundamental Rights, the National Center for Patients’ Rights, Children’s Rights and 
Documentation (OBDK - established by government decree in 2012) and the network 
of patients’ rights advocates play a key role in the enforcement of patients’ rights.  
Self-determination & confidentiality 
The Health Care Act of 1972 recognized the duty to inform patients. The Health Care 
Act of 1997 protects the right to informed consent, and the Civil Code ensures that 
individual has final word regarding body and health. Patients are entitled to receive 
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comprehensive and individualized information. Article 15(3) of the Health Care Act 
entitles patients to participate in clinical decision-making regarding their own health, 
but “the lack of health literacy often limits the enforcement of his right”. There are no 
specific provisions for cross-border patients, but the Health Care Act requires provision 
of interpreters if necessary. Article 14 provides for a right not to know. With regard to 
enforcement, criminal sanctions can be imposed, or damages claimed. 
In terms of a right to privacy, there is a stronger emphasis on the patients’ personality 
rights and the rights to confidentiality and medical secrecy than on privacy. 
Confidentiality must be respected, with some exceptions, and there are no provisions 
for cross-border patients. Article 25(1) of the Health Care Act states that “a patient 
shall have the right to have persons involved in his health care disclose his health care 
and personal data which they might learn in the course of delivering such care to 
those entitled thereto and to have them handle such data confidentially.” 
Data protection is strongly emphasized in Hungarian law. Medical documentation is at 
the disposal of the health care provider, but data contained therein is at the disposal 
of the patient, meaning that “the patient has the right to gain knowledge of the data 
contained in the medical documentation concerning the patient.” Copies are available 
on a paid basis. Incorrect medical data cannot be deleted after a complaint; “the 
originally included data remains visible.” No provisions for cross-border patients. 
Quality & safety 
In Hungary, healthcare services shall only be provided in the possession of an 
operator’s license. The healthcare administration (the Office of the Chief Medical 
Officer, OTH) shall only issue the license if the petitioner fulfils the statutory 
requirements relevant to the specific service (“de minimis requirements”) including 
having liability insurance. The Health Care Act defines quality health care services and 
provide the general outlines of the quality management system. Specifically, the 
Health Care Act prescribes for healthcare providers to operate internal quality control 
systems. 
Besides the often applied general quality control frameworks (ISO 9001), to date, 
some healthcare-specific frameworks also appeared (DIN EN 15224:2012) in the 
practice of healthcare providers. These include the definition of general quality 
requirements, and their benchmarking of performance, control, assessment, 
improvement and documentation; however, these do not include in a mandatory 
fashion any system of basic conditions relevant to the practice of professional 
activities. This is why the ISO framework is often complemented by a system of 
standards defining professional quality requirements as well. 
The professional foundations of Hungarian healthcare are guaranteed by the 
application of professional guidelines and adjacent local protocols (rules of procedure) 
based on evidence-based medicine and on the consensus of the different professions. 
Choice 
Section 8.1 of the Health Care Act recognizes the patient’s “right to choose his 
attending physician with the agreement of the healthcare provider of the level justified 
by his condition and, unless a legal rule sets forth an exception, the physician so 
chosen, provided it is not precluded by the professional contents of the health service 
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justified by his condition, by the urgency of care or the legal relationship serving as 
the basis for the use of the service.” Also this right may be exercised in accordance 
with the rules of operation of the healthcare provider (Section 8.2). Patients usually – 
but not necessarily - register with a GP in their geographic area of residence. The GP 
are meant to act as a gatekeeper. Except for certain disciplines, patients need to get a 
referral from their family doctor to access secondary care. If they bypass the referral 
system they will have to pay user charges. Patients are generally referred to the 
nearest outpatient care institution or to another specialized health care institution if 
the nearest hospital does not perform the particular treatment. Patients can also ask 
to be referred to another healthcare provider, who can charge an extra fee for this. He 
may refuse if there is no financial free capacity or if it would endanger care for 
patients in his catchment area.  
Patients in Hungary have a right to second opinion “in connection with any diagnosis 
made or therapy recommended by his attending physician, or regarding his planned 
discharge from an in-patient institution or referral to another healthcare provider.” 
(Section 8.3) 
 
ICELAND 
General context 
The WHO patient rights framework was transferred into law in Iceland in 1997 with 
the Act on the rights of patients no. 74/1997. The objective of the Patients’ Rights Act 
is to ensure specific rights for patients in accordance with general human rights and 
human dignity, and thus to strengthen patients’ legal status vis-à-vis the health 
service and to support the confidential relationship between patients and health-care 
practitioners. It also accords patients the right to the best health service available for 
their condition. Moreover, patients have the right to continuity of service and 
cooperation between all health-care practitioners and institutions involved in their 
treatment.  
More specific acts, e.g. on medical records and patient insurance as well on the 
obligations of healthcare providers (including ethical codes), together with general 
provisions in the Constitution and administrative and criminal law complete the 
framework. These developments follow from a generally increased awareness of 
human rights; advances in knowledge and technology as well as the EEA-Agreement 
(particularly for consumer-oriented rights). The Ministry of Welfare is responsible for 
ensuring that information on patients’ rights, patients’ associations and health 
insurance is accessible to patients. It is made available at health-care facilities and at 
the premises of self-employed health-care practitioners. 
Self-determination & confidentiality 
The right to consent is recognized in the Act on the Rights of Patients (Articles 5-11), 
in the Act on Biobanks and Health Databanks (Articles 3 and 7), and the Act on 
Medical Research (Articles 18-24). The appropriate form of consent depends on the 
context. Patients are entitled to comprehensive information (Information about 
condition, prognosis, treatment (including risks and benefits, alternative treatment 
options, consequences of refraining from treatment) with no form specified. There is a 
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right not to know. The Act on the Rights of Patients stipulates a right to interpretation 
for cross-border patients.  
The right to privacy is enshrined in the Act on the Rights of Patients (Articles 12-13), 
the Act on Healthcare Practitioners (Articles 17-18), and the Act on Medical Records 
(Articles 7, 13, 19 and 21. There is a legal obligation to respect confidentiality, with 
some exceptions. There are no specific provisions for cross-border patients. 
The right to access records is protected by the Act on Medical Records. A request for 
access is directed to a specially nominated supervisor of health records within each 
institution. Copies are available, and there is a right to alter records. 
Quality & safety 
The Act on the rights of patients in Iceland states: “The patient has the right to the 
best health service available at each time. The patient has the right to service 
appropriate to his/her condition and prognosis at each time and the best knowledge 
available. The healthcare practitioner shall endeavour to establish a sound relationship 
with the patient. The patient has the right to continuity of service and cooperation 
between all healthcare practitioners and institutions involved in the treatment.” 
Binding licensing of healthcare practitioners, including various thresholds, see Articles 
3-12 of the Act on healthcare practitioners and numerous administrative regulations 
for different types of practitioners. Binding licensing of healthcare facilities, including 
thresholds for staffing, housing, equipment etc. applies. 
The Medical Director of Health issues clinical guidelines and quality indicators (cf. 
administrative regulation no. 1148/2008). The Directorate is responsible for quality 
development and the monitoring of health services and healthcare practitioners. There 
is a system of mandatory reporting of unforeseen incidents The Medical Director of 
Health makes a plan for quality development within the health service, which shall be 
submitted to the Minister for confirmation. The quality development plan shall aim to 
enhance the quality and security of health services, and be conducive to its 
development. Healthcare facilities and healthcare practitioners shall in the making of 
quality plans take account of the Medical Director’s confirmed quality development 
plan. The Medical Director of Health assesses quality and performance within the 
health service with respect to yardsticks laid down by the Minister in Regulations. 
Comparable findings of quality and performance assessment shall be published in 
health reports  
Acceptable waiting times are provided in the Act on the rights of patients, Article 18: 
“If a patient has to wait for treatment, the physician concerned shall explain the 
reasons for the delay and provide him/her with information on the estimated waiting 
time. If it is possible to receive the necessary treatment sooner elsewhere, the patient 
must be made aware of the fact.” No list of acceptable waiting times has been 
published on the website of the Medical Director of Health.  Prioritization Act on the 
rights of patients, Article 19: “If it proves necessary to place patients waiting for 
treatment in order of priority, the order should be based primarily on medical grounds, 
and other professional criteria, as the case may be.  
Directive 2011/24/EU has not been implemented in Iceland, but Parliament is 
considering a bill intended to implement it. Currently, the framework for cross-border 
care is in the following terms: “If a health insured person urgently requires 
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internationally recognised medical treatment abroad, cf. Article 44, when it is not 
possible to provide the necessary assistance in Iceland, health insurance will pay the 
cost of the treatment. The same applies to the cost of the stay, pharmaceuticals and 
medical assistance needed abroad in connection with the treatment. Also, health 
insurance will pay a travel grant to the health insured person and an escort in special 
circumstances. 
Choice 
The patients’ rights to choose their medical provider and to obtain a second opinion 
are recognized in Article 20 Patients’ Rights Act N° 74/1997. “Notwithstanding the 
division of the country into different health regions, a patient has the right to consult 
the physician most convenient to him. A patient also has the right to seek the opinion 
of another physician regarding diagnosis, treatment, condition and prognosis. The 
same applies to other healthcare practitioners.” In the absence of a gatekeeping 
system patients have unrestricted access to medical specialists outside hospitals. In 
practice, provider choice is restricted by the limited number of providers outside the 
Capital Region.  
The government operated website www.island.is provides user oriented information on 
where to seek different types of healthcare services. The Directorate of Health (DH) 
maintains a list of all licensed healthcare facilities under Article 26 of the Health 
Service Act, which can be consulted on its web site. Also healthcare facilities in health 
regions and those of Primary Health Care of the Capital Area have an obligation to 
keep users of services informed of the activities of their facilities (Article 12 Health 
Service Act). Based on the Directorate’s role in monitoring health services and 
healthcare practitioners and fostering quality development data on waiting times and 
other performance-related information is gathered (Article 4 Act on the Medical 
Director of Health and Public Health) and made available to the public. While the DH 
keeps a register of medical misconduct and medical errors, these data are not 
systematically published. However, incidences of medical error or medical misconduct 
often enter the media either via coverage of a particular court case or as a result of 
freedom of information applications (Act No. 50/1996). 
 
IRELAND 
General context 
The approach to patients’ rights in Ireland is a mix of legal and quasi-legal 
approaches. The framework consists of a mix of legislative instruments, disciplinary 
codes for health practitioners, health policy documents, and guidelines from the Irish 
national health service provider (HSE). Some of the fundamental patients’ rights such 
as the right to self-determination, right to privacy and procedural rights largely arise 
from the jurisprudence of the Irish Supreme Court in interpreting the Irish 
Constitution 1937. As consumer rights (e.g. information and choice) are newer rights, 
they tend to be based on legislation, which also provides for legal mechanisms of 
enforcement. The development of patients’ rights in Ireland is mainly driven by 
national reform strategies, reports and controversies in the media, and constitutional 
jurisprudence of the courts.  
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Self-determination & confidentiality 
The right to consent is recognized through case law (e.g. Walsh v Family Planning 
Services & ors [1992] IR 496; Geoghegan v Harris [2000] IR 536; Fitzpatrick v White 
[2007] IESC 51), policy documents (e.g. Health Service Executive National Consent 
Policy, 2013), and disciplinary codes (e.g. Medical Council’s Guide to Professional 
Conduct and Ethics, 2009). There is no requirement for consent to be written, though 
some practitioners prefer this form. Information should be clear and comprehensible 
and tailored to patients, including alternative treatment options. There is a right not to 
know. In terms of participation, there is a National Strategy for Service User 
Involvement. There are no specific cross-border patient provisions, but translation is 
available where necessary; “a professional interpreter should be sought rather than 
relying on the patient’s family or carers.” Reforms are in progress with regard to 
capacity. Enforcement is via general complaints mechanisms. 
The right to privacy is a constitutional right, but it also provided for in Data Protection 
and Freedom of Information Acts. No specific cross-border patient provisions. The 
main issues reported relate to use of data in specific contexts such as clinical audit, 
teaching activities and research. Enforcement is via the Data Protection Commissioner. 
The right to access one’s medical records is provided in the Freedom of Information 
Acts 1997-2014 and in the Data Protection Acts 1998-2003. Access to records is 
straightforward: they are available via written request for a 6 euro fee within 40 days. 
There are limited exceptions to release of data. Enforcement is via the Data Protection 
Commissioner or the Freedom of Information Commissioner.  
Quality & safety 
In Ireland, quality and safety is not described as a legal right as such but rather a 
standard of care that patients/service users are entitled to expect. The HSE has 
published a National Charter which sets out what patients can expect from their health 
service: At present there is no licensing system for healthcare facilities such as 
hospitals but this is expected in 2016. The standards with which healthcare facilities 
will have to comply are set by the Health Information and Quality Authority and these 
set out clearly the expectation of patients and the public in relation to safe and quality 
treatment HIQA carries out announced and unannounced site inspections in relation to 
matters such as hand hygiene and publishes its reports online. The Department of 
Health publishes clinical guidelines on a range of topics including MRSA, early warning, 
clinical handover etc. The HSE has a dedicated division for patient safety which 
publishes guidelines on matters such as risk management, audit, and clinical 
governance: There is also a national patient safety initiative through which healthcare 
organisations declare their ongoing commitment to patient safety.  
Waiting periods are a big source of controversy in Ireland due to the budgetary cuts 
sustained by the health service during the economic recession. The National 
Treatment Purchase Fund is responsible for the collection, collation and publication of 
in-patient and day case waiting lists. All public hospitals have the responsibility to 
ensure they meet the maximum waiting time guarantees for their patients. These 
admission targets are 8 months for adults, 20 weeks for paediatrics, 13 weeks for 
endoscopy and 12 months for first outpatient appointment. There is no specific avenue 
for patients to challenge waiting lists but they could complain to the Ombudsman  
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The HSE states that any service which is provided by the public health services in 
Ireland can be availed of under the Cross Border Directive.  
Choice 
Where private patients can freely choose their healthcare provider, patients treating in 
the public sector are more limited in their choice. They may choose a GP from a panel 
of GPs in their area who have contracts with the Health Service Executive (HSE) to 
provide general medical services. For patients holding a medical card or a GP Visit 
Card, which entitles them to care free of charge, choice may be restricted to those 
providers operating within the Primary Care Reimbursement Scheme (PCRS). Patients 
usually may only be referred to specialists by their GP and may discuss any choices 
available in that regard with the GP depending on which specialists provide services 
within the public system.  
The HSE provides a map of health services available in each geographical area which 
may accessed by patients (www.hse.ie/eng/services/maps). Under supervision of 
professional regulatory bodies such as the Medical Council and the Competition and 
Consumer Protection Commission, individual providers may publish information 
relating to their service as long as it is factually accurate and not misleading. Patients 
may access information relating to fitness to practice or any disciplinary sanctions 
imposed on practitioners through the professional regulatory bodies. Data on waiting 
times are collated by the National Treatment Purchase Fund (NTPF) as part of the 
government’s health reform strategy. The NTPF is designed to ensure that public 
patients who have been waiting excessively long for treatment have the choice to 
obtain, at public expense, treatment in the private sector either in Ireland or abroad.  
The right to a second opinion is provided in the Medical Council’s Guide to Professional 
Conduct and Ethics (para.60). In practice, the patient has to ask the doctor to refer 
him to another provider and to make copies of medical records available for that 
purpose. A second opinion may be sought in private settings, but in public setting 
choice may be limited depending on which specialists are available. It may include 
doctors in other member states. 
 
ITALY 
General context 
Italy doesn’t have a specific law on patients’ rights. They are mostly derived from the 
fundamental right to health contained in Article 32 of the Constitution and the general 
principles of dignity, solidarity, autonomy and professionalism that underpinned the 
institution of the National Health Service in 1978. Several rights are explicitly 
encompassed in the law establishing the National Health Service (833/1978) and the 
Code of Ethics of Physicians (last update in 2014). Fundamental patients’ rights have 
been steadily implemented by statutes, public interventions and judicial enforcement 
expanding both their scope and effectiveness. More consumer-oriented rights have 
undergone an increasing revision/curtailment due to increasing financial constraints. 
Several initiatives at national and local level aim at raising patients’ rights awareness. 
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Self-determination & confidentiality 
The right to informed consent is expressly stated in the act that ratified the Oviedo 
Convention 1997 (Italian Act n. 145/2001). However, a legal framework including 
Constitutional principles, statutory laws, case-law and soft law had already be defined 
it. Fundamental rights are expressed in the constitution. Consent is usually given 
verbally. Information must be comprehensive, including risks of different treatments 
and of non-treatment. Explicit right not to know. Final decision on treatment lies with 
patient. No specific SBP provisions, but services designed to break down language and 
culture barriers. Challenges regarding Jehovah’s Witness refusal of blood, and the 
issue of whether even competent patients are making rational decisions. Supreme 
court ruling means that failure to respect right to consent can result in criminal 
sanctions. 
Right to privacy. Code of Data Protection states that everyone has the right to 
personal data protection. Same code guarantees this to CBPs as well. Data Protection 
Authority strictly protects data, criminal sanctions available. 
Data Protection Code also enshrines right to access records, obtain a copy and alter 
records. Access regulated by medical institutions. Record storage fragmented between 
providers. DP Authority has guidelines on e-records. 
Quality & safety 
The right to quality of care emerges from several statutes dealing with specific 
services and in the CME. Law no. 502/1992 explicitly deals with quality of assistance 
and treatments apportioning the tasks of ensuring and monitoring them between the 
State and the Regions. Quality assurance and risk prevention in healthcare delivery 
are mutually related which requires healthcare facilities to analyse clinical risks, 
envisaging and putting in place solutions necessary for their management, bearing in 
mind dispute prevention and reduction of insurance costs. The contours of the quality 
of care are defined by the CME in several norms, in terms of continuity of care, 
professional quality, and patient safety and clinical risk management. It is compulsory 
for every healthcare professional to improve their knowledge through Continuous 
Education in Medicine (CEM). Against this background, in Italy, accreditation is an 
activity that promotes and verifies the level of excellence in consideration not only of 
the minimum requirements stipulated in national laws but also in consideration of the 
services provided. Accreditation is conditional to regular assessment of the quality of 
the organizational, managerial and technological infrastructure of healthcare providers 
and of the skills and practices of health professionals. 
The National Plan on Waiting Lists 2010-2012 published some guidelines to monitor 
waiting times. In particular, performances and services are divided in class of priority: 
Urgent <72h, <10 days, <30 days, <60days, to be planned. The referral operator is 
entitled to identify the class. At least in theory when a public entity is involved their 
decisions can be challenged before an administrative court or if there is a risk an 
injunctory relief can be requested to an ordinary court. Such a procedure has been 
historically used in cases of doubts on the appropriateness of a treatment (see for 
instance the so called Stamina litigation). 
Cross border health care is subject to prior authorization only when: a) it is subject to 
planning requirements relating the goal of ensuring, in the national territory, sufficient 
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and permanent access to a balanced range of high quality care or to the intention to 
ensure the supervision of costs and avoid, as far as possible any wastage of involves 
treatments presenting a particular risk for the patient or the population; or c) it is 
provided by a healthcare provider that could raise serious and specific concerns 
relating to the quality or safety of the services provided.  
Article 10 of the Act 38/2014 states that against a refusal of authorization, a patient 
could make a complaint before the General Director of the ASL within 15 days. The 
Director should answer then in the next 15 days or the patients can file a case before 
both an administrative and ordinary courts. 
Choice 
The organic law establishing the national health service SSN (Act 833/1978) as well as 
the Code of Medical Ethics (Article 27) recognise a patient’s right to both freely choose 
a physician and to freely choose among the proposed treatments. However, this right 
must be exercised within the limits provided for by law, especially those pertaining to 
the organization of the delivery of healthcare. This means that choice is restricted to 
those facilities and accredited professionals with whom the SSN has established 
specific relationships. Also the organizational rights of each local health authority 
(ASL) and the availability constraints have to be taken into account. Patients can 
either receive treatment within the ASL of their place of residence or in another ASL 
(in the same Region or in another Region) (Article 8ter and following D.L. no. 
502/1992), in which case the ASL of residence will pay for the services. Every citizen 
can choose his or her GP or paediatrician at any time, provided that the number of 
registered patients on his list has not reached the allowed maximum (1,500 for GPs 
and 800 for paediatricians). This choice is effectively valid for one year and is tacitly 
renewed, but patients can change at any time. Doctors must accept all patients and 
can only refuse a patient or remove them from their list due to exceptional and proven 
reasons of incompatibility (see also Article 28 Code of Medical Ethics). The primary 
care physician acts as a gatekeeper to higher levels of care. Only some types of 
specialist care, like dental care, obstetric and gynaecological services are accessible 
without referral. Direct access is also guaranteed for private (intra-moenia) specialist 
services without public coverage. Given the level of decentralisation, the degree of 
choice may vary between Regions, with some Regions (e.g. Lombardy) having opened 
provision of health care to private actors. Within the hospital patients do not have the 
right to choose their treating hospital specialists. 
To facilitate the provider choice the Italian Ministry of Health has a statutory duty to 
publish and regularly update the list of all public and private institutions that provide 
high-performance medical specialities, indicating the availability of high-tech 
equipment as well as the prices for the most relevant services (Article 14. 6, of D.L. 
30 December 1992, no. 502). The National Plan on Waiting Lists 2010-2012 published 
guidelines to monitor waiting times (Article 50 Act 326/2003).Information regarding 
waiting times can be retrieved from a central booking service (Centro Unico di 
Prenotazione – CUP). CUP operators can suggest both public and private accredited 
hospitals where a specific intervention would be available sooner. As to performance 
and quality of health services, the National Health Outcomes Programme since 2009 
develops an articulate system of indicators. While these data are not publicly 
accessible a research-driven initiative was started late 2013 to publicly report health 
outcomes data (www.doveecomemicuro.it).  
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The right to second opinion is not explicitly recognised within the public health service 
and each local health authority and public hospital has developed their own protocols. 
In some cases the right to second opinion is limited to specific conditions with a list of 
specialists per pathology. For patients suffering from a rare disease (or for whom a 
suspected diagnosis of rare disease was made) a clinical evaluation by experts of the 
National Network for Rare Diseases is possible (Art. 9 para 4 of law 38/2014). If no 
experts can be found within the national territory - or if the expert’s opinion is 
inconclusive - scientific advice can be asked to foreign expert centers.  
 
LATVIA 
General context 
Patients’ rights development in Latvia only started in 2000, when a group of lawyers 
and healthcare professionals established the „Patients’ Rights Office”, a small NGO 
supported by international private and public donors. While some issues, like the right 
to health care and the treatment of patients with mental illnesses, were already 
regulated by the 1997 Medical Treatment Law, the first real Patients’ Rights Law came 
into force in March 2010. However, the traditional paternalistic model of doctor- 
patient relationship still prevails in many respects and there is still a considerable gap 
between the legal situation and real practice. Patients’ rights are sometimes 
considered in opposition to “doctors’ rights”. Despite of a poor knowledge about 
patients’ rights they attract a lot of media coverage and public interest. They are more 
based as fundamental patients’ rights rather than consumer oriented rights. 
Self-determination & confidentiality 
The right to consent is recognized in the Patient Rights Law, but the patient does not 
have a right to choose treatment: “if several types of medical treatment are 
permissible, a patient has the right to the professional choice of the physician”  The 
right to self-determination and right to choose are limited by the obligation to comply 
with doctors’ instructions. In many cases requirements of the Patient Rights Law are 
not fulfilled. Some hospitals require patients to sign a general consent in order to be 
treated in hospital. There is a right to relatively basic information: “A patient has the 
right to receive information regarding his or her state of health from the attending 
physician, including regarding the diagnosis, the plan for medical treatment, 
examination and rehabilitation of the disease, the prognosis and consequences, the 
functional restrictions caused by the disease and the opportunities for prophylaxis, as 
well as the right to receive information after examinations and surgical or other type 
of invasive intervention performed within the framework of medical treatment 
regarding the results of the medical treatment, regarding the previously unforeseen 
outcomes and the reasons thereof.” (Article 4.3) There is no entitlement to be 
informed of different treatment options, and no right to participation in decision-
making other than the right to consent to a specific treatment. There is a right not to 
know but no specific provisions for cross-border patients. The National Health Services 
states that the “key obligation of the patient is to care for their health and get actively 
involved in the treatment process, and to provide the doctor with all information 
necessary for the treatment.” No reforms are currently proposed and there are no 
specific enforcement remedies if rights are not respected. 
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There is no specific right to privacy; in the Patient Rights Law any such rights are 
covered by the right to data protection. There is, however, a right to receive 
treatment in privacy. There is also no legal obligation to respect confidentiality, though 
there is an administrative penalty of up to EUR 350 for breaches and misuse of data 
can be in breach of the Criminal Code. (“Previously such obligation was stated by the 
Medical Care Act, Art. 50.1., but since the PRL was enacted, the relevant article was 
removed.”) There are no specific provisions regarding cross-border patients. Right to 
privacy is a particularly challenging issue in Latvia, where breach of privacy is a “daily 
practice”. There is some case law relating to privacy. Enforcement is via the Health 
Inspectorate or State Data Inspectorate. 
The Patient Rights Law provides a right to access and alter records and obtain copies. 
Written request is required. In practice there may be difficulties in obtaining records, 
as some hospitals try to restrict access. Copies should be free but some institutions 
charge. There are no provisions for cross-border patients and all medical records are 
written in Latvian. No research publications are known to exist on the topic of access 
to records, but there is some case law. Enforcement is via the State Data 
Inspectorate. 
Quality & safety 
The right to safe and quality treatment received in a timely manner is formally 
recognized. The PRL, Section 5.2 provides: “A patient has the right to a respectful 
attitude and qualitative and qualified medical treatment regardless of the nature and 
severity of his or her disease.” The PRL, Section 5.4 provides: “A patient has the right 
to timely medical treatment. A medical treatment institution, to which the patient has 
turned, shall provide information regarding the opportunities and terms for the receipt 
of medical treatment, as well as regarding other medical treatment institutions where 
appropriate medical treatment may be received.” The Medical Treatment Law, states: 
“Medical treatment shall be performed in conformity with clinical guidelines or by 
methods used in medical treatment and an evaluation of the safety of use of medicinal 
products and the effectiveness of the medical treatment, which is performed taking 
into account medical principles based upon evidence. To assure control over the 
quality of the provided healthcare services, the healthcare institution shall develop, 
approve, and implement a quality management system that ensures continuous 
control. The following shall be entitled to provide healthcare services in the respective 
profession independently: 1) Registered healthcare professionals. 2) Persons listed in 
the Registry of Health Care Professionals and Medical Support Staff. The Health 
Inspectorate of Latvia is a state administrative institution supervised by the Ministry of 
Health of the Republic of Latvia. One of its functions is to supervise the 
implementation of the laws and regulations governing healthcare institutions, and to 
check the quality and capacity of professional healthcare services. 
Since January 2015 there are waiting times for medical care in few cases stated by the 
Regulations of Cabinet No. 1529. It is stated that a visit to a General Practitioner 
should be provided within 5 working days. Furthermore it is provided that the first 
consultation of an oncologist or haematologist should be provided within 10 working 
days, however waiting time for required diagnostic procedures or following 
consultation is not stated. It is stated that a person with predicted disability should 
receive required ambulatory or rehabilitation care services required in the Individual 
Rehabilitation Plan within 15 working days and planned operations within 5 month. 
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There is no system established for a patient to challenge decisions about waiting times 
besides a general right to dispute.  
According to the Cabinet Regulations No. 1529, prior authorization should not been 
granted where the NHS has been informed about potential dangers for the person 
while receiving healthcare services abroad, as well as when there are serious concerns 
regarding the quality of service and safety in a particular healthcare institution. 
Currently, there is no comprehensive quality management system that encompasses 
reliable quality indicators and mechanisms for monitoring and continuous quality 
improvement. Analysis of health service outcomes and quality of care is hampered by 
lack of data on key indicators, such as patient safety, both at national and 
organizational level.  
Choice 
The right of free choice of provider has existed since 1991 and is guaranteed under 
Latvian law (Article 8 Law on the Rights of Patients 2010). In principle choice applies 
to all providers but in the context of state-covered healthcare choice is limited to the 
list of contracted providers. Patients can freely choose their family doctor, provided 
the maximum number of patients to be treated according to his contract has not been 
reached yet. The GP acts as the main point of entry into the health care system and as 
the gatekeeper to secondary ambulatory and hospital care, except some specialist 
services (e.g. paediatrician) for which no referral is needed. In practice choice in the 
statutory system is often limited, in particular in rural areas, because of waiting lists 
and unavailability of alternative providers to choose from.  
Information for patients from reliable sources, especially on quality of care, is still 
limited. However, Article 4.1 of the Patients’ Rights Act states that “a patient has the 
right to information regarding the opportunities for the receipt of health care services 
and the procedures for the payment for health care services. This information shall be 
available to the public.” General information about health care services, prices and co-
payments ceilings is provided by the National Health Service, mainly through its 
website or call center. Also medical facilities provide general information to patients, 
such as registration status, the identity of practitioners, available services. Outpatient 
institutions are also obliged to publish a price list. The NHS is collecting data on 
waiting times every month but information is difficult to obtain. The Patients’ Rights 
Act guarantees a patient’s right to information about the quality of care but 
information is limited. The Centre for Disease Prevention and Control only publishes 
outcome data as general health/disease statistics. Some institutions give information 
that they have been implementing a quality management system and/or provide 
healthcare services of high quality.  
The right to second opinion only exists for private patients. There is no legal provision 
to enforce it within the statutory health system.  
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LITHUANIA 
General context 
Patients’ rights in Lithuania are well-established and patient-oriented. The Law on the 
Rights of Patients and Compensation for the Damage to Their Health No I-1562 was 
adopted in 1996. It contains a mix of fundamental and more consumer-oriented 
patients’ rights. Certain elements (e.g. access to medical records) are further specified 
through governmental executive acts. Also relevant provisions are found in the Civil 
Code. Patients are familiar with the means of redress in case damage is caused to 
their health and they do know the means of enforcement of their rights, like the 
complaints procedure with the State Health Care Accreditation Agency. Also 
competent state authorities provide information to patients on patients’ rights, health 
care providers, pricing etc. Patients’ rights are constantly debated in the media and in 
Parliament. 
Self-determination & confidentiality 
The right to consent is protected by Chapter III of the Law on the Rights of Patients 
and Compensation for Damage to their Health, and by Section Two of Chapter XXXV of 
the Civil Code of Lithuania. Written consent is required for surgery. The right to 
information is broad and must include alternatives. There is a right not to know. There 
are no special provisions for cross-border patients but translations should be made 
available. There has been some case law and several academic articles. No specific 
remedies or enforcement avenues exist. 
The right to privacy is enshrined in Article 22 of Constitution of Lithuania and Article 
2.23 of Civil Code of Lithuania. It is also protected by Articles 8 and 9 of the 
aforementioned Law on the Rights of Patients. Written consent is required for 
disclosure. There are no special provisions for cross-border patients. There are fines 
for illegal processing of data (Code of Administrative Offences) as per the Law on 
Legal Protection of Personal Data. (ranges from 104 to 289 Euros.) 
The right to access/amend records is protected by Article 6.735 of the Civil Code of 
Lithuania, Article 7 of the Law on the Rights of, the Order of the Minister of Health of 1 
July 2011 No V-658 on the Implementation of the Right of the Patient to Get 
Acquainted with Information in Medical Records. Written requests are required, and 
data released within 10 days. No relevant case law exists, and there are no specific 
enforcement remedies. 
Quality & safety 
The Lithuanian Law on the Rights of Patients and Compensation for the Damage to 
their Health determines that the patient shall have the right to high quality health care 
services. The same law provides the following definition of high quality health care 
services: accessible, safe, efficient health improvement, disease prevention, 
diagnostic, patient treatment and nursing services which are provided to an 
appropriate patient at an appropriate time and place by an appropriate health care 
professional or a team of health care professionals according to the level of modern 
medical and nursing science and good practice, taking into account the service 
provider’s possibilities and the patient’s needs and expectations by satisfying or 
exceeding them. Health care service providers and health care specialists (broadly 
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speaking) must obtain a license in order to perform their activities. The licenses issued 
for health care institutions are registered in the special public register. The work of 
health care specialists (broadly speaking) is also regulated by the laws, namely, 
special medical standards approved by the Minister of Health which are special legal 
provisions that are supposed to regulate doctor activities in treating a disease or a 
group of diseases. These medical standards include the professional, qualification 
requirements for each of health care specialists, their working field, etc.  
In practice, timely treatment is a problematic aspect in Lithuanian health care system. 
In order to provide solutions, the Minister of Health adopted an order. It imposes a 
duty on health care service providers to provide information about the waiting lines for 
the appointments with various health care specialists. This information should be 
provided to the Territorial Health Insurance Fund. However, the mentioned Order does 
not provide information about the acceptable or waiting times for the appointment 
with the doctor. 
The Commission set for cross-border care can refuse to issue the prior authorisation in 
the following cases: 1) when the requirements set in Article 20(2) of the Regulation 
(EC) No 883/2004 of the European Parliament and the Council of 29 April2004 on the 
coordination of social security systems are not met or 2) or if the same treatment can 
be provided timely Lithuania, according to a person's health status and the expected 
course of the disease. 
In the majority of cases the quality of treatment provided by the health care 
specialists and their responsibility are challenged in the courts. The Supreme Court of 
Lithuania has established the criteria according to which the actions of health care 
professionals/physicians have to be evaluated and also stated that not only the legal 
acts regulating the activity and practice of particular health care specialists has to be 
taken into account but also the provisions of professional ethic of health care 
specialists. 
As regards the quality of the health care service, it can be challenged according to the 
procedure set in Articles 23 and 24 of Law on the Rights of Patients and Compensation 
for the Damage to Their Health. 
Choice 
The right to choose a health care professional and health care institution is stated as a 
basic principle of the health system (Article 49(3) Law on Health System of Lithuania 
No I-552 of 19 July 1994) and a patient right (Article 4 of the Law on the Rights of 
Patients and Compensation for the Damage to Their Health). However, when 
exercising this right of free choice the patient’s right to receive free of charge health 
care may be restricted in accordance with the procedure established by legal acts. In 
practice, free choice is limited to health care institutions and health care specialists 
belonging to the Lithuanian National Health System. The procedure for choosing a 
health care professional shall be established by the head of the healthcare institution. 
Since 2001 patients need to register with a GP or a primary care institution but they 
can change every six months (Order of the Minister of Health No 583 of 9 November 
2001 on Regulation of Enrolment of Persons to the Primary Health Care Institutions). 
Except for dermatologist/venereologist and psychiatrists, patients need a signed 
referral by their GP to access specialist care free of charge. Patients can also opt to 
consult private providers or seek specialist care without referral but in that case they 
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will pay the fee. This also counts for the patient seeking a second opinion from 
another specialist of the same professional qualification. In reality, the formal choice 
of primary and secondary care providers depends on actual availability and is 
sometimes rather theoretical, especially in rural areas.  
The National Health Insurance Fund (NHIF) and the State Health Care Accreditation 
Agency provide information about providers, including information on waiting times. 
Also providers present their services on web site but many of these websites are not 
very suitable and useful for helping patients to make an informed choice. NGOs and 
patient associations are particularly active in this field and competent to provide 
objective information to patients. 
 
LUXEMBOURG 
General context 
The development of patients’ rights in Luxembourg started with the Law of 28 August 
1998 on hospitals, which defined a catalogue of patients’ rights applicable in the case 
of hospital care. In 2005, the Deontological Code of the Medical Profession, which is 
legally binding, recognized main patients’ rights to be observed by all medical doctors. 
While this was followed by other healthcare professions, these obligations were still 
essentially provider-oriented and very well known by the patients. Inspired by the 
patients’ rights law in Belgium and France – and to some extent also the Directive on 
cross-border care - the law of 24 July 2014 relating to the rights and obligations of the 
patient was finally adopted. Next to these patient rights, which are now generally well-
established, also some more consumer-oriented rights with a long tradition in 
Luxembourg (e.g. second opinion, free choice of provider) are well accepted and 
enforced. Informational rights are more weakly enforced and there is only very limited 
transparency about quality of care. 
Self-determination & confidentiality 
Article 8 of the Patient Rights Law enshrines the right to information about one’s 
health, the right to informed consent and the right to participate in decision making. 
This new law anticipates “a collaborative model of healthcare delivery”. In theory, 
consent should be express but in practice it is often implied. The burden of proof that 
consent was properly obtained lies on professionals, and doctors strongly oppose this; 
“proof can be provided by any means and establishes a rebuttable presumption in 
favor of the documentation contained in the patient file.” Comprehensive information 
including all options must be provided and the right not to know must be respected. 
Patients can be more passive if they wish and are entitled to choose third persons to 
aid in decision-making. No special provisions for cross-border patients, with 
information provided in one of three official languages, but translations are permitted. 
There is some evidence that patients receive less information than patients elsewhere 
in EU. In terms of enforcement, there are no specific remedies. 
The right to privacy is protected by the Patient Rights Law, by the Constitution, the 
law concerning protection of private life, and the data processing law. Article 3 of the 
Patient Rights Law protects principles of “of respect for the patient’s private life, of 
privacy, of confidentiality as well as of religious and philosophic convictions.” Explicit 
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consent is required for sharing of data. Luxembourg is about to launch a new eHealth 
records system, and is taking part in the EXPAND cross-border project. The aim is to 
make cross-border patient data sharing more efficient. Breach of confidentiality is a 
criminal offence under article 458 of the Penal Code. 
The right to access and amend records is protected by Article 16 of the Patient Rights 
Law. Copies of records are available, and a fee is sometimes required. Personal notes 
from doctors can be exempted from disclosure. Any access request must be granted 
within 15 days. 
Quality & safety 
According to the patient rights law, patients have the right to a safe and quality 
treatment and an equal access to health care. The Health Scientific Council issues 
recommendations for good medical practice standards. For hospital services, each 
hospital has a Quality Evaluation Committee which assesses how well the hospital 
functions and the quality of its services. Patients are thus generally not well informed 
about the quality achieved and are not able to detect where quality might be lacking 
There is no national organism defining today acceptable waiting times for a treatment 
or matters concerning periodization.  
In practice, prior authorization is granted very largely (in over 90% of requests) and – 
although not formally foreseen in legislation – de facto granted if a specific treatment 
could be provided under better conditions abroad. 
Choice 
The right to free choice of provider is enshrined in article 19 of the Luxembourg Social 
Security Code and article 5 of the patient rights law, which specially stresses that the 
initial choice may be modified at any time. Luxembourg patients are very much 
attached to the principle of free patient choice, which applies not only to the primary 
health care provider but also to secondary care. A reference physician model 
(“médecin référent”) was introduced as a soft gatekeeping model by the 2010 
healthcare reform law but this is not mandatory and only serves as guidance. Given 
the limited size of the country, choice is sometimes limited in some specialties. In 
practice, however, Luxembourg generously allows access to healthcare abroad. 
The patient rights law created a patient information and mediation service that should 
have become operational since May 2015 (www.mediateursante.lu). It is open to both 
domestic and cross-border patients and provides general information as mentioned in 
Directive 2011/24. Next to a health portal under the direction of the Ministry of Health 
(www.sante.lu) a web directory of all licensed healthcare providers and their right to 
provide service is available (www.esante.lu). It will be further enhanced with a geo-
localization feature and information about languages and accessibility for persons with 
disabilities will be added. Providers are legally required to provide information on 
quality and safety of healthcare if available, including the number of medical 
procedures treated and the number of incidents (Article 8 (4) subparagraph 5 of the 
PRL). An important challenge is that there is no consistency in the availability, 
readability and objectivity of information provided due to the lack of an agreed, visible 
and applied national information strategy. Especially information on the quality of 
health services is poorly available to the public and information about medical errors is 
mostly not accessible at all. Consolidated objective data about outcomes is partly 
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accessible through the “carte sanitaire”, a publication that serves as a tool for the 
strategic orientation of the hospital sector. Furthermore some data about general 
patient satisfaction or other outcomes is publicly available through the annual reports 
of the main hospitals. However, these data are controlled by the providers and not 
necessarily comparable between providers. Patients are thus generally not well 
informed about the quality level achieved and where quality might be subject to 
caution. 
 
MALTA 
General context  
Malta doesn’t seem to have a patients’ rights framework. Only some special laws cover 
certain aspects like the legal acts on data protection or health care professions. The 
recent Health Act states that a patients’ rights Charter should be developed but this is 
not yet implemented. The cross-border care Directive may have had some influence in 
this respect. 
Self-determination & confidentiality 
The right to consent is recognized in the Health Act and in the Civil Code. Written 
consent is required for procedures, but verbal consent sufficient for out-patients and 
general consultations. There are no specific information requirements and the 
reasonable person standard is used (although not required in law). The Health Act and 
the Patients’ Rights Charter enable patient participation. The cross-border treatment 
of patients law is still being drafted as a bill; it was originally to be added to the health 
act but it is still to be implemented due to delays. Enforcement is via the Ombudsman 
for Patients’ Rights or recourse to the courts. 
The right to privacy is stipulated in the Data Protection Act, which imposes a legal 
obligation with some exceptions (danger to others, under Mental Health Act). Patients 
are usually informed about datasharing but it is only implied that consent should be 
sought. There are not yet any cross-border patient provision and there is no health 
related data protection case law. Enforcement is via the Data Protection Act or the 
constitution. 
The right to access records is stipulated in the Data Protection Act and in the Health 
Act (Article 28). Records are usually accessed indirectly through a doctor or lawyer. 
Data can be corrected or erased but not added to. There is no right to a copy, 
although they are sometimes provided. No cross-border patient provisions yet. 
Enforcement via Data Protection Commissioner or courts. 
Quality & safety 
Quality and safety is not yet specified in Maltese law. There are no defined waiting 
times. People can write to consultants through their GPs. Patients with more severe 
diseases are given priority; urgent cases such as cancers are treated immediately. 
This has its toll on waiting lists. For a review of a certain decisions patients can write 
to the Ombudsman.  
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Choice 
Free choice of healthcare in Malta mainly relates to the private sector, which accounts 
for about two-thirds of the workload in primary care. Most patients choose their own 
private family doctor and are willing to pay out-of-pocket because it offers greater 
convenience and better continuity of care. They can also self-refer to any private 
specialist of their choice. The state primary health-care system is offered mainly 
through eight public health centres and local health clinics. These services are free of 
charge but choice of the individual doctor is limited. The same applies for secondary 
care. People have access free-of-charge to out-patient or in-patient specialist care in 
public hospitals but need a doctor’s referral (either from a public or private provider). 
A preference for a particular specialist can be specified in the referral but waiting time 
for an appointment depends on the urgency of the case. Since 2009 under the 
“Pharmacy of Your Choice” scheme patients government-procured pharmaceuticals are 
also supplied through private retail pharmacies and patients can collect their 
medicines from any pharmacy of their choice. 
Under the supervision of the Medical Council, providers are required to provide 
information to patients. However, there are no legal requirements to publish data on 
performance, waiting times and prices. The right to second opinion is not formally 
stated in the law.  
 
NETHERLANDS 
General context 
The Netherlands were the first European country to codify patients’ rights as part of a 
medical treatment contract between patient and healthcare provider within its Civil 
Code. The Medical Treatment Contract Act that entered into force on 1 April 1995 was 
the result of a movement that started already in the 1960s with the establishment of 
health law as a new legal discipline, later followed in 1983 by the enactment of two 
new constitutional rights to privacy and physical integrity. The Dutch legal framework 
that is completed by other general and specific legal norms, also leaves room for the 
development of instruments of professional self-regulation. More recently,  a draft 
Clients’ Rights Care Bill is being discussed containing rules aimed at ensuring a good 
and effective complaints and disputes management in healthcare as well as promoting 
the quality of care. With the 2006 healthcare reform the Dutch healthcare system 
assigned a more significant role to patients with greater opportunity for them to 
influence the quality of services and a more pronounced right to receive information 
needed to make an informed choice of healthcare provider. 
Self-determination & confidentiality 
The right to consent is enshrined in Article 7:448 in conjunction with Article 7:450 of 
the Act on the Medical Treatment Contract as part of Book 7 of the Dutch Civil Code, 
which entered into force on 1 April 1995. Right to consent generally recognized as 
following from the constitutional right to physical integrity, protected by Article 11 of 
the Dutch Constitution. Consent to treatment is separate from consent to enter into a 
treatment contract. Other specific laws are also relevant (Organ Donation Act, and the 
Medical-Scientific Research with Human Subjects Act.). Written consent is not required 
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unless the patient requests it, although the practitioner may wish to obtain written 
consent for surgery etc. Consent can be presumed for non-invasive actions. 
Information can be provided verbally but must be given in written form if requested 
and must include what the “reasonable” patient would wish to know. Written 
information can never replace the requirement of verbal information; written 
information is then always provided in addition to the verbally provided information. 
There is a right not to know (Article 7:449 of the Act on the Medical Treatment 
Contract). Dutch government policies ‘strive’ towards patient participation. No specific 
cross-border patient provisions but translations must be provided to meet information 
criteria. Useful evidence is available in the Evaluation of the Act on the Medical 
Treatment Contract, which was performed in 2000. There is a large body of case law. 
Enforcement is via a complaints officer, complaints mediator, or healthcare institution 
complaints committees as regulated by the Clients’ Right of Complaint (Care Sector) 
Act, and health professional disciplinary courts. 
The right to privacy is protected by Article 10 of the Dutch constitution and by civil, 
criminal and administrative law, as well as various professional codes (not only 
doctors have an obligation to respect confidentiality). Key protections are present in 
Article 7:457 of the Act on the Medical Treatment Contract, Article 88 of the Individual 
Healthcare Professions Act, and Article 272 of the Dutch Penal Code. The Personal 
Data Protection Act is also relevant. There are no specific cross-border patient 
provisions. In addition to the aforementioned enforcement options, the Dutch Data 
Protection Authority has powers (see Chapters 8 (Legal protection) and 9 
(Supervision) and 10 (Sanctions) in the Dutch Personal Data Protection Act.) 
The right to access records is guaranteed by Chapter 6 of the Personal Data Protection 
Act, with copies available subject to a fee. Patients can add notes of their own to 
medical records. No specific cross-border patient provisions. 
Quality & safety 
In the Netherlands, the laws relevant in the area of quality and safety of healthcare in 
general are the Care Institutions Quality Act and the Individual Healthcare Professions 
Act. Both Acts, together with the Act on the Medical Treatment Contract, could be 
seen as the core of the (quality) legislation in the area of Dutch health law. In 
addition, standards and guidelines on quality and safety of healthcare are also 
reflected in other, more specific laws, as well as in documents of professional elf-
regulation Regarding the Care Institutions Quality Act and the Individual Healthcare 
Professions Act, the Dutch legislator has set general standards, with broad outlines 
that leave room for self-regulation. As such, both Acts place great responsibility on 
healthcare professionals and health institutions to ensure the delivery of appropriate 
and high-quality care. Directly related to quality healthcare is the general provision in 
the Act on the Medical Treatment Contract requiring the healthcare provider to act as 
a competent care provider and in doing so to comply with the responsibility emanating 
from the medical professional standard. 
The individual patient/ citizen should contact their own health insurer with a request 
for information about conditions to grant or refuse prior authorization for cross-border 
care. 
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Choice 
The right to have choice and to information that supports making informed choices 
was one of the “seven consumer rights in health care” that the Dutch government 
wanted to strengthen in its 2008 programme presented to Parliament. The right to 
free choice of provider in the Netherlands is derived from the right to self-
determination and relevant constitutional rights. In practice, the Dutch health system 
attributes a gatekeeping function to primary care physicians. Patients have to register 
with a GP and need a referral to obtain out-patient or in-patient specialist care. In 
principle they can freely choose their GP and can switch to a new one without 
restriction. However, GPs have the right to refuse a patient, e.g. when they already 
have too many patients on their list or when the patient lives too far from the practice. 
Choice can also be restricted by the health insurer. When choosing their health 
insurer, citizens can either opt for an in-kind policy, which guarantees them free-of-
charge health services from providers who have been contracted by the health insurer, 
or they can choose a restitution policy, which allows them to maintain free provider 
choice but limits reimbursement to a maximum level. Of particular importance is 
Article 13 of the Health Insurance Act (entered into force in 2006), which prescribes 
that if in the context of an in-kind policy the insured decides to choose a non-
contracted provider health insurers are also required to reimburse the services. In this 
case the insurer can determine the level of reimbursement but according to Dutch 
jurisprudence it should be sufficiently high that it remains a financially feasible option 
for the patient. (so-called “hindrance criterium”). The Dutch government has proposed 
to abolish the insurers’ obligation to reimburse non-contracted care, at least for 
secondary care, which would limit free choice of provider. In an advice to the First 
Chamber the highest administrative court has found this proposal consistent with 
European law, i.e. the Directive 2011/24. Also in long-term care patients can either 
opt to receive benefits in kind from contracted providers or receive a personal care 
budget with which he or she can individually purchase care from professional 
organizations, but also from family or other non-professionals. 
Healthcare providers are obliged to make information available about the services they 
provide and their performance (Article 38, Paragraph 4 of the Dutch Healthcare Market 
Regulation Act). Also Article 10 paragraph 1 of the proposed Quality, Complaints and 
Disputes Care Bill 1 imposes an information obligation upon the healthcare provider. 
This information concerns at least the tariffs and the quality of the services provided 
and should be provided in such a way that these data are easily comparable for 
consumers. Providers are also obliged to publish their tariffs for non-contracted care. 
They are also legally bound to transfer information about the quality of care to the 
Quality Institute for Healthcare, which is responsible for providing clear and reliable 
information to patients, providers and insurers. Various web sites present information 
to patients to make an informed choice of the provider, including the governmental 
National Health Care Institute (www.kiesbeter.nl) as well as the Dutch Patients’ and 
Consumers’ Federation (www.zorgkaartnederland.nl). The Dutch Association of 
Hospitals (NVZ) has developed the Quality Window that since May 2014 provides 
hospital and rehabilitation centre scores and data on indicators like waiting lists, 
credentials and patient experience. 
The right to a second opinion is derived from the free choice of provider. It is seen as 
part of the healthcare provider’s information duty to inform about ‘other possible 
methods of examination or treatment’ (Royal Dutch Medical Association). Except for a 
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second opinion about work incapacity, it is covered by statutory health insurance 
under the same conditions. This often means that a referral will be needed.  
 
NORWAY 
General context 
Norway has a Patients’ Rights Act (No. 63) since 1999. This was the result of a 
process that started already in the 1970 when the traditional provider-oriented 
approach gradually changed through media reports (e.g. the so-called “Reitgjerdet” 
case about unlawful detention in a psychiatric hospital), landmark decisions by the 
Supreme Court and the institution of health law as a separate legal discipline. As the 
health care in Norway is mainly publicly funded and provided by public entities, the 
Public Administration Act also plays an important role. This may have hampered the 
development of more consumer-oriented rights, even though the heading of the 
Patients’ Rights Act was revised in 2011, adding “users of care services”. Next to 
specific legislation on relevant issues such as patient injury, medical research, the 
Criminal Code as well as the 1999 Human Rights Act (No. 30) that incorporates 
various international human rights treaties, are also important sources. 
Self-determination & confidentiality 
The right to informed consent is expressed as a general rule in the Patients’ Rights 
Act, section 2-1. Specific laws also apply, for example the Mental Health Care Act, cf. 
sect. 2-1). In some areas consent is regulated separately (i.e. the Health Research Act 
(20 June 2008 No. 44) sect. 13 (medical research) and the Biotechnology Act sect. 2-
5 (medically assisted reproduction). There are no formal requirements for an 
“ordinary” consent. In certain contexts particular laws require written consent (such as 
the Biotechnology Act (5 December 2003 No. 100) sect. 5-4 (genetic testing) and the 
Mental Health Care Act sect. 2-2 (consent to being withheld in a psychiatric hospital 
for a limited time). Patient must have received the necessary information concerning 
his or her health condition and the content of the health care, including choice of 
treatment. Invasive treatment may be given when consent cannot be obtained if in 
best interests and consent would have been probable. There is a right not to know 
genetic information about oneself. The Patients’ Rights Act focuses on the right to 
participation. Cross-border patients have a right to translations according to the Act. 
Compensation for violation of rights is available.  
The right to private life has been protected in the constitution (section 102) since 
2014. The right to protection of medical records grew from pharmacy regulations and 
is also protected by the Patients’ Rights Act. There is a legal obligation under the 
Health Personnel Act to protect records, with violations punishable by up to three 
months in prison. Transgressions are also punishable via the Penal Code by up to 3 
years’ incarceration. There are no specific cross-border patient provisions. There have 
been several privacy cases in the Supreme Court.  
The right to access records on request is laid down in the Patients’ Rights Act and 
Health Personnel Act. Copies are available for EUR 10. “Shadow” health records are 
not permitted. There are specific procedures for altering and removing health data. 
There are no specific cross-border patient provisions. 
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Quality & safety 
The time dimension is two-folded in the specialized health care sector. If a patient is 
referred by a general practitioner to specialized health care, the patient has the right 
to an assessment within 30 days (to be reduced to 10 days by law 21 June 2013 No. 
79, this part of the amendment yet not in force), cf. the Patients' Rights Act sect. 2-2. 
If the disease is life threatening, the patient has the right to a swifter assessment, and 
some patients groups are have shorter, specific time limits. This regime does not 
apply to emergency health care. An evaluation shall be made of whether the patient 
has a right to necessary health care, and if so a time limit for the provision of health 
care shall be set. 
Health personnel shall conduct their work in accordance with the requirements to 
professional diligence and diligent care that can be expected based on their 
qualifications, the nature of their work and the situation in general, cf. the Health 
Personnel Act sect. 4. Health personnel must be authorized or have a license. 
For many groups of diseases the Directorate of Health has issued clinical guidelines. 
Quality indicators and waiting times are published on public web sites. Providers of 
health services are under an obligation to conduct internal controls. The main 
responsibility to monitor patient safety and quality policy is vested to the Norwegian 
Board of Health Supervision and is also responsible for administrative sanctions of 
health personnel. 
Waiting times for specialized health care services shall according to the Patients' 
Rights Act be set according to the patient’s individual needs. The three main factors 
for prioritization are the severity of the disease, the expected treatment outcome and 
cost. The patient has a right to appeal decisions on assessment on specialized health 
care. 
If the regional health enterprise has not ensured that a patient has received necessary 
health care according to the individual time limit, the patient obtaining an explicit 
authorization from the competent body (e.g. statutory health insurer, health 
authority) in order to get statutory reimbursement for healthcare services provided in 
another Member State than the state of affiliation is entitled to immediate health 
services, also outside the realm, The foreign health care provider must be authorized 
in the country where the treatment is taking place, and be a specialist in the field, if 
this is required for national treatment.  
The Norwegian Board of Health Supervision is regularly making investigations on the 
matter, and whether specialized health care is provided timely and of sufficient quality 
is often a topic discussed in mass media. 
The Patients’ Rights Act sect. 2-2, paragraph 2 stipulates that a patient that is 
considered to be entitled to necessary health care shall be notified on the outcome 
and the fixed time limit. This notification shall also include information about the 
possibility to appeal. 
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Choice 
The Patients’ Rights Act sections 2-4 establish the right to free choice of provider. The 
patient’s choice of his or her general practitioner is also guaranteed by Regulation No. 
843 (29 August 2012). Based on the RGP scheme introduced in 2001 people register 
with a regular GP of their choice, provided this GP still has available capacity. They can 
only change GP twice a year. Access to free-of-charge specialized health services 
(inpatient or outpatient) is subject to referral from a GP. Upon referral patients can 
freely choose the institution as long as it is either owned by a regional health authority 
or is contracted by. In some cases hospitals can refuse to admit patients coming from 
other regions in order to prioritize patients from the hospital’s own region. Recently, 
an amendment to the Patients’ Rights Act and the Specialist Health Services Act was 
approved in Parliament to extend choice of hospitals. This will give patients the right 
to seek treatment in all approved hospitals, public and private and treatments will be 
refunded according to fixed rates set in regulations. 
Although there are no specific legal requirements on clear and objective information 
about providers, the Health Directorate takes a leading role. The Norwegian 
information service "Fritt sykehusvalg Norge" (Free Hospital Choice Norway) provides 
up-to-date relevant information to patients about the different hospitals, including 
patient’s rights, waiting times and quality information. Also information on quality 
indicators is made available (https://helsenorge.no/kvalitetsindikatorer). In addition 
the Norwegian Patient Organization” (www.pasient.no) ) and various individual 
providers inform patients about available services. Patients who have received a 
referral may obtain information from the free hospital choice telephone service about 
waiting times for privately practising specialists within their home region. 
The right to a second opinion is also recognized by the Patients’ Rights Act. However, 
a referral from a GP is need and it is only allowed once for the same condition. 
Patients can freely choose from which provider they want to receive a second opinion 
within the limits as described above. 
 
POLAND 
General context 
It took a long time of institutional and mental acceptance for Poland to move away 
from the provider-oriented approach that was mainly based on the Professions of 
Physician and Dentist Act (1996) and the binding rules contained in the Code of 
Medical Ethics (1993). The new basic legal fundament of patients’ rights is the Act of 6 
November 2008 on Patients’ Rights and the Patient Ombudsman (Journal of Laws 
2009, No. 52, item 417 and No. 76, item 641). It contains a mix of fundamental and 
more consumer-oriented rights and introduces the notion of “collective patients’ 
rights”, modelled after the notion of “consumer collective rights”. All patients’ rights 
regulations are to be interpreted in compliance with the Polish Constitution of 1997. 
The rights-based approach facilitates the enforcement of the rights through a private 
law remedy, in particular compensatory remedy, based on the Civil Code. Despite of 
the presence since 2005 of a central body responsible for patients' interests - the 
Patient Rights Ombudsman - in the Polish Ministry of Health, the state of enforcement 
of patients’ rights is still considered to be weak in reality.  
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Self-determination & confidentiality 
The right to consent is laid down in the Physicians Act of 1996 (articles 32–35) and in 
the Patient Rights Act of 2008. Although the rules contained in the two Acts are almost 
identical, there are slight inconsistencies between them and the Patient Rights Act is 
the prevailing document. Consent can normally be oral but written consent is required 
for surgery (though the law is unclear on the consequences of lack of written consent). 
Article 34 of the Patient Rights Act states that “a physician may perform an operation 
or apply a treatment or diagnostic method that creates an increased risk for the 
patient only after having obtained the latter’s written consent.”  Burden of proof that 
consent was obtained rests with the doctor. Information is stipulated in the Patient 
Rights Act to include “health condition, diagnosis, suggested and possible diagnostic 
and treatment methods, foreseeable consequences of their application or omission, 
results of treatment and prognoses.” Patients should be participants in decision-
making and have a right not to know. In practice, patients sign a case history after a 
brief initial examination, which gives general consent despite the treatment not being 
known yet. Patients should therefore be consented again for specific treatment. 
Damages can be sought for violations stipulated in the Patient Rights Act. Of note is 
the high rate of consent violations in psychiatric hospitals: “violations of the consent 
requirements (procedure of admittance) were found in about 10% of all reported 
violations, while the patients’ right to information on planned therapeutic procedure 
was violated in 22% of cases.” 
The right to privacy is protected by the constitution (article 47), articles 13-14 of the 
Patient Rights Act, and art. 40 sec. 1 of the Physicians’ Act. It also includes a right to 
respect of dignity when health services are provided, and a right to die in peace and 
with dignity. Confidentiality is protected by civil and criminal law, with exceptions 
listed in articles 14 sec. 240 and article 40 sec. 2 2 of the Physicians Act. No major 
problems regarding right to privacy, although “around 8% of all complaints to the 
Patient Rights Ombudsman related to the violation of this right in 2013”.  
There is a constitutional right to access records. Access is granted directly by 
practitioners or institutions. Medical records and documents (including prescriptions) 
that are attached to the request for reimbursement of cost of cross-border services 
must be accompanied by an official translation into Polish. A process of digitalization of 
records is underway. In the past, hospitals have hindered access to records. 
Complaints relating to record access should be made via the Ombudsman. 
Quality & safety 
According the Patient Rights Act patients are entitled to ‘health care services which 
meet the requirements of medical science and, in cases of limited availability of 
provision of treatment, to honest medical procedure based on medical criteria and 
determining the sequence of access to those services.’ Two major factors that 
determine the quality of health care services are i) the diligence of medical 
professionals and ii) the quality and technical standards of appliance. 
There is no licencing or approval system. The entity wishing to perform medical 
activity must be entered in a register kept by the voivode (the head of the provincial 
authorities) or another competent body (medical/professional chambers – as regards 
individual and group practices of physicians, nurses, midwives, dentists and 
pharmacists). If a person who sets up a health care entity fulfils all the requirements, 
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the voivode may not refuse to register the entity. Act on Accreditation in Health Care 
was passed, defining accreditation rules and procedures. The law followed the 1998 
national accreditation programme for hospitals, implemented by the Centre for Quality 
Monitoring in Health Care. The accreditation process is voluntary. The Centre has 
developed accreditation standards with regard to the functioning and provision of 
health care.  
As regards the quality and standards of healthcare services the two main regulatory 
bodies are the Ministry of Health and the National Health Fund. Due diligence and 
quality of treatment provided by medical personnel is controlled by professional 
chambers, which are charged with the enforcement of vocational (disciplinary) liability.  
The Act on Health Care Services Financed from Public Resources prescribes detailed 
rules on waiting lists. The maintenance of the waiting lists is an obligation of the 
service providers, and it is monitored very closely by the National Fund. A patient 
cannot challenge decisions about waiting times.  
Prior authorisation can be refused if the healthcare service (incl. healthcare provider) 
sought will expose the patient to a significant patient-safety risk that cannot be 
balanced by potential benefits flowing form the receipt of the healthcare. 
In recent years substantial activities have been undertaken in the area of quality 
control, including HTA and the introduction of accreditation standards for hospitals and 
primary care. Nevertheless, standards of care are still missing in many areas of care 
(e.g. rehabilitation), making it difficult to assure and monitor quality of care. As 
regards timely access to health care, both the two Ombudsmen (the Civic Rights 
Ombudsman and the Patient Rights Ombudsman) and the Supreme audit Office have 
repeatedly reported that in many specialised outpatient and inpatient or clinics the 
waiting time for medical advice or service is too long. 
Choice 
The free choice of a healthcare provider is stipulated in articles 28-31 of the Act on 
Health Care Services Financed from Public Resources (2004). It applies to all providers 
at all levels and without geographical restrictions, including a primary care physician 
(nurse and midwife), a specialist (outpatient and inpatient), a hospital and a dentist 
(dental clinic). However, choice is limited to providers who were contracted by the 
National Health Fund (NFZ) (except for hospital emergency care). Patients need to 
register with a GP, usually within their region of residence. They can change twice a 
year free of charge, but every next change is subject to a fee of 80 PLN unless the 
change is due to special reasons (e.g. the change of residence). A referral from a 
primary care physician (or another specialist) is usually needed to access specialist 
and hospital care but exceptions are made for certain specialist types and certain 
conditions (e.g. HIV, tuberculosis). Physician can only refuse a patient if there is no 
emergency or risk and if he points at real alternatives by another doctor or in another 
hospital. He also needs to motivate this refusal in a written medical record and report 
to his supervisor if he is employed or on call. In reality, the right to choose is often 
theoretical and clearly hampered by the limited financing. According to the annual 
reports of the Patients’ Rights Ombudsman and the Civic Rights Ombudsman it seems 
that choice is mainly based on a waiting time. 
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The right to information to enable patients to make decisions about accessing health 
services is expressed in the Patients’ Rights Act. The main sources of information are 
the NFZ and health care providers. The NFZ obliges each contracted health care 
provider to display specific information in their facilities. They also need to a NFZ sign 
at an accessible and clearly visible spot on the outside of the building to inform 
patients that the institution provides health care services within the public system of 
health care insurance (2004 Law on Health Care Services Financed from Public 
Sources and by the NFZ). The NFZ itself also provides comprehensive information on 
its website, including waiting times for elective care and quality certificates held by the 
health care facilities. Monthly updated information on waiting lists is obtained from all 
contracted health care providers and is available for various types of service. 
Information on quality certificates (in particular, accreditation certificates) held by 
health care providers is available through the Health Care Units Register (RZOZ) and 
the Centre for Quality Monitoring in Health Care (CMJ). Apart from the voluntary 
accreditation system, there is no comprehensive information system on the quality of 
inpatient care in Poland. In recent years, voluntary hospital rankings have occasionally 
been published by some newspapers (e.g. Wprost, Rzeczpospolita) with the support of 
the CMJ and the Society for the Promotion of Quality.  
The right to a second opinion is stated in Article37 Physicians Act: in case of diagnostic 
or therapeutic doubts, the physician, on his own initiative or at the patient’s (or legal 
representative’s) request shall consult an appropriate specialized physician or organize 
medical consultation if he deems it justified in the light of art of medicine’s 
requirements. The consultant’s opinion has an advisory character and the treating 
physician is still responsible for the whole treatment (art. 53 of Code of Ethics). This 
second opinion or medical council also applies to services of nurses and midwives. The 
decision to consult lies with the treating provider and a patient cannot freely choose 
the specialist who will be asked for a second opinion. If the request for a second 
opinion is denied that provider has to make an annotation in the patient’s medical file. 
Following the ECtHR judgment in Tysiac v. Poland (app. No. 5410/03) of 20 March 
2007, the 2008 Patients’ Right Act also included a right to second opinion Articles 31–
32 PRA) framed as a right to object to a medical opinion or a medical decision. This 
medical appeal, including a written motivation referring to legal norms that have been 
impacted by the challenged opinion or decision, is to be filed within thirty days to the 
Medical Commission operated by the Patient Rights Ombudsman office. This 
Commission consists of three physicians, two of which must be specialists in the 
branch of medicine pertinent to the case, selected from a special list and appointed by 
the Ombudsman. The Commission takes a decision within thirty days on the basis of 
the medical records and any necessary examination. No appeal is possible, neither by 
a patient nor by the Ombudsman. In 2013, 28 objections were filed but only 2 met the 
formal requirements and were processed to the Commission 
 
PORTUGAL 
General context 
Patients’ rights are of growing importance in Portugal, also due to increasing interest 
from the media in cases of medical malpractice. A special law on the rights and duties 
of the Health Care System beneficiaries was adopted in 2014 (Law no. 15/2014), 
which is complemented by professional ethical codes and administrative rules from the 
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General Health Administration. Despite the growing attention and monitoring by the 
regulatory health authorities the level of implementation at the level of healthcare 
institutions may still seem weak. Also the judicial system seems to be hesitant as to 
sanctioning violations of informed consent or enforcing medical liability. A similar 
reluctance is observed about applying consumer protection law to healthcare 
situations.  
Self-determination & confidentiality 
The right to consent is anchored in the constitutional right to physical and 
psychological integrity and in the Basic Law of Health Care. Verbal consent is more 
common, but such consent should always be recorded in records. Several situations 
require written consent, including voluntary termination of pregnancy; realization of 
invasive procedures in pregnant women, voluntary sterilization, medically assisted 
procreation (MAP); the installation of anticonception devices, blood and organ 
donation, research, off-label prescriptions and many others. There is a right to be 
informed about one’s condition, possible treatment plans and the expected 
development of one’s situation. There is a right not to know. The general rule is that 
the patients should be encouraged to participate in decisions regarding their health. 
There are no specific cross-border patient provisions. In terms of enforcement, there 
are no specific procedures; lawsuits and disciplinary action are the only avenues of 
recourse. 
A right to privacy is the established in Article 26 of the Constitution and in Article 80 of 
the Civil Code; the Personal Data Protection law is also relevant, as are various 
specific laws (Law on Clinical Trials, Law on Medically Assisted Procreation, Law on 
Personal Genetic Information and Medical Information, and others). There is a legal 
obligation to respect confidentiality, which flows from article 195º of the Portuguese 
Criminal Code. The Ethics Code of the Medical Association (article 85th and following) 
also imposes responsibilities. There are no specific cross-border patient provisions. 
The right to access records is present in soft law, in the Oviedo Convention (which is 
applied in Portugal as national law), the Law on Protection of Personal Data and the 
Law on Personal Genetic Information and Health Information. In private health care 
units, there is an indirect access system to records (via practitioner), whereas in 
public health care units, there is a direct access system. In the public sector the Law 
on Access to Administrative Documents applies and in the private sector the Law on 
Personal Genetic Information and Health Information and the Law on Protection of 
Personal Data) apply. There are no specific cross-border patient provisions. 
Quality & safety 
The guarantee of quality is, from the very beginning, constitutionally granted at the 
subparagraph (d) of paragraph 3 of article 64 of the Constitution of the Portuguese 
Republic which establishes that in order to ensure health protection, the state should 
regulate and supervise business and private forms of medicine, articulating them with 
the national health service, in order to ensure adequate standards of efficiency and 
quality in the institutions of public and private health. There are very clear rules 
regarding the licensing of private healthcare units since 2009. The Decree-Law no. 
279/2009 establishes the legal regime of opening, modification and operation of these 
units. In procedural terms, the opening and operation of private healthcare units 
depends on the registration in the Regulatory Authority of Health and the license 
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issued by the Regional Administration of Health that through the licensing and the 
subsequent supervision control the quality of the provided healthcare.  
In accordance with Law 15/2014 the user/patient of health services is entitled to 
receive the healthcare he/she needs in a promptly way or in a period of time 
considered clinically acceptable.  
If the healthcare abroad in question can be provided in Portugal within a useful term 
from a clinical point of view, having regard to the state of health and the probable 
evolution of the patient disease. he patient is exposed to a safety risk that may not be 
considered acceptable, having regard to the potential benefit of cross-border 
healthcare for the patient; be If there is a reasonable certainty to conclude that the 
population is exposed to a considerable safety risk as a result of cross-border 
healthcare; c If the healthcare in question are administered by a healthcare provider 
that will inspire serious and specific concerns regarding to compliance with the 
standards and guidelines of healthcare quality and patient safety;  
Besides possible complaints to the Health Regulatory Authority and the General 
Inspection of Health Activities, as well as disciplinary procedures and lawsuits there 
are no specific procedures.  
Choice 
Patients have the right to choose services and healthcare providers depending on 
existing resources in accordance with the rules of organization (Article 2 of Law no. 
15/2014 and the law on Foundations of Health). This right is also considered as a 
fundamental principle of the relationship between the patient and the practitioner in 
the Code of Ethics of Medical Association (art 40). While choice of provider is greater 
for those covered by a health subsystem or private health insurance, patients in the 
national health service (NHS) have to register with a GP either in a public primary care 
centre or in a private providers contracted by the NHS. Their choice is limited to the 
available providers within a geographical area based on their residence. People may 
change GPs at any time if they apply in writing, explaining their reasons, to the 
Regional Health Authority’s board (RHA). For secondary specialist care a referral is 
needed. In practice, patients bypass their GP by visiting emergency departments. 
Frequently, there is a delay in obtaining a consultation depending on the specialty. 
Just as free choice the right to second opinion, although included in the Charter of 
Patient Rights and Duties of the General Directorate for Health (point 7), remains 
rather theoretical. As a way to increase choice for patients in the NHS the “dental 
voucher” was established in 2008 specifically designed for dental care, where the 
public sector is residual. Pregnant women have access to three “dental vouchers”, 
which give them the right to schedule a dentist appointment. The elderly are entitled 
to two of these vouchers per year. They were the first groups to benefit from this 
measure, and since then it has been expanded to children with DMFT in permanent 
teeth, when referred by their primary care physician. 
While there is no specific legal obligation the Health Regulatory Authority and the 
General Inspection of Health Activities provide some information on healthcare 
provider, including information on available services and reports on quality of care. 
Data on the waiting times for specialist care and diagnostic services are not available. 
The Ministry of Health also developed a health portal in 2011 and since 2007 an NHS 
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call centre (“Saúde 24”) was. Also patients' organizations play an important role in 
informing and guiding patients. 
 
ROMANIA 
General context 
Within the context of the Law no. 95/2006 that regulates the functioning of the 
statutory health system, the Law no. 46/2003 defines the patients’ rights. Other 
relevant provisions can be found in specific acts on mental health, data protection etc. 
Governmental decisions or orders further organize specific aspects such as the access 
to medical records, patients' feedback mechanisms in public hospitals, membership in 
hospital Boards of Ethics. Enforcement follows the more traditional way determined by 
disciplinary, administrative, civil, or criminal law. However, given the poor patients’ 
rights knowledge among the population and the fragmentation in complaint and 
redress procedures, enforcement remains weak. Shortcomings of underfunded public 
healthcare system, including the poor conditions and cases of neglect in long term and 
mental care facilities (covered by media reports, but also the ECtHR's Judgement on 
Campeanu) have stirred the public debate. It encouraged patients to set up or join 
patients’ organisations that provide counselling, support and practical guidance (even 
to seek treatment abroad).  
Self-determination & confidentiality 
The right to informed consent is provided for in the Health Law and the Patient Rights 
Law. Written consent is normally required except for simple observations. Patients are 
entitled to information on “diagnosis, the nature and the purpose of the treatment, the 
risks and the consequences of the suggested treatment, the feasible alternatives to 
the treatment, the risks and their consequences, the expected evolution of the 
condition in the absence of treatment”. The right not to know applies in two 
circumstances: when information could cause suffering or when another person is 
appointed to receive the information. Patients can discuss alternative treatments but 
there is no right in law to participate. There are no cross-border patient provisions 
except translation. A national Survey on the quality of healthcare services and 
perceived corruption was conducted in 2013-14: “28% of them report having to follow 
the treatment or the procedure imposed by the medical personnel, without being 
informed of alternatives.” Complaints are made via professional colleges or Malpractice 
Commissions. 
The right to privacy is defined in Chapter IV, Law 46/2003; Article 21 reads "all 
information regarding the patient's condition, the results of investigation, the 
diagnosis, the expected evolution, the treatment, personal data, are confidential even 
after the patient's death". All healthcare personnel have an obligation to maintain 
confidentiality. Law 95/2006, Article 872 states that cross-border patients are entitled 
to respect for their private lives with regard to the processing of personal data.  
The right to access records is provided in Article 24, Law 46/2003. Access is via a 
doctor, with time limits for direct access. Electronic access is possible online using 
national health insurance card and a pin code. There is also a right to add, correct, 
erase or destroy data. Access not reported to be a difficulty in survey. For cross border 
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EU patients, the right to access medical records held in Romania is provided for in 
article 872, Law 95/2006. Cross-border patients have a right to a copy or e-copy.  
Quality & safety 
The Patient's Rights Law provides in Article 2 that patients have the right to receive 
the highest attainable quality treatment, available according to the available human, 
financial and material resources. The timely provision of healthcare as a right not 
expressly stated as an independent right, but it is done indirectly but via guidelines 
laying down procedures for assessing “reasonable delay” by the doctor. 
Hospitals must obtain a sanitary authorization prior to commencing their activities, 
and subsequently they have a delay of five years for obtaining the accreditation from 
the National Authority for Healthcare Quality Management, that enables them to enter 
contract with Health Insurance Houses and provide services covered from the health 
insurance funds Exhaustive and detailed safety protocols and clinical guidelines for 
diagnosing, treating and prevention measures are published through orders by the 
Ministry of Health, upon the recommendation of specialised commissions, or 
professionals' associations or societies. Professional competence and fitness to 
practice is certified and monitored by Colleges. The national framework contract for 
the provision of services covered by public health insurance funds and the 
implementation methodological norms sets out activity thresholds: maximum number 
of consultations which can be given by doctors within a limited time, the duration of 
the consultations. The minimum number of personnel / shift /section /unit, their 
required qualifications, and working times are regulated through orders issued by the 
Ministry of Health, observing the units types.  
Acceptable waiting times for treatment are individually determined by the patients' 
treating doctors based on their personal and health circumstances. Prioritisation of 
health services, including medical devices and home provided healthcare must be 
done in accordance with guidelines provided by the National Health Insurance House 
and the decentralised Health Insurance Houses. Guidelines are available for several 
categories of conditions and factors. 
The National Health Insurance House will only grant approval of reimbursement for 
cross-border care if (a) no hospital can provide the services within a reasonable term 
and (b) the patient's state of health or treatment will not be endangered by the 
journey itself. In these circumstances, the safety, timeliness and quality of healthcare 
can be debated upon if it rests on the personal financial resources of the insured 
patients. 
Choice 
Free choice of healthcare provider is formally recognized by the statutory health 
insurance Law 95/2006 (Article 208.3.c) as well as the Law on Patient Rights. 
However, patients cannot easily exercise this in the countryside or in small cities 
where there’s often only one family doctor or hospital. Even if there are no 
geographical restrictions with respect to choosing a provider, most patients’ choice is 
limited as they will have to bear the travel costs. Patients register with the family 
doctor of their choice and can change every six months. Access to treatment in a 
public or contracted hospital is subject to the family doctor's (GP) prior referral, and 
this referral is indicating the unit and the specialty within which the further 
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investigations, treatment or rehabilitation shall be done. Referrals are valid for 30, 60 
or 90 days and subsequent referrals for conditions connected to the main investigated 
one can be issued by the specialist doctor. The choice of the hospital does not include 
a guaranteed choice of physician or surgeon: specialists in certain areas of treatment 
are few in numbers and hospitals' sections cannot function properly due to insufficient 
personnel. Parallel health insurance funds (e.g. the military) tend to recommend the 
use of associated hospitals. 
Healthcare providers have an obligation to provide information on the services they 
offer, including their personnel and its corresponding specialisations, fitness to 
practice, the prices of services that are not reimbursed by health insurance etc. 
Patients can also obtain individualised information regarding waiting times. Objective 
information is provided by the National Health Insurance Fund that centralises 
information on fitness to practice, sanctions and provided services. Their territorial 
branches can provide information on prices, waiting lists and times for treatment 
funded by them. Medical professionals' colleges are also under a duty to gather data 
and report on their members in terms of numbers, fitness to practice and sanctions 
applied by the Malpractice commissions. Based on statistical data from the Public 
Health Departmental Authorities (decentralised bodies of the Health Ministry) and 
quantitative indicators from the National Institute of Public Health the Ministry of 
Health has started to develop a performance ranking of hospitals in 2011, which can 
be consulted on its web site.  Finally, patients' associations also inform patients on 
specific treatments and the providers that offer them. 
Patients are entitled to seek and to obtain "another medical opinion" (article 11 
Patients' Law) but in practice may be more difficult to obtain.  
 
SLOVAKIA 
General context 
In 2002-2003 the project "Promotion of Patients' Rights in Slovakia" that was 
supported by the Dutch government and included the creation of a Patients' Rights 
Unit in the Slovakian Health Ministry for administrative support, lead to the adoption 
of Act No. 576/2004 Coll. as part of the 2004 health care reform. This special law 
incorporates all the usual patients’ rights into the legislation. These rights are well 
established and citizens are well-aware of them as well as of some of the more 
consumer-oriented rights. The rights to second opinion and information are not legally 
defined.  
Self-determination & confidentiality 
The right to consent is stipulated in Section 6 of Act. No. 576/2004 Coll. on health 
care and health care-related services. Any form of consent is appropriate unless 
written consent is required. Patients are entitled to comprehensive information. There 
is no formal right not to know, but patients can refuse to be told information. Patients 
have right to choose between alternatives but most patients only give consent to 
suggested specific treatment. The burden of proof is with the health care provider.  
There are no cross-border patient provisions and no specific remedies. 
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The right to privacy is recognized both in the constitution (general right to privacy) 
and in specific legislation - Act No. 578/2004 Coll. This is one of the most respected 
patient rights. From time to time there are leaks of health data to the media especially 
in cases of celebrities. Enforcement is via the Personal Data Protection Authority or the 
courts. 
The right to directly access records is provided in the act on health care, and is only 
denied to patients receiving psychiatric or psychological treatment that would be 
adversely affected by access. There are no formal conditions for access but copies 
must be paid for. The right to access records is well established but providers 
sometimes try to restrict access. 
Quality & safety 
The Act on health care, health care-related services and on the amendment and 
supplementing of certain laws as amended provides that health care is delivered lege 
artis when all the medical services necessary to for identification of the disease are 
provided to the patient which shall ensure timely and effective treatment taking into 
account the present medical knowledge. All health care providers require permit. The 
permit has a gatekeeping function and depending on the type of provider it is issue by 
a self-government or Ministry of Health. The provider ensures a continual system of 
quality to maintain and increase the standard of quality. The system of quality is 
systematically documented in writing which has purpose to minimize deficiencies in 
provision of the health care and increase degree of satisfaction of patients while 
maintaining providers economic effectiveness. The provider’s system of quality should 
apply to all activities in the medical facility which may influence the health of persons 
or the course of their treatment, warrant that the staffing and equipping of the 
medical facility corresponds at least to the requirements set out in Act on providers or 
in separate regulation 
Waiting lists are regulated by a decree of the Ministry of Health. The decree does not 
define acceptable waiting times only specifies for which conditions waiting lists are 
created. There is no formal procedure allowing the patient to challenge the decision on 
waiting times.  
Prior authorization for cross-border care is granted by health insurance company if the 
health care is covered by the scope of by public health insurance and a) disease can’t 
be treated in the Slovak Republic within a reasonable time (usually 12 months) taking 
into account the current state of health of the insured person and the possible 
development of the disease, b) the treatment is not carried out in the Slovak Republic, 
c) have exhausted all treatment options in the Slovak Republic and the treatment in 
another Member State is expected to substantially improve health or prevent 
deterioration of the insured person, d) the insured person is resident in another EU 
member state and wishes to continue treatment, which began in the Slovak Republic, 
the place of residence, or e) disease requires the use of highly specialized and cost-
intensive medical infrastructure or medical equipment that are not available in the 
Slovak Republic. The health insurance company may refuse to grant prior approval for 
the provision of cross-border healthcare) disease involves treatments presenting a 
particular risk for the policyholder or the population, taking into account the potential 
contribution of cross on which the insured seeks, b) the treatment is provided by a 
healthcare in another Member State of the European Union, which casts doubt on the 
credibility of quality and safety in health care provision. 
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Choice 
The right to free choice is legally recognized (§ 11 Act. No. 576/2004 Coll.). It applies 
to any inpatient or outpatient health care provider. However, free choice in the 
context of statutory health insurance is restricted to contracted health care providers, 
except if the health insurance company grants a prior authorization to reimburse care 
provided by a certain non-contracted provider. Patients register with a GP through a 
written agreement for a period of at least six months, which can only be terminated in 
writing. The providers may not refuse patients except in specified cases, for example 
work overload or a conflict of interests. GPs cannot reject a patient due to work 
overload if the patient is a permanent resident in the physician’s district or if the 
patient is in need of urgent care. Also for specialized care, there is a free choice of 
specialist. Admission to a hospital requires a referral from GP or a specialist, except 
for urgent care, psychiatric patients and patients in the specialist’s dispensary.  
Although the law guarantees all citizens the right to obtain information from the 
various public institutions, in practice there are often no data. Health insurance 
companies are obliged to publish the list of the health care providers they have 
contracted with. There is no specific legislation related to the collection of information 
related to the performance of providers, waiting times and prices. Information on 
quality of providers is scarce. Based on their own analysis, the privately managed 
health insurance company Dôvera published the first quality assessment of hospitals 
in 2008, followed by the state-owned General Health Insurance Company later that 
year. Also certain NGOs and think tanks have collected and published information on 
performance.  
Patients are not formally entitled to a second opinion but could obtain it if they want 
to. There is no formal process for it.  
 
SLOVENIA 
General context 
Next to the special Patient Rights Act No 15/2008 the relevant legal framework in 
Slovenia also includes specific provisions in the Health Services Act (which lays down 
individual obligations by medical professionals), the Health Care and Health Insurance 
Act as well as the General Practitioners Services Act (with a chapter on Interpersonal 
Relations between the doctor and the patient), followed by a series of acts dealing 
with specific issues. The enforcement of patients’ rights is weak but improving 
gradually. The driver for patients’ rights development has been essentially the 
introduction of health law as a legal discipline together with the ratification of the 
Biomedicine Convention. General awareness among patients, doctors and other 
medical professionals is still quite low. More recently, media reports on cases of 
alleged medical errors (cf. Nekrep case) are catching public attention. 
Self-determination & confidentiality 
The right to informed consent is rooted in the constitution (Articles 34 and 35) and 
specified in the Patient Rights Act (Articles 26 and 27), which “amends and upgrades” 
the Health Care and Health Insurance Act. The General Practitioners Services Act also 
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imposes responsibilities on doctors. Verbal consent is normally used, but written 
consent is necessary in certain cases. Patients have a right to be informed about their 
medical condition, the likely course and consequences of the illness or injury, the 
purpose, type, manner of implementation, the likelihood of success and the expected 
benefits and the outcome of the proposed medical treatment. A right not to know is 
also stipulated in the Patient Rights Act. The patient “has the right to actively 
participate in selecting the method of treatment after being presented with all the 
necessary explanations on the treatment” (Article 21). However, in practice “many 
problems were detected….most of them are connected to shortage of the doctor`s 
time devoted to conference with patients.” No specific duties for cross-border patients 
and no specific remedies. 
The right to privacy is protected by Article 35 of the constitution and the Patient Rights 
Act (Articles 5 and 43). A legal obligation to preserve confidentiality is imposed by 
Article 51 of the Health Services Act. The Patient Rights Act also imposes an obligation 
to identify anyone responsible for breaches. No specific duties for cross-border 
patients. Criminal liability is a possibility for violations. 
The Patient Rights Act provides the right to access medical records if legal grounds are 
given, within five days. Proxies can also access on behalf of patients. There is also a 
right to alter records. The Healthcare Databases Act is in the process of being updated 
regarding the implementation of Directive 2011/24/EU on the application of patients’ 
rights in cross-border healthcare; it includes e-health measures. Enforcement is via 
the information commissioner, whose annual report provides some evidence.  
Quality & safety 
The Patient Rights Act guarantees the right to adequate, quality and safe healthcare. 
Receiving treatment in a timely manner is a principle that is protected in a special 
patient right, defined as a right to due consideration of patient`s time. The patient has 
the right to adequate, quality and safe healthcare in accordance with the medical 
doctrine meaning that care as responsive to the patient’s needs and in line with the 
capabilities of the Slovenian healthcare system. As a systemic law, the Health Services 
Act and the General Practitioner Services Act are key in judging the quality of the 
performance of the core provider of healthcare activities – the physician. The 
legislation provides a specific system of appraisal which serves as the ground to 
award, extend or revoke licences for independent performance of healthcare activities. 
The licence needs to be renewed every seven years. Tasks relating to that are 
entrusted to the Medical Chamber of Slovenia. 
The Patient Rights Act tasks its performers to ensure the shortest waiting times 
possible, while balancing between the available finances and the (reasonable) waiting 
period. If a patient must wait for the service for longer than three months, he or she 
has the right to request a check-up at the physician who referred him or her to the 
service.  
A reason for refusal is the fear that a patient will be, with sufficient certainty, exposed 
to safety risk that could not be understood as acceptable. Nevertheless the possible 
advantages of proposed healthcare service should also be taken into consideration. A 
prior authorization will also be denied if the public would be, in case of approval, with 
sufficient certainty exposed to safety risk or in case the healthcare service will be 
executed by a provider for which there are serious and concrete concerns regarding 
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respecting of standards and guidelines of quality, safety and supervision over 
healthcare services.  
Many problems were noticed regarding the exercise of the right in practice. One of the 
most problematic ones is the issue of long waiting time for all kinds of first medical 
examinations on secondary and tertiary level.  
There is a special misdemeanour procedure for remedies in case of violation of some 
of the regulations regarding the question on managing the waiting lists. In case 
healthcare provider doesn`t keep waiting lists in accordance with prescribed 
standards, it can be charged with a fine of 400 – 4.100 EUR. 
Choice 
The right to choice of provider is one of the 14 explicitly listed patients’ rights in Article 
5 of Patient Rights Act. However, it is not an absolute right as it is linked in practice to 
the capabilities and norms within a healthcare network. Services are only covered if 
the provider is contracted by the Health Insurance Institute of Slovenia (HIIS). Every 
Slovene citizen has the right to choose one personal physician (GP or paediatrician) as 
well as a personal gynaecologist and dentist without administrative and/or territorial 
constraints. Patients can change their choice at any time, while physicians can only 
reject a patient for specific and well-grounded reasons which have to be 
communicated in writing to the patient within eight days. The majority of providers at 
the primary care level are contracted by the HIIS and are still employed in health 
centres, while a smaller group of them work in private practices. The personal 
physician acts as a gatekeeper for specialist services and refers the patient to a 
particular outpatient specialist or to hospital diagnostics and treatment. However, the 
patient ultimately decides which specialist provider to turn to, provided he has a 
contract with the HIIS. For patients suffering from a chronic disease which requires 
long-term treatment by certain specialists, the personal physician can transfer some of 
his authority to the consulting specialists or hospital. The latter has to report back on 
a regular basis to the personal physician about the patient’s progress. 
In accordance with the Patient Rights Act providers should ensure that patients are 
properly informed of who they are, what is their professional and (or) scientific title, 
what services they offer and their time availability, and which laboratory and other 
providers they collaborate with. Patients should also be informed in advance about the 
costs of treatment if it is not fully covered by statutory health insurance (Article 25 of 
Patient Rights Act). The Medical Chamber of Slovenia has an online application named 
“Public search for doctors”, which helps patients to identify doctors or dentists who are 
specialized in a certain field of medicine. They can also check whether a certain doctor 
has a valid license for the healthcare services he/she provides. Data on a quality of 
doctors is only accessible in a limited way: in the year 2009 the Medical Chamber of 
Slovenia for the first time granted the awards for the best doctors on certain fields of 
medicine. The Slovenian Code of Medical Deontology prohibits any direct or indirect 
advertising or publicity (Article 10). The National Institute of Public Health next to its 
duty to inform and educate public in the field of public health also has an obligation to 
collect and publish statistical data on waiting periods. According to Article 15 Patients’ 
Rights Act, a patient has the right to be informed about the reasons for the waiting 
time and has additionally the right to the insight of the waiting list, of course with 
certain limitations needed for the protection of personal data of other patients.  
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The right to a second opinion is formally recognized in Article 5 and 40 of Patient 
Rights Act. While it is unlimited for private patients, for patients with statutory health 
insurance it is subject to certain conditions. It only applies to secondary or tertiary 
care, it can only be exercised once for the same health condition or anticipated 
procedures, it requires a prior discussion between the treating doctor and patient. In 
principle the second opinion should be given by a doctor in same institution, only if 
this is not possible the patient may be referred to another institution.  
 
SPAIN 
General context 
Spain started to legally define patients’ rights already in its General Health Law 
14/1986. It took until 2002 however before a special patients’ rights law was adopted: 
the Basic Law 41/2002 on the autonomy of the patient and the rights and obligations 
with regard to clinical information and documentation. This followed the ratification in 
1999 of the Biomedicine Convention. Also the Spanish General Council of the Medical 
Order recognized patients’ rights in the third chapter of the Code of Deontology. Also 
the Law on data protection and the Criminal Code, which addresses specific violations 
such as confidentiality and unconsented access to clinical records, are part of the legal 
framework. Consumer-oriented patients’ rights have been the object of a much more 
recent development in the Spanish legal system and as a consequence there are still 
many issues that remain unsettled. The implementation of the cross-border Directive 
is considered an important driver in that respect.  
Self-determination & confidentiality 
The right to informed consent is considered one of the basic principles in the Patients’ 
Rights Law. Article 8 of the law states that informed consent must be given verbally, 
but in certain cases such as surgery, written consent is required. The information 
provided should be comprehensive, and it should be provided in writing when consent 
will be obtained in writing. Specifically, information should cover: “Relevant or 
important consequences; risks related to the personal or professional circumstances of 
the patient; probable risks under normal conditions, in accordance with the experience 
and state of the science, or directly related to the type of intervention;  and counter-
indications.” There is no specific right to participate, though it is implied in article 2.3 
of the Patients’ Rights Law. No legal attention has yet been paid to cross-border 
patient issues. The enforcement avenues depend on the context: in the private 
sphere, the Civil Code applies. In the public context, Law 30/92 on Public 
Administration and Common Administrative Procedure applies. 
The right to privacy is both specific and broad, being grounded in both the Patients’ 
Rights Law and the Constitution. A legal obligation to respect confidentiality is present 
in civil, criminal and administrative laws. Article 6 of Royal Decree 81/2014 on cross-
border health care establishes that in order to facilitate health care, the right to 
privacy regarding personal and health data protection shall be guaranteed according 
to Organic Law 15/1999 on the Protection of Personal Data and the Patients’ Rights 
Law. No reform is currently planned. The PRL refers to General Health Law 14/1986 
with regard to infringements of rights. 
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The right to access records is provided in Article 15 of the Patients’ Rights Law (also to 
proxies and heirs). Access to records is via hospitals and staff, and copies are 
available for no fee. Articles 5 and 6 of the Royal Decree on Cross-Border Health Care 
provide that in order to facilitate healthcare, patients shall be supplied with a copy, in 
adequate support, of the clinical record and results of the diagnostic tests and 
therapeutic procedures. Violations are punishable with fines via the General Health 
Law of up to EUR 300,000. 
Quality & safety 
Article 4.b of the Law on the Cohesion and Quality of the National Health System 
recognises the right to receive healthcare in the Autonomous Community of residence 
within a maximum time frame, in accordance with implementing regulations. In this 
respect, the Royal Decree 605/2003 establishes the criteria, indicators and minimum 
and common requirements regarding information about waiting lists in external care, 
diagnostic and therapeutic tests and surgical interventions in centres of the National 
Health System. Most healthcare professions are regulated by professional bodies. 
Moreover, in the public healthcare system, healthcare providers must be public 
servants or assimilated to public servants. Article 60 of the Law on the Cohesion and 
Quality of the National Health System establishes the Agency for the Quality of the 
National Health System, which is related to the Ministry of Health and which is in 
charge of elaborating and maintaining quality and safety rules, indicators, clinical 
practice and assistance guides, good practices records and adverse situations records. 
The Agency is advised by scientific societies and experts, based on national and 
international experience. Article 61 of the same law provides that the Ministry of 
Health and the Autonomous Communities must periodically elaborate quality plans 
which must contain the priority quality objectives for the relevant period.  
Although Royal Decree 605/2003 lays down some general criteria, it is up to the 
Autonomous Communities to establish waiting times depending on the type of health 
care. Implementing rules differentiate between surgical interventions, first external 
consultations and certain diagnostic or therapeutic tests. Depending on the specific 
Autonomous Community, the typical waiting time is between 90 and 180 days for 
surgical interventions, 30 to 50 days for first external consultations and 30 days for 
tests. If waiting times are exceeded or close to their end, most Autonomous 
Communities allow the patient to ask to receive health care in another center of 
his/her choice in the relevant Autonomous Community.  
A cause for refusal is where the patient will, accordingly to a clinical evaluation, be 
exposed with reasonable certainty to a risk (incl. healthcare provider) that cannot be 
regarded as acceptable, taking into account the potential benefit for the patient of the 
sought cross-border healthcare.  
Choice 
The right to free choice of healthcare provider is established by the General Health 
Law 14/1986 (Article 10.13 and Article 14). The implementing rules are contained in 
Royal Decree 1575/1993 on free choice of healthcare provider in primary healthcare. 
Royal Decree 8/1996 regulates the free choice of doctor in specialised care centres of 
the National Health Service (SNS). However, there is some regional variation in the 
degree of patient choice as Autonomous Communities have developed their own 
norms, with some having integrated also private providers in their public network of 
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healthcare provision (e.g. Catalonia) or lifting geographical restrictions (e.g. Madrid). 
GPs play the gatekeeper role in the SNS. Choice of GP and pediatrician (for users 
under 14 years old) is restricted to those available in the relevant health area, but in 
cities of more than 250K inhabitants, this is extended to GPs and pediatricians across 
the city. Access to specialist care requires referral, except for emergencies. For the 
most advanced health services and interventions in tertiary care hospitals access is 
subject to a referral by another specialized health care services rather than a GP. The 
possibility to choose a specialist and hospital is relatively less developed. Patients may 
choose their provider only for certain medical specialties. Change is only possible after 
one year, unless the SNS authorizes based on legitimate reasons.  
The National Health Service has to give to the users sufficient information for them to 
exercise their right to free choice. Each center must provide information and 
documentation that allows users to know which doctors can be chosen, places and 
times for consultations and, if applicable, waiting times, as well as any other 
information that may be of interest for the user to exercise his/her right (Article 8 of 
Royal Decree 8/1996). The Basic Act 41/2002 on Patient Autonomy, Rights and Duties 
on Information and Clinical Documentation further elaborated those rights related to 
information and clinical documentation within the SNS. Rules governing information on 
providers are laid down by the different Autonomous Communities.  
Patients in the SNS are entitled to a second opinion (Article 4.a of Law 16/2003 on the 
Cohesion and Quality of the National Health System). However, this right is restricted 
to defined illnesses or therapeutic situations and can only be requested (in writing) 
once in each care process. Furthermore, the second opinion has to be issued by a 
physician acting within the same Autonomous Community of residence of the patient. 
The implementing provisions are adopted by the different Autonomous Communities.  
SWEDEN 
General context 
For a long time there was no specific law regulating patients’ rights in Sweden, as 
opposed to Nordic countries. Instead, different rights for patients, such as patient 
choice or the right to information, were incorporated in other legislation and are 
formulated in policy agreements between the state and the county councils. 
Regulations were mainly targeted at the behaviour of personnel and only indirectly at 
patients’ rights. The 1982 Health and Medical Services Act defined the county councils’ 
responsibility to provide all their citizens with high-quality health care services. In 
1999, patients’ rights in the health care system were further strengthened. The 
revised Act ordered the county councils’ obligations to improve individualized 
information, increase opportunities to choose between alternative treatments and 
ensure the right to a second opinion when suffering from a life-threatening or other 
particularly serious disease or injury. Moreover, every county council and municipality 
was to establish a patients’ committee to support and help individual patients and 
contribute to quality development in the health care system. 
On 1 January 2015 a new Patient Act entered into force. This law aims to strengthen 
and define the position of patients and to promote patient integrity, self-determination 
and participation. Many of the provisions in the new law are derived from other 
statutes, while some have been adjusted and some are new. The idea of the Patient 
Act is to gather all statutes regarding patients in one, single law to make it clear to 
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care providers, patients, and family what applies in the area. The law extends and 
clarifies the current information duty towards patients, expands the patient’s ability to 
receive a second opinion and increase choice of publicly financed primary care and 
outpatient specialist care throughout the country. 
Self-determination & confidentiality 
The right to consent is explicitly stated in Chapter 4 Section 2 of the Patient Act 
(2014:821), though it is also protected by constitutional law, the Health and Medical 
Services Act, and the Patient Safety Act. No specific form of consent is mandated. 
There is a right to comprehensive information in oral or written form including 
treatment options and a right not to know. No specific duties for cross-border patients. 
Enforcement is via administrative, penal or tort law. 
The right to privacy is regulated by Chapter 25 Section 1 of the Public Access to 
Information and Secrecy Act (2009:400) for public healthcare and Chapter 6 Section 
12 first paragraph, and Section 16 of the Patient Safety Act (2010:659) for private 
healthcare. Public healthcare personnel must respect confidentiality. The regulations 
governing confidentiality in private healthcare are less clear. Case law appears to 
primarily address issues concerning (wrongful) disclosure of health data to authorities 
such as the Police Authority, the Swedish Migration Board, and Swedish Social 
Insurance Agency. Enforcement is again via administrative, penal or tort law. 
The right to access medical records is governed by Chapter 2 Section 1 of the 
Freedom of the Press Act. In public healthcare, a request should be made to the 
doctor in writing or orally, and information must be provided as soon as possible. 
Access can be to the physical record, or to a transcription. There are no fees for 
access, but a small fee for copies. Recourse in cases of rights violations are via the 
Health and Social Care Inspectorate, the Parliamentary Ombudsman, or the Swedish 
Data Protection Authority. 
Quality & safety 
The right to safe and quality treatment is stipulated in many various acts, such the 
Health and Medical Services Act (1982:763) and the Patient Safety Act (2010:659). 
According to Section 2a of the Health and Medical Services Act health care must be 
carried out so that it meets the demands of good care. The Swedish quality assurance 
system is complex and contains many actors. Public institutions include the Health and 
Social Care Inspectorate, the National Board of Health and Welfare, the Medical 
Responsibility Board and Patients´ Advisory Committee.  
A health care guarantee is regulated in Chapter 2 Section 3 of the Patient Act, Section 
3 g of the Health and Medical Services Act and Ordinance (2010:349) on healthcare 
guarantee.  
The health care provider: Providers’ has the overarching responsibility for patient 
safety as well as quality assurance. Section 31 of the Health and Medical Services Act 
(1982:763) stipulates that the quality of health care shall be guaranteed and 
systematically and continuously developed. According to Chapter 3 Section 5 of the 
Patient Safety Act severe adverse events must be reported to the Health and Social 
Care Inspectorate (called “lex Maria reports”). If a provider does not fulfill its duties, 
the Health and Social Care Inspectorate (IVO) can require the provider to take 
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appropriate measures and in very severe cases IVO has a legal possibility to close the 
provider’s health care activity  
The heath care personal shall perform his/her work in accordance with scientific 
knowledge and approved experience. All health professionals have a duty to report to 
the health care provider if a patient in connection with health care is struck by, or 
exposed to, the risk of serious injury or illness. If a health care professional does not 
fulfill his/her duties, several measures can be taken such as a probationary period, a 
restraint of the right to prescribe medicine and the revocation of a license. 
The National Board of Health and Welfare (Socialstyrelsen): The National Board of 
Health and Welfare has responsibility for the issuing of statutes and national 
guidelines. The goal of these guidelines is to contribute towards patients receiving a 
high standard of medical care.  
The Health and Social Care Inspectorate (IVO): IVO is a government agency 
responsible for supervising health care. Its supervision remit covers the processing of 
complaints concerning, for example, the reporting of irregularities in health care (lex 
Maria reports).Primarily the health care providers, who are supervised by the Health 
and Social Care Inspectorate.  
A health care guarantee means that a patient shall receive healthcare within a certain 
period of time. This is regulated in Chapter 2 Section 3 of the Patient Act, Section 3 g 
of the Health and Medical Services Act and Ordinance (2010:349) on healthcare 
guarantee. The health care guarantee indicates the frame of time within which a 
patient shall be offered care from the county council or the region. However, it does 
not regulate whether care shall be provided or what type of care a patient shall 
receive. Note: Emergency care is not tied to the health care guarantee.  
From the time it is decided that a patient should be seen by a physician for a first visit 
at the district health care clinic, or alternatively, make a visit or receive a treatment 
within specialized care, the health care guarantee indicates how long, at the longest, a 
patient shall be required to wait. If it is not possible to receive care or treatment at 
the health care facility where a patient has sought care within the designated time 
frames, a patient shall be offered an appointment or treatment at another health care 
facility. It is possible that a patient can be referred to another health care facility in 
another region or under the jurisdiction of another county council. 
If healthcare providers do not properly respect the right to safe and quality treatment 
received in I timely manner, this omission may result in critical statements/decisions 
taken by the Health and Social Care Inspectorate. 
Choice 
Since the 1st of January 2015 patients have the right to choose any outpatient health 
centre or clinic without geographical restriction, as long as it is run by - or has an 
agreement with - the county council or region (Chapter 9 Section 1 of the Patient Act). 
The patient is entitled to have a fixed medical contact at this health centre (Section 5 
second paragraph Health and Medical Services Act and Chapter 6 Section 3 of the 
Patient Act). Since primary care has no formal gate-keeping role and county councils 
or regions have their own referral procedures, patients are mostly free to consult 
specialists directly, depending on where they live or want to receive care. Patients can 
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also freely choose any hospital. In any case, based on the care guarantee that was 
introduced in 2005, patients are entitled to access to care within maximum waiting 
times (cf. The so-called “0–7–90–90” rule meaning instant contact for consultation; 
GP within 7 days; specialist within 90 days; treatment after diagnosis within 90 days) 
which apply throughout the whole country and include all elective care in the county 
councils (Chapter 2 Section 3 of the Patient Act, Section 3 g of the Health and Medical 
Services Act and Ordinance).  
Patients are entitled to receive all necessary information adapted to their particular 
circumstances and capabilities (e.g. age, maturity, experience, language background) 
to choose their healthcare provider (Chapter 3 Section 2 of the Patient Act). This also 
includes information on when he or she can expect to get treatment within the context 
of the care guarantee. All county councils and regions provide information about how 
and where to seek care through their websites. There are also several national 
projects aimed at improving the access and use of information for patients and 
citizens. The initiative 1177.se is a collaborative project between all county councils 
and regions in Sweden. Next to the website it also comprises a 24/7 phone line 1177, 
with medical staff available to give advice about medical conditions and where or at 
what level to seek care if necessary. Information about waiting times is compiled by 
the Swedish Association of Local Authorities and Regions (SALAR) and published as a 
database (www.vantetider.se). Developments in the Swedish health system towards 
choice and privatization have also increased the need for information on performance 
and differences in quality and patient satisfaction between providers. Since 2006 the 
National Board of Health and Welfare and SALAR collaborate to develop an annual 
comparison and ranking across county councils (Öppna jämförelser), including a 
comparison of hospitals based on some 50 indicators. Also private initiatives were 
developed to provides citizens and patients with comparative information about 
providers, such as the one financed by the Confederation of Swedish Enterprises 
(www.omvard.se), which is partly based on information collected through National 
Patient Surveys, which are conducted every two years. 
Patients in Sweden have a right to a new medical evaluation (a second opinion) if they 
have a life-threatening or highly serious disease or injury (Chapter 8 section 1 first 
paragraph of the Patient Act and Section 3a second paragraph of the Health and 
Medical Services Act) and if the healthcare provider is a county council or region 
(Chapter 1 Section 2 second paragraph of the Patient Act). The county council is 
obliged to pay for a new medical evaluation and travel, even if the second doctor is in 
another county. If the doctor recommends an alternative treatment the treatment will 
only be covered if it is . justified on the basis of scientific evidence and clinical 
experience, and it is reasonably priced in view of the particular illness or injury 
involved. 
 
UNITED KINGDON 
General Context  
It is only very recently that the UK has adopted an approach to patient rights whereby 
patients can see their rights set out in a codified, user-friendly form. Under the Health 
Act 2009, the “NHS Constitution” (The Constitution) and the “Handbook to the NHS 
Constitution” (The Handbook) must be published by the Secretary of State. These 
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publications are the codification of patient rights within the Law - the Health Act 2009 
does not create the rights or even give the content of the Constitution - but for the 
patient (and NHS staff) they are the first comprehensive expression of the rights, 
expectations and duties that operate within the NHS. The Constitution and Handbook 
have four parts. The first two outline seven principles and six core values upon which 
the NHS is built. Part three outlines first the seven areas of rights and pledges that the 
patient can enjoy and the responsibilities owed to the NHS by patients and the public. 
Part four outlines NHS staff members’ rights and pledges to them, and their 
responsibilities.  
This brings together two lines through which patient rights have developed in the UK. 
The first line relates to the more traditional rights - the rights relating to the definition 
of the relationship between the carer and the patient within the consultation or 
treatment room. The second line relates to the more modern, consumer-style rights 
about access and choice within the broader provision of healthcare.  
The more traditional rights had their origin in the medical professions themselves. It 
concerns the quality of care and the nature of the doctor-patient interaction - 
adherence to professional norms, being registered as a suitably qualified practitioner, 
etc.  This starts in the self-regulation of the (Royal) Colleges (for physicians and 
surgeons from the 15th and 16th centuries), with the twin elements of registration and 
definition of professional standards. These bodies remain strong and have been added 
to with colleges of medical specialisms and other health professions.15 The Medical Act 
1853 created the General Medical Council (GMC) with the mandate to create a 
compulsory register of doctors. Under the Act, to practice medicine with the claim to 
being ‘a doctor’, one must be registered. Further, the GMC was charged with setting 
the standards for medical education, regulating University courses and requirements 
for admission to the profession. The GMC, whilst a statutory body, has a very strong 
professional self-regulatory element. Section 35 of the Medical Act 1983 gives the 
GMC power to determine, ‘in such manner as the Council think fit, advice for members 
of the medical profession on standards of professional conduct or on medical ethics’. 
The subsequent sections of that Act concern the powers of the GMC in regulating 
‘fitness to practice’ and ‘professional conduct’ of doctors. The GMC publishes a number 
of codes of guidance to practitioners, particularly “Good Medical Practice” (GMP)16 and 
the various specific advice. This is the core of (traditional) patient rights in the UK; it 
is enforced on practitioners through the requirement to follow the professional 
standards as a continuing condition of registration, and that registration is compulsory 
to be able to claim to be a professional medical practitioner (and thereby gain access 
to mainstream employment).17 
Alongside this traditional patient rights have two other origins: further statutory 
requirements, and the Common Law. English Law is Common Law - i.e. its origins are 
                                                 
15 See, for example, Royal College of Physicians (established, 1518); Company of Barber-Surgeons (1540, 
splitting into Royal College of Surgeons in 1754); British Medical Association (1832); Royal College of 
Nursing (1916). A number of specialisms also have their own bodies, for example, the Royal College of 
General Practitioners (1953). 
16 http://www.gmc-uk.org/guidance/index.asp This code and the further explanatory notes, via the website, 
is supported by case studies and education materials that readers can use to develop their understanding of 
the concepts. 
17 This rather obtuse wording is because it is not compulsory to register to offer medical services; it is a 
criminal offence to make a false claim or pretend to be a professional practitioner (see, for example, Medical 
Act 1858, s. 40). 
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in judge-made Law. From the mid-19th century, this has accommodated the more 
democratic aspect of Parliament-made Law, in statutes. The Medical Acts are a good 
example of this; from the 1980s, and particularly post-2000, there have been more 
statutory codifications and original Acts in the area of standards and quality in the 
NHS (which will be referred to in the text below). Judge-made Law has also 
contributed to the development of actions for compensation (the Tort of medical 
negligence) and to the definition of standards (for example, in informed consent), and 
in relation to criminal Law. These developments (from the 19th and 20th century) have 
in some cases (but not all) been incorporated into Acts of Parliament, and have 
influenced the developments of the Codes of Guidance.  
Whereas traditional patient rights are well established in UK Law, albeit in a number of 
sources, the new, or consumer, patient rights (dealing more overtly with patient 
choice in a market) are more difficult to identify. The UK famously developed the 
National Health Service as part of the Welfare State under the National Health Service 
Act 1946 (NHS Scotland, 1947 and NHS Northern Ireland, 1948). Before this, the 
provision of health was a mixture of private, charitable and local government 
provision, where the right to health was entirely based upon the ability to pay at the 
point of use, or upon a local charitable opportunity. The National Health Service 
nationalised much of health care (the hospitals, the expectation of provision and cost), 
making health a right for all citizens (based on a universal “National Insurance” 
payment and underpinned by taxation), free at the point of use. This right remains at 
the heart of the majority of NHS provision, and it remains a strong part of the cultural 
identity of ‘Britishness’. 18 
The idea of consumer medicine has some traction in current political discussions. 
However, patients remain in a ‘doctor-patient’ relationship in the NHS with and 
expectation that the NHS will address any health problem. There is no clearly defined 
‘basket of goods’ to which individuals are entitled. Rather, entitlement is to all health 
care with regulation in two ways: first by waiting lists and budgets; second by 
approval of therapies for use in the UK by the National Institute for Health and Care 
Excellence (NICE). NICE operates with an element of economic effectiveness as well 
as clinical effectiveness. Waiting lists and budget are the most interesting element in 
terms of patient expectations and rights. Individuals interact with the institution of the 
NHS. Waiting times and budgets are more political questions than rights questions. 
Increasingly, expectations of being seen within a particular time are more common as 
part of the political drive for efficiency in the NHS, but they are more difficult to 
exercise as hard legal rights to timely healthcare. The NHS is rooted in collectivism, 
and this is reflected in the approach that is taken towards the ‘new’ or consumerist 
patient rights. Further, there is an alternative for those who can afford which acts as a 
self-help against individually unacceptable waiting times, in the parallel provisions of 
‘private healthcare’ in the UK. Alongside the NHS, there are private providers who 
offer services paid at the point of use. Often, because of the deal struck by the doctors 
with the Government in the initial creation of the NHS in the 1940s, the doctors also 
work within the NHS (and are therefore regulated in terms of traditional patient rights 
in the same, professional, way); other health workers, for example nursing staff, 
working within the private system (for example, in private hospitals) again have to be 
registered in their profession and are subject to that professional regulation. Thus, the 
                                                 
18
 Timmins, N. (1995) The Five Giants: A Biography of the Welfare State London: Harper Collins. 
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patient right to choice operates with a two-tier way: within the NHS, there are 
opportunities for second opinions and a choice of doctor, but this is subject to waiting 
times and what one might describe as ‘soft rights’ of general practitioner (GP) referral; 
the greater choice operates for those who can afford additional health insurance, but 
this tends to operate in the middle ground of care - not at the GP level or at the 
emergency or highly expensive, technical care (e.g. oncology), but at the realm of 
more routine operations (e.g. hip replacements, etc.).19 
The Constitution starts with the six core values and seven principles that frame the 
NHS. The values are “working together for patients”, “respect and dignity”, 
“commitment to quality of care”, “compassion”, “improving lives”, and “everyone 
counts”. The handbook explanations of the values stress the primacy of the patient 
and the coordination of the various elements of the service to serve the needs of the 
patient. There is a commitment to respect and dignity, to excellence, and to just 
delivery of services. Interestingly, questions of efficiency and value for money do not 
appear in the values; these appear in the principles. Whereas the values point to the 
quality and manner of care, the principles point more to access. Thus the principles 
are that: “the NHS provides a comprehensive service available to all”,  “access to NHS 
services is based on clinical need, not on an individual’s ability to pay”, “the NHS 
aspires to the highest standards of excellence and professionalism”, “the NHS aspires 
to put patients at the heart of everything it does”, “the NHS works across 
organisational boundaries and in partnership with other organisations in the interest of 
patients, local communities and the wider population”, “the NHS is committed to 
providing best value for taxpayers’ money and the most effective, fair and sustainable 
use of finite resources”, and “the NHS is accountable to the public, communities and 
patients that it serves”. These values and principles are expressed through rights and 
pledges to patients in the areas of: access; quality of care and environment; nationally 
approved treatments, drugs, and programmes; respect, consent and confidentiality; 
informed choice; involvement in your healthcare and in the NHS; and, complaint and 
redress. 
The right of access to healthcare 
This has been to a large extent covered in the discussion of the origin of the NHS 
above. However, the Constitution includes a number of rights that make rights to 
access explicit, and that connect those rights to broader issues of equality. Therefore, 
in the first and second principles, the duties expressed in the Equality Act 2010 are 
made explicit for the NHS: there can be no discrimination by virtue of “age, disability, 
race, gender or gender reassignment, sexual orientation, pregnancy and maternity, 
religion or belief, or marital or civil partnership status”20; ‘health inequalities’ must 
also be alleviated. Further, unless specifically addressed by statute,21 individuals are 
entitled to the benefit of a “comprehensive health service designed to secure 
improvement (a) in the physical and mental health of the people of England, and (b) 
in the prevention, diagnosis and treatment of illness” and provided “free of charge” 
                                                 
19 Propper, C., (2000) “The demand for private health care in the UK.” Journal of Health Economics 19(6): 
855–876. 
20 The Handbook, p. 20, derived from the Equalities Act 2010. The provision must also comply with the 
Human Rights Act 1998. 
21 See the rules relating to prescription, dental and opthalmic services, and for ‘overseas visitors’, under the 
National Health Service Act 2006 (as detailed in The Handbook, pp 18 and 19). 
Study on Patients’ Rights in the European Union - MApping eXercise 
110 | P a g e  
 
(commonly understood as ‘free at the point of use’).22 Further, under the Constitution, 
the right of access includes a right to expect a local assessment of health needs and a 
planning of the service accordingly.  
As indicated above, in a system that aims to offer a fully comprehensive health care, 
rather than a limited range of core services, but that has finite resources, waiting 
times become one of the key measures for providers to regulate access to the service 
(in conflict with successive Governments in broad conflicts over funding levels). The 
Constitution outlines the rights to access within defined acceptable waiting times. 
There is a general right to start “consultant-led”, “non-urgent” treatment within 18 
weeks of referral; oncology patients have rights to be seen and to start treatment 
much more quickly - for example, to be seen within two weeks from a GP referral 
where cancer is suspected. (The Handbook, p. 27) Medical factors, for the patient’s 
welfare, can extend these time-limits.  
It is interesting, given the comprehensive and rather collectivist approach of the NHS, 
there is no corresponding duty owed by the patient to take responsibility for his or her 
own health. The first ‘responsibility’ that the Constitution places upon the patient is, 
“Please recognise that you can make a significant contribution to your own, and your 
family’s, good health and wellbeing, and take personal responsibility for it.” (The 
Handbook, p. 86) This is explained in the Handbook as follows, “You have a role to 
play in staying healthy...You can ask about what support you might be offered in 
managing your condition yourself or changing to a healthy lifestyle stopping smoking, 
reducing weight, taking up exercise or reducing excessive alcohol consumption.”23 
There is no sanction attached for failure to take this responsibility.  
The Constitution explicitly refers to the right to seek health care in other jurisdictions 
under the EU Regulation 883/2004 and Directive 2011/24/EU. The National Contact 
Point24 has largely been constructed to assist out-going patients (NHS patients going 
abroad), with country-by-country explanations; in-coming patients have information 
on the NCP,  but might also need to access, for example, the “NHS Choices” portal for 
broader detail of patient rights.25 
Self-determination and confidentiality 
Patients have the right to informed consent in UK Law. “You have the right to accept 
or refuse treatment that is offered to you, and not to be given any physical 
examination or treatment unless you have given valid consent. If you do not have the 
capacity to do so, consent must be obtained from a person legally able to act on your 
behalf, or the treatment must be in your best interests.” (The Handbook, p. 51) This 
has been developed over a long period in the Common Law. Its origins are in Tort and 
Criminal Law relating to assault and battery. In relation to competent adults, cases 
have defined the extent of the right, and the corresponding duties of practitioners. 
Particularly, two cases are landmarks: Bolam v. Friern Hospital Management 
Committee [1957] 1 WLR 582 and Sidaway v. Board of Governors of the Bethlem 
Royal Hospital [1985] AC 871. The practical detail of informed consent is explained in 
                                                 
22 National Health Service Act 2006, s. 1. 
23 Ibid. 
24 http://www.nhs.uk/NHSEngland/Healthcareabroad/Pages/Healthcareabroad.aspx 
25 http://www.nhs.uk/choiceintheNHS/Rightsandpledges/Pages/Rightsandpledgeshome.aspx 
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the GMP supplements the NHS Choices website “Consent to Treatment”26, and the 
GMC supplement to GMP “Consent: Doctors and Patients Making Decisions Together”27 
These make clear the distinction between the information required, the consent, and 
the evidencing of consent. Implied consent is discussed only in relation to organ 
donation, and then only as a possible future option.  
Children of the age of 16 and 17 are presumed to have competence to make their own 
medical decisions like adults (and in the same way it is a rebuttable presumption). 
Those under the age of 16 are subject to the decision making of their parents or 
guardians. However, under the decision of Gillick v. West Norfolk and Wisbeck Area 
Health Authority [1986] AC 11 a child is entitled to make decisions for him- or herself 
where the medical practitioner (and ultimately a court, where the judgement of the 
doctor is challenged) judges the child to be competent to make that particular 
decision. “Gillick competence” is a situation-dependent judgement; the child does not 
have to show general competence. Adults who do not have competence are 
represented by guardians, or where no such person is appointed the doctor “they must 
consult with family members and other interested people where possible. For serious 
medical treatment decisions, if there is no family available with which to consult, they 
must consult an independent mental capacity advocate (an IMCA).”28  
There is a distinction in English Law between medical confidentiality and privacy. The 
distinction is in no small part because the Common Law did not recognise privacy as a 
right, and it is introduced into English Law directly by the Human Rights Act 1998, and 
before that only indirectly by reference to the European Court of Human Rights.29 
Medical records, which must be created and kept by the practitioner, are regulated 
under Statute by the Data Protection Act 1998 (and previously by the Access to 
Medical Reports Act 1988 and the Data Protection Act 1984). The 1998 Act follows the 
European Directive on the processing of personal data (95/46/EC). There is, in the 
background of the early Law, a more protectionist position; the right to access one’s 
data was not immediately forthcoming, with a sense of the record being owned by the 
practitioner or the NHS, and the information being of a specialist nature from which a 
patient might need to be protected. The presumption today is that a patient must 
have access to his or her medical data.  
Under the Constitution there are a number of rights relating to patient confidentiality 
and privacy, particularly around their personal data. As a patient, you have the right: 
“of access to your own health records and to have any factual inaccuracies corrected.” 
(The Handbook, p. 54); “to privacy and confidentiality and to expect the NHS to keep 
your confidential information safe and secure.” (p. 55); “to be informed about how 
your information is used” (p. 57); “to request that your confidential information is not 
used beyond your own care and treatment and to have your objections considered, 
and where your wishes cannot be followed, to be told the reasons including the legal 
basis” (p. 58). There are corresponding duties on doctors in both the Constitution and 
the GMC’s GMP. There is also a pledge that the NHS “commits to ensure those 
                                                 
26 http://www.nhs.uk/conditions/consent-to-treatment/pages/introduction.aspx 
27 http://www.gmc-uk.org/guidance/ethical_guidance/consent_guidance_index.asp 
28 The Handbook, p. 51, following the Mental Capacity Act 2005. 
29 For key cases in the development of confidentiality and privacy are Attorney-General v Guardian 
Newspapers (No 2) (the Spycatcher case), [2004] UKHL 22 and Campbell v Mirror Group Newspapers 
[1990] 1 AC 109 
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involved in your care and treatment have access to your health information so they 
can care for you safely and effectively”, “to anonymise the information collected 
during the course of your treatment and use it to support research and improve care 
for others,” and “where identifiable information has to be used, to give you the chance 
to object wherever possible” (pp. 60–61), and “to share with you any correspondence 
sent between clinicians about your care” (p. 62). The second of these pledges is 
fascinating. In many jurisdictions, this would be contentious (and indeed, the response 
to the “Care. Data” initiative indicates that it is controversial for many in the UK). 
However, here, the use of personal data, albeit anonymised is presumed to be 
acceptable, and presented as a positive ‘good’ for the patient. This positive 
presentation of medical research continues in the pledge “to inform you of research 
studies in which you may be eligible to participate” (p. 61). Point 50 of the GMP 
requires that a registered practitioner “must treat information about patients as 
confidential. This includes after a patient has died.” 
Quality and safety 
One of the first, and oldest, mechanisms for ensuring quality is registration of 
practitioners with the obligation as part of the registration that the applicants have 
successfully completed prescribed study. This is a measure found in the earliest 
colleges of physicians and of surgeons, and it is formalised as the main duty of the 
General Medical Council from the Medical Act 1853. Today, that initial validation and 
the regulation of providers of medical education remains a major duty on the GMC. 
Equally, today practitioners undergo a rigorous revalidation process every five years, 
requiring a self-prepared, reflective portfolio, evidencing the candidate’s continuing 
education, ‘quality improvement activity’, significant events, colleagues’ and patients’ 
feedback, ‘review of complaints and compliments’.30 The portfolio forms the basis of 
an assessment with the candidate. This has been developed in no small part because 
of the scandals that medical practice has undergone in recent years, for example, the 
actions of the GP Shipman, and the practices in Alder Hey Hospital and Bristol Royal 
Infirmary.31  
Under the Constitution, the “commitment of quality of care” is one of the core values 
and the third principle is that “the NHS aspires to the highest standards of excellence 
and professionalism”. These are translated into a number of rights (and corresponding 
duties). Patients have “the right to be involved, directly or through representatives, in 
the planning of healthcare services commissioned by NHS bodies, the development 
and consideration of proposals for changes in the way those services are provided, 
and in decisions to be made affecting the operation of those services”, and there is a 
corresponding pledge to provide patients (and the public) with information to enable 
them to participate in such discussions. (The Handbook, p. 71–72) Patients “have the 
right to be treated with a professional standard of care, by appropriately qualified and 
experienced staff, in a properly approved or registered organisation that meets 
required levels of safety and quality.” (p. 33) Further, patients “have the right to be 
treated with a professional standard of care, by appropriately qualified and 
experienced staff, in a properly approved or registered organisation that meets 
required levels of safety and quality.” (p. 36) This has corresponding pledges in 
                                                 
30 http://www.gmc-
uk.org/RT___Supporting_information_for_appraisal_and_revalidation___DC5485.pdf_55024594.pdf 
31 See, for example, Dixon-Woods, M., Yeung, K., Bosk, C L., (2011) “Why is U.K. medicine no longer a self-
regulating profession? The role of scandals involving "bad apple" doctors.” Soc Sci Med. 73(10): 1452–9. 
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relation to standards of hygiene and “to identify and share best practice in quality of 
care and treatments.” (pp. 39–41) Patients “have the right to drugs and treatments 
that have been recommended by NICE for use in the NHS, if your doctor says they are 
clinically appropriate for you.” (p. 44) 
Choice 
A patient has a right to choose a GP practice (and a doctor within that practice): this 
choice is honoured in all but exceptional circumstances, including the patient’s 
misconduct or a ‘breakdown in the doctor-patient relationship’, but the NHS 
Commissioning Board has a duty to assist in finding an alternative.32 Likewise, with 
the exception of mental health, emergency, maternity care and oncology services 
under the two-week referral time, a patient has the right to choose the NHS provider 
of outpatient, consultant-led care.33 
This is a right under the Health and Social Care Act 2012 as a duty on the NHS 
Commissioning Board, expressed as follows: “Where a range of potentially suitable 
treatments or forms of healthcare is available, an adult, competent person has the 
right to receive the information they need in order to decide their preference. NHS 
staff will involve you in discussions to decide, with you, on the right choice for you. If 
you wish, this can include your family and carers”. (The Handbook, p. 69) Further, as 
a patient “[you have] the right to be given information about the test and treatment 
options available to you, what they involve and their risks and benefits.” (The 
Handbook, p. 53) These rights are reflected in the GMC’s “Good Medical Practice”, 
where the first two points of GMP are “1. Patients need good doctors. Good doctors 
make the care of their patients their first concern: they are competent, keep their 
knowledge and skills up to date, establish and maintain good relationships with 
patients and colleagues, are honest and trustworthy, and act with integrity and within 
the law. 2. Good doctors work in partnership with patients and respect their rights to 
privacy and dignity. They treat each patient as an individual. They do their best to 
make sure all patients receive good care and treatment that will support them to live 
as well as possible, whatever their illness or disability.” Point 49 requires that 
registered practitioners “must work in partnership with patients, sharing with them the 
information they will need to make decisions about their care,15 including: a) their 
condition, its likely progression and the options for treatment, including associated 
risks and uncertainties; b) the progress of their care, and your role and responsibilities 
in the team; c) who is responsible for each aspect of patient care, and how 
information is shared within teams and among those who will be providing their care; 
d) any other information patients need if they are asked to agree to be involved in 
teaching or research”. Point 51 requires that registered practitioners “must support 
patients in caring for themselves to empower them to improve and maintain their 
health. This may, for example, include: a) advising patients on the effects of their life 
choices and lifestyle on their health and well-being; b) supporting patients to make 
lifestyle changes where appropriate”. Point 68 requires the registered practitioner to 
GMP 68 “be honest and trustworthy in all your communication with patients and 
colleagues. This means you must make clear the limits of your knowledge and make 
                                                 
32 The Handbook, p. 63 and 64, referencing the National Health Service Act 2006, National Health Service 
(General Medical Services Contracts) Regulations 2004 and National Health Service (Personal Medical 
Services Agreements) Regulations 2004. 
33 The Handbook, p. 65, referencing National Health Service Commissioning Board and Clinical 
Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012. 
Study on Patients’ Rights in the European Union - MApping eXercise 
114 | P a g e  
 
reasonable checks to make sure any information you give is accurate”. There is an 
expectation under the Constitution that medical practitioners “should aim to involve 
patients, their families, carers or representatives fully in decisions about prevention, 
diagnosis, and their individual care and treatment.” (The Handbook, p. 133) 
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3.3 Enforcement – a country by country review 
The following pictures are taken from the reports of the Country Experts. In the main 
they are using the words of those experts, consolidated from a number of separate 
questions. Where an opinion is expressed about the effectiveness of the system, for 
example, this is the opinion of the particular country expert. In the main, the experts 
completed the questionnaire as requested. Some, however, departed slightly from 
that format. Equally, some gave very detailed answers which have been presented in 
full, almost as case studies. Hence, the balance between the different country reports 
is not equal.  
In relation to Cross-border health care, there must be a presumption that unless 
otherwise stated, the general domestic Law applies and that no special provisions are 
made for those exercising their rights under the Directive. In some cases, country 
experts pointed this out. 
Criminal Law This survey or report does not systematically address the criminal 
procedures including, for example, manslaughter, assault, battery, molestation, sexual 
molestation, causing bodily harm, duress, and causing unlawful detention, relating to 
a failure of informed consent of other criminal liability. This is more a State 
investigation and punishment issue which is indirectly interesting for patient rights in 
terms of the environment that it creates for the health carer to follow the Law in 
relation to informed consent, but it is not directly on the point about the enforcement 
of patient rights for the individual patient. Further, the effectiveness of the preventive 
impact of the criminal Law requires a very different questionnaire to a different sample 
of professionals in comparison with that required to illicit information about the 
enforcement of patient rights at the individual level. We are reminded by the German 
expert that there might be situations where the breach of, for example, the right to 
informed consent, is justified in the public interest. 
The Italian expert provided a detailed example of how criminal liability might be 
addressed. 
In general terms, the state of the art for the criminal relevance regarding the 
lack of informed consent is summarized by a Supreme Court decision, rendered 
in a plenary session (no. 2437 del 2009). The Court ruled on the two most 
suitable incriminating rules that would apply to the lack or invalidity of consent 
to treatments (610 Criminal Code: private violence; and 582 Criminal Code: 
personal injury). On the former, it excluded the potential of that particular legal 
provision to encompass the conduct. On the latter, the court ruled that lack (or 
invalidity) of duly informed consent may lead to criminal sanctions unless there 
is a ‘favourable outcome’ understood as the appreciable improvement of the 
health condition of the patient, in relation not only to the typical rules of 
medical science, but also to the possible alternatives considered alongside any 
manifestation of will either positively or indirectly expressed by the patient. 
 
Data Protection Further, all European Union and European Economic Area Member 
States are required under Directive 95/46/EC to have provisions in relation to breach 
of duties concerning the processing of personal data. This requires that there is a 
Supervisory Authority for personal data processing in place, and that specific 
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procedures are in place for the processing of sensitive personal data such as medical 
data (particularly Article 8). There are duties to allow access to personal data, to 
require rectification of personal data, and to have a civil and criminal structure in place 
for investigate breaches and to impose measures to redress breaches should they be 
found to have occurred. As this is a standard requirement for all the jurisdictions, it 
will not be repeated for each country hereunder. However, where specific divergence 
from those standard requirements are noted in a country report, they are reported in 
this country-by-country report. 
Broader considerations Other Law is in force that relates to patient rights. The 
Swedish expert pointed to two examples that are useful at this point: 
The Medical Products Agency (Läkemedelsverket) is a government agency 
responsible for the regulation and monitoring of pharmaceuticals and herbal 
remedies in addition to other medicinal products - Medicinal Products Act 
1992:859. A patient can contact the Medical Products Agency if he or she has a 
complaint about a pharmaceutical product. For more information: 
https://lakemedelsverket.se/english/overview/About-MPA/ 
If a patient feels that he or she is subject to discrimination from the healthcare 
services on the basis of gender, gender identity, gender expression, ethnic 
origin, religion or other beliefs, sexual orientation, disability or age, he or she 
can report this to the Equality Ombudsman (Diskrimineringsombudsmannen). 
The Equality Ombudsman is a government agency. The Equality Ombudsman 
can pursue a complaint through court or reach a settlement between the 
claimant and defendant. For more information: http://www.do.se/en/ 
If a patient is injured as a result of medication, then he or she should contact 
the Pharmaceutical Insurance (LFF). The Pharmaceutical Insurance covers 
everyone who has been treated with prescribed pharmaceutical products or 
pharmaceuticals purchased from a legitimate dealer in Sweden. It also extends 
to include patients who received their pharmaceuticals at a hospital. For more 
information: http://lff.se/a-unique-type-of-insurance/for-patients/ 
 
  
Study on Patients’ Rights in the European Union - MApping eXercise 
117 | P a g e  
 
AUSTRIA 
There is a Civil Law Right to Complain about breaches of medical contracts. Civil court 
proceedings are available for breach of contract and in tort Law. Where a patient 
cannot afford representation, a legal-aid lawyer can be provided. 
Administrative court proceedings for the more structural aspects of the system - for 
breaches of procedural duties in the provision of health care to the individual. 
Patient Ombudsmen, Arbitration Boards at the Medical Chambers of the Federal 
States, and Patient Compensation Funds, provide mechanisms to explore out of court 
settlements of disputes and the Federal State has a duty to provide these ‘alternative 
dispute resolution’ services. 
Patient Representatives are established to represent patients in disputes, even offering 
to negotiate with insurers on their behalf. Patient Advocates represent psychiatric 
patients.  
Tortious liability in Civil Law is based on establishing fault. Where fault cannot be 
established, Patient Compensation Funds provide (partial) compensation. Where 
liability is established against an individual physician outside a hospital, but the 
compensation cannot be paid, a fund of the Austrian Medical Chamber is established 
(by subscription by all independent physicians) since 2006 to address this unmet 
need. - Leischner A, Zeinhofer C, Lindner C, Kopetzki C, Medical Law in Austria, 
Kluwer Law International BV (NL), 2011, at p 110-111 
See, Helmut Koziol, Basic Questions of Tort Law from a Germanic Perspective, Jan Sramek Verlag, 
Wien, (2012) www.jan-sramek-
verlag.at/fileadmin/user_upload/Koziol_BasicQuestions_ePDF_HighResOpen_FINAL.pdf 
Cross-border enforcement issues 
The National Contact Point shall consult cross-border patients. 
 
BELGIUM 
The Right to Complain is a specific right under the Patient Rights Law. A complaint 
must be registered with the relevant Ombudsperson’s office. In addition to a 
preventive (preventing complaints and preventing the shortcomings that gave rise to 
them) and mediating function, the ombudsperson also has a twofold informative 
function: to provide information about alternate possibilities for dealing with a 
complaint in the event that mediation fails and to provide information about the 
organization and functioning of the ombudsperson's office itself. Under the hospital 
legislation every hospital must appoint an ombudsperson. 
A Federal Ombudsperson service for patient rights has been established at the Ministry 
of Public Health. This service is responsible for handling complaints of patients 
concerning the exercise of their rights, granted by the Law on Patient Rights, by 
referring patients to the appropriate local ombudsperson. The complaint is treated by 
the Federal Ombudsperson service if there is no appropriate local ombudsperson. It 
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concerns, for example, GPs, dentists, pharmacists, independent nurses and 
physiotherapists. 
Civil court proceedings for negligent breach of duty of care to the patient (not contract 
law) 
Administrative Law does not provide specific sanctions in relation to patient rights 
(e.g. failure to give adequate information to ensure informed consent). In the 
informed consent example, the patient must establish the negligence of the health 
carer. 
Patients can make a complaint to the provincial disciplinary councils. These bodies 
cannot compensate; the investigation is about professional fitness to practice rather 
than redress for breach of patient rights. The councils have disciplinary powers over 
professionals. Reflecting the seriousness of the proceedings, the professional accused 
has a number of due process safeguards to protect him or her - Crown Order, 6-02-
1970. 
There is no assistance in the patient rights law available to the patient.  
Compensation 
As the civil liability system was found inappropriate as a compensation mechanism in 
the context of medical malpractice (e.g., risk of so-called defensive medicine; liability 
risks that can no longer be insured, prejudice to confidentiality and trust between 
patient and physician) the law of 15 May 2007 was meant to introduce a system of 
compensation of medical damage based on solidarity instead of liability. The 
inspiration came from the Scandinavian so-called no-fault (although it is more correct 
to use the term no blame) insurance schemes. The act of 15 May 2007 was 
characterized by the following elements: no proof of negligence was required; the 
individual civil liability of the physician was to be abolished and he or she could no 
longer be sued by the patient before a civil judge except in case of intentional or 
serious error; for certain types of damages thresholds and caps were planned; 
compensation of the damage was to be paid by a fund which was to have been 
financed by the State and the health care professionals. However, the entrance into 
force of this act had been postponed several times because of doubts as to its financial 
viability, and it was finally repealed by the law of 31 March 2010 regarding the 
compensation of damage due to health care (Moniteur belge, 2 April 2010). This latter 
act which entered into force on 1 September 2012 contains a system inspired by the 
French regime embedded in the 2002 Act which combines in a rather unique way the 
classic liability system as a rule with compensation of very severe damage caused by 
an unavoidable risk and based on national solidarity with the victim. The law is 
applicable to damage caused by a fact that happened after 2 April 2010 (Article 35,§ 
2). 
The law organizes a Medical Accidents Fund with three goals: compensating (very) 
severe health damage not caused by a fault, intervening as mediator between patient 
and insurer and compensating as substitute with recourse against the failing insurer. 
Cross-border enforcement issues 
No specific provisions apply. 
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BULGARIA 
There is no specific right to complain. However, complaints about breaches of patient 
rights can be made to   the Health Insurance Fund, to Medical Audit Agency and 
Bulgarian Medical Union. The legislation also contain Codes of professional ethics 
issued by Bulgarian Medical Union, sanctioned by the Minister of Health in year 2000, 
amended in 2013 and the Code of professional ethics issued by the Union of Dentists 
in Bulgaria - Guilds of Doctors and Dentists Act.  Further, the law contains a Code of 
ethics of the masters of pharmacy. The Medical Guilds have arbitration committees 
and an Ombudsman; there is no healthcare ombudsman outside the Guilds. In 2009 
the Public Council for the Rights of the Patient was established under the Minister of 
Health. It has a wide stakeholder membership, and is an advisory board to the Minster 
in relation to all aspects of patient rights. 
Medical Audit Agency can impose fines for the breach of patient rights, e.g. in relation 
to the provision of adequate information for informed consent). The Professional 
Guilds also have powers in relation to breaches of patient rights. 
Cross-border enforcement issues 
No specific provisions apply. Pursuant to Art. 80f Health Insurance Act persons who 
exercise cross-border health services rights shall be entitled to have reimbursed their 
healthcare in the Member State of treatment to the extent of costs that National 
Health Insurance Fund or the Ministry of Health would have paid for the relevant 
healthcare in Bulgaria, but not more than actual costs. 
The right to reimbursement does not apply to healthcare provided to compulsorily 
insured persons in the Republic of Bulgaria hospitals established in its territory that 
are not contracted to provide medical care with the National Health Insurance Fund 
and are not financed or subsidized with funds from the budget of the Ministry of 
Health. 
 
Croatia 
The right to complain is seen as a right to the protection of legal rights - Health 
Protection Act. Complaints must be addressed by providers without delay, with a 
requirement to provide a written answer within 8 days. If the outcome is not 
satisfactory for the patient, he or she may pursue the complaint further through the 
Ministry of Health, Croatian Medical Chamber or through the Courts. 
There is a right to sue both the health carer and the institution within which the care is 
provided for damages in civil Law for a breach of a patient’s rights (e.g. to informed 
consent) - Civil Obligations Act and Patients’ Rights Protection Act. This is through an 
action in the Misdemeanour Court. Actions before the Croatian Medical Chamber 
(professional sanctions) are also possible.  
The right to compensation is formally recognized as a specific patient's right - 
Patients` Rights Protection Act, Art. 29 - where it is stipulated that patients have right 
to claim damage in accordance with regulation of obligatorily law. The right to 
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compensation is stipulated in article 1046 and 1100 of Civil Obligations Act. Patients 
whose rights are violated can also seek compensation through criminal court case. 
 
CYPRUS 
There is no right to complain per se. However, the Law protects the rights created 
under the Law - Patient Rights Act. These include a statutory duty to assist 
patients in making complaints, to investigate fully the complaint without 
delay, and to inform the patient of the reasoned outcome as soon as it is 
reached. State hospitals are obliged to have a Patients’ Rights Officer. The same Law 
requires the creation of a Complaints Examination Committee and a National Bioethics 
Committee both with power to hear complaints within the scope of their jurisdictions - 
Patient Rights Act. The CEC hears disputes in the public sector that are not resolved 
by the PROs, and can hear first instance complaints in the private sector.  
Private hospitals do not have to give assistance to complainants, but must provide 
accurate information; public hospitals are obliged to assist patients. 
Cross-border enforcement issues 
One of the duties of the National Contact Point is to help the patients with their 
complaints procedure - Cross Boarder Health Law, Article 8(3)(d). 
 
CZECH Republic 
There is a right to complain - Act no. 372/2011 Coll., on Health Care Services. 
Breaches, for example of the right to information in relation to informed consent, can 
constitute “moral damage” and are actionable as such for financial damages. Providers 
must accommodate complaints and adjudicate on them. Patients can also pursue their 
complaints through Regional Offices, the Ministry of Health, health insurance funds, 
professional organizations (e.g. the Czech Medical Chamber), and the Ombudsman. 
Where these mechanisms are not successful in resolving the complaint, there are 
appeal structures and the patient can resort to the Civil or Administrative Counts. The 
right to compensation is not a patient right, but rather is a broader right, concretely in 
the Act no. 89/2012 Coll., Civil Code, as amended. 
Cross-border enforcement issues 
No specific provisions apply. 
 
DENMARK 
The right to complaint is recognized as a specific patient right in the Act on Complaints 
and Compensation within the Health Care Services (Consolidating Act no. 1113 of 7 
November 2011 Act on Complaint and Compensation). In cases of a breach of patient 
rights, the patient can make a complaint to the National Agency for Patients’ Rights 
and Complaints (Patientombuddet) - http://www.patientombuddet.dk. Complaints 
about specific professionals can be made to Disciplinary Boards, who assess 
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professional competence issues.  They can issue ‘criticisms’ or ‘serious criticisms’ 
against the professional. Further sanctions are only available through the jurisdiction 
of the Danish Health and Medicines Authority. Complaints can also be made to the 
secretariat about the general standard of care given by a provider. A first offer for 
dialogue will be made as a way of seeking resolution. If this fails or is not undertaken 
(it is not compulsory) the process moves to a formal complaint. Under the Act on 
Complaints and Compensation, a complaint must be made within 2 years of the 
patient becoming aware of the reason for complaint with an absolute deadline of 5 
years from the actual incident itself. 
Complaints must be heard in the general administrative Law duty towards openness 
and awareness towards citizens. Patients must be informed of their rights in relation to 
making complaints. In the private sector, however, these rights and duties are much 
more restricted. 
Regions employ Patient Councilors who assist patients in making complaints. NGO 
support is also available.  
For compensation, there is a special no-fault compensation system for patients, which 
is regulated by the Act on Complaints and Compensation within the Health Care 
Services (Consolidating Act no. 1113 of 7 November 2011 Act on Complaint and 
Compensation). Information (in English) about the scheme is available on this website 
http://patienterstatningen.dk 
Cross-border enforcement issues 
There are no special procedures for cross-border patient rights enforcement. The 
domestic provisions are used. 
 
ESTONIA 
No information available 
 
FINLAND 
There is a right to complain to the health carer or institution providing the health care 
- Patient Rights Act (particularly s. 10). The patient may also make a complaint to the 
Supervisory Authority or to the Parliamentary Ombudsman. Submitting a complaint to 
the health carer or institution does not limit the patient’s right to make a further 
complaint to the supervisory authority or ombudsman. A right to redress for breaches 
of the duty of care is provided in Civil Law - Patient Injury Act 585/1986, and the Act 
of Torts 412/1974. The process also allows the authorities to address questions of 
continuing fitness to practice of the health carers involved. Patient Ombudsmen must 
be appointed in ‘health care units’. These Ombudsmen must provide patients with 
some assistance in complaining. See 
https://www.finlex.fi/fi/laki/kaannokset/1992/en19920785.pdf. 
Compensation is available through the Patient Injury Act (585/1986)  The Act is not 
translated to English unfortunately, but Patient Insurance Centre (www.pvk.fi/en) 
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provides information in English. The patient may also claim compensation through a 
civil law procedure under Tort Liability Act (412/1974) or in connection of penal law 
case - https://www.finlex.fi/fi/laki/kaannokset/1974/en19740412.pdf 
Cross-border enforcement issues 
The national focal point must produce information about patient rights and procedure 
to appeal and complain - Act on Cross-border Health Care, s. 24. The same 
procedures apply as in all health care.  
 
FRANCE 
The right to complain is established in Loi 2002/303. Every victim of a medical 
accident must be informed - Article L1142-4. Complaints commence with a letter of 
complaint to the health care provider (e.g. hospital). This starts an administrative 
inquiry. Mediation is available to seek a resolution of the complaint at this stage with 
compensation given by the insurance company (a legal requirement for health 
practitioners and institution - Loi 2002/303). Compensation is awarded on the basis of 
fault, where it is not agreed, it is ultimately established in a particular case by Civil or 
Criminal Courts. Every victim of a medical accident must be informed of the same - 
Article L1142-4. The patient has the right to ask for compensation the Commission of 
Indemnification (CCI) when he or she is considered the victim of a medical accident, a 
iatrogenic accident, a nosocomial infection, a vaccination accident, an accident in 
biomedical research (Article L1142-5). The procedure is free and quick (6 months to 
get an offer of compensation). This procedure can be started at the same time as the 
complaint before the courts. If the CCI considers that the damage is a consequence of 
a fault, the case will be sent to the Court, if there is no fault the indemnification will be 
given by the ONIAM www.oniam.fr . This office is funded by the state, on the principle 
of solidarity to compensate the damages resulting of medical accidents (no fault 
compensations system). Beyond these provisions, under Civil Law patients have rights 
to bring an action for breach of duties where there is damage. Equally, actions might 
be brought for violations of the Deontology Code. 
In hospitals there are commissions for patients’ rights. This is a kind of mediation. The 
commission informs the patient of the rights and the processes that could be used, 
conciliation, submission to the CCI, or action in justice. Each year the commission 
provides a report to the administration of the establishment. Family members can do 
the process when the patient is not able (incompetent, minor, deceased patient) 
The right to compensation is found in Loi 2002-303 of 4 March 2002 setting up Art. 
L1142-4 in the public health code (CSP) 
 
Cross-border enforcement issues 
The general law applies without difference. 
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GERMANY 
The right to complain is considered under the general Civil Law, and the general right 
to complain about the breach of the so called “Behandlungsvertrag”, a contract 
between patient and provider. Such complaints are then heard under the general Civil 
Law procedures and rules. Complains about the provider are checked like any other 
civil struggle by the court and prosecutors. There are also institutions 
(Schlichtungsstellen für Arzthaftpflichtfragen) specialized on mediation between 
patients and providers. 
Compensation is provided in the general Law (BGB), as follows: 
Section 253: Intangible damage 
Money may be demanded in compensation for any damage that is not 
pecuniary loss only in the cases stipulated by law. 
If damages are to be paid for an injury to body, health, freedom or sexual self-
determination, reasonable compensation in money may also be demanded for 
any damage that is not pecuniary loss. 
Section 823: Liability in damages 
A person who, intentionally or negligently, unlawfully injures the life, body, 
health, freedom, property or another right of another person is liable to make 
compensation to the other party for the damage arising from this. 
The same duty is held by a person who commits a breach of a statute that is 
intended to protect another person. If, according to the contents of the statute, 
it may also be breached without fault, then liability to compensation only exists 
in the case of fault. 
Cross-border enforcement issues 
The general Law applies. 
 
GREECE 
A breach of patient rights can be raised as a complaint in administrative Law at the 
health Ministry’s “Office of Patient Rights” or before the Ombudsman (Law 
2477/1997, 3094/3003). It can also be brought as an action for compensation in Civil 
Law (medical liability) or administrative Law. The provider must answer the complaint 
- Law 2071/1992. 
Cross-border enforcement issues 
Cross-border patients may file complaints to the Ministry’s Office for Patient Rights - 
article 4 para 2 d of l. 4213/2013. This does not exclude them from submitting 
applications through the general Law, for example, to the Ombudsman’s office. 
 
Study on Patients’ Rights in the European Union - MApping eXercise 
124 | P a g e  
 
HUNGARY 
Patients have the right to complain to the health care provider (including the right to 
make a written complaint to the supervisory body of the health care institution). A 
complaint must be answered with a written report within 10 days - Health Care Act. 
Exercising this right does not prejudice the patient’s rights to use other legal avenues 
to seek redress; the health care provider or supervisory body must advise the patient 
of this. The health care provider must have detailed rules concerning the making of 
complaints; the details of any particular complaint must be kept for 5 years. Breaches 
of patient rights may give rise to actions for damages, or in less serious cases to a 
complaint to and action by the Patients’ Rights Advocate. 
At the beginning of the 1990s it became clear in Hungary that the empowerment of 
patients can be best achieved if fundamental patients’ rights are implemented. At that 
time, the Committee of Ministers of the Council of Europe developed a set of 
guidelines for the member states on how to create structures for citizens and patient 
participation in decision-making processes in the health care system. In Hungary, the 
patients’ rights advocacy system was introduced in 1997 with the hope that basic 
rights would be observed in daily practice. The patients’ rights advocate protects the 
patients’ rights based on Article 30 of the Health Care Act. His/her main duty is to 
provide information on patients’ rights and to enforce them. The tasks of the patients’ 
rights representative include especially the following: to provide assistance in 
accessing medical documentation and in questions related to medical documentation; 
to help patients in articulating their complaints and, based on a written authorization 
received from the patient, initiate investigation at the director of the health care 
provider institution or at the maintaining body of the institution, or—in cases relating 
to the treatment of the patient—initiate the procedure at the competent authority and 
represent the patient throughout the procedure; to inform the health care workers on 
the regulations referring to the rights of patients or the amendments to these, as well 
as on the enforcement of the rights of patients in the health care provider institution. 
Thus, the patients’ rights representative may only proceed in individual cases within 
the framework of an authorization received from the patient and may initiate private 
complaints based on the permission of the patient. The patients’ rights representative 
has to alert the health care provider’s director or the supplier of the health care 
provider about the unlawful practices and other omissions connected to the 
functioning of the health care provider institution as noticed throughout their activity, 
and make suggestions for their termination. If the problem persists, the patients’ 
rights representative has the right to take the complaint to the competent authority, 
organ or person. The patients’ rights representative gives special consideration for the 
protection of the rights of patients who are exposed because of their age, physical or 
mental disability, health condition or social status. The patients’ rights representative 
has the right to enter the territory where the health care provider functions, to have 
access to relevant documentation and to formulate questions to the employees of the 
health care providing institution. The patients’ rights representative is obliged to keep 
the medical secrets relating to the patient, and to process the patient’s personal data 
in accordance with the relevant laws. The patients’ rights representative cannot have 
employment contract with the health care providers where the patients they represent 
are being treated. The patients’ rights advocates and representatives now work within 
the framework of the National Center for Patients’ Rights, Children’s Rights, and 
Documentation (OBDK). 
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Compensation: damage resulting from health services is compensated according to 
the provisions of the Hungarian Civil Code (Act V of 2013). Title XXVI of the Civil Code 
on General Provisions and Common Rules on Liability for Damages is also applicable to 
damages caused by health care providers. Under this Title, Sections 6:518 to 6:534 
provide general rules on the unlawfulness of torts, the extent of liability, the mode and 
due date of compensation, etc. 
Cross-border enforcement issues 
Complainants may opt for different channels of legal recourse (below) besides the 
healthcare provider and its financing organization (GYEMSZI): 
The National Center for Patients’ Rights, Children’s Rights, and 
Documentation (OBDK) can be contacted in case of questions regarding patients’ 
rights (in case of any violation of patient rights). The OBDK assist the complainant 
in finding the patient rights advocate assigned to the healthcare provider at issue, who 
then will help put together the complaint and to file it through the appropriate 
channels. The OBDK houses and operates the national bureau of complaints. 
The Office of the Chief Medical Officer (OTH) can be contacted with (primarily 
medical-professional) service-related issues. The OTH operates a system of specialized 
physicians in every specialty field. The OTH conducts an official inquest and issues and 
order then informs the complainant on the result. 
Complainants may file a claim in civil litigation (in a court of law) against the 
healthcare provider. The court may establish the liability of the institution and may 
oblige the institution to pay damages. 
The Authorities above may also have competence to decide on compensation claims 
arising out of cross-border care. 
 
ICELAND 
Patients have a right to complain (in writing, clearly stating the cause of the 
complaint) about breach of the duty of care owed to them - Patient Rights Act. 
Complaints about medical service should be directed to the management of the health 
care provider; to the Medical Director of Health where the complaint relates to specific 
treatment. The Medical Director has powers in relation to the investigation, particularly 
to call for expert examination of the patient and to hear evidence in the case. Staff or 
health institutions must provide “guidance to a patient, or a relative, who wishes to 
put forward comments or make a complaint. Furthermore, the management of a 
health institution is obliged to investigate notifications from staff who believe that the 
rights of patients are being infringed on. A patient shall receive a reply to his/her 
comments and complaints in writing at the earliest opportunity.” Patient Rights Act, 
Article 29. No legal-aid or legal representation is available. 
Other options, potentially pursued simultaneously or subsequently to the complaints 
procedure before the Medical Director of Health, consist of a) a criminal investigation 
for criminal medical negligence, c) claiming compensation under the no-fault 
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compensation scheme established by the Act on patient insurance no. 111/2000, c) 
pursuing a tort (fault-based) claim before the courts. 
There is a special Act establishing a no-fault compensation scheme, Act on patient 
insurance no. 111/2000. There is a statutory limit on compensation amounts under 
the Act, and patients also have recourse to the general legal framework to seek 
compensation for acts in tort. 
Cross-border enforcement issues 
No specific provisions apply. 
 
IRELAND 
Patients have a right to complain - Health Act 2004, part 9. They also have the right 
to complain to the Medical Council and the Ombudsman - under the Medical 
Practitioners Act 2007 and Ombudsman Act 1980 (respectively). Breaches of patient 
rights can give rise to actions for personal injury (negligence) for damages in the Civil 
Counts. Complaints can also be made for breach of professional standards to the 
professional bodies. A complaint can also be made through the internal procedures of 
the Health Service Executive - Health Act 2004.  
Public health care providers are under a duty to respond to complaints within 30 days 
of receipt of the complaint. Advocacy services are available to assist patients. 
Compensation is only available through Court actions. There is no ‘right to 
compensation’ per se. There is a right of access to justice through the court system as 
a result of which, if the plaintiff is successful in establishing negligence, compensation 
may be awarded. 
Country expert comments on the efficiency of the system: 
The main challenge is for patients to understand the mechanism for making a 
complaint and the appropriate body to which to refer a complaint. The 
complexity of the healthcare system can be difficult for patients to navigate 
and sometimes they send their complaints to the wrong organization. A very 
useful website was launched to assist patients in this regard 
http://www.healthcomplaints.ie/. It sets out a pathway for persons who want 
to make a complaint and provides assistance in advocacy etc. Sometimes 
patients misunderstand the nature of the complaints process e.g. they think 
that the regulator will ‘fix’ their problem with their doctor, or get them the 
procedure they want. The job of the regulator is to act in the public interest to 
ensure the fitness to practice of practitioners on the register – it is not a 
private dispute resolution mechanism as such. Patients also sometimes use the 
complaints mechanism as a prelude to litigation as the investigation (which is 
free of charge) will enable them and their legal advisors to get access to the 
explanations and defence of the practitioner. They can then use this 
information as a basis for legal action for compensation. 
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Cross-border enforcement issues 
No specific provisions apply. To comply with Article 4(2)(d) of the CBD all doctors will 
be required by law (Medical Practitioners Amendment Bill 2014) to ensure that they 
have adequate indemnity insurance. 
 
ITALY 
Patients have a right to complain under the Carta dei Servizi Sanitari (Charter of 
Healthcare Services)  - Act 273/1995. There is a presumption of patient-centricity in 
the service, requiring an agreement between the patient and the provider; the general 
expectations of the Charters can be set regionally. For instance, according to the 
Tuscan Charter of Healthcare Services report 2014 all the Tuscan ASL have a protocol 
for complaints management, and encourage information on the right to complain in 
their website, through brochures, posters, etc. Pursuing these complaints procedures 
does not prejudice or preclude the use of other mechanisms.  
Tortious liability for breach can arise in a complex way in Italian civil Law. For 
example, a breach of the right to informed consent can constitute a breach of a duty 
concerning information and autonomy, but also a question in relation to the duty of a 
medical practitioner to treat the patient - Supreme Court (ex ultimis Cass. 
2854/2015). See, G. Comandé, Medical Law in Italy, Wolters Kluwer, 2014, 192 ff. 
Worked example on informed consent and tortious liability in Italian Law: 
“In relation to the eventual compensation of damages ensuing from a violation 
of the right to informed consent, it is important to distinguish between two 
hypothetical situations: (1), where the violation only infringes upon the right to 
self-determination with reference to one’s own health and (2) a situation where 
an actual damage to the health of the patient has been caused (i.e., where an 
impairment of physical or mental health can be causally linked to the lack of 
consent). In the former situation, the patient can claim only non-economic 
damages for such an infringement. In the latter case, if the patient shows that 
s/he would not have undergone the treatment – upon receiving full information 
of the risks – and it can be demonstrated that the risks s/he was not informed 
of actually materialized, s/he can recover full economic and non-economic 
damages (Cass. 2847/2010).”  
There are some mediation services offered by providers. These are offered following 
consideration of the formal letter of complaint. Complaints are explained in the 
Ministry of Health Guidelines for Adverse Events (2011) and the “Manuale di 
formazione del governo clinico: la sicurezza dei pazienti e degli operatori” (2012). 
Cross-border enforcement issues 
Article 5 Act 38/2014 states that the patient who suffers damage as a result of 
healthcare services received in Italy by healthcare providers operating in the Italian 
territory has the right to bring the ordinary remedies provided for a national.  
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The National Contact Point website is in both in Italian and in English and provides the 
basic information. 
 
LATVIA 
No information available 
 
LITHUANIA 
Patients have a right to complain in signed writing - Law on the Rights of Patients and 
Compensation for Damage to their Health, Art. 23. The patient must lodge the 
complaint not later than one year after s/he becomes aware that his or her rights have 
been violated and not later than three years after the date of the violation of those 
rights. Where the first decision does not resolve the complaint, patients can appeal to  
a number of bodies, depending on the particular case: the National State Insurance 
Fund or its Territorial branches, or the State Health Care Accreditation Agency. These 
institutions act more like an arbiter in the appeal. The patient can also pursue an 
action for breach in Civil Law. The right to compensation is established by Articles 
6.247- 6.250 of Civil Code of Lithuania, Article 23 of Law on the Rights of Patients and 
Compensation for the Damage to their Health. 
Country expert comments on the efficiency of the system:  
To the best of our knowledge, there is no case law where the right to complain 
attributed to the patients is challenged directly, i.e. the restrictions or limits of 
this right. This question was indirectly raised and analyzed by the Supreme 
Administrative Court of Lithuania in the following cases: case No AS-602-2-14 
of 18 January 2014 in the context of determining whether the person who filed 
a complaint to the competent authority had the right to do so, case No I-671-
121/2014 of 6 January 2014 where the claimant challenged the fact that the on 
Law on the Rights of Patients and Compensation for the Damage to Their 
Health does not foresee the requirements for complaints (particularly to the 
form and annexes to complaints) which can be filed to the national competent 
authorities acting as appeal institutions and due to this the competent authority 
can restrict and impede the right to complain by asking to provide the same 
documentation several times. According to the publicly available information, 
namely the sociological survey made by “Baltijos tyrimai” in 2007, 70% of 
respondents were familiar with the right to complain and the content of this 
right. 
There are constant discussions on this topic in the public and media, several 
amendments of the laws are currently negotiated in the Parliament of 
Lithuania, and including the one on the compensation to patients for damages 
causes to their health (turn form insurance to special fund is proposed). To be 
more precise, the amendment of the Law on the Rights of Patients and 
Compensation for the Damage to Their Health was registered on 11 December 
2014. This amendment aims at changing the instruments and ways of how the 
compensation for damage to patients’ health is made. It also aims at including 
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the compensation without previous acknowledgment of the “guilt” made by the 
health care provider or its employees (health care specialists). In other words 
the proposed model does not include the evaluation of “guilt” in cases the 
damage is made to patients’ health. Please note, that at the current stage the 
Government of Lithuania did not accept this amendment of the Law on the 
Rights of Patients and Compensation for the Damage to Their Health by on 25 
March 2015 by Order No 297 of the Government of Lithuania. 
Cross-border enforcement issues 
No specific provisions apply. 
 
LUXEMBOURG 
There is no specific right to complain directly recognized as a patient right in medical 
law. Generally, complaints can be made to the patient information and mediation 
service that can be contacted to help resolve all complains; the complaints structure is 
open to patients and healthcare professionals, is free and is confidential. The mediator 
has no adjudication power - Patient Rights Law. Every hospital provides a department 
dealing with patient complaints. Patients can also bring their complaint before the 
competent deontological order, for example the “College of Physicians“ (“Collège 
médical”). Finally an action for damages can be granted according to Civil Law rules, 
before a Civil Court. 
Hospitals are under a duty to investigate complaints made against them. The 
approaches vary, with some using mediators. There is a movement to increase the 
availability of mediation, and to ensure a degree of due process in mediation - Patient 
Rights Law, 2014. An NGO - “Patiente Vertriedung a.s.b.l.” - is available to assist 
patients in the complaint process. 
Compensation may be sought according to civil law rules. In general, the relationship 
between a patient and a healthcare provider is of a contractual nature, although this is 
not always the case. Liability can thus be both in tort and in contract. It is always 
based on the Civil Code. 
Cross-border enforcement issues 
No specific provisions apply. 
 
MALTA 
NO information available 
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THE NETHERLANDS 
There are various ways in the Netherlands, both informal and formal, of dealing with 
complaints about the performance of healthcare providers and claims for 
compensation or damages. In addition to the role and supervision of the Dutch 
Healthcare Inspectorate on the basis of the Care Institutions Quality Act, these ways 
include a complaints officer or complaints mediator, healthcare institutions’ complaints 
committees - Clients’ Right of Complaint (Care Sector) Act. There are also health 
professional disciplinary courts (five Regional and one Central) - Individual Healthcare 
Professions Act. Civil liability for breach of patient rights and breach of the duty of care 
can also be pursued through the Civil Courts. Redress can also be sought through the 
health insurers and dispute committees. It should be noted that the proposed Quality, 
Complaints and Disputes Care Bill, presently being discussed in the Dutch Parliament 
(Upper Chamber), may bring some changes to this situation. The Dutch National 
Contact Point provides information about the procedures. 
There are three possible options available to patients in the Netherlands seeking to 
claim compensation for damage caused by a health professional: patients can contact 
the professional’s insurance company, file a claim with the Conciliation Board, or 
initiate a civil law procedure. 
See L. Bongers and D. Townend (2014) “The Implementation of the Directive on the Application of 
Patients’ Rights in Cross-border Healthcare in the Netherlands” European Journal of Health Law 
21(1): 65–78. 
Cross-border enforcement issues 
No specific provisions apply. 
 
NORWAY 
Citizens can appeal “individual [administrative] decisions” - Public Administration Act, 
§ 2a and 28. The Patients’ Rights Act states that the Public Administration Act shall 
not apply to administrative decisions made pursuant to Chapter 2 in the Patients’ 
Rights Act (thus including decisions on necessary health care). However, the Patients’ 
Rights Act has a separate regime for complaints; partly reintroducing the procedural 
requirements that are lacking due to the no appliance of the Public Administration Act 
(see also sect. 7-6 on the application of the Public Administration Act). Sect. 7-2 has 
provisions on complaints and sect. 7-4 has provisions on the right to request for 
assessments of possible breach of duty.  A complaint must be submitted in writing, s. 
7-3. The complaint should state the details of the complaint and provide necessary 
additional information. There are time limits for submitting requests (four weeks) and 
complaints (three weeks), s. 7-5. The Patient can make a complaint to the Patient 
Ombudsman under the Patient Rights Act chapter 8. Complaints can also be 
considered by one of the 19 County Governors. The Ombudsmen and County 
Governors have more informal procedures (e.g. oral complaints). County Governor 
and National Board of Health Supervision decisions can be challenged under 
Administrative Law procedures in the Courts.  
The Norwegian Board of Health Supervision produces annual reports as well as reports 
on selected topics (see https://helsetilsynet.no/no/Norwegian-Board-of-Health-
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Supervision/Publications/, where summaries in English are available). Topics in recent 
report have included health services for elderly, long term use of antibiotics and 
strengthened involvement of patients and their next of kin. 
The rights to compensation regulations are found in the Patient Compensation Act (15 
June 2001 No. 53). 
Cross-border enforcement issues 
There are separate complaints’ procedures for cross border patients in regulation 22 
November 2010 No. 1466 sect. 10 and 11. The complaint body is the Norwegian 
Health Economics Administration (https://helfo.no/english, with some information in 
English). The appeal body is the Norwegian Directorate of Health (and some decisions 
may even be reviewed by a separate administrative court). See 
http://www.npe.no/en/Patient/How-do-I-claim-compensation/ for a brief presentation 
in English on access to compensation; the forms etc. are only available in English. 
 
POLAND 
There is no explicit right to complain in the Law. However, the right can be inferred 
from art. 2 of the Patient Rights Act which creates a statutory duty on public health 
care authorities (the National Health Fund), the providers of healthcare services, 
persons performing medical professions and other persons assisting in the provision of 
healthcare services in relation to the enforcement of patients’ rights. Complaints to 
providers can be rather informal in process terms and have to be investigated. 
Complaints can be made to the National Health Fund where there is a contractual 
relationship between the parties.. Complaints can also be made to the Patient Rights 
Ombudsman (or the Ombudsmen for the patients of psychiatric hospitals) (now 
totalling some 60,000 per year. Complaints against medical personnel can also be 
made to the relevant medical chamber. Complaints against specific doctors are 
considered in the Medical Chambers (professional bodies) and by the Supreme Medical 
Court of Physicians’ Professional Liability - Act of 2-12-2009 on Chambers of 
Physicians. Complaints must be made within 3 years of the event in question. The 
action can result in a number of fitness to practice outcomes, but not in compensation 
or direct remedy for the patient. That is only available in the Courts. Appeals on 
administrative grounds from the professional count are by cassation to the Supreme 
Court.  
A breach of certain patient rights duties, for example relating to informed consent, can 
be actionable even where the practitioner has performed the medical procedure with 
due diligence. The claim for damages for non-pecuniary loss is available - Patient 
Rights Act. 
The general right to compensation was first envisaged in 1997 by the revision of the 
Medical Care Establishment Act and then transferred to the 2008 Patients’ Rights Act. 
Art. 4 of the PR Act provides for compensation in the case of violations of rights 
envisaged in the Act: “A person harmed by a negligent breach of patient rights may 
claim pecuniary compensation for moral damage in an action based on art. 448 of the 
civil code (“In the case of infringement of personal interests, the court may award an 
injured person an adequate sum as compensation for non-pecuniary loss or, if he so 
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demands, award an appropriate sum for a designated social purpose, irrespective of 
other means necessary to eliminate the effects of the damage caused”.) (art. 4 sec 1). 
In a case of breach of the right to die in dignity, a spouse, the next of kin or a 
guardian may claim a sum of money to be paid for the benefit of a charitable 
institution (art. 4 sec 2). As Poland belongs to the group of systems where damages 
for non-pecuniary loss may be awarded in specific cases only, the above provision 
introduces a specific legal avenue for seeking pecuniary remedies by patients’ whose 
rights were infringed. Moreover, there are also specific entitlements to compensation 
scattered over other medical laws 
Cross-border enforcement issues 
No specific provisions apply. 
 
PORTUGAL 
Under the Law, there is no specific right to complain, only general rights under the 
Law. Patients and patient organizations or similar bodies can also make complaints 
and suggestions about the quality of health care, made to the “Patient’s Office” 
(Gabinete do Utente). The Office receives these complaints (and comments) and must 
respond in a timely fashion, including any information about the follow-up to their 
suggestions and complaints - Charter of Rights and Duties of the General Health 
Directorate. Article 9 of Law No. 15/2014, which consolidates the rights and 
obligations of users of health services, provides that the user of health services has 
the right to complain and complain in health facilities, under the law, and to receive 
compensation for damages. Complaints and grievances may be present in a 
complaints book or informally, with a requirement for a response under the law. 
Health services, suppliers of goods or health services and health operators are 
required to have a complaints book, which can be filled in on request. Complaints can 
also be made to the Ombudsman. 
There are general actions available in Civil Law for breaches of patient rights. Further, 
complaints can be made to the professional bodies. Alternative dispute resolution is 
beginning to be seen, particularly in relation to appeals.  
Cross-border enforcement issues 
No specific provisions apply. 
 
ROMANIA 
No information available. 
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SLOVAKIA 
Patients have a right to complain to the health care provider. The management of the 
facility must investigate the complaint and the patient must be given information 
about the result of investigation. Complaints related to professional or ethical 
behaviour may also be made to the relevant professional chamber. The professional 
licensing authority has the power to investigate and where necessary punish breach of 
obligation when it has jurisdiction over the providers. 
Patients also have the right to complain to the Health Care Surveillance Authority 
(HCSA), and independent legal entity established by the Act No. 581/2004 Coll. The 
Authority has public administration duties, relating to surveillance over health 
insurance companies, public health insurance and over the provision of health care. 
The HCSA must investigate the complaint and give notice of the result of the 
investigation to the patient. It may initiate a procedure leading to the cancellation of 
the permit for the health care facility or cancellation of the license of the health care 
professional by the respective chamber. 
The right for compensation is a specific right codified in Civil Code, s. 444 The details 
how lump sum damages are calculated is set out in Act No. 437/2004 Coll. on 
Compensation for Suffered Pain. 
Cross-border enforcement issues 
No specific provisions apply. 
 
SLOVENIA 
The right to complain is formally recognized as a specific patient right - Patient Rights 
Act, Art. 5. The Patient Rights Act introduces a special right of the patient regarding 
the dealing with a violation of his/her rights. The act gives the patient who believes 
his/her rights laid down in this act have been violated the right to be dealt with in the 
following procedures:  
 Procedure of the s. c. first hearing of the violation of patient’s rights at the 
responsible person of the provider of healthcare services, based on the 
patient’s oral request or request in writing (Articles 56 to 63);  
 Procedure of the s. c. second hearing of the violation of patient’s rights at the 
Commission of the Republic of Slovenia for the Protection of Patient’s Rights, 
also based on the patient’s oral request or request in writing (Articles 64 to 
79). This procedure also includes a procedure of mediation. 
Article 58 of Patient Rights Act contains the so called mandatory announcements 
which means that every provider of healthcare services must assure that all of the 
important data on the possible exercise of the right to complain are published on a 
conspicuous part of the waiting room (or on usual bulletin board of a hospital). The 
requirement applies to the name, contact details and workplace of a person authorized 
for receiving the first request for protection of patient rights, to the data on a manner 
of filing the request and the time of its admission and to the name and contact details 
of the closest patient`s rights representative. The possibilities of representation and 
other possible help from him or her should be explained too. 
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The Act points out that its provisions that govern the procedures to protect the rights 
of patients in no way encroach in regulations that guarantee supervision over 
professionalism of health services as well as do not infringe on regulations that deal 
with health insurance violations. Article 48 of the act lays down the general procedural 
principles, which are summarized in nine basic items:  
a) Informing and supporting the patient; b) Simple, transparent, quick and efficient 
solving of the issue; c) Free advice and aid of the patient’s rights representative; d) 
Impartial and fair treatment; e) Adequate and ongoing recording of procedural 
activities by the participants; f) Solving and closing the procedure where the cause for 
it arose; g) Oral procedure, in general; h) Exclusion of the public; i) Options for 
peaceful problem solving. Regarding the question of the capacity to sue and be sued in 
procedures dealing with patient rights, the patients who do not have disposing 
capacity use mutatis mutandis those provisions of this act that determine a special 
manner to enforce the rights of such patients. When children’s parents are deciding on 
launching a procedure, consensus is not needed. The demand for launching 
procedures can also be filed by the immediate family or people close to the patient, if 
the patient agrees. Immediate family can also demand the procedures to be launched 
after the patient’s death. Patients who do not have disposing capacity have the right 
that their cooperation is ensured to the largest extent possible and their opinion, if 
they are able to express it and if they understand its meaning and consequences, 
considered in procedures on violation of their rights. The act introduces an institution 
of the patient’s rights representative. The representative’s core function is to provide 
basic information to the patient, provide expert aid and give substantiated guidelines 
in exercising the rights of patients in healthcare, health insurance and provision of 
healthcare services. The representative can address proposals, opinions, criticisms or 
recommendations to the providers of healthcare services, who are obliged to discuss 
and reply to them. The provider of healthcare services must also give the 
representative access to all data that he required for his/her activities. The patient’s 
medical records and other data are made available to the ombudsman pursuant to the 
patient’s written consent. The representative’s activities are not paid for by the patient 
and are confidential. The representative is not paid for his or her work. Every province 
as a rule names one representative, appointed by the province’s representation body 
after a public call for bids. The representative is located in the province’s capital. The 
province provides the necessary conditions for the representative’s activities. The 
representative is entitled to a reward and reimbursement of costs. S/he is appointed 
for a five-year term and can be reappointed. The candidate must, apart from the 
general requirements, have a university diploma and at least ten years of experience 
in the field of law, healthcare, consumer protection or patient’s rights. The 
representative requires written authorization by the patient for his or her activities. 
Should s/he assess that the patient’s claim is manifestly unfounded, s/he is not 
required to accept the authorization for representation. The act also gives certain 
powers regarding the protection of patient’s rights to the human rights ombudsman. 
The human rights ombudsman should, in the scale of his legal tasks, also monitor the 
situation in the field of enforcement of patient’s rights and, on the basis of such 
monitoring, request that the responsible national bodies, local community bodies and 
holders of public powers provide for the conditions for effective enforcement of this 
act. The ombudsman appoints one of his or her substitute to deal with the field. The 
important general principle is the assurance that exercising the rights regarding 
violation of the patient's rights under this act is not a precondition for demanding a 
potential judicial protection. Patients have free access to it at any time they decide to. 
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Regular courts guarantee the protection of general rights to patients, while the 
protection of rights stemming from health insurance can be requested with the 
specialized Labour and Social Court. Regular courts give the patient the possibility to 
enforce his/her damage claims in line with the general rules of the law of obligations. 
The criminal court allows the patient to enforce the protection of his key rights and 
values, protected by the Penal Code of the Republic of Slovenia. These include criminal 
acts, such as dereliction of medical help in contrary to professional duty, malpractice, 
prohibited acts by the doctor regarding organ transplants etc. 
The right to compensation is not formally recognised as a specific patient right as they 
are otherwise defined in Article 5 of Patient Rights Act. The issue of compensation for 
the damages is arranged in the general provisions of Slovenian civil law, in the Code 
of Obligations (OG RS, No 97/2007 (UPB1). Two key principles of the law of 
obligations provide the basis for liability for damages - neminem laedere, the principle 
that prohibits causing damages and from which we deduce the non-contractual 
responsibility for compensation; and the principle of diligence, which is used for 
contractual responsibility for the compensation. Discerning between liability due to a 
breach of contract or a wrongful act is not of key importance in Slovenian law, as 
substantial differences among the two of them do not exist. 
Country expert comments on the efficiency of the system: 
In Slovenia the Ministry of Health regularly publishes annual reports on a status 
regarding protection of patient rights. The latest available report is The State 
Report on Status of Patient Rights for the Year of 2013. It includes the reports 
of all of the Slovenian patient`s rights representatives (we have 12 
representatives at the moment – April 2015) and also the report of the 
Commission of the Republic of Slovenia for the Protection of Patient’s Rights. 
Patient`s rights representatives dealt with 6.611 complaints of patients (which 
was a 5,8% increase compared to a year before). Patients most usually 
complained because of allegedly violated: a) Right to an adequate, quality and 
safe healthcare; b) Right to due consideration of the patient’s time; c) Right to 
free choice of the physician and the provider of healthcare services and d) 
Right to information and participation of patient in treatment procedures. 
Commission of the Republic of Slovenia for the Protection of Patient’s Rights 
received only 9 demands for second hearing of the violation of patient’s rights 
in year 2013. It was by half less than in a year 2012. The reduction of the 
number of demands for a second level hearing showed that there was an 
important increase of obtained solutions already on the first level and that the 
Slovenian patient`s rights representatives solved majority of patients` 
complaints with informal mediation. For more details see:  
http://www.mz.gov.si/si/delovna_podrocja/pacientove_pravice/porocila_o_stan
ju_na_podrocju_varstva_pacientovih_pravic/, 22. 4. 2015.  
Another important report is also the regular annual report of the human rights 
ombudsman. In every report, beside other fields of work of ombudsman, also 
the field of patient rights is covered. The latest available report is for the year 
2013 and there we can find some opinions and suggestions of ombudsman 
regarding the improvement of the situation on the field generally and also a 
brief presentation of the discussed individual complaints by patients. The main 
issues in complaints regarding the right to complain were two: first was the 
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human resource problem that prevented the (current, updated) dealing with 
complaints before the Commission of the Republic of Slovenia for the Protection 
of Patient’s Rights and the second was the problem of cessation of work of one 
of patient’s rights representative due to financial difficulties of Ministry of 
Health. For more details see http://www.varuh-
rs.si/fileadmin/user_upload/pdf/lp/Devetnajsto_redno_letno_porocilo_Varuha_
CP_RS_za_leto_2013.pdf, 22. 4. 2015.  
Regarding reform initiatives I should mention the suggestion of the human 
rights ombudsman that there is a need for reform of Patient Rights Act 
regarding the question of its adaptation to foreign patients who don`t speak 
Slovenian language. Namely, until now the corresponding demands of the 
Directive 2011/24/EU on the application of patients’ rights in cross-border 
healthcare have not been met yet.  
Cross-border enforcement issues 
There are no specific provisions, but the human rights ombudsman acknowledged the 
need for reform of Patient Rights Act regarding the question of its adaptation (in all 
possible ways) to foreign patients who don’t speak Slovenian language. 
 
SPAIN 
General Health Law recognizes the right of any citizen to issue a complaint, and 
guarantees the protection of patients’ rights. A distinction must be drawn as to 
whether the health care is provided within a public or private setting. In private health 
provision, complaints can be made through the Civil Law and the damages provisions 
in the Civil Code. Public provisions of health care complaints are dealt with under Law 
30/92 on Public Administration and Common Administrative Procedure. Further, 
actions can be brought for breaches under the Patient Rights Law with fines under the 
General Health Law, classifying breaches as ‘minor’, ‘serious’ and ‘very serious’. The 
right to compensation works through the application of the general Law. Operating 
differently between the private and public sectors, as follows: If the liability has taken 
place in the private system, the Spanish Civil Code applies. Articles 1101 et seq. 
regulate compensation for breach of contract and articles 1902 et seq. regulate tort 
liability. Regarding the public healthcare system, article 106.2 of the Spanish 
Constitution provides that citizens are entitled to compensation for any damage to 
their rights and property, provided that such damage arises from the normal or 
abnormal functioning of public service. This provision is developed by Law 30/1992 
(see above) and Royal Decree 429/1993 laying down the procedure for claiming 
damages from the Administration. 
Complaint procedures are subject to implementing regulations adopted by the 
Autonomous Communities. Generally speaking, patients have a relatively easy access 
to complaints procedures, mainly thanks to the complaint forms that can be 
downloaded from the hospitals websites. However, patients lack visibility on how the 
procedure works, how decisions are adopted and how to challenge those decisions. 
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Cross-border enforcement issues 
No specific provisions apply. 
 
SWEDEN 
Patients have a specific right to complain about a healthcare related injury or 
experienced deficiencies in patient safety in connection with care or treatment 
provided by a healthcare provider or healthcare personnel - Patient Safety Act. The 
Complaint is made to the Health and Social Care Inspectorate (Inspektionen för vård 
och omsorg, IVO). The IVO has disciplinary power over providers and professionals. 
Under the Law of the Patients’ Advisory Committee (1998:1656) all county councils 
must establish a Patients’ Advisory Committee. The Committee is a central 
independent authority. A patient can contact the Patients’ Advisory Committee if he or 
she wants to make a comment or complaint relating to his or her treatment, patient 
fees, diagnosis or medication. The Patients’ Advisory Committee has no disciplinary 
powers but can help the patient to receive proper information and give advice on what 
to do next. There are no costs associated with filing a complaint with the Committee. 
See http://www.1177.se/Other-languages/Engelska/Regler-och-rattigheter/Om-man-
inte-ar-nojd-med-varden/#section-1. 
Breaches of patient rights can be actionable in Tort Law (medical negligence - Tort 
Liability Act 1972:207. However, this is difficult, for example, in relation to a breach of 
the duties relating to informed consent. 
In Administrative Law, complaints can be brought before the IVO - Patient Safety Act. 
The Parliamentary Ombudsman (Riksdagens ombudsman) can also hear complaints 
against public authorities or public officials. (https://www.jo.se/en/About-JO/) 
Since 1975 Sweden has had a patient insurance system to compensate patients for 
health-related injuries. The system was initially based on a voluntary patient insurance 
solution, but in 1997 it was replaced by the Patient Injury Act (1996:799). In 
accordance with the Patient Injury Act, any person who suffers an injury in connection 
to health, medical or dental care in Sweden, can receive compensation, as long as the 
other provided conditions are met (Section 6 of the Patient Injury Act). 
Cross-border enforcement issues 
No specific provisions apply. 
 
UNITED KINGDON 
The Handbook to the NHS Constitution, pp. 85–92, outlines the rights to complain and 
to redress. There are rights to complain to the NHS providers (from the 
immediate carer to the institution providing the structure of the care) – Local 
Authority Social Services and National Health Service Complaints England Regulations 
2009 and NHS Bodies and Local Authorities (Partnership Arrangements, Care Trusts, 
Public Health and Local Healthwatch) Regulations 2012. The complaint must be 
acknowledged within three working days and “investigated properly”. The complainant 
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must be informed of the options for the conduct of the complaint, and the likely 
timeframe for the completion of the process. Throughout the process the complainant 
must be informed of the progress of the complaint, and any outcome of the 
investigation of the complaint. This provides a statutory ‘internal’ complaints 
procedure.  
Complaints can also be made to the Parliamentary and Health Service Ombudsman – 
Health Service Commissioners Act 1993. The most formal options for complaints are 
through Judicial Review of administrative actions and made to the High Court. Here 
the question concerns, essentially, the reasonableness of the decision that is made 
and the procedural appropriateness of the decision-making. An action for medical 
negligence is also available, and depends upon proving a duty of care and a negligent 
breach of that duty (i.e. a breach that would be outside the range of actions by a 
similar professional that would be acceptable generally in the profession; not a ‘best 
practice’ but a sufficient practice). This requires a court action (commenced within 
three years), most often brought with the assistance of lawyers, often in this area 
working under ‘no win, no fee’ arrangements. Breach of statutory duty is a tort that is 
also available in the area, and would require similar legal assistance; it remains a 
back-stop action where other dispute resolution tools have failed. Negligence actions 
allow damages to be ordered; judicial review actions and adjudications by the 
ombudsman allow for remedies requiring, for example, retaking decisions with 
appropriate considerations. Breaches relating to the processing of personal data are 
made under the Data Protection Act 1998 and through the powers under the Act given 
to the Information Commissioner (including investigation and the ordering of 
damages). NHS staff can use employment Law for their complaints.  
Whereas the measures described above relate to the State’s mechanisms for 
enforcement of rights, the professional conduct of doctors can also be addressed 
through a complaint, largely concerning fitness to practice, against a member of a 
profession to the particular professional body of which s/he is a member.  
Cross-border enforcement issues 
No specific provisions apply. 
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3.4 Council of Europe activities 
 
3.4.1 The Convention on Human Rights and Biomedicine 
The most significant contribution to Patient Rights from the Council of Europe is found 
in the Convention for the protection of Human Rights and Dignity of the Human Being 
with regard to the Application of Biology and Medicine: Convention on Human Rights 
and Biomedicine. It establishes a number of fundamental patient rights both in 
relation to healthcare and where citizens are participants in biomedical or other 
scientific research. The principles are as follows (Article-by-Article): 
The first four articles establish a general position in relation to the duties of Member 
States in relation to human dignity in biomedical science.  
“Parties to this Convention shall protect the dignity and identity of all human beings 
and guarantee everyone, without discrimination, respect for their integrity and other 
rights and fundamental freedoms with regard to the application of biology and 
medicine. Each Party [State] shall take in its internal law the necessary measures to 
give effect to the provisions of this Convention.” (Article 1) 
“The interests and welfare of the human being shall prevail over the sole interest of 
society or science.” (2) 
“Parties, taking into account health needs and available resources, shall take 
appropriate measures with a view to providing, within their jurisdiction, equitable 
access to health care of appropriate quality.” (3) 
“Any intervention in the health field, including research, must be carried out in 
accordance with relevant professional obligations and standards.” (4) 
Thereafter, the Convention outlines specific aspects relating to these general 
principles. 
Articles 5 to 9 concern Consent. In line with other international standards on 
consent,34 consent must be “free and informed” on the basis of “appropriate 
information as to the purpose and nature of the intervention as well as on its 
consequences and risks” and on the basis that it may be “freely withdrawn” at any 
time.   
Private Life and the Right to Information (10); Genetic discrimination, predictive 
genetic testing and modification of human genome, restriction on sex selection (11–
14); scientific research (15–18); living donor organ transplantation (19–20); 
prohibition on financial gain from human organs (21), restriction on use of removed 
human tissue (22). 
                                                 
34
 Helsinki Declaration; WHO (Eds.), Promotion of the Rights of Patients in Europe, Proceedings of a WHO 
Consultation, Published on behalf of the World Health Organization, Regional Office for Europe, in 
collaboration with the Health Law Section, University of Amsterdam (The Hague: Kluwer Law International, 
1995) 
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Articles 23–25 require that MS put sanctions and compensation mechanisms in place 
for the infringement of rights. 
Article 28 requires that “fundamental questions raised by the developments of biology 
and medicine are the subject of appropriate public discussion in the light, in particular, 
of relevant medical, social, economic, ethical and legal implications, and that their 
possible application is made the subject of appropriate consultation”. 
What is not seen in the Convention is detailed pre- and proscription in relation to the 
rights. There is a great deal of discretion for individual Member States in the 
interpretation of the rights. For example, ‘appropriate information’ in relation to 
consent, or the manner in which consent is interpreted is left to the MS practice. This 
is, perhaps, inevitable, but it leaves the sense that the Convention is a framework of 
rights and expectations that have to be further articulated in practice.  
 
3.4.2 The impact of Council of Europe Activities in their countries. 
From the Country Expert Survey it is clear that Council of Europe activities are not 
reported to have a great influence on individual States. Decisions of the European 
Court of Human Rights are followed in the countries, but there are few decisions that 
directly bite on patient rights without leaving scope for a margin of appreciation. 
Indeed, one could suggest that the patient rights aspects of the Oviedo convention are 
drafted in such a broad way that they accommodate the range of approaches to 
patient rights that have emerged in the Countries of the EU and EEA. It is very difficult 
to say, given the wide discretion that is found in the Convention, whether the 
Convention itself was instrumental in producing the rights, rather than reflecting the 
general European environment of patient rights. The responses from the experts, 
indicating a relatively low level of impact of the Council of Europe activities in their 
jurisdictions suggests, perhaps, the latter.  Likewise, in the broader areas, the EU has 
either assimilated the duties – with the development of the Charter of Fundamental 
Rights – or overtaken the duties – as in data protection. 
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APPENDIX 
 
Annex 1: Survey template (Final Version) 
 
PRE-MaX 
Patients’ Rights in the European Union – Mapping Exercise 
Survey 
 
Introduction 
With the adoption and implementation of the Directive 2011/24/EU on the application of 
patients’ rights in cross-border health care, the EU has not only attempted to clarify the 
entitlements of citizens to reimbursement for cross-border health care, it has also introduced a 
framework of rules to ensure a set of common values and operating principles that EU citizens 
would expect to find - and structures to support them - in any Member State’s health system in 
the EU. They are considered necessary to ensure patients’ trust in cross-border healthcare (recital 
5), and also more broadly to establish a high level of trust between the patient and healthcare 
provider (recital 19). However, as has been recognised in the Council Conclusions on Common 
values and principles in European Union Health Systems (2006), Member States have taken 
different approaches in the broad area of patients’ rights - some have chosen to express them in 
terms of the rights of patients, others in terms of the obligations of healthcare providers. 
Enforcement is also carried out differently across the Union.  
With this mapping exercise, which was commissioned by the EU Commission’s Consumers Health 
and Food Executive Agency (CHAFEA/2014/Health/03), we want to take stock of patients’ rights 
(in the broadest sense) in all EU Member states as well as in Norway and Iceland. More 
specifically, we want to explore how the more traditional types of patients’ rights are connecting 
to the more consumer-oriented types, and what structures, procedures and mechanisms are in 
place to enforce them. This work should be able to inform the activities of the National Contact 
Points (NCPs) that have been established as part of the cross-border care Directive.  
For the sake of this mapping exercise we are considering both fundamental patients’ rights as well 
as more consumer-oriented patients’ rights (*), including procedural rights that help to enforce 
them. At this point we are not considering rights related to social cover for health care, neither 
are we regarding ethical questions. We are clustering them in the following way: 
 Self-determination 
a) The right to informed consent (incl. ...) 
i) The right to information about one’s health 
ii) The right to participate in (clinical) decision-making / to choice of treatment 
options (*) 
 Confidentiality 
a) The right to privacy 
b) The right to access one’s medical record 
 Choice 
a) The right to choice of healthcare provider (incl. ...) (*) 
i) The right to second opinion (*) 
ii) The right to information about the healthcare provider (*) 
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 Quality and safety 
a) The right to safe and high-quality treatment received in a timely manner (*) 
 Procedural rights 
a) The right to complain 
b) The right to compensation 
c) The right to information about rights and entitlements (*) 
 
 
 
 
 
 
Practical instructions for correspondents 
 
Please answer the questions in English. 
Provide answers in the text boxes below each of the questions. Feel free to enlarge the boxes as 
you wish. There is no need to edit all your answers to a coherent report or extended summary 
document. 
Please try to answer the questions with a broad interpretation of sources of the law, and perhaps 
also including soft law provision, professional regulations and standards. Where you cannot see 
answers, please feel free to leave the question; likewise, if you feel you can go beyond the specific 
question we have asked to capture the spirit of your law, please add what you feel is necessary.  
Sub-questions, indicated as a, b, c, etc. are meant to specify the aspects to be covered in your 
answers, no detailed and long contributions on each of the sub-questions are needed. 
Please provide full references to the specific national laws, regulations, acts in-text you are 
addressing. 
In case there is any literature (in English) as well as English-language websites where we can find 
additional information regarding a certain patient rights aspect in your country, please provide a 
reference or link too. 
Please hand back the document as a word file 
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Questionnaire 
General context 
Fundamentally patients’ rights encompass a set of rules and principles governing the relationship 
between the patient and the provider. However, they can also extend to rights determining the 
patient’s broader position within the health system.  
How would you assess the legal importance of patients’ rights in your country?  
a. What is the general approach taken towards patients’ rights? (e.g. legal approach, 
awareness raising, patient-oriented, provider-oriented etc.) 
 
 
What (if any) are the main instruments or sources for defining and implementing patients’ 
rights in your country? (e.g. special law, administrative law, criminal law, disciplinary code, 
charter, strategy paper etc.) 
 
Where would you situate your country with respect to both the state of development (newly-
established vs established) and of the enforcement (weak vs strong) of both (A) fundamental 
patients’ rights and (B) more consumer-oriented patients’ rights? (please mark A and B in one of 
the squares below) 
State of  
development 
State of  
enforcement 
Newly-established Well-established 
 
Weak 
 
  
 
Strong 
 
  
Please explain your choice: 
 
 
What are/have been the main drivers for the development of patients’ rights in your country? 
(e.g. ratification of the Council of Europe’s Convention on Biomedicine, transposition of the 
cross-border care Directive, national reform strategy, specific reports or scandals in the media, 
motivation from first principles in medicine or law, etc.). Please comment. 
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Individual patients’ rights 
Self-determination 
The right to informed consent (incl. the right to information about one’s health and the right to 
choice of treatment options/participate in (clinical) decision making) 
Although informed consent is a fundamental principle for clinical decision-making, it faces many 
challenges in terms of putting it into practice, especially in a cross-border context.  
Is the right to informed consent formally recognized35 in your country?  
a. If so, where is it stipulated in the law?  
b. Or is it defined through other means? (e.g. soft law) 
 
 
How is this right implemented in practice?  
a. What form does it take? (i.e. written consent required; verbal consent; non-verbal 
consent) 
b. Who should prove that consent was given? (i.e. patient; provider) 
c. Under what conditions is consent presumed?  
 
 
How is the right to information defined in this context? 
a. What are the specific requirements (e.g. form, content) for providing information 
preceding consent (assuming that there is no valid consent without information)? 
b. Are patients formally entitled to be informed of alternative treatment options? 
c. Is also a “right not to know” provided for? 
 
 
                                                 
35
 This should be read broadly 
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Are patients formally entitled to participate (beyond the scope of consenting to a specific 
treatment) in the clinical decision making regarding their own health?  
a. What are the main policies/instruments to empower patients in their own 
treatment pathway? (e.g. health literacy)  
b. Alternatively, are there any non-binding guidelines or best practices in this field that 
were developed by certain actors in your country? 
 
 
Does the law provide for any specific duties to accommodate the right to informed consent for 
cross-border patients? (i.e. the use of language)  
a. Alternatively, are there any non-binding guidelines or best practices in this field that 
were developed by certain actors in your country? 
 
 
Is there any evidence in your country of how the right to informed consent is used in practice? 
(e.g. research, case law)  
a. What are the main issues/challenges reported?  
b. Is there any reform in this area underway? 
 
 
What specific procedures or remedies exist (if any) in case the right to informed consent is not 
properly respected?  
a. General procedural rights are to be covered under 2.2.5. Procedural rights 
 
 
 
Confidentiality 
The right to privacy 
The right to respect a patient’s private life and/or the duty of medical secrecy/confidentiality in 
relation to health data and information are crucial elements for the trust relation between 
patients and providers. Differences in privacy protection legislation between Member States might 
be an obstacle to patient mobility and impede continuity of care. 
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Is the right to privacy formally recognized36 in your country as a specific patient right or is it 
embedded as a broader right (e.g. in constitutional law)?  
a. If so, where is it stipulated in the law?  
b. Or is it defined through other means? (e.g. soft law) 
 
 
How is this right exercised in practice in relation to health data?  
a. Does a legal obligation exist to respect the secrecy/confidentiality of health data? 
(e.g. in criminal law; civil law; public (administrative) law; disciplinary law)? Does 
this apply only to physicians? Are there any exceptions allowed? (i.e. overriding 
reasons) 
b. Is the patient’s consent required to process/transfer health data in the context of 
delivering health care? (i.e. explicit; implied; presumed under certain 
circumstances) 
c. What mechanisms/policies are currently in place to ensure safe processing of 
patients’ health data? 
 
 
Does the law provide for any specific duties regarding privacy protection and data processing 
for cross-border patients? Alternatively, are there any non-binding guidelines or best practices 
in this field that were developed by certain actors in your country? 
 
 
Is there any evidence in your country of how the right to privacy is used in practice? (e.g. 
research, case law)  
a. What are the main issues/challenges reported?  
b. Is there any reform in this area underway? 
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What specific procedures or remedies exist (if any) in case the right to privacy is not properly 
respected?  
a. General procedural rights are to be covered under 2.2.5. Procedural rights) 
b. If the specific measures here are the same as those outlined in one of the previous 
questions (e.g. XII), please just cross-reference or mention any difference from that 
approach (or specific application of those rules) for this right here.  
 
 
 
The right to access one’s medical record/data 
Beyond the scope of information provided to operate consent to clinical decisions, everyone is 
entitled to know any information collected about his or her health. This is mostly operationalised 
through the right to have access to one’s medical record. This right is key to “enforcing” other 
patients’ rights (i.e. privacy, quality and safety, compensation, etc.), including to ensuring 
continuity of care. This is also why the Directive 2011/24/EU guarantees this right for cross-border 
patients.  
Is the right to have access to one’s medical record formally recognized37 in your country?  
a. If so, where is it stipulated in the law?  
b. Or is it defined through other means? (e.g. soft law) 
 
 
How is this right implemented in practice? 
a. How is access organized? (e.g. directly or indirectly with the help of a health care 
practitioner)? Is it subject to certain modalities (e.g. time restrictions; payment of a 
fee) 
b. Is the content of the medical record prescribed by law? (e.g. in a general or detailed 
way) Does the right to have access relate to all information or are certain elements 
excluded? (e.g. personal notes of the health care practitioner; data related to a third 
person/provided by a third person) 
c. Is there a right to add information/documentation to the record? Is there a right to 
correct, erase or destroy health data in the record? 
d. Is there a right to receive a copy of the medical record/data? Can a fee be charged 
for this copying? 
 
                                                 
37 This should be read broadly 
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Does the law provide for any specific duties or facilities regarding access to medical record in 
the context of cross-border care?  
a. Alternatively, are there any non-binding guidelines or best practices in this field that 
were developed by certain actors in your country? 
 
 
Is there any evidence in your country of how the right to access one’s medical record/data is 
used in practice? (e.g. research, case law)  
a. What are the main issues/challenges reported?  
b. Is there any reform in this area underway? 
 
 
What specific procedures or remedies exist (if any) in case the right to access one’s medical 
record/data is not properly respected?  
a. General procedural rights are to be covered under 2.2.5. Procedural rights) 
b. If the specific measures here are the same as those outlined in one of the previous 
questions (e.g. XII), please just cross-reference or mention any difference from that 
approach (or specific application of those rules) for this right here.  
 
 
 
Choice 
The right to (informed) choice of healthcare provider (incl. the right to second opinion) 
Choice in health care is a complex issue. It can relate to various aspects (e.g. provider, insurer, 
insurance plans). It can be modified in various ways (e.g. gatekeeping, financial incentives, etc.). In 
some countries choice is an intrinsic value of the health systems, in others it is more regarded as a 
tool to increase efficiency and improve quality. The right to second opinion is closely linked to the 
right to choose one’s provider. Countries have put in place different mechanisms to enable choice. 
Different groups usually make a different use of choice. Information is key to making an informed 
choice about what healthcare provider to consult. 
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Is the right to (free) choice of healthcare provider formally recognized38 within your country’s 
statutory health system?  
a. If so, where is it stipulated in the law?  
b. Or is it defined through other means? (e.g. soft law) 
 
 
How is this right implemented in practice? 
a. Does the right to free choice apply to all or specific types of providers (e.g. primary 
physician, specialist, hospital)? 
b. Is choice in any way limited or modulated? (e.g. within a geographical area, within 
the same hospital, restriction to change within a given time frame, gatekeeping, to a 
list of contracted providers, financial incentives) 
 
 
How is the right to information defined in this context? 
a. What are the specific legal requirements for providing clear and objective 
information about providers? Who is responsible for collecting and providing the 
information on 
i. Performance? (outcomes, quality indicators, safety standards, right/fitness 
to practice) 
ii. Waiting times? 
iii. Prices? 
b. What tools/mechanisms (e.g. dedicated web sites, league tables) are available for 
enabling or helping patients to make an informed choice?  
c. Which organizations play a role in providing objective information about available 
providers and treatments?  
d. What information are healthcare providers allowed/obliged to provide (see also a.i-
iii)?  
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 This should be read broadly 
Study on Patients’ Rights in the European Union - MApping eXercise 
150 | P a g e  
 
Are patient formally entitled to a second opinion? 
a. Is it subject to any conditions, restrictions or formalities (e.g. authorisation, 
referral)? 
b. Can the patient freely choose from who they can get a second opinion? Can it also 
include doctors in other Member States? 
 
 
Does the law provide for any specific duties regarding (informed) choice in the context of cross-
border health care?  
a. Alternatively, are there any non-binding guidelines or best practices in this field that 
were developed by certain actors in your country? 
 
 
Is there any evidence in your country on whether/how/which individuals exercise choice? (e.g. 
research, case law)  
a. What are the main issues/challenges reported?  
b. Is there any reform in this area underway? 
 
 
What specific procedures or remedies exist (if any) in case the right to choice is not properly 
respected?  
a. General procedural rights are to be covered under 2.2.5. Procedural rights) 
b. If the specific measures here are the same as those outlined in one of the previous 
questions (e.g. XII), please just cross-reference or mention any difference from that 
approach (or specific application of those rules) for this right here.  
 
 
  
Study on Patients’ Rights in the European Union - MApping eXercise 
151 | P a g e  
 
Quality and safety 
The right to safe and high-quality treatment received in a timely manner 
Patients have a right to expect treatments and care that are safe and of a high quality. This 
requires an authoritative discussion on what constitutes safe and high quality care, and bodies 
that can then implement and monitor the observation of these standards. Timeliness can be 
considered as an essential aspect of patient safety and quality. The concept of ‘undue delay’ has 
been accepted at EU level as a criterion for the right to seek treatment abroad.  
Is the right to safe and quality treatment received in a timely manner formally recognized39 in 
your country?  
a. If so, where is it stipulated in the law?  
b. Or is it defined through other means? (e.g. soft law) 
 
 
How is this right implemented in practice in the patient-provider relationship?  
a. What main approach(es) is/are taken towards ensuring patient safety and quality of 
care in your country? Please briefly describe the policies and strategies in place and 
specify if they are binding or voluntary. 
i. structural norms (e.g. licensing/accreditation norms, activity thresholds) 
ii. process protocols (e.g. safety protocols, clinical guidelines, quality 
management) 
iii. outcome measurement (e.g. indicators, monitoring, reporting, publicity)  
b. Which main bodies are responsible for implementing these patient safety and 
quality policies (e.g. inspections, accreditation agency, licensing bodies)?  
 
 
How is the right to timely treatment implemented in practice? (This may be in guidelines.) 
a. How are acceptable waiting times for treatment defined, and by whom? (e.g. 
maximum waiting times) 
b. Is there an agreed system of prioritization for specific interventions/treatments? 
Are foreign patients included in these waiting lists? 
c. How can a patient challenge decisions about waiting times? 
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Under what conditions is prior authorization40 for cross-border care in your country … 
a. granted on the basis that the specific treatment could be provided under better 
conditions (patient safety, quality and/or timeliness) in another Member State?  
b. refused on the basis that the patient would be exposed to an unacceptable patient-
safety risk if treatment would take place in another Member State? (cf. Article 8.6 
(a) Directive 2011/24/EU) 
c. refused on the basis that the cross-border healthcare provider raises serious and 
specific concerns relating to the respect of standards and guidelines on quality of 
care and patient safety, including provisions on supervision? (cf. Article 8.6 (c) 
Directive 2011/24/EU) 
 
 
Is there any evidence in your country on how the right to safe and quality treatment received in 
a timely manner is exercised in practice? (e.g. research, case law, evaluations of legislation)  
a. What are the main issues/challenges reported?  
b. Is there any reform in this area underway? 
 
 
What specific procedures or remedies exist (if any) in case the right to safe and quality 
treatment received in a timely manner is not properly respected?  
a. General procedural rights are to be covered under 2.2.5. Procedural rights) 
b. If the specific measures here are the same as those outlined in one of the previous 
questions (e.g. XII), please just cross-reference or mention any difference from that 
approach (or specific application of those rules) for this right here.  
 
 
 
Procedural rights 
The right to complain 
In the event of a breach of rights, rights must be enforceable. The right to complain allows 
patients to report those breaches and to be heard. These complaints can be heard in a variety of 
                                                 
40 i.e. the condition of obtaining an explicit authorization from the competent body (e.g. statutory health 
insurer, health authority) in order to get statutory reimbursement for healthcare services provided in 
another Member State than the state of affiliation..  
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fora, with varying degrees of formality, requiring differing responses depending on, for example, 
admissions of liability or requirements of negligence. We appreciate that this right is in many ways 
covered by the last question in each of the preceding rights, but this section is an opportunity to 
ensure that the issue is covered in depth. 
Is the right to complain formally recognized41 in your country as a specific patient right or is it 
embedded in a broader right to complain?  
a. If so, where is it stipulated in the law?  
b. Or is it defined through other means? (e.g. soft law) 
 
 
How is this right implemented in practice in the patient-provider relationship?  
a. Do providers (individual or institution) have any obligations to accommodate 
complaints patients may have against them? 
b. What others instances exist for patients to make a complaint? Do these instances 
act as mediator between patient and provider or rather as an arbiter? 
c. Are these complaint procedures subject to any restrictions, conditions or 
formalities? (e.g. type of complaints, consecutive steps to take) 
d. How and by whom is a complaint investigated? Briefly describe the process from 
the first, perhaps informal complaint, to more formal disciplinary or compensatory 
hearings.  
e. Is the patient given any assistance during the complaint process?  Can others file 
complaints on behalf of the patient? (e.g. family members) 
f. What further options are available in case the patient is not happy with the 
outcome of his/her complaint? 
 
 
Does the law provide for any specific duties or facilities regarding the right to complain for 
cross-border patients?  
a. Alternatively, are there any non-binding guidelines or best practices in this field that 
were developed by certain actors in your country? 
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Is there any evidence in your country on how the right to complain is exercised in practice? (e.g. 
research, case law)  
a. What are the main issues/challenges reported?  
b. Is there any reform in this area underway? 
 
 
 
The right to compensation 
If harm was done to patients or their rights were denied, they could claim some form of 
compensation (e.g. financial).  
Is the right to compensation formally recognized42 in your country as a specific patient right or 
is it embedded in a broader right to seek compensation?  
a. If so, where is it stipulated in the law?  
b. Or is it defined through other means? (e.g. soft law) 
 
 
How is this right implemented in practice?  
a. In what circumstances is a patient entitled to compensation? 
b. Is the right to claim compensation subject to any restrictions, conditions or 
formalities? (e.g. proof of harm and liability) 
c. What system of professional liability insurance (or similar guarantee or 
arrangement) exists in your country to compensate for any harm done to patients? 
d. Besides financial compensation, what other sanctions or penalities could apply to 
settle a claim?  
 
 
Does the law provide for any specific duties or facilities regarding the right to compensation for 
cross-border patients?  
a. Alternatively, are there any non-binding guidelines or best practices in this field that 
were developed by certain actors in your country? 
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Is there any evidence in your country on how the right to compensation is exercised in practice? 
(e.g. research, case law)  
a. What are the main issues/challenges reported?  
b. Is there any reform in this area underway? 
 
 
 
The right to information about rights and entitlements 
In order to enforce their rights patients in the first place need to be informed about what their 
rights and entitlements are. Whereas national contact points have been established to provide 
cross-border patients with easily accessible information on patients’ rights, procedures to file 
complaints and seek remedies, they can draw on information mechanisms already in place for 
domestic patients.  
Is the right to information about rights and entitlements formally recognized43 in your country 
as a specific patient right or is it embedded in a broader right to seek compensation?  
a. If so, where is it stipulated in the law?  
b. Or is it defined through other means? (e.g. soft law) 
 
 
How is this right implemented in practice?  
a. What are the specific legal requirements for providing information on rights and 
entitlements? Who is primarily responsible for providing the information? What 
mechanisms are used? 
i. Basket of care; conditions, criteria and formalities for statutory coverage 
ii. Other patients’ rights 
b. Which other actors play an important role in informing and assisting patients and 
citizens to enforce their rights?  
c. How will the “National Contact Point” be used? Will the NCP also be available for 
domestic patients seeking information about their own jurisdiction? 
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Does the law provide for any specific duties regarding the use of language in this context (i.e. 
with respect to foreign patients or language minorities, etc.)?  
a. Alternatively, are there any non-binding guidelines or best practices in this field that 
were developed by certain actors in your country? 
 
 
Is there any evidence in your country on how the right to information about rights and 
entitlements is exercised in practice? (e.g. research, case law)  
a. What are the main issues/challenges reported?  
b. Is there any reform in this area underway? 
 
 
 
Council of Europe 
The Council of Europe has been a strong and important force in the development of patients’ 
rights in Europe. As part of PRE-MaX we are assessing the impact of the Council of Europe’s work. 
This will in part be done through a literature review of the Council of Europe’s opus on patients’ 
rights, but we are also interested to see how far the activities of the Council of Europe in relation 
to patients’ rights have had an impact in nation states.  
Has your country ratified the Biomedicine Convention? How has this been done? 
 
 
Which other Council of Europe activities in relation to patients’ rights have been implemented 
in your National Law? 
 
 
What key cases have occurred in your country resulting from Council of Europe inspired 
legislation?  
 
 
How far have decisions based on Council of Europe activities from other jurisdictions or fora 
been implemented and/or applied in your national Law or practice? 
 
 
Thank you for your input!  
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Annex 2: Identified sources of the literature review 
 
Introduction 
The aim of the Literature Review was to locate published information (studies, reports 
etc.) on areas that would benefit from greater formal cross-border co-operation and 
collaboration in healthcare provision, or information that would assist in developing a 
methodology to investigate this. 
The term cross border was included in searches in relation to quality of care; these 
only produced 8 relevant hits. For this work a search was carried out using PubMed 
and the terms health care and cross-border. Health care is used as a MESH term in 
PubMed, and includes delivery of health care, as well as the three words individually. 
Cross-border also includes “cross border” as two separate words. This search 
produced 498 hits, all of which were reviewed. 
In addition, searching was also carried out using Google Scholar and Google. These 
searches began with the four words cross, border, health and care.  
The types of documents included in the search results are peer-reviewed articles, 
journal entries and book chapters. The results are provided as tables of bibliographic 
information for the identified references, combining the results from the PubMed and 
Google searches. The results have been grouped into the following categories.  
Cross-border and inter-regional projects and studies 32 results 
Health care “tourism” – reproduction   32 results 
Health care “tourism” – other, non-specific  16 results 
Patients’ rights and legal issues    42 results 
Telemedicine, E-health, information exchange  19 results 
Trade in health services     5 results 
Other        20 results 
 
The term health “tourism” has been used as it appears in a number of the results, but 
it intended to cover any travel for treatment. 
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Results 
 
Cross-border and inter-regional projects and studies – 32 references 
Author(s) Bibliographic information Title of reference Author information (if available) 
Alkerwi A, Guillaume M, 
Zannad F, Laufs U, Lair 
ML; NESCAV project 
group. 
 
BMC Public Health. 2010 Nov 15;10:698. doi: 
10.1186/1471-2458-10-698 
Nutrition, environment and 
cardiovascular health 
(NESCAV): protocol of an 
inter-regional cross-
sectional study 
Centre de Recherche Public Santé, 
Centre d'Etudes en Santé, Grand-
Duchy of Luxembourg. 
alaa.alkerwi@crp-sante.lu 
Anogianakis G, Ilonidis 
G, Anogeianaki A, 
Lianguris J, Katsaros K, 
Pseftogianni D, Klisarova 
A, Temelkov T, Tatsis C 
J Telemed Telecare. 2004;10 Suppl 1:4-6 The Varna-Thessaloniki 
telemedical collaboration in 
setting up a regional 
transborder transplantation 
network 
Department of Physiology, Faculty 
of Medicine, Aristotle University of 
Thessaloniki, Thessaloniki, Greece. 
anogian@auth.gr 
Brand H, Hollederer A, 
Wolf U, Brand A 
Health Policy. 2008 May;86(2-3):245-54. Epub 
2008 Feb 21 
Cross-border health 
activities in the Euregios: 
good practice for better 
health 
Institute of Public Health NRW 
(lögd), Westerfeldstr. 35-37, 
33611 Bielefeld, Germany 
Burger R, Kostera T World Hosp Health Serv. 2010;46(4):4-6 Striking a balance between 
national interests and 
patients' needs: cross-
border projects meeting 
European challenges 
University of Applied Sciences IMC 
Burnett S, Renz A, Wiig 
S, Fernandes A, 
Weggelaar AM, Calltorp 
J, Anderson JE, Robert G, 
Vincent C, Fulop N. 
 
Int J Qual Health Care. 2013 Feb;25(1):1-7. 
doi: 10.1093/intqhc/mzs079. Epub 2013 Jan 4 
Prospects for comparing 
European hospitals in terms 
of quality and safety: 
lessons from a comparative 
study in five countries 
Centre for Patient Safety and 
Service Quality, Faculty of 
Medicine, Imperial College London, 
Room 508 Medical School Building, 
St Mary's Campus, Norfolk Place, 
W2 1PG London, UK. 
s.burnett@imperial.ac.uk 
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Calnan M, Palm W, Sohy 
F, Quaghebeur  DNA 
 
 
European Journal of Public Health. 1997, 7(3), 
26-32. DOI: 
http://dx.doi.org/10.1093/eurpub/7.suppl_3.26 
26-32 
Cross-border use of health 
care: A survey of frontier 
workers' knowledge, 
attitudes and use 
 
Daniels-Haardt I, 
Verhoeven F, Mellmann 
A, Hendrix MG, Gemert-
Pijnen JE, Friedrich AW 
Gesundheitswesen. 2006 Nov;68(11):674-8 [EUREGIO-projekt MRSA-
net Twente/Münsterland. 
Creation of a regional 
network to combat MRSA]. 
[Article in German] 
Landesinstitut für den Offentlichen 
Gesundheitsdienst NRW, Münster, 
Germany. inka.daniels-
haardt@loegd.nrw.de 
Danne T 
 
Dtsch Med Wochenschr. 2011 
May;136(21):1135-9. doi: 10.1055/s-0031-
1280526. Epub 2011 May 17 
[Cross-border health care in 
Europe: will centers of 
reference for pediatric 
diabetes serve as a 
model?]. 
[Article in German] 
Zentrum für 
Kinderendokrinologioe– und 
Diabetologie, Kinderkrankenhaus 
auf der Bult, Hannover. 
danne@hka.de 
Dara M, de Colombani P, 
Petrova-Benedict R, 
Centis R, Zellweger JP, 
Sandgren A, Heldal E, 
Sotgiu G, Jansen N, 
Bahtijarevic R, Migliori 
GB; Wolfheze 
Transborder Migration 
Task Force 
Eur Respir J. 2012 Nov;40(5):1081-90. doi: 
10.1183/09031936.00053012. Epub 2012 May 
31 
Minimum package for cross-
border TB control and care 
in the WHO European 
region: a Wolfheze 
consensus statement 
World Health Organization, 
Regional Office for Europe, 
Copenhagen, Denmark 
Deurenberg RH, Nulens 
E, Valvatne H, Sebastian 
S, Driessen S, Craeghs J, 
De Brauwer E, Heising B, 
Kraat YJ, Riebe J, Stals 
FS, Trienekens TA, 
Scheres J, Friedrich AW, 
van Tiel FH, Beisser PS, 
Stobberingh EE 
Emerging Infectious Diseases , May 2009,Vol. 
15, No. 5, 727-734 
Cross-Border Dissemination 
of Methicillin-Resistant 
Staphylococcus aureus, 
Euregio Meuse-Rhin  Region 
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Di Iorio CT, Carinci F, 
Brillante M, Azzopardi J, 
Beck P, Bratina N, 
Cunningham SG, De 
Beaufort C, Debacker N, 
Jarosz-Chobot P, Jecht 
M, Lindblad U, Moulton T, 
Metelko Ž, Nagy A, 
Olympios G, Pruna S, 
Røder M, Skeie S, Storms 
F, Massi Benedetti M* 
Eur J Public Health. 2013 Apr;23(2):247-53. 
doi: 10.1093/eurpub/cks043. Epub 2012 May 4 
Cross-border flow of health 
information: is 'privacy by 
design' enough? Privacy 
performance assessment in 
EUBIROD 
Serectrix snc, Pescara, Italy. 
ct.diiorio@serectrix.eu 
Di Iorio CT, Carinci F, 
Azzopardi J, Baglioni V, 
Beck P, Cunningham S, 
Evripidou A, Leese G, 
Loevaas KF, Olympios G, 
Federici MO, Pruna S, 
Palladino P, Skeie S, 
Taverner P, Traynor V, 
Benedetti MM* 
J Med Ethics. 2009 Dec;35(12):753-61. doi: 
10.1136/jme.2009.029918 
Privacy impact assessment 
in the design of 
transnational public health 
information systems: the 
BIRO project 
Serectrix s.n.c., Pescara, Italy. 
tania_diiorio@virgilio.it 
Doering N, Legido-
Quigley H, Glinos I, 
McKee M, Maarse H  
 
 
Health Policy and Technology. 2013, 2 (2). pp. 
4-9. 
A success-story in cross-
border telemedicine in 
Europe: the use of intra-
operative 
teleneuromonitoring during 
aorta surgery 
 
Evers S, Paulus A, 
Boonen A 
 
Int J Integr Care. 2001;1:e18 Integrated care across 
borders: possibilities and 
complexities 
Maastricht University, Faculty of 
Health Sciences, Department of 
Health, Organisation, Policy and 
Economics, PO Box 616, 6200 MD 
Maastricht, The Netherlands. 
secretariaat@beoz.unimaas.nl 
Friedrich AW, Daniels-
Haardt I, Köck R, 
Euro Surveill. 2008 Aug 28;13(35). pii: 18965 EUREGIO MRSA-net 
Twente/Münsterland--a 
Institute of Hygiene, University 
Hospital Munster, Germany. 
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Verhoeven F, Mellmann 
A, Harmsen D, van 
Gemert-Pijnen JE, Becker 
K, Hendrix MG 
 
 
Dutch-German cross-border 
network for the prevention 
and control of infections 
caused by methicillin-
resistant Staphylococcus 
aureus 
alexander.friedrich@ukmuenster.de 
Glinos IA, Baeten R 
 
Soc Sci Med. 2014 Sep;117:18-24. doi: 
10.1016/j.socscimed.2014.07.015. Epub 2014 
Jul 7 
Dream vs. reality: seven 
case-studies on the 
desirability and feasibility of 
cross-border hospital 
collaboration in Europe 
European Observatory on Health 
Systems and Policies, Eurostation, 
Place Victor Hortaplein 40/10, 1060 
Brussels, Belgium. Electronic 
address: igl@obs.euro.who.int. 
Groene O, Suñol R 
 
Health Policy. 2010 Dec;98(2-3):107-13. doi: 
10.1016/j.healthpol.2010.05.011. Epub 2010 
Jun 17 
Factors associated with the 
implementation of quality 
and safety requirements for 
cross-border care in acute 
myocardial infarction: 
Results from 315 hospitals 
in four countries 
Avedis Donabedian Research 
Institute, Autonomous University of 
Barcelona, CIBER Epidemiology 
and Public Health, C/ Provenza, 
293, pral., 08037 Barcelona, Spain. 
ogroene@fadq.org 
Hermans HE, den Exter A 
 
Croat Med J. 1999 Jun;40(2):266-72 Cross-border alliances in 
health care: international 
co-operation between health 
insurers and providers in 
the Euregio Meuse-Rhine 
Department of Health Policy and 
Management, Erasmus University 
Rotterdam, Room L4-85, P.O. Box 
1738, 3000 DR Rotterdam, The 
Netherlands. Hermans@bmg.eur.nl 
Houyez F, Sanchez de 
Vega R, Brignol TN, 
Mazzucato M, Polizzi A 
 
Interact J Med Res. 2014 May 5;3(2):e9. doi: 
10.2196/ijmr.2867 
A European network of 
email and telephone help 
lines providing information 
and support on rare 
diseases: results from a 1-
month activity survey 
European Organisation for Rare 
Diseases (Eurordis), Paris, France. 
francois.houyez@eurordis.org 
Hughes D, Allen P, 
Doheny S, Petsoulas C, 
Vincent-Jones P 
 
BMC Health Serv Res. 2013;13 Suppl 1:S7. 
doi: 10.1186/1472-6963-13-S1-S7. Epub 2013 
May 24 
Co-operation and conflict 
under hard and soft 
contracting regimes: case 
studies from England and 
Department of Public Health & 
Policy Studies, Swansea University, 
UK. D.Hughes@swansea.ac.uk 
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Wales 
Immonen I, Anderssen 
N, Lvova M 
 
 
Nurse Educ Today. 2008 Oct;28(7):841-8. doi: 
10.1016/j.nedt.2008.02.001. Epub 2008 Mar 
19 
Project work across borders 
in the arctic Barents region: 
practical challenges for 
project members 
Faculty of Health Sciences, 
Finnmark University College, N-
9613 Hammerfest, Norway. 
ingrid.immonen@hifm.no 
Kiasuwa Mbengi RL, 
Baeten R, McKee M, Knai 
C 
Facts Views Vis Obgyn. 2014;6(3):127-32 Issues arising when crossing 
a border to give birth: an 
explora-tory study on the 
French-Belgian border 
Scientific Institute of Public Health, 
J. Wytsmanstraat 14, 1050 
Brussels, Belgium 
Köck R, Brakensiek L, 
Mellmann A, Kipp F, 
Henderikx M, Harmsen 
D, Daniels-Haardt I, von 
Eiff C, Becker K, Hendrix 
MGR, Friedrich AW 
Journal of Hospital Infection, April 2009 Volume 
71, Issue 4, Pages 320–326 DOI: 
http://dx.doi.org/10.1016/j.jhin.2008.12.001 
Cross-border comparison of 
the admission prevalence 
and clonal structure of 
meticillin-resistant 
Staphylococcus aureus 
 
Miguel LS, Augustin U, 
Busse R, Knai C, Rubert 
G, Sihvo S, Baeten R* 
 
Health Policy. 2014 Jun;116(2-3):206-13. doi: 
10.1016/j.healthpol.2013.11.003. Epub 2013 
Nov 17 
Recognition of 
pharmaceutical 
prescriptions across the 
European Union: a 
comparison of five Member 
States' policies and 
practices 
European Social Observatory 
(OSE), Rue Paul Emile Janson 13, 
Brussels 1050, Belgium. Electronic 
address: 
Lorena.SanMiguel@kce.fgov.be. 
Post GB Prehosp Disaster Med. 2004 Jul-
Sep;19(3):235-44 
Building the Tower of Babel: 
cross-border urgent medical 
assistance in Belgium, 
Germany and The 
Netherlands 
ITS, Institute for Applied Social 
Sciences, Nimegen, The 
Netherlands. B.Post@its.kun.nl 
Rosenmöller M, McKee M, 
Baeten R 
  
World Health Organization 2006, WHO Regional 
Office for Europe, Scherfigsvej 8, DK-2100 
Copenhagen Ø, Denmark. On behalf of the 
Europe 4 Patients project and the European 
Observatory on Health Systems and Policies. 
ISBN 92 890 2287 6 
Patient Mobility in the 
European Union. Learning 
from experience 
 
Europe for Patients project, IESE 
Business School, Barcelona, Spain 
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Saliba V, Muscat NA, 
Vella M, Montalto SA, 
Fenech C, McKee M, Knai 
C. 
J Health Serv Res Policy. 2014 Jan 
31;19(3):153-160. [Epub ahead of print] 
 
Clinicians', policy makers' 
and patients' views of 
pediatric cross-border care 
between Malta and the UK 
Research fellow, European Centre 
on the Health of Societies in 
Transition, London School of 
Hygiene and Tropical Medicine, 
London, United Kingdom 
vanessa.saliba@lshtm.ac.uk. 
Simoes E, Zumbrunn A, 
Zisselsberger G, Schmahl 
FW 
 
Gesundheitswesen. 2011 Mar;73(3):e61-7. 
doi: 10.1055/s-0030-1249644. Epub 2010 Mar 
29 
[Country-specific differences 
in the utilisation profiles of 
cross-border health care 
point to differentiated 
degrees of interest and 
selective use. Results of a 
German-Swiss pilot 
project].[Article in German] 
Institut für Arbeits- und 
Sozialmedizin Universitätsklinikum 
Tübingen, Tübingen. 
elisabeth.simoes@med.uni-
tuebingen.de 
Spyrou S, Vartzopoulos 
D, Bamidis P, Maglaveras 
N 
Stud Health Technol Inform. 2008;136:653-8 Cross-border collaboration 
between Greece and 
FYROM: mobile healthcare 
provision 
3rd Regional Healthcare Authority 
(Macedonia), Greece 
Starmans B, Leidl R, 
Rhodes G 
 
 
European Journal of Public Health. 1997, 7(3), 
33-41. DOI: 
http://dx.doi.org/10.1093/eurpub/7.suppl_3.33 
33-41 
A comparative study on 
cross-border hospital care in 
the Euregio Meuse–Rhine 
 
Vallejo P, Suñol R, Van 
Beek B, Lombarts MJ, 
Bruneau C, Vlcek F 
 
Qual Saf Health Care. 2009 Feb;18 Suppl 1:i8-
14. doi: 10.1136/qshc.2008.029553 
Volume and diagnosis: an 
approach to cross-border 
care in eight European 
countries 
Avedis Donabedian Institute, 
Autonomous University of 
Barcelona, and CIBER 
Epidemiology and Public Health 
(CIBERESP), Provenza 293 Pral, 
Barcelona 08037, Spain.  
Verhoeven F, Hendrix 
RMG, Daniels-Haardt I, 
Friedrich AW, Steehouder 
MF, van Gemert-Pijnen 
JEWC 
International Journal of Infection Control, 
2008, 4(1), DOI: 
http://dx.doi.org/10.3396/ijic.v4i1.2622 
The development of a web-
based information tool for 
cross-border prevention and 
control of Methicillin 
Resistant Staphylc. aureus 
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Health care “tourism”: reproduction – 32 references 
Author(s) Bibliographic information Title of reference Author information (if 
available) 
Bassan S, Michaelsen MA Philos Ethics Humanit Med. 2013 
Aug 20;8:9. doi: 10.1186/1747-
5341-8-9 
Honeymoon, medical treatment 
or big business? An analysis of 
the meanings of the term 
"reproductive tourism" in German 
and Israeli public media 
discourses 
Faculty of Law, Tel Aviv 
University, Ramat Aviv, PB 
39040, Tel Aviv 69978, Israel. 
bassansh@post.tau.ac.il 
Berg Brigham K, Cadier B, 
Chevreul K 
Hum Reprod. 2013 
Mar;28(3):666-75. doi: 
10.1093/humrep/des418. Epub 
2012 Dec 6 
The diversity of regulation and 
public financing of IVF in Europe 
and its impact on utilization 
URC Eco Ile-de-France (AP-HP), 
Hôtel Dieu, 1 Place du Parvis 
Notre Dame, Paris 75010, 
France. karen.brigham@urc-
eco.fr 
Blyth E, Thorn P, Wischmann T  
 
Reprod Biomed Online. 2011 
Nov;23(5):642-51. doi: 
10.1016/j.rbmo.2011.07.009. 
Epub 2011 Jul 23 
CBRC and psychosocial 
counselling: assessing needs and 
developing an ethical framework 
for practice 
University of Huddersfield, 
School of Human and Health 
Sciences, Queensgate, 
Huddersfield HD1 3DH, United 
Kingdom. e.d.blyth@hud.ac.uk 
Blyth E 
 
Fertil Steril. 2010 Jun;94(1):e11-
5. doi: 
10.1016/j.fertnstert.2010.01.046. 
Epub 2010 Mar 6 
Fertility patients' experiences of 
cross-border reproductive care 
Department of Social Work, 
School of Human and Health 
Sciences, The University of 
Huddersfield, Queensgate, 
Huddersfield, United Kingdom. 
e.d.blyth@hud.ac.uk 
Collins J, Cook J 
 
Cross-border reproductive care: 
now and into the future 
Fertil Steril. 2010 Jun;94(1):e25-
6. doi: 
10.1016/j.fertnstert.2009.12.009. 
Epub 2010 Feb 11 
Mahone Bay, Nova Scotia, 
Canada. johncollins@eastlink.ca 
Connolly M 
 
Reprod Biomed Online. 2011 
Dec;23(7):817-9. doi: 
10.1016/j.rbmo.2011.09.006. 
Cross-border reproductive care: 
market forces in action or market 
failure? An economic perspective 
Global Market Access Solutions, 
St Prex, Switzerland. 
mark@gmasoln.com 
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Epub 2011 Sep 21 
Couture V, Drouin R, Tan SL, 
Moutquin JM, Bouffard C 
Clin Genet. 2014 May 2. doi: 
10.1111/cge.12418. [Epub ahead 
of print] 
Cross-border reprogenetic 
services: a narrative overview 
and thematic analysis of the 
literature 
Laboratory of Transdisciplinary 
Research in Genetics, Medicines 
and Social Sciences, Division of 
Genetics, Department of 
Pediatrics, Faculty of Medicine 
and Health Sciences, Université 
de Sherbrooke, Sherbrooke, 
Quebec, Canada 
Crockin SL* 
 
Reprod Biomed Online. 2011 
Dec;23(7):811-3. doi: 
10.1016/j.rbmo.2011.09.015. 
Epub 2011 Oct 8 
Legal perspectives on cross-
border reproductive care 
Crockin Law & Policy Group, 29 
Crafts Street, Newton, MA 
02460, USA. 
slcrockin@crockinlaw.com 
Culley L, Hudson N, Rapport F, 
Blyth E, Norton W, Pacey AA 
  
 
Hum Reprod. 2011 
Sep;26(9):2373-81. doi: 
10.1093/humrep/der191. Epub 
2011 Jun 29 
Crossing borders for fertility 
treatment: motivations, 
destinations and outcomes of UK 
fertility travellers 
School of Applied Social 
Sciences, De Montfort 
University, Hawthorn Building, 
The Gateway, Leicester LE1 9BH, 
UK. lac@dmu.ac.uk 
Davies T 
 
Fertil Steril. 2010 Jun;94(1):e20-
2. doi: 
10.1016/j.fertnstert.2009.11.005. 
Epub 2010 Jan 8 
Cross-border reproductive care: 
quality and safety challenges for 
the regulator 
Human Fertilisation and 
Embryology Authority, London, 
United Kingdom. 
trish.davies@hfea.gov.uk 
De Sutter P 
 
Reprod Biomed Online. 2011 
Nov;23(5):652-6. doi: 
10.1016/j.rbmo.2011.07.016. 
Epub 2011 Aug 19 
Considerations for clinics and 
practitioners treating foreign 
patients with assisted 
reproductive technology: lessons 
from experiences at Ghent 
University Hospital, Belgium 
Department of Reproductive 
Medicine, University Hospital 
Ghent, De Pintelaan 185, 9000 
Ghent, Belgium. 
petra.desutter@ugent.be 
Donchin A 
 
 
Bioethics. 2010 Sep;24(7):323-
32. doi: 10.1111/j.1467-
8519.2010.01833.x 
Reproductive tourism and the 
quest for global gender justice 
Indiana University, Indianapolis, 
USA 
Ethics Committee of American 
Society for Reproductive 
Fertil Steril. 2013 
Sep;100(3):645-50. doi: 
Cross-border reproductive care: a  
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Medicine 10.1016/j.fertnstert.2013.02.051. 
Epub 2013 Mar 21 
committee opinion 
Ferraretti AP, Pennings G, 
Gianaroli L, Natali F, Magli MC 
 
Reprod Biomed Online. 2010 
Feb;20(2):261-6. doi: 
10.1016/j.rbmo.2009.11.009. 
Epub 2009 Nov 26 
Cross-border reproductive care: a 
phenomenon expressing the 
controversial aspects of 
reproductive technologies 
SISMER Reproductive Medicine 
Unit, Bologna, Italy. 
annapia.ferraretti@sismer.it 
Forman R 
 
Reprod Biomed Online. 2011 
Dec;23(7):808-10. doi: 
10.1016/j.rbmo.2011.10.002. 
Epub 2011 Oct 8 
Cross-border reproductive care: a 
clinician's perspective 
CRM London, 111 Park Road, 
London, United Kingdom. 
RobertForman@crmlondon.co.uk 
Franklin S 
 
Reprod Biomed Online. 2011 
Dec;23(7):814-6. doi: 
10.1016/j.rbmo.2011.09.016. 
Epub 2011 Oct 8 
Not a flat world: the future of 
cross-border reproductive care 
University of Cambridge, 
Cambridge, UK. 
sbf25@cam.ac.uk 
Gürtin ZB* 
 
Reprod Biomed Online. 2011 
Nov;23(5):555-64. doi: 
10.1016/j.rbmo.2011.08.004. 
Epub 2011 Aug 27 
Banning reproductive travel: 
Turkey's ART legislation and 
third-party assisted reproduction 
Centre for Family Research, 
Convener, Cambridge 
Interdisciplinary Reproduction 
Forum, CRASSH, University of 
Cambridge, Cambridge CB2 3RF, 
United Kingdom. 
zbg20@cam.ac.uk 
Hudson N, Culley L, Blyth E, 
Norton W, Rapport F, Pacey A 
 
Reprod Biomed Online. 2011 
Jun;22(7):673-85. doi: 
10.1016/j.rbmo.2011.03.010. 
Epub 2011 Mar 13 
Cross-border reproductive care: a 
review of the literature 
School of Applied Social 
Sciences, De Montfort 
University, 0.15b Hawthorn 
Building, The Gateway, Leicester 
LE1 9BH, UK. 
nhudson@dmu.ac.uk 
Inhorn MC, Patrizio P 
 
Curr Opin Obstet Gynecol. 2012 
Jun;24(3):158-63. doi: 
10.1097/GCO.0b013e328352140a 
The global landscape of cross-
border reproductive care: twenty 
key findings for the new 
millennium 
Department of Anthropology and 
MacMillan Center for 
International and Area Studies, 
Yale University, New Haven, 
Connecticut 06520-8277, USA 
Inhorn MC, Gürtin ZB Reprod Biomed Online. 2011 Cross-border reproductive care: a Centre for Family Research, 
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 Nov;23(5):665-76. doi: 
10.1016/j.rbmo.2011.08.002. 
Epub 2011 Aug 26 
future research agenda University of Cambridge, 
Cambridge CB2 3RF, UK 
Mancini F, Clua E, Martínez F, 
Battaglia C, Veiga A, Barri PN 
 
Fertil Steril. 2011 
Jun;95(7):2432.e13-5. doi: 
10.1016/j.fertnstert.2011.03.092 
Heterotopic pregnancy in a cross 
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Annex 3: Identified activities from the project review 
   Short Description Project 
No 1 
Name Monitoring Medicines 
Acronym / 
Website http://monitoringmedicines.org/ 
Mission/ Objectives Optimizing drug safety monitoring to enhance patient safety and achieve better health outcomes 
Lead Partner Uppsala Monitoring Centre, Sweden 
Database/source FP7-HEALTH 
Link to patient right Patient safety 
    
No 2 
Name   
Acronym ORCAB 
Website http://ec.europa.eu/research/health/public-health/clinical-outcome-into-practice/projects/orcab_en.html 
Mission/ Objectives 
Improving quality and safety in the hospital: The link between organisational culture, burnout, and quality of care. ORCAB 
aims at benchmarking the organisational and individual factors that impact on quality of care and patient safety and at 
designing bottom-up interventions that both increase quality of care and physician well-being. 
Lead Partner Medical School Department Social Medicine, Thessaloniki, Greece 
Database/source FP7-HEALTH 
Link to patient right Quality of care and patient safety 
    
No 3 
Name EUropean Cross Border Care Collaborations Short Title: CrossEurope 
Acronym EUCBCC 
Website 
http://ec.europa.eu/research/health/public-health/health-systems/projects/eucbcc_en.html    OR   
http://www.ecabeurope.eu/ 
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Mission/ Objectives 
EUCBCC aims to facilitate a process whereby Europe's citizens can make informed choices about whether to seek health 
care in another Member State and, if they so choose, to ensure that the administrative and clinical processes are 
straightforward and ensure continuity of care. It takes as its starting point the recent draft Directive on Patients' Rights, 
augmented by the existing body of research on cross-border care. 
Lead Partner London School of Economics and Political Science 
Database/source FP7-HEALTH 
Link to patient right Patient informed choices on cross border healthcare 
    
No 4 
Name 
Establishment of Quality Assurances for Detection of Highly Pathogenic Bacteria of Potential Bioterrorism 
Risk 
Acronym EQADeBa 
Website www.rki.de/EN/Content/Prevention/EQADeBa/ EQADeBa__node.html 
Mission/ Objectives 
The project, supported by the second Health Programme, aimed at improving the preparedness of laboratories designated 
by the authorities in EU Member States to respond to any potential bioterrorist threat or natural outbreak of diseases 
caused by highly pathogenic bacteria like anthrax, plague, or tularaemia. In the case of such an attack or outbreak, 
laboratories must be able to achieve a quick and precise diagnosis of highly potentially dangerous threats. 
Lead Partner Robert Koch Institute, Berlin, Germany 
Database/source EU Health Programme 2008-2013 
Link to patient right Quality of care / patient safety in case of emergency / prevention  
    
No 5 
Name Vigilance and Surveillance of Substances of Human Origin 
Acronym SOHOV 
Website http://www.sohovs.org/soho/ 
Mission/ Objectives 
The aim of SOHOV&S is to support EU MS in the establishment of Vigilance and Surveillance(V&S)systems for tissues and 
cells in transplantation and in assisted reproduction. The project will drive harmonisation in terminology, investigation 
approaches, facilitating communication and cross-border management of serious adverse events and reactions (SAR/E). 
Lead Partner Istituto Superiore di Sanità - ISS (Roma) 
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Database/source EU Health Programme 2008-2013 
Link to patient right Safety of medical procedures and quality of donated blood, tissues, etc - Surveillance and quality 
    
No 6 
Name European network social inclusion and health 
Acronym Correlation II  
Website www.correlation-net.org/ 
Mission/ Objectives 
We aim to improve the access to and the quality of medical and social services and work for a social Europe, in which 
marginal and vulnerable groups have a permanent place with the same (human) rights then everyone else. 
Lead Partner De Regenboog Groep, Amsterdam, Netherlands 
Database/source EU Health Programme 2008-2013 
Link to patient right Access and quality medical care 
    
No 7 
Name EUropean Best Information through Regional Outcomes in Diabetes 
Acronym EUBIROD 
Website http://www.eubirod.eu/ 
Mission/ Objectives 
EUBIROD targets the sustainability of complex systems of health indicators requiring continuous update and regular 
maintenance. The project proposes an action to implement, extend, and customize the application of the BIRO technology 
in at least 20 European Member States. Participants will be connected through a system that will safely collect aggregated 
data and produce systematic EU reports of diabetes indicators. 
Lead Partner Università degli Studi di Perugia, Italy 
Database/source EU Health Programme 2008-2013 
Link to patient right (Global) Indicators 
    
No 8 
Name European Heart Health Strategy 
Acronym EuroHeart (2006) 
Website http://www.escardio.org 
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Mission/ Objectives 
The objectives of the project are to: strengthen cross-sector cooperation; obtain comprehensive comparable information 
on policies and actions on cardiovascular health (CVH) promotion and cardiovascular disease (CVD) prevention; improve 
the awareness, diagnosis and treatment of women with CVD across Europe; and achieve a level playing-field by 
introducing national versions of CVD guidelines. 
Lead Partner European Society of Cardiology, France 
Database/source EU Health Programme 2008-2013 
Link to patient right CVD Guidelines 
    
No 9 
Name European Heart Health Strategy II 
Acronym EuroHeart II (2010) 
Website http://www.ehnheart.org/projects/euroheart-ii.html 
Mission/ Objectives 
The project recommends investing in data collection systems in order to monitor trends in CVD risk factors,mortality rates 
and incidence. Policy makers are also encouraged to adopt legislative measures to improve dietary standards and reduce 
smoking, while at the same time promoting greater physical activity. Finally, the project underlines the need for scientific 
and professional bodies to draw up effective strategies for implementing professional guidelines and overcoming barriers. 
Lead Partner European Heart Network, Brussels, Belgium 
Database/source EU Health Programme 2008-2013 
Link to patient right Guidelines for effective and action of quality in the field of CVD 
    
No 10 
Name Quantification of sun exposure in Europe and its effects on health 
Acronym EuroSun 
Website http://eurosun-project.org/Home/EuroSun-introduction-background-and-objectives.html 
Mission/ Objectives 
EuroSun aims to monitor ultraviolet exposure across Europe and its effects on incidence of skin cancers and cataracts. 
E.g. Development of indicators of changing risk of melanoma and non-melanoma skin cancers and of cataracts,… 
Measuring the exposure of individuals and populations in Europe to UV radiation by using the data of meteorological 
satellites.  
Lead Partner International Prevention Research institute, Lyon, France 
Database/source EU Health Programme 2008-2013 
Link to patient right Development of Indicator 
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No 11 
Name Improving access to health care for asylum seekers and undocumented migrants in the EU 
Acronym AVERROES Network 
Website http://averroes.medecinsdumonde.org/ 
Mission/ Objectives 
The project contributes to enhancing the European Union population’s health, by improving asylum seekers’ and 
undocumented migrants’ access to health care. Médecins du Monde (MdM) aims at documenting asylum seekers and 
undocumented migrants’ access to health care in the EU. MdM also seeks to promote these populations’ right to access 
health care on equal terms with nationals, and a right to protection against deportation for seriously ill foreigners. 
Lead Partner Medecins du Monde, Paris, France; Brussels, Belgium and Madrid, Spain 
Database/source EU Health Programme 2008-2013 
Link to patient right Patient rights within socio economic factors 
    
No 12 
Name 
Expanded European Information System to Monitor Short and Long Term outcomes and Improve Quality of 
Care and Safety for Very-Low-B 
Acronym EuroNeoStat II 
Website 
http://www.euroneostat.org/ --> Link expired Check: 
http://ec.europa.eu/chafea/projects/database.html?prjno=20081311 
Mission/ Objectives 
EuroNeoStat II mission or strategic goal is that all Very Low Gestation (VLGA, gestation <32 wks) and Very Low Birth 
Weight (VLBW, birthweight <1501 g) infant born in Europe, receive the best possible health care no matter where born 
by preventing existing inequalities and that all Neonatal Units use the indicators developed, to assess the quality of care 
provided and implement strategies to improve outcome. 
Lead Partner Fundación Vasca de Innovación e Investigación Sanitarias  
Database/source EU Health Programme 2008-2013 
Link to patient right Quality evaluation and patient registries, patient safety 
    
No 13 
Name Better Statistics for Better Health for Pregnant Women and Their Babies: European Health Reports 
Acronym EURO-PERISTAT III 
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Website http://www.europeristat.com/ 
Mission/ Objectives 
The EURO-PERISTAT project’s goal has been to develop valid and reliable indicators that can be used for monitoring and 
evaluating perinatal health in the EU. The project began in 1999 as part of the Health Monitoring Programme and has 
continued into a third phase, with the ultimate aim of producing a European Perinatal Health Report and establishing a 
sustainable system for reporting perinatal health indicators. 
Lead Partner / 
Database/source EU Health Programme 2008-2013 
Link to patient right Indicator development, patient registries, health reports 
    
No 14 
Name Information network on good practice in health care for migrants and minorities  
Acronym MIGHEALTHNET 
Website http://mighealth.net/index.php?title=Main_Page 
Mission/ Objectives 
The MIGHEALTHNET project aims to stimulate the exchange of knowledge on migrant and minority health through the 
development of interactive data bases in each of the participating countries. These 'wikis' will contain the following sorts 
of data: 1. Background information concerning migrant and minority populations. 2. The state of health of migrants and 
minority populations. 3. The health care system and the entitlement of migrants and minorities. 4. Accessibility of health 
care. 5. Quality of care: 'good practices' developed to improve the matching of service provisions to the needs of migrants 
and minorities. 6. Achieving change: centers of expertise, general reports and policy documents, training programmes, E-
mail groups, etc.  
Lead Partner National and Kapodistrian University of Athens 
Database/source EU Health Programme 2008-2013 
Link to patient right Access to healthcare, quality of care 
    
No 15 
Name European Haemophilia Network  
Acronym EUHANET 
Website http://www.euhanet.org/ 
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Mission/ Objectives 
The objective of this project is to establish the European Haemophilia Network (EUHANET) to harmonise and improve the 
care received by European citizens with inherited bleeding disorders. The European Health Professionals and Patient 
Organisations will work together to enhance the quality of the delivered care. Criteria will be developed for the definition 
of levels of care provided by haemophilia centres and these will be applied to centres throughout Europe. A new public 
Haemophilia Central website will provide all the information relevant to patients with inherited bleeding disorders and 
their carers. EUHANET will also support collaboration between the expanded and developed pharmacovigilance system, 
the European Haemophilia Safety Surveillance System (EUHASS), and the new prospective Rare Bleeding Disorders 
Database (RBDD). 
Lead Partner The University of Sheffield, UK 
Database/source EU Health Programme 2008-2013 
Link to patient right quality of care, surveillance, database 
    
No 16 
Name An EU Rare Diseases Registry for Wolfram Syndrome, Alstrom Syndrome and Bardet Biedl Syndrome 
Acronym EURO-WABB 
Website http://www.euro-wabb.org/en/ 
Mission/ Objectives 
The EURO-WABB Project is a collaboration of doctors, scientists and patient support groups from all over Europe. Within 
the EU Health Programme 2008-2013 and its call for promoting health through the creation of new registers for rare 
diseases, EURO-WABB is supported by The EU Directorate General for Health and Consumers (DG-SANCO) via its 
Executive Agency for Health and Consumers. The overall aim is for this register to be a key instrument to increase 
knowledge on these rare diseases, improve the lives of affected people through better management, and to develop 
clinical research. 
Lead Partner University of Birmingham, UK 
Database/source EU Health Programme 2008-2013 
Link to patient right Quality evaluation, patient registries 
    
No 17 
Name EUROPEAN QUALITY SYSTEM INDICATORS AND METHODOLOGY ON ORGAN DONATION 
Acronym ODEQUS PROJECT 
Website http://odequs.eu/ 
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Mission/ Objectives 
ODEQUS specific objectives were to identify Quality Criteria (QC) and to develop Quality Indicators (QI) in 3 types of 
organ donation: after Brain Death, after Cardiac Death and Living Donation. Those tools will be useful for hospitals self-
assessment, external evaluation as well as for developing an European auditing model. 
Lead Partner Universitat de Barcelona, Spain 
Database/source EU Health Programme 2008-2013 
Link to patient right Quality indicators, quality standards,  
    
No 18 
Name 
Chain of Trust–Understanding patients and health professionals' perspective on Telehealth to build 
confidence and acceptance 
Acronym Chain of Trust 
Website http://www.eu-patient.eu/whatwedo/Projects/Chain-of-Trust/ 
Mission/ Objectives 
The paramount objective of the "Chain of Trust" project is to advance the empowerment of patients, health professionals 
and national health authorities across the EU in their understanding and effective use of telehealth services in an effort to 
actively contribute to the vision of high quality, patient-centred, equitable healthcare for all EU patients.  
Lead Partner European Patients' Forum - EPF, Brussels, Belgium 
Database/source EU Health Programme 2008-2013 
Link to patient right Patient rights, privacy, telemedicine 
    
No 19 
Name International Research on Quality in Healthcare 
Acronym INTERQUALITY 
Website http://interqualityproject.eu/ 
Mission/ Objectives 
Project Objectives: 1. To investigate the effect of different financing methods and incentives on the quality, effectiveness 
and equity of access to health care in four patient groups affected by: - pharmaceutical care - hospital care - outpatient 
care - integrated care. 2. To develop collaborative practice models of healthcare, in the context of financing treatment of 
chronic diseases. 3. To establish the feasibility and effectiveness of developed models in the settings of each partner 
healthcare system. 
Lead Partner WARSZAWSKI UNIWERSYTET MEDYCZNY, Poland 
Database/source FP7-HEALTH 
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Link to patient right quality outcomes, clinical efficacy, safety, equity 
    
No 20 
Name Guiding Patients Anytime Everywhere 
Acronym MobiGuide 
Website http://www.mobiguide-project.eu/ 
Mission/ Objectives 
MobiGuide research's main objective is to create a scalable, secure, ubiquitously accessible, and user-friendly mobile 
solution for designing, deploying, and maintaining Patient Guidance Systems based on clinical guidelines and personal 
health records, that provide personalized evidence-based clinical recommendations, increase the patients' satisfaction and 
compliance to evidence-based clinical guidelines, and reduce risk to patients and healthcare costs. 
Lead Partner University of Haifa (HU), Israel 
Database/source FP7 - ICT 
Link to patient right monitoring, patient data, patient empowerment, hospital records 
    
No 21 
Name Consent in a Trial and Care environment 
Acronym CONTRACT 
Website http://contract-fp7.eu/site/ 
Mission/ Objectives 
CONTRACT seeks to understand the way the European Data Protection Directive and the Clinical Trials 
 Directive have had and continue to have an impact on the success of translational research. 
Lead Partner GOTTFRIED WILHELM LEIBNIZ UNIVERSITAET HANNOVER, Germany 
Database/source FP7-HEALTH 
Link to patient right Consent, data, new alternatives for consent, ethics 
    
No 22 
Name Deepening our understanding of quality improvement in Europe 
Acronym DUQuE 
Website http://www.duque.eu/ 
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Mission/ Objectives 
The main goal of the DUQuE project is to study the effectiveness of quality improvement systems in European hospitals. 
This has been done by assessing the relationship of organisational quality improvement systems/management and 
culture, professionals’ involvement, and patient empowerment with the quality of hospital care (including clinical 
effectiveness, patient safety and patient involvement). 
Lead Partner FAD Avedis Donabedian University Institute,Autonomous University of Barcelona, Spain 
Database/source FP7-HEALTH 
Link to patient right Quality hospitals in Europe, quality improvements, patient empowerment 
    
No 23 
Name Using operations management to improve healthcare outcomes 
Acronym MANAGED OUTCOMES 
Website http://www.managedoutcomes.eu/ 
Mission/ Objectives 
This main goal can be divided in seven specific objectives: Develop more effective and efficient healthcare systems 
models with new a scientific approach building on service operations management. Investigate relationships among 
quality of care, cost, efficiency and accessibility. Develop tools, methods, and models to create more sustainable health 
systems to encounter universal challenges of healthcare demand. Understand the relationship between healthcare 
outcomes and cost-benefits using technical, allocative and economic efficiency measures of service production systems. 
Identify different demand segments of healthcare. Enhance cooperation between researchers in Europe to promote the 
integration and excellence of European healthcare systems research. Develop future European healthcare system model 
scenarios.  
Lead Partner AALTO UNIVERSITY, Finland 
Database/source FP7-HEALTH 
Link to patient right Quality of healthcare, accessibility 
    
No 24 
Name Improvement in Postoperative PAIN OUTcome 
Acronym PAIN-OUT 
Website http://pain-out.med.uni-jena.de/ 
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Mission/ Objectives 
PAIN OUT is a multi-national research project that provides a unique and user-friendly web-based information system to 
improve treatment of patients with post-operative pain. The project offers a system for measurement and feedback of 
outcome quality and supports the process of decision making in order to achieve an optimized treatment of patients. From 
2009-2012, it was funded by European Commission's 7th Framework Programme (Grant Agreement no. 223590). 
Lead Partner Universitätsklinikum Jena, Germany 
Database/source FP7-HEALTH 
Link to patient right Improving clinical decision making 
    
No 25 
Name Clinical decision making and outcome in routine care for people with severe mental illness 
Acronym CEDAR 
Website http://www.cedar-net.eu/ 
Mission/ Objectives 
Background: A considerable amount of research has been conducted on clinical decision making (CDM) in short-term 
physical conditions. However, there is a lack of knowledge on CDM and its outcome in long-term illnesses, especially in 
care for people with severe mental illness. Thus, this project entitled "Clinical decision making and outcome in routine 
care for people with severe mental illness" (CEDAR) is proposed by participants in six European countries (Denmark, 
Germany, Hungary, Italy, Switzerland and UK). 
Lead Partner UNIVERSITAET ULM, Germany 
Database/source FP7-HEALTH 
Link to patient right Clinical decision making 
    
No 26 
Name Promoting patient safety and quality improvement in critical care 
Acronym PROSAFE 
Website http://prosafe.marionegri.it/ 
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Mission/ Objectives 
The project will: a. Build a collaboration network of ICUs for collecting and comparing clinical data for improving 
patient safety and quality of services. b. Develop a web-based multilingual system for gathering data from ICU 
networks. c. Permit the analysis and comparison of clinical data through multivariable methods and provide ICUs 
with tools for identifying and eliminating weaknesses and for fostering and sharing strengths with other 
network members. d. Enhance patient safety in terms of quality of delivered healthcare. e. Improve outcome in 
ICUs by reducing mortality and avoiding medical errors through continuous monitoring of activity. f. Introduce effective 
strategies of good practice exchange between different EU countries in the critical care domain. 
Lead Partner Mario Negri Institute for Pharmacological Research, Italy 
Database/source EU Health Programme 2008-2013 
Link to patient right Patient safety 
    
No 27 
Name 
Surveillance System: Occurrence of Urinary Incontinence in Women as a Consequence of Inefficient or 
Inappropriate Obstetric Care 
Acronym Ob.Surve 
Website http://www.obsurve.eu/ --> Website down 
Mission/ Objectives 
The project aims at setting up a surveillance system to monitor the occurrence of urinary incontinence (UI) in women in 
the EU. The project will focus on incontinence as a consequence of inefficient or inappropriate obstetric care, with the 
ultimate view to formulate appropriate strategies, policies and actions to avoid these conditions, and thus improve the 
quality of life of particular sections of the female population. 
Lead Partner AZIENDA ULSS 20 Verona, Italy 
Database/source EU Health Programme 2008-2013 
Link to patient right Health surveillance 
    
No 28 
Name European Union Network for Patient Safety 
Acronym EUNetPaS 
Website http://www.eunetpas.eu/ 
Mission/ Objectives 
EUNetPaS seeks to establish an umbrella network to improve cooperation among Member States in the field of patient 
safety, particular with respect to culture, reporting and learning systems, and education, and thus avoid overlap and 
duplication of efforts.  
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Lead Partner Haute Autorité de Santé - HAS, France 
Database/source EU Health Programme 2008-2013 
Link to patient right Patient safety 
    
No 29 
Name European Haemophilia Safety Surveillance System 
Acronym EUHASS 
Website http://euhass.org/ 
Mission/ Objectives 
EUHASS is a pharmacovigilance program to monitor the safety of treatments for people with inherited bleeding disorders 
in Europe. Haemophilia treatment centres report adverse events directly to the EUHASS website and regular surveillance 
reports are produced. 
Lead Partner The University of Sheffield, UK 
Database/source EU Health Programme 2008-2013 
Link to patient right Patient Safety and surveillance 
    
No 30 
Name Learning from International Networks about Errors and Understanding Safety in Primary Care 
Acronym LINNEAUS EURO -PC 
Website http://www.linneaus-pc.eu/ 
Mission/ Objectives 
The main focus of the co-ordination action is to build a network of researchers and practitioners working on patient safety 
in primary care the European Union. 
Lead Partner School of Community Based Medicine, University of Manchester, UK 
Database/source FP7-HEALTH 
Link to patient right Patient safety 
    
No 31 
Name 
Quality and safety in European Union hospitals: A research-based guide for implementing best practice and a 
framework for assessing performance 
Acronym QUASER 
Website 
http://www.quaserproject.eu/ --> http://ec.europa.eu/research/health/public-health/clinical-outcome-into-
practice/projects/quaser_en.html 
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Mission/ Objectives 
This translational study aims to design and disseminate an evidence based guide for hospitals to implement quality and 
safety improvement programmes, and an evidence based framework for payers to assess and monitor the quality and 
safety of hospitals across the EU. 
Lead Partner UNIVERSITY COLLEGE LONDON, UK 
Database/source FP7-HEALTH 
Link to patient right Quality and safety in EU hospitals 
    
No 32 
Name European Consortium in Healthcare Outcomes and cost-benefit research 
Acronym ECHOUTCOME  
Website http://www.echoutcome.eu/index.php/en/home.html 
Mission/ Objectives 
ECHOUTCOME is an interdisciplinary European research platform with the aim of assessing methodological properties of 
Healthcare Outcome and Cost-Benefit studies. The ECHOUTCOME consortium is composed by eight partners from 4 
countries including three academic international experts in Outcome Research from, the French Scientific Society in 
Health Economics, the European office of one Multinational BioPharma industry, two research organisations (SME) 
specialized in advanced statistics and modelling and one organization specialized in international research administration. 
The general objective of this consortium is to study European health systems in order to assess decision making criteria in 
the frame of national needs and expectations across member states concerning healthcare outcomes and cost-benefit 
analyses Using both the descriptive and the experimental approaches, the ECHOUTCOME consortium will be able to 
investigate the relationship between quality of care with costs, efficiency and accessibility by indentifying and 
assessing existing approaches, but with the capability to develop new approaches for Decision Making purpose. 
Lead Partner UNIVERSITE LYON 1 CLAUDE BERNARD, France 
Database/source FP7-HEALTH 
Link to patient right Quality of care and accessibility 
    
No 33 
Name European Health Care Outcomes, Performance and Efficiency 
Acronym EuroHOPE 
Website http://eurohope.info/ 
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Mission/ Objectives 
By using available databases as well as by collecting additional data on health-related quality of life measures (enabling 
Quality Adjusted Life Years as an outcome measure) and patient satisfaction (including expectations) the EuroHOPE 
project will evaluate, through a microeconomic disease-based approach, the performance of European health care 
systems in terms of outcomes, quality, use of resources and cost. Concentration will be on five important health 
problems/diseases: acute myocardial infarction, stroke, hip fracture, breast-cancer, and very low birth weight infants.  
Lead Partner TERVEYDEN JA HYVINVOINNIN LAITOS, Finland 
Database/source FP7-HEALTH 
Link to patient right patient satisfaction, quality of care 
    
No 34 
Name European Collaboration for Healthcare Optimization 
Acronym ECHO 
Website http://echo-health.eu/ 
Mission/ Objectives 
ECHO, European Collaboration for Healthcare Optimization, gathers the interests for Healthcare Performance 
Measurement of different Academic and Research Institutions from six European countries and an International Body for 
Healthcare Policy Analysis. Designed as a 48 months project, it has been conceived as a “pilot study” based on available 
administrative databases. It aims at describing the actual performance of six different Healthcare Systems at hospital, 
healthcare area, regional and country level. To tackle performance measurement in this project, two different 
methodological approaches will be used: [a] a population geographical-based, responding the question: Is the access to a 
diagnostic or surgical procedure dependant on the place where a person lives? And, [b] a provider-specific, answering the 
question: Is the risk for a patient to access high quality care -and have better health outcomes- different regarding the 
provider in which he or she is admitted? Utilization, equity in access and allocative efficiency will be analysed as 
performance measures in the former approach; and, healthcare outcomes and associated costs will be measures in the 
latter one. 
Lead Partner INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD, Spain 
Database/source FP7-HEALTH 
Link to patient right Access to health care, assessment of performance 
    
No 35 
Name Prevention of Hospital Infections by Intervention and Training 
Acronym PROHIBIT 
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Website https://plone.unige.ch/prohibit/ 
Mission/ Objectives 
The aim of PROHIBIT is to understand existing guidelines and practices to prevent healthcare associated infections (HAI) 
in European hospitals, identify factors that enable and prevent compliance with best practices, and test the effectiveness 
of interventions of known efficacy. The project will employ a mixed-methods approach combining the strengths of 
qualitative research, survey methods, observational and experimental designs.  
List of publication https://plone.unige.ch/prohibit/publications 
Lead Partner UNIVERSITE DE GENEVE, Switzerland 
Database/source FP7-HEALTH 
Link to patient right Guidelines and best practices, evaluation of effectiveness 
    
No 36 
Name IMPROVING PATIENT SAFETY OF HOSPITAL CARE THROUGH DAY SURGERY  
Acronym DAYSAFE 
Website http://www.daysafe.eu/ 
Mission/ Objectives 
The general objective of the project is to improve patient safety and quality of hospital care through the promotion of DS 
best practices and standards. This project intends to elucidate main issues concerning ambulatory surgery, investigating 
DS at different levels of MSs health systems, and also offer realistic solutions, recommending evidence-based best 
practices and standards identified through benchmarking. This initiative aims to provide some relevant, practical and 
flexible answers to European health systems increasingly facing an ethical and political dilemma regarding how to assure 
sustainable and equitable access to safe and high quality health care 
Lead Partner Agenzia Nazionale per i Servizi Sanitari Regionali , Rome, Italy 
Database/source EU Health Programme 2008-2013 
Link to patient right Quality of care and patient safety 
    
No 37 
Name IMplementation of quality indicators in PAlliative Care sTudy 
Acronym IMPACT 
Website http://www.impactpalliativecare.eu/ 
Mission/ Objectives 
The overall aim of the IMPACT project was to develop optimal improvement strategies to improve the organization of 
palliative cancer and dementia care in Europe and to study factors influencing the effectiveness of the strategies. 
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List of publication   
Lead Partner STICHTING KATHOLIEKE UNIVERSITEIT, Netherlands 
Database/source FP7-HEALTH 
Link to patient right Effectiveness of strategies, quality of care 
No 38 
Name The European Union Network for Patient Safety and Quality of  Care,  
Acronym PaSQ Joint Action 
Website http://www.pasq.eu/ 
Mission/ Objectives 
The general objective of PaSQ Joint Action (JA) is to contribute to Patient Safety (PS) and good Quality  
of Care (QC) by supporting the implementation of the Council Recommendations on PS through cooperation between 
European Member States (EU MS), EU stakeholders and international organisations on issues related to quality of health 
care, including PS and Patient Involvement (PI). This will be done by sharing knowledge, experience and good 
practices with each other, the Commission and relevant European and international bodies, as well as examining 
transferability of these practices. 
Lead Partner French National Authority for Health (HAS) 
Database/source EU Health Programme 2008-2013 
Link to patient right implementation of good practice 
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Annex 4: Council of Europe activities - Tables  
 
1.Ratification Status 
The Council of Europe is the best source for this, and provides the following data on the situation 
(http://conventions.coe.int/Treaty/Commun/ChercheSig.asp?NT=164&CM=8&DF=29/07/2015&CL=ENG Last visited 3 August, 2015).  
Here the basic information of the table is included, with the addition of the details concerning the four Protocols to the Convention: on the 
prohibition on the cloning of human beings  
(http://conventions.coe.int/Treaty/Commun/ChercheSig.asp?NT=168&CM=8&DF=29/07/2015&CL=ENG Last visited 3 August, 2015);  
on the transplantation of human organs and tissue  
(http://conventions.coe.int/Treaty/Commun/ChercheSig.asp?NT=186&CM=8&DF=29/07/2015&CL=ENG  Last visited 3 August, 2015);  
on biomedical research 
(http://conventions.coe.int/Treaty/Commun/ChercheSig.asp?NT=195&CM=8&DF=29/07/2015&CL=ENG Last visited 3 August, 2015);  
and on genetic testing for health purposes  
(http://conventions.coe.int/Treaty/Commun/ChercheSig.asp?NT=203&CM=8&DF=29/07/2015&CL=ENG Last visited 3 August, 2015). 
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 Convention Human Rights and Biomedicine  
Protocol: Prohibition on 
Human 
Cloning 
 Protocol: Organ and Tissue  
Protocol Biomedical 
Research  
Protocol: Genetic 
Testing  
   Signature  Ratification  Entry into 
force  
Signature  Ratification  Entry into 
force  
Signature  Ratification  Entry into 
force  
Signature  Ratification  Entry into 
force  
Signature  Ratification  Entry into 
force  
Albania   30/3/2011   30/3/2011   1/7/2011                                                   
Andorra                                                               
Armenia                                                               
Austria                                                               
Azerbaijan                                                               
Belgium                                                               
Bosnia and 
Herzegovina   
16/12/2005   11/5/2007   1/9/2007   31/7/2014   4/6/2015   1/10/2015               16/12/2005   11/5/2007   1/9/2007               
Bulgaria   31/5/2001   23/4/2003   1/8/2003   23/9/2005   30/10/2006   1/2/2007   23/9/2005   30/10/2006   1/2/2007   23/9/2005   30/10/2006   1/9/2007               
Croatia   7/5/1999   28/11/2003   1/3/2004   7/5/1999   28/11/2003   1/3/2004   29/10/2003   28/11/2003   1/5/2006                           
Cyprus   30/9/1998   20/3/2002   1/7/2002   30/9/1998   20/3/2002   1/7/2002               9/7/2010                       
Czech Republic   24/6/1998   22/6/2001   1/10/2001   24/6/1998   22/6/2001   1/10/2001                                       
Denmark   4/4/1997   10/8/1999   1/12/1999   12/1/1998                       25/1/2005                       
Estonia   4/4/1997   8/2/2002   1/6/2002   12/1/1998   8/2/2002   1/6/2002   24/1/2002   17/9/2003   1/5/2006                           
Finland   4/4/1997   30/11/2009   1/3/2010   12/1/1998   30/11/2009   1/3/2010   26/6/2006   30/11/2009   1/3/2010               27/11/2008           
France   4/4/1997   13/12/2011   1/4/2012   12/1/1998           13/12/2011                       13/12/2011           
Georgia   11/5/2000   22/11/2000   1/3/2001   11/5/2000   22/11/2000   1/3/2001   25/3/2002   18/12/2002   1/5/2006   21/2/2005   8/4/2010   1/8/2010               
Germany                                                               
Greece   4/4/1997   6/10/1998   1/12/1999   12/1/1998   22/12/1998   1/3/2001   24/1/2002           25/1/2005                       
Hungary   7/5/1999   9/1/2002   1/5/2002   7/5/1999   9/1/2002   1/5/2002   4/5/2005   30/11/2006   1/3/2007   28/9/2005   30/11/2006   1/9/2007               
Iceland   4/4/1997   12/10/2004   1/2/2005   12/1/1998   12/10/2004   1/2/2005   24/1/2002   12/10/2004   1/5/2006   25/1/2005           7/7/2009           
Ireland                                                               
Italy   4/4/1997           12/1/1998           28/2/2002           19/10/2005                       
Latvia   4/4/1997   25/2/2010   1/6/2010   12/1/1998   25/2/2010   1/6/2010                                       
Liechtenstein                                                               
Lithuania   4/4/1997   17/10/2002   1/2/2003   25/3/1998   17/10/2002   1/2/2003               7/3/2005                       
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 Convention Human Rights and Biomedicine  
Protocol: Prohibition on 
Human 
Cloning 
 Protocol: Organ and Tissue  
Protocol Biomedical 
Research  
Protocol: Genetic 
Testing  
   Signature  Ratification  Entry into 
force  
Signature  Ratification  Entry into 
force  
Signature  Ratification  Entry into 
force  
Signature  Ratification  Entry into 
force  
Signature  Ratification  Entry into 
force  
Luxembourg   4/4/1997           12/1/1998           24/1/2002           25/1/2005           27/11/2008           
Malta                                                               
Moldova   6/5/1997   26/11/2002   1/3/2003   12/1/1998   26/11/2002   1/3/2003   8/2/2007   5/2/2008   1/6/2008   25/1/2005   7/8/2013   1/12/2013   27/11/2008   29/4/2011       
Monaco                                                               
Montenegro   9/2/2005   19/3/2010   1/7/2010   22/3/2010   8/12/2010   1/4/2011   9/2/2005   19/3/2010   1/7/2010   9/2/2005   12/2/2013   1/6/2013   12/2/2013   12/2/2013       
Netherlands   4/4/1997           4/5/1998           4/2/2002                                   
Norway   4/4/1997   13/10/2006   1/2/2007   12/1/1998   26/5/2015   1/9/2015               25/1/2005   26/5/2015   1/9/2015   26/5/2015   26/5/2015       
Poland   7/5/1999           7/5/1999                                               
Portugal   4/4/1997   13/8/2001   1/12/2001   12/1/1998   13/8/2001   1/12/2001   21/2/2002           4/2/2005           17/3/2015           
Romania   4/4/1997   24/4/2001   1/8/2001   12/1/1998   24/4/2001   1/8/2001   20/2/2015           17/7/2006                       
Russia                                                               
San Marino   4/4/1997   20/3/1998   1/12/1999   12/1/1998                                               
Serbia   9/2/2005   10/2/2011   1/6/2011               9/2/2005           9/2/2005                       
Slovakia   4/4/1997   15/1/1998   1/12/1999   31/3/1998   22/10/1998   1/3/2001               25/1/2005   23/9/2005   1/9/2007               
Slovenia   4/4/1997   5/11/1998   1/12/1999   12/1/1998   5/11/1998   1/3/2001   24/1/2002   19/1/2006   1/5/2006   25/1/2005   19/1/2006   1/9/2007   25/5/2009   3/9/2009       
Spain   4/4/1997   1/9/1999   1/1/2000   12/1/1998   24/1/2000   1/3/2001   27/11/2006   22/12/2014   1/4/2015                           
Sweden   4/4/1997           12/1/1998                       25/1/2005                       
Switzerland   7/5/1999   24/7/2008   1/11/2008   7/5/1999   24/7/2008   1/11/2008   11/7/2002   10/11/2009   1/3/2010                           
The former 
Yugoslav 
Republic of 
Macedonia   
4/4/1997   3/9/2009   1/1/2010   12/1/1998   3/9/2009   1/1/2010   15/3/2002   3/9/2009   1/1/2010                           
Turkey   4/4/1997   2/7/2004   1/11/2004   12/1/1998                       25/1/2005   21/9/2011   1/1/2012               
Ukraine   22/3/2002           10/4/2006           26/6/2006           26/6/2006                       
United Kingdom                
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2. Thematic List of Council of Europe Treaties relating to Patient Rights. 
 
This list is from the Council of Europe’s own (complete) Chronological List of Treaties  
http://conventions.coe.int/Treaty/Commun/ListeTraites.asp?CM=8&CL=ENG (last visited 2 August, 2015) 
Key:  
 
No. Treaty 
  
 European Convention on Human Rights   Social Security 
 Convention on Human Rights and Biomedicine  Social Charter 
 Data Protection  Animals 
 Access to Medicines and HealthCare  Torture 
 Organs, Blood, etc.  Other 
 Movement of People   
 
(Priority regarding Patient Rights) = H (High); M (Medium); L (Low); P (Procedural) 
No. = Number in chronological sequence of creation of Council of Europe Treaties 
“Contribution” to patient rights 
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P. No. Treaty Contribution Opening 
of Treaty 
Entry into 
Force 
H 5 Convention for the Protection of Human Rights 
and Fundamental Freedoms   
Rights to life (Article 2); no inhuman treatment (article 3) ;private and family life (8); 
thought, conscience and religion (9); freedom of expression (10); marry (12); effective 
remedy (13) - premise of human dignity, but note the derogations in the public interest 
(esp. in 8 and 10). 
4/11/1950   3/9/1953   
L 9 Protocol to the Convention for the Protection of 
Human Rights and Fundamental Freedoms   
Right to private property (1), education (2). 20/3/1952   18/5/1954   
P 44 Protocol No. 2 to the Convention for the 
Protection of Human Rights and Fundamental 
Freedoms, conferring upon the European Court 
of Human Rights competence to give advisory 
opinions   
ECtHR empowered to give opinions 6/5/1963   21/9/1970   
P 45 Protocol No. 3 to the Convention for the 
Protection of Human Rights and Fundamental 
Freedoms, amending Articles 29, 30 and 34 of 
the Convention   
Amendment to powers over rejection of petitions (Treaty No. 5/ Article 29 - ‘5/29’ herein) 6/5/1963   21/9/1970   
M 46 Protocol No. 4 to the Convention for the 
Protection of Human Rights and Fundamental 
Freedoms, securing certain rights and freedoms 
other than those already included in the 
Convention and in the first Protocol thereto   
Freedom of movement within territory (and freedom of exit)(2) 16/9/1963   2/5/1968   
P 55 Protocol No. 5 to the Convention for the 
Protection of Human Rights and Fundamental 
Freedoms, amending Articles 22 and 40 of the 
Convention   
Composition of Human Rights Commission 20/1/1966   20/12/1971 
  
P 67 European Agreement relating to Persons 
participating in Proceedings of the European 
Commission and Court of Human Rights   
Immunities and rights of audience before ECtHR 6/5/1969   17/4/1971   
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P. No. Treaty Contribution Opening 
of Treaty 
Entry into 
Force 
P 155 Protocol No. 11 to the Convention for the 
Protection of Human Rights and Fundamental 
Freedoms, restructuring the control machinery 
established thereby   
Revision of Section 2 (procedure of the ECtHR). 11/5/1994   1/11/1998   
M 160 European Convention on the Exercise of 
Children's Rights   
Creates expectations about treatment of Children in legal proceedings - particularly about 
involving the child to the extent of his/her competence.  
25/1/1996   1/7/2000   
H 177 Protocol No. 12 to the Convention for the 
Protection of Human Rights and Fundamental 
Freedoms   
“The enjoyment of any right set forth by law shall be secured without discrimination on 
any ground such as sex, race, colour, language, religion, political or other opinion, national 
or social origin, association with a national minority, property, birth or other status” (1.1) 
“No one shall be discriminated against by any public authority on any ground such as 
those mentioned in paragraph 1.” (1.2) 
4/11/2000   1/4/2005   
H 164 Convention for the protection of Human Rights 
and Dignity of the Human Being with regard to 
the Application of Biology and Medicine: 
Convention on Human Rights and Biomedicine   
See section 1, above. 4/4/1997   1/12/1999   
H 168 Additional Protocol to the Convention for the 
Protection of Human Rights and Dignity of the 
Human Being with regard to the Application of 
Biology and Medicine, on the Prohibition of 
Cloning Human Beings   
“Any intervention seeking to create a human being genetically identical to another human 
being, whether living or dead, is prohibited.” (1.1) 
“For the purpose of this article, the term human being ‘genetically identical’ to another 
human being means a human being sharing with another the same nuclear gene set.” (1.2) 
No derogation permitted. (2) 
12/1/1998   1/3/2001   
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P. No. Treaty Contribution Opening 
of Treaty 
Entry into 
Force 
H 186 Additional Protocol to the Convention on 
Human Rights and Biomedicine concerning 
Transplantation of Organs and Tissues of 
Human Origin   
“Parties to this Protocol shall protect the dignity and identity of everyone and guarantee, 
without discrimination, respect for his or her integrity and other rights and fundamental 
freedoms with regard to transplantation of organs and tissues of human origin.” (1) 
Chapter 2: General provisions concerning the transplant process and system 
Chapter 3: Removal of organs and tissue from living people 
Chapter 4: from deceased people 
Chapter 5: Implantation of an organ removed for a purpose other than implantation 
Chapter 6: Prohibition on financial gain 
Chapter 7: Confidentiality 
24/1/2002   1/5/2006   
H 195 Additional Protocol to the Convention on 
Human Rights and Biomedicine, concerning 
Biomedical Research   
Parties to this Protocol shall protect the dignity and identity of all human beings and 
guarantee everyone, without discrimination, respect for their integrity and other rights and 
fundamental freedoms with regard to any research involving interventions on human 
beings in the field of biomedicine. (1) 
Chapter 2: general presumptions: primacy of human dignity (3), freedom of science 
(subject to 3)(4), no available alternative (5), and justifiable proportional risk to benefit (6), 
approval for ethics and science (7), and scientific quality (8) 
Chapter 3: independent ethics committee review of protocols. 
Chapter 4: informed consent 
Chapter 5: protection of incompetent people in research 
Chapter 6: special research participants - breastfeeding mothers, emergency situations, 
prisoners. 
Chapter7: ‘safety and supervision’ 
Chapter 8: ‘confidentiality and right to information’ 
Chapter 9: ‘research in States not party to this Protocol’ 
Chapter 10: infringement, compensation and sanctions 
25/1/2005   1/9/2007   
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P. No. Treaty Contribution Opening 
of Treaty 
Entry into 
Force 
H 203 Additional Protocol to the Convention on 
Human Rights and Biomedicine concerning 
Genetic Testing for Health Purposes   
Purpose: protection of fundamental rights and freedoms of people in relation to (1)... 
“tests, which are carried out for health purposes, involving analysis of biological samples of 
human origin and aiming specifically to identify the genetic characteristics of a person 
which are inherited or acquired during early prenatal development (hereinafter referred to 
as ‘genetic tests’)” (2.1) 
Excluding:  
“a) to genetic tests carried out on the human embryo or foetus; 
b) to genetic tests carried out for research purposes.” (2.2) 
Where: 
a) “‘Analysis’ refers to i) chromosomal analysis, ii) DNA or RNA analysis, iii) analysis of 
any other element enabling information to be obtained which is equivalent to that 
obtained with the methods referred to in sub-paragraphs a.i. and a.ii.; and, 
b) “‘biological samples’ refers to i) biological materials removed for the purpose of the 
test concerned, and ii) biological materials previously removed for another purpose. 
(2.3) 
Chapter 2: General principles of non-discrimination and human primacy over ‘sole 
interest of society or science’; Chapter 3: ‘Genetic services’; Chapter 4: Informed consent 
and counselling; Chapter 5: Incompetent people; Chapter 6: ‘tests for the benefit of family 
members’; Chapter 7: privacy and information rights; Chapter 8: health screening 
programmes; Chapter 9: ‘public information’. 
27/11/2008   NB 
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P. No. Treaty Contribution Opening 
of Treaty 
Entry into 
Force 
H 108 Convention for the Protection of Individuals with 
regard to Automatic Processing of Personal Data   
Early response to international movement on protection of personal data. 
Limited to ‘automated processing’ (1)  
Established the key language - data subject, ‘controller’ of the data.(2) 
Distinguishes personal data and special personal data (particularly sensitive data) (6) 
Duties - process fairly and lawfully, storage, quantity of data fit for purpose only, accuracy, 
and presumption of deidentification where possible (5) 
Data security (7); Sanctions (10); Cross-border data flows (12) 
Mutual assistance between States (13–17); 
Inter-State Consultative Committee on data protection (18–20) 
28/1/1981   1/10/1985   
L 180 Convention on Information and Legal Co-
operation concerning "Information Society 
Services"   
“In accordance with the provisions of this Convention, the Parties shall exchange texts, 
where practicable by electronic means, of draft domestic regulations aimed specifically at 
‘Information Society Services’ and shall co-operate in the functioning of the information 
and legal co-operation system set up under the Convention.” (1.1) NB. Not 
telecommunications, etc. 
MS must designate an Information Society Services (ISS) Authority responsible for 
communicating Law/draft legislation on ISS (3) 
4/10/2001   NB 
L 181 Additional Protocol to the Convention for the 
Protection of Individuals with regard to 
Automatic Processing of Personal Data, regarding 
supervisory authorities and transborder data 
flows   
Supervisory DP Authorities in each MS (1) 
Transborder data flows to non-Convention countries only where an ‘adequate level of 
protection’ is shown (2) 
8/11/2001   1/7/2004  
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P. No. Treaty Contribution Opening 
of Treaty 
Entry into 
Force 
M 14 European Convention on Social and Medical 
Assistance   
“Each of the Contracting Parties undertakes to ensure that nationals of the other 
Contracting Parties who are lawfully present in any part of its territory to which this 
Convention applies, and who are without sufficient resources, shall be entitled equally with 
its own nationals and on the same conditions to social and medical assistance (hereinafter 
referred to as ‘assistance’) provided by the legislation in force from time to time in that 
part of its territory.” (1) 
“The cost of assistance to a national of any of the Contracting Parties shall be borne by the 
Contracting Party which has granted the assistance.” (4) 
Section 2: Repatriation (6–10). Section 3: Residence (11–14). 
11/12/1953   1/7/1954   
L 14A 
  
Protocol to the European Convention on Social 
and Medical Assistance   
“For the purposes of this Protocol the term ‘refugee’ shall have the meaning ascribed to it 
in Article 1 of the Geneva Convention, provided that each Contracting Party shall make a 
declaration at the time of signature or ratification hereof or accession hereto, specifying 
which of the meanings set out in paragraph B of Article 1 of that Convention it applies for 
the purpose of its obligations under this Protocol, unless such Party has already made such 
a declaration at the time of its signature or ratification of that Convention.” (1) 
“The provisions of Section I of the Assistance Convention shall apply to refugees under 
the same conditions as they apply to the nationals of the Contracting Parties thereto.” (2) 
11/12/1953   1/7/1954   
M 33 Agreement on the Temporary Importation, free 
of duty, of Medical, Surgical and Laboratory 
Equipment for use on free loan in Hospitals and 
other Medical Institutions for purposes of 
Diagnosis or Treatment   
“The Contracting Parties shall, provided that they have sufficient stocks for their own 
needs, make medical, surgical and laboratory equipment available on free loan to such 
other Contracting Parties as may, in exceptional circumstances, have urgent need of it; 
such equipment shall, upon request, be sent to the Party concerned and shall subsequently 
be returned.” (1.1a) 
“Each Contracting Party benefiting under the terms of the previous paragraph shall grant 
all possible facilities for the importation on a temporary basis of the equipment loaned.” 
(1.1b) 
28/4/1960   29/7/1960   
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P. No. Treaty Contribution Opening 
of Treaty 
Entry into 
Force 
H 38 European Agreement on Mutual Assistance in 
the matter of Special Medical Treatments and 
Climatic Facilities   
“The provisions of this Agreement shall apply to persons residing in the territory of one of 
the Contracting Parties who are eligible for compulsory or optional medical benefits: a) 
under social security schemes, whether general or special, contributory or non-
contributory, including special schemes for civil servants or persons treated as such and 
schemes relating to employer's obligations in regard to medical benefits; or b) under social 
and medical assistance schemes; or c) under schemes of benefits for victims of war or its 
consequences.” (1) 
“Each Contracting Party shall endeavour to have admitted to medical establishments or 
spas in its territory which can provide appropriate medical treatment any persons referred 
to in Article 1, for the medical treatment required which they need but which is not 
available in the territory of the Contracting Party where they reside, in accordance with a 
certificate issued by the doctor designated by the institution to which the patient is 
affiliated.” (2) 
14/5/1962   15/6/1962   
H 91 European Convention on Products Liability in 
regard to Personal Injury and Death   
Producers (including importers who rebrand products to their own name, and suppliers of 
unbranded products) are liable to pay compensation for death or personal injuries from 
defective products (3) 
Liability in multi-component products is each for the total (in solidum) (3.5) 
Contributory negligence included (4) 
27/1/1977   NB 
P 110 Additional Protocol to the Agreement on the 
Temporary Importation, free of duty, of Medical, 
Surgical and Laboratory Equipment for Use on 
free loan in Hospitals and other Medical 
Institutions for Purposes of Diagnosis or 
Treatment   
The EEC by this protocol can become a contracting party to the Agreement. 
Now incorporated into Agreement ETS033. 
1/1/1983   1/1/1985   
M 129 Arrangement for the Application of the European 
Agreement of 17 October 1980 concerning the 
Provision of Medical Care to Persons during 
Temporary Residence   
Creates competent bodies in each State and addresses information flows and certificates of 
entitlement to medical care. 
26/5/1988   NB 
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P. No. Treaty Contribution Opening 
of Treaty 
Entry into 
Force 
L 144 Convention on the Participation of Foreigners in 
Public Life at Local Level   
Extends rights of free expression, association and assembly to non-nationals of CofE 
States. Also ensures local representation bodies and rights to participate in local elections. 
(3–6) 
5/2/1992   1/5/1997   
M 166 European Convention on Nationality   “Each State shall determine under its own law who are its nationals.” (3.1) 
“This law shall be accepted by other States in so far as it is consistent with applicable 
international conventions, customary international law and the principles of law generally 
recognised with regard to nationality.” (3.2) 
Nationality based on the principles: “a) everyone has the right to a nationality; b) 
statelessness shall be avoided; c) no one shall be arbitrarily deprived of his or her 
nationality; d) neither marriage nor the dissolution of a marriage between a national of a 
State Party and an alien, nor the change of nationality by one of the spouses during 
marriage, shall automatically affect the nationality of the other spouse.” (4) 
Applied under non-discrimination principles (5) 
6/11/1997   1/3/2000   
P 200 Council of Europe Convention on the avoidance 
of statelessness in relation to State succession   
This provides for continuity of citizenship into a new State on State succession, and 
underlines the need to avoid statelessness (particularly 1–4) 
19/5/2006   1/5/2009   
L 211 Council of Europe Convention on the 
counterfeiting of medical products and similar 
crimes involving threats to public health   
This is a public health measure concerning the counterfeiting and trafficking in counterfeit 
medical products. (1, 3 and 4) 
It creates a criminal investigation and prosecution framework, including corporate liability 
(Chapters 2 and 3) 
28/10/2011   NB 
L 26 European Agreement on the Exchange of 
Therapeutic Substances of Human Origin   
“The Contracting Parties undertake, provided that they have sufficient stocks for their own 
needs, to make therapeutic substances of human origin available to other Parties who are 
in urgent need of them and to charge only those costs involved in the collection, 
processing and carriage of such substances.” (2)  
Where “therapeutic substances of human origin” are “human blood and its derivatives” 
(1) 
15/12/1958   1/1/1959  
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P. No. Treaty Contribution Opening 
of Treaty 
Entry into 
Force 
L 39 European Agreement on the Exchanges of 
Blood-Grouping Reagents   
“The Contracting Parties undertake, provided that they have sufficient stocks for their own 
needs, to make blood-grouping reagents available to other Parties who are in urgent need 
of them and to charge only those costs of collection, processing and carriage of such 
substances and the cost (if any) of their purchase.” (2) 
14/5/1962   14/10/1962 
  
L 80 Agreement on the Transfer of Corpses   Maximum conditions and terms, including relevant documentation, required for the 
transfer of corpses between signatory States. 
26/10/1973   11/11/1975  
L 84 European Agreement on the Exchange of Tissue-
Typing Reagents   
“The Contracting Parties undertake, provided that they have sufficient stocks for their own 
needs, to make tissue-typing reagents available to other Parties who are in need of them 
and to charge only those costs of collection, processing and carriage of such substances 
and the cost (if any) of their purchase.” (2) 
17/9/1974   23/4/1977   
P 89 Additional Protocol to the European Agreement 
on the Exchange of Tissue-Typing Reagents   
The EEC by this protocol can become a contracting party to the Agreement. 24/6/1976   23/4/1977   
P 109 Additional Protocol to the European Agreement 
on the Exchange of Therapeutic Substances of 
Human Origin   
The EEC by this protocol can become a contracting party to the Agreement. 1/1/1983   1/1/1985   
P 111 Additional Protocol to the European Agreement 
on the Exchanges of Blood-Grouping Reagents   
The EEC by this protocol can become a contracting party to the Agreement. 1/1/1983   1/1/1985   
L 216 Council of Europe Convention against 
Trafficking in Human Organs   
Purposes: “a) to prevent and combat the trafficking in human organs by providing for the 
criminalisation of certain acts; b) to protect the rights of victims of the offences established 
in accordance with this Convention;  c) to facilitate co-operation at national and 
international levels on action against the trafficking in human organs.” (1) 
Creates criminal liability for illicit removal and trafficking in human organs, and illicit 
soliciting to procure such organs.  
25/3/2015     
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P. No. Treaty Contribution Opening 
of Treaty 
Entry into 
Force 
L 19 European Convention on Establishment   “Each Contracting Party shall facilitate the entry into its territory by nationals of the other 
Parties for the purpose of temporary visits and shall permit them to travel freely within its 
territory except when this would be contrary to ordre public, national security, public 
health or morality.” (1) 
“Nationals of any Contracting Party shall enjoy in the territory of any other Party treatment 
equal to that enjoyed by nationals of the latter Party in respect of the possession and 
exercise of private rights whether personal rights or rights relating to property.” (4) 
Revocable in specified circumstances (national interest, etc.) (5) 
13/12/1955   23/2/1965   
M 12 European Interim Agreement on Social Security 
Schemes Relating to Old Age, Invalidity and 
Survivors   
Entitlement relating to “a) benefits in respect of old age;b) benefits in respect of invalidity, 
other than those awarded under an employment injury scheme; c) benefits payable to 
survivors, other than death grants or benefits awarded under an employment injury 
scheme.” (1.1) 
Subject to conditions, “a national of any one of the Contracting Parties shall be entitled to 
receive the benefits of the laws and regulations of any other of the Contracting Parties 
under the same conditions as if he were a national of the latter, provided that: a) in the 
case of invalidity benefit under either a contributory or non-contributory scheme he had 
become ordinarily resident in the territory of the latter Contracting Party before the first 
medical certification of the sickness responsible for such invalidity; b) in the case of benefit 
payable under a non-contributory scheme, he has been resident in that territory for a 
period in the aggregate of not less than fifteen years after the age of twenty, has been 
ordinarily resident without interruption in that territory for at least five years immediately 
preceding the claim for benefit and continues to be ordinarily resident in that territory; c) 
in the case of benefit payable under a contributory scheme, he is resident in the territory 
of any one of the Contracting Parties.” (2.1) 
11/12/1953   1/7/1954   
M 12A 
  
Protocol to the European Interim Agreement on 
Social Security Schemes Relating to Old Age, 
Invalidity and Survivors   
Makes the Interim Agreement available to refugees (2) 11/12/1953   1/10/1954   
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P. No. Treaty Contribution Opening 
of Treaty 
Entry into 
Force 
M 13 European Interim Agreement on Social Security 
other than Schemes for Old Age, Invalidity and 
Survivors   
Agreement concerning the following benefits: “a) sickness, maternity and death (death 
grants), including medical benefits insofar as they are not subject to a needs test; b) 
employment injury; c) unemployment; and d) family allowances.” (1.1) 
“This Agreement shall apply to schemes of contributory and non-contributory benefits, 
including employers' obligations to compensate for employment injuries. It shall not apply 
to public assistance, special schemes for civil servants, or benefits paid in respect of war 
injuries or injuries due to foreign occupation.” (1.2) 
Such that “a national of any one of the Contracting Parties shall be entitled to receive the 
benefits of the laws and regulations of any other Contracting Parties under the same 
conditions as if he were a national of the latter: a) in the case of benefit in respect of 
employment injury, provided that he resides in the territory of one of the Contracting 
Parties; b) in the case of any benefit other than benefit in respect of employment injury, 
provided that he is ordinarily resident in the territory of the latter Contracting Party; c) in 
the case of benefit claimed in respect of sickness, maternity or unemployment, provided 
that he had become ordinarily resident in the territory of the latter Contracting Party 
before the first medical certification of the sickness, the presumed date of conception or 
the beginning of the unemployment, as the case may be; and d) in the case of a benefit 
provided under a non-contributory scheme, other than a benefit in respect of employment 
injury, provided that he has been resident for six months in the territory of the latter 
Contracting Party. 
11/12/1953   1/7/1954   
M 13A 
  
Protocol to the European Interim Agreement on 
Social Security other than Schemes for Old Age, 
Invalidity and Survivors   
Makes the Interim Agreement available to refugees (2) 11/12/1953   1/10/1954   
 48 European Code of Social Security   The Code seeks to encourage the development of a minimum standard for Social Security 
across the Member States. It relates to the minimum provision to be expected in relation 
to medical care for those with a morbid condition or pregnant women (7–12); for sickness 
benefits generally (13–18); unemployment benefit (19–24); old-age benefit (25–30); 
‘employment injury benefit’ (31–38); family allowances (39–45); maternity benefits (46–
52); invalidity benefits (53–58); and benefits to support the survivors of a breadwinner 
(59–64).  
16/4/1964   17/3/1968   
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P. No. Treaty Contribution Opening 
of Treaty 
Entry into 
Force 
 48A 
  
Protocol to the European Code of Social 
Security   
This protocol is designed to further a desire amongst the members to move from a 
minimum to the highest standard of social security.  
16/4/1964   17/3/1968   
 78 European Convention on Social Security   The convention builds on the European Code of Social Security to build obligations 
accepted by the Member States.  
14/12/1972   1/3/1977   
 78A 
  
Supplementary Agreement for the Application of 
the European Convention on Social Security   
Technical procedural provisions for the implementation and operation of the Convention. 14/12/1972   1/3/1977   
 139 European Code of Social Security (Revised)   Revision of the Code to reflect changing European cultural values and expectations in 
relation to Social Security. (Given it is not in force, the question must be asked how far 
this represents shared values.  
6/11/1990   NB 
 154 Protocol to the European Convention on Social 
Security   
Technical revisions. 11/5/1994   NB 
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P. No. Treaty Contribution Opening 
of Treaty 
Entry into 
Force 
 35 European Social Charter   Commitment to the following: 
“1. Everyone shall have the opportunity to earn his living in an occupation freely entered 
upon. 
2. All workers have the right to just conditions of work. 
3. All workers have the right to safe and healthy working conditions. 
4. All workers have the right to a fair remuneration sufficient for a decent standard of 
living for themselves and their families. 
5. All workers and employers have the right to freedom of association in national or 
international organisations for the protection of their economic and social interests. 
6. All workers and employers have the right to bargain collectively. 
7. Children and young persons have the right to a special protection against the physical 
and moral hazards to which they are exposed. 
8. Employed women, in case of maternity, and other employed women as appropriate, 
have the right to a special protection in their work. 
9. Everyone has the right to appropriate facilities for vocational guidance with a view to 
helping him choose an occupation suited to his personal aptitude and interests. 
10. Everyone has the right to appropriate facilities for vocational training. 
11. Everyone has the right to benefit from any measures enabling him to enjoy the 
highest possible standard of health attainable. 
12. All workers and their dependents have the right to social security. 
13. Anyone without adequate resources has the right to social and medical assistance. 
14. Everyone has the right to benefit from social welfare services. 
15. Disabled persons have the right to vocational training, rehabilitation and resettlement, 
whatever the origin and nature of their disability. 
16. The family as a fundamental unit of society has the right to appropriate social, legal 
and economic protection to ensure its full development. 
17. Mothers and children, irrespective of marital status and family relations, have the right 
to appropriate social and economic protection. 
18. The nationals of any one of the Contracting Parties have the right to engage in any 
gainful occupation in the territory of any one of the others on a footing of equality with the 
nationals of the latter, subject to restrictions based on cogent economic or social reasons. 
19. Migrant workers who are nationals of a Contracting Party and their families have the 
right to protection and assistance in the territory of any other Contracting Party.” (Part 
1) 
 
Right to Protection of Health: MS commitment “1) to remove as far as possible the causes 
of ill-health; 2) to provide advisory and educational facilities for the promotion of health 
and the encouragement of individual responsibility in matters of health; 3) to prevent as 
far as possible epidemic, endemic and other diseases.” (11) 
Right to medical assistance regardless of means (13) 
18/10/1961   26/2/1965   
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P. No. Treaty Contribution Opening 
of Treaty 
Entry into 
Force 
 128 Additional Protocol to the European Social 
Charter   
Workers employment rights. Rights of elderly people (4). 5/5/1988   4/9/1992   
 163 European Social Charter (revised)   Revisions to Social Charter. Addition to 11.3 of accidental injury;  3/5/1996   1/7/1999   
 123 European Convention for the Protection of 
Vertebrate Animals used for Experimental and 
other Scientific Purposes   
Accepts the principle that animal experimentation in science (including medicine) is 
acceptable within safeguards. 
18/3/1986   1/1/1991   
 106 European Outline Convention on Transfrontier 
Co-operation between Territorial Communities 
or Authorities   
Administrative measures ‘reinforce and foster neighbourly relations’ for co-existence in 
border regions (1), including the development of cross-border regional agreements. 
Annexes have model agreements (NB nothing specifically on patient rights, but on local 
governance.) 
21/5/1980   22/12/1981 
  
 50 Convention on the Elaboration of a European 
Pharmacopoeia   
 22/7/1964   8/5/1974   
 59 European Agreement on the Instruction and 
Education of Nurses   
 25/10/1967   7/8/1969   
 100 European Convention on the Obtaining Abroad 
of Information and Evidence in Administrative 
Matters   
 15/3/1978   1/1/1983   
 119 European Convention on Offences relating to 
Cultural Property   
 23/6/1985   NB 
 122 European Charter of Local Self-Government    15/10/1985   1/9/1988   
 134 Protocol to the Convention on the Elaboration of 
a European Pharmacopoeia   
 16/11/1989   1/11/1992   
 135 Anti-Doping Convention    16/11/1989   1/3/1990   
 188 Additional Protocol to the Anti-Doping 
Convention   
 12/9/2002   1/4/2004   
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P. No. Treaty Contribution Opening 
of Treaty 
Entry into 
Force 
 199 Council of Europe Framework Convention on 
the Value of Cultural Heritage for Society   
 27/10/2005   1/6/2011   
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3. Recommendations of the Council of Europe 
Recommendation/ Report  url date 
Recommendation on Xenotransplantation https://wcd.coe.int/ViewDoc.jsp?id=45827 19/06/2003 
Recommendation on protection of human rights 
and dignity of persons with mental disorder 
http://www.coe.int/t/dg3/healthbioethic/Act
ivities/08_Psychiatry_and_human_rights_e
n/Rec%282004%2910%20EM%20E.pdf 
22/09/2004 
Recommendation on research on biological 
materials of human origin 
https://wcd.coe.int/ViewDoc.jsp?id=977859 
 
15/03/2006 
Guidelines for RECs https://rm.coe.int/CoERMPublicCommonSea
rchServices/DisplayDCTMContent?document
Id=0900001680307e6c 
3/12/2010 
Report on Ethical Issues Raised by Emerging 
Sciences and Technologies 
Roger Strand and Matthias Kaiser (U of Bergen) 
https://rm.coe.int/CoERMPublicCommonSea
rchServices/DisplayDCTMContent?document
Id=090000168030751d 
23/01/2015 
From Bio to NBIC Convergence: From Medical 
Practice to Daily Life 
Rathenau 
https://rm.coe.int/CoERMPublicCommonSea
rchServices/DisplayDCTMContent?document
Id=0900001680307575 
2014 
Guide on the decision-making process regarding 
medical treatment in end-of-life situations 
https://rm.coe.int/CoERMPublicCommonSea
rchServices/DisplayDCTMContent?document
Id=090000168039e8c5 
2014 
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4. Activity of the ECtHR  
 
4.1 Principal CaseLaw 
Area Name  Citation 
Art 8 Von Hannover n°3 V. Germany  Discussion of the proper considerations in determining Article 8 cases in 
domestic court 
264(2013) 
19.09.2013 
Art 8 Case of Söderman v. Sweden Filming in a domestic setting without consent - privacy violation given nature of 
the filming. 
5786/08 
12.11.2013 
Art 8 
(medical 
files) 
Avilkina and Others v. Russia Disclosing refusal to have blood transfusion whilst in hospital (part of medical 
record) breach of privacy  
171(2013) 
6.06.2013 
Art 8 DP Bernh Larsen Holding As and 
Others v. Norway 
Extent of 8(2) in relation to tax authorities 080(2013) 
14.03.2015 
Art 8 
DNA 
after 
release 
without 
charge 
S. and Marper v. United 
Kingdom 
Proportionality of retaining genetic information of a person on the national 
criminal data base when that person was not charged or convicted of a crime 
30562/04 and 
30566/04 
4.12.2008 
Art 8 K.U. v. Finland Telecommunications - identifying data - confidentiality agreement in identity of 
telecoms user not a shield where against violation of another’s privacy 
2872/02 
2.12.2008 
Art 8 Judgment M.K. v. France Privacy in electronic communication 120(2013) 
18.04.2013 
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Area Name  Citation 
Art 8 Iordachi and others v. Moldova  Privacy - illegal telephone tapping - outside the scope of criminal investigation 25198/02 
10.02.2009 
Oviedo Glass v. the United Kingdom Decisions concerning a child with disabilities 61827/00 
9.03.2004 
Oviedo Vo v. France Status of the Embryo 53924/00 
8.07.2004 
Oviedo Lambert v. France Correct procedure for removing hydration and feeding from person in vegetative 
state 
46043/14 
5.06.2015 
 
4.2 Complete lists of Judgements in ECtHR 
Area Chamber Judgement 
Data 
Protection 
Grand Chamber http://hudoc.echr.coe.int/eng#{"fulltext":["data%20protection"],"documentcollectionid2":["GRANDCHAMBER"]} 
Data 
Protection 
Chamber http://hudoc.echr.coe.int/eng#{"fulltext":["data%20protection"],"documentcollectionid2":["CHAMBER"]} 
Patient Rights Grand Chamber http://hudoc.echr.coe.int/eng#{"fulltext":["patient%20rights"],"documentcollectionid2":["GRANDCHAMBER"]} 
Private life Grand Chamber http://hudoc.echr.coe.int/eng#{"fulltext":["private%20life"],"documentcollectionid2":["GRANDCHAMBER"]} 
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Annex 5: Programme of the one-day workshop 
 
 
PRE-MAX 
Patients’ Rights in the European union – MApping eXercise 
 
 
 
 
CHAFEA/2014/Health/03 concerning mapping patients’ rights in 
all Member States in the European Union 
 
 
 
Practical information for participants 
 
Workshop on implementation of patients’ rights 
 
 
 
We are looking forward to welcoming you to the workshop at the UM Brussels Campus   
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Programme: 
 
 
Workshop Day 1     Thursday, September 10th 
12.00- 13.00hrs Arrival and Registration plus Light Lunch 
13.00- 13.15hrs  Welcome address 
13.15-13.30hrs Introductory address: meeting’s objectives and methodology 
(Brand) 
13.30-15.00hrs Session 1 Patient rights law – preliminary results (Nys/ 
Shaw) 
15.00 -15.30hrs Break 
15.30- 17.00hrs Session 2 Enforcement systems (Townend/Shaw) 
 
 
19.00 -22.00hrs  Dinner 
 
 
Workshop Day 2     Friday, September 11th 
09.00 -9.15hrs Opening thoughts – reflections from Day 1 & agenda for Day 2 
(Brand) 
09.15- 10.45hrs Session 3 Council of Europe activities (Townend/Shaw) 
10.45-11.15hrs Break 
11.15 -12.45hrs Session 4 The Role of the EU (Brand/Palm) 
12.45 -13.00hrs  Preliminary Reflections on the workshop  
13.00 -13.15hrs Closing (Brand) 
13.15 -14.30hrs  Light Lunch 
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Annex 6: Discussion paper D5 
 
(D5) Discussion Paper 
for the one –day workshop (Task 4) on implementation of patients’ 
rights 
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1. Introduction 
With the adoption and implementation of the Directive 2011/24/EU on the application 
of patients’ rights in cross-border health care, the EU has not only attempted to clarify 
the entitlements of citizens to reimbursement for cross-border health care, it has also 
introduced a framework of rules to ensure a set of common values and operating 
principles that EU citizens would expect to find - and structures to support them - in 
any Member State’s health system in the EU. They are considered necessary to ensure 
patients’ trust in cross-border healthcare (recital 5), and also more broadly to 
establish a high level of trust between the patient and healthcare provider (recital 19). 
However, as has been recognised in the Council Conclusions on Common values and 
principles in European Union Health Systems (2006), Member States have taken 
different approaches in the broad area of patients’ rights - some have chosen to 
express them in terms of the rights of patients, others in terms of the obligations of 
healthcare providers. Enforcement is also carried out differently across the EU.  
2. Rationale and framework of the mapping 
Within this context the Commission is looking for a mapping exercise of existing 
patients’ rights in 30 countries (including the 28 EU Member States, Norway and 
Iceland). This study provides an overview of the various legal frameworks as well as 
other policy tools and mechanisms in place (or in the making) to define, implement 
and enforce patients’ rights. More specifically it is: 
(1) To carry out a review of national legislation including soft laws and draft 
legislation in the field of patients’ rights in all EU Member States, Norway and 
Iceland 
(2) To assess the existence and functioning of the structures, procedures and 
mechanisms instrumental to enforce the identified patients’ rights under (1). 
(3) To map Council of Europe activities in the field of patients’ rights 
(4) To organise a workshop to discuss the findings of above tasks with relevant 
stakeholders and to develop a comprehensive list of useful and achievable 
patients’ rights  
This mapping exercise is based on a solid conceptual framework to map and 
categorise various approaches and national strategies. We focus on three domains of 
patients ‘rights: 
 Basic individual patients’ rights, such as the right to informed consent; to 
privacy and dignity; to access to the medical file;  
 Consumer-oriented patients’ rights, such as to choose one’s provider, to second 
opinion, to safe and timely treatment (patient safety and quality of care) and 
the right to information of one’s health 
 Procedural patients’ rights, such as the right to complain, to compensation, and 
to participate in decision-making. 
Clearly, these different patients’ rights cannot be totally separated from each other. 
Some could even be considered as ‘derived’ rights that help to implement and enforce 
other rights.   
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3. Preliminary findings per task 
In the following sections 3.1 -3.3 the preliminary findings of the mapping exercise on 
patients’ right in all member states of the EU, Norway and Iceland and conclusions 
drawn from these preliminary findings are presented. At the end of each (sub-)section 
a text box poses questions and statements derived from the preliminary findings 
which will be addressed/ put forward for discussion during the workshop. Then, 
Section 4 focusses on patients’ rights in the cross-border setting. On the basis of the 
preliminary findings section 5 suggests a number of recommendations for further 
actions subject for discussion as well 
General context 
Gradually all Member States are developing a legal approach to defining and 
implementing patients’ rights. Only a few Members States are still lacking a special 
law on patients’ rights (Austria, Bulgaria, Ireland, Italy, Malta). However, the legal 
framework on patients’ rights usually extends beyond the scope of a single patients’ 
rights law. Other specific legal acts or governmental decisions addressing specific 
issues or aspects, the application of general principles derived from civil, criminal or 
administrative law, or even direct reference to the Constitution will complete the 
picture. Even if in most cases the adoption of a patients’ rights law meant an 
important shift towards a more patient-oriented approach, still in many cases laws 
defining the obligations of health professionals or deontological codes continue to be 
an important source for patients’ rights.  
Clearly, countries like Finland, the Netherlands and Hungary belong to the patients’ 
rights pioneers. They also represent a different approach in terms of legally defining 
and implementing patients’ rights: the nominate contract model (Netherlands), a 
special patients’ rights law with legally enforceable rights (Hungary) and the vertical or 
public model (Finland). These pioneers were followed by a next group of countries in 
the late 1990s and early 2000s, which often were inspired by the adoption and 
ratification process of the Council of Europe’s Biomedicine Convention. Among the 
most recent group of countries introducing special patients’ rights legislation, some 
actually consolidated or coordinated their existing framework (e.g. Germany, 
Denmark, Sweden) while others were pushed by increased public interest (e.g. 
Portugal) or inspired by patients’ rights law in neighbouring countries (Luxembourg). 
Whereas basic patients’ rights seem to have become well-established in most Member 
States, this seems to be less the case for the more consumer-oriented rights. They 
also represent a more recent trend that is inspired by an increased attention for 
ensuring quality and safety in the health sector, but also more generally for 
responsiveness and efficiency in public service provision. At least in some cases the 
development of a body of more consumer-oriented patients’ rights seems to be 
directly inspired by the transposition process of the Directive 2011/24/EU on the 
application of patients’ rights in cross-border health care. 
For all types of patients’ rights alike the main problem remains the actual enforcement 
of patients’ rights. At least for six countries weak enforcement was explicitly 
mentioned as one of the main challenges (Croatia, Cyprus, Greece, Poland, Romania, 
Slovenia). On the other hand, it seems that courts are increasingly engaging in this 
field. Also a lot of alternative enforcement mechanisms are emerging, ranging from 
monitoring bodies (Bulgaria), patients’ rights advocates (Hungary) and 
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ombudspersons (Poland) to legal representation of individual patients by patients’ 
associations (France). 
3.1 Task 1 Review of national legislation in the field of patients’ rights 
3.1.1 Basic individual rights 
All Member States are developing a legal approach to defining and implementing the 
basic fundamental or classic patient rights to self-determination and 
confidentiality (including the rights to consent; privacy; accessing the medical 
records). These rights are embedded in several individual human rights frameworks 
(for example the Biomedicine Convention). In a way this mapping exercise concludes 
that we will arrive at a minimum set of patient rights in all 30 States. 
Despite a common base for basic individual rights, the rights to consent, privacy and 
accessing medical records are protected by multiple mechanisms in each member 
state. The right to privacy is perhaps the most heavily protected, with strong 
penalties in many states for breaches of confidentiality and data protection. Most 
countries also have strong protections for the right to consent, with some notable 
exceptions such as Latvia. The right to access one’s medical record is also provided for 
strongly in most member states, although many respondents reported that some 
hospitals do try to limit access in practice. 
 
 
 
 
 
 
3.1.2 Consumer-oriented patients’ rights 
With regard to the more consumer-oriented patients' rights our mapping exercise 
shows that these rights are not yet formally recognized in a lot of member states in 
general. Some trends can be discerned. 
Choice in health care is a complex issue. There is a huge variation in the way it is 
implemented in various health systems. In some countries choice is an intrinsic value 
of the health systems, in others it is more regarded as a tool to increase efficiency and 
improve quality. Although free choice of provider is often stated as a fundamental 
principle and patient right, necessary to protect the trust relationship between the 
individual provider and the patient, in practice it is often restricted by regulation and 
reality.  
Traditionally, provider choice has been more limited in tax-based health system, with 
patients being registered with public primary care providers within their local 
community who act as gatekeepers to control access to specialised care provider. 
While we see in some of these systems geographical restrictions being lifted and 
choice being extended to private providers who are contracted by the system, in social 
How to strengthen the awareness of basic individual rights among patients and 
professionals? 
Good examples of translating basic individual rights in the practice in different setting 
(rights to consent, access to med. file, privacy) 
Ways to develop more common approaches in Europe apart from the general 
principles 
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health insurance systems choice is sometimes reduced by more selective contracting 
or the introduction of (soft) gatekeeping mechanisms in primary care or for chronic 
patients. On the other hand, in long-term care the introduction of personalized 
budgets are seen as a way to increase self-determination and choice (Germany, 
Netherlands). 
Perhaps more than regulatory restrictions, practical obstacles created by limited 
capacity, long waiting times and shortage of providers make choice a theoretical right, 
especially for people living in rural and remote areas. Often the degree of choice is 
balanced with the financial implications/risk patients are willing or capable to take. For 
instance, if patients want to choose for a more distant provider they will have to bear 
the travel costs. In some health systems people can opt explicitly for more extensive 
choice options in return for higher user charges (e.g. Denmark, Netherlands). But 
especially in countries with an important sector of private healthcare provision, 
differences in choice between public and private patients are considered an 
importance source of inequity (e.g. Greece).  
Even if the right to second opinion is often derived from the right to free choice and 
has been formally recognized in a growing number of Member States, this right is 
often even more theoretical with procedural conditions and significant restrictions.  
Despite of the fact that clear and objective information about providers and their 
performance is considered key to making an informed choice about what healthcare 
provider to consult, a unified, clear and coherent regulation is often still lacking. 
Increasingly, web sites are set up to provide this kind of information but there are not 
always well organised and targeted to patients’ needs. Quality is the most wanted type 
of information but generally the least available. 
 
 
 
 
 
 
 
In contrast to the concept of a right to safe and quality treatment many 
respondents refer here to the obligation of the physician, sometimes framed as a 
patient right, to adhere to a standard of care. In many countries ‘the standard of care 
patients/clients are entitled to expect' is very broadly described in various legal acts as 
"meeting certain patients' expectation and or "adhering to the current scientific 
medical knowledge". The right is embedded in the contractual relationship between 
provider and patient (e.g. Austria), in dedicated patient rights acts (e.g. Finland, 
Iceland) or can be recognized in a set of different laws (e.g. Italy) However, this 
remains often very broad and not further specified. 
Can a minimum degree of provider choice be agreed for all member states? How 
could the patients’ right to freely choose one’s provider be formulated in a European 
context? 
What kind of information needs to be provided to enable choice?  
Who should provide? How? In what way? What is the role of the NCPs in that 
respect? 
How could the patients’ right to a second opinion be warranted in practice? How can 
the EU help to ensure that patients are treated according to the best available 
standards and evidence? 
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The obligation of professionals to adhere to a certain standard of care is structurally 
ensured by the formal recognition via licensing and accreditation of healthcare 
professionals in almost all countries and to a lesser degree - but increasingly - of 
healthcare institutions (e.g. hospitals) providing care. Poland is an exception here only 
providing voluntary system of accreditation. 
In addition – from a process perspective, a majority of countries operate professional 
standards and clinical guidelines whereas the use of protocols is practiced to a lesser 
extent. Reporting publicly about outcomes is practiced in Scandinavian countries 
(Iceland, Norway, Denmark, Finland) but not common in many other countries. 
Countries which have not stipulated patient safety and quality formally include Ireland 
and Malta.  
Implementation of patient safety and quality policies is a task often spread over 
various institutions in the healthcare sector including typically the Ministry of Health, 
professional chambers and a dedicated institute for quality. 
The recognition of the right to treatment in a timely manner, hence provisions on 
waiting times and list are to a lesser degree – compared to quality and safety - 
formally recognized in the 30 countries. Among the countries addressing waiting time, 
some have set maximum waiting times whereas other only have established criteria 
how waiting lists need to be established without specifying limits.  
 
 
 
 
 
 
 
 
 
 
 
3.2 Task 2 Review of enforcement mechanism for the identified patients’ 
rights under (1) 
This mapping exercise considers the enforcement mechanisms in the abstract – i.e. 
not how they are applied in practice (how discretions are used or the standards of 
evidence that are required for a successful complaint or action, or whether the system 
is adequately funded to make it available to patients) but the range of possibilities 
that are available in the Law. In this General Context section, it must be stressed that 
not all the mechanisms described occur in each jurisdiction.  
What needs to be done beyond the actions included in the2009 Recommendation for 
patient safety to enhance the right to safe and quality treatment? 
- Who should do what? 
How do national quality institutes that coordinated/ supervise domestic standards of 
care need to be equipped (remit, position, controls, etc.) to effectively perform 
checks? 
What kinds of outcome indicators are needed? For whom?  
European exchange of quality/patient safety indicator for x-border care needed, so 
that patient can decide if she/he wants to go? 
Should quality of care and patient safety be approached from a consumer protection 
route by the EC?  
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Legal Bases range from sanctions in the criminal Law for assaults or violation of data 
protection rights (under Directive 95/46/EC) or in professional (contract) Law for 
violation of codes of practice or professional standards. Here the sanctions include 
imprisonment, fines, or suspension or removal of a licence to practice. Civil or tortious 
liability for compensation is seen through either a no-fault approach, or a fault- or 
negligence-based system. Administrative or constitutional Law (including human rights 
Law) is also used as the basis for an action, with redress being available either 
through the formal court structure or through more informal ‘ombudsmen’ or other 
tribunals. It is interesting that the Directive on Cross-border Patient Rights does not of 
itself create legal bases for redress, although in a number of jurisdictions the National 
Contact Point is indicated as a procedural route. The forums that are available to 
address breaches of patient rights are from the formal to the informal. Criminal, civil, 
administrative and constitutional courts are possible forums for complaint, as are 
professional ‘courts’, ombudsmen and tribunals. In the first instance, however, a 
complaint will be made to the health care provider, be that the professional directly 
dealing with the treatment or the institution within which the care is provided. Here, a 
range of dispute resolution mechanisms is used, again with varying degrees of 
formality. At this general level, however, it is very interesting to see that two of the 
key elements that patients making a complaint might want to see are not present in 
the patient rights legal landscape: explanation and apology.  
Sources of the Law differ between jurisdictions. A large number of MS have 
specific patient rights legislation containing the right to complain. Equally, many use 
general Laws relating to compensation, or the general tort Law system to find a 
solution to the complaint. This relates most obviously to quality of care issues, and the 
long-established area of medical negligence – areas that have a physical or 
psychological damage. What is not as well established is redress for a breach of a right 
per se. This diversity in approaches to procedural rights within each jurisdiction that 
ensure the patient’s ability to complain and ‘manage’ any adverse effects of their 
treatment, and that could make complaint difficult and unpredictable, is amplified in 
the cross-border situation. Take for example, the enforcement of the right to informed 
consent. 
From the Country Correspondent reports, there are many Member State where the full 
range of legal remedies and mechanisms is available to a patient, i.e. the patient can 
pursue his or her complaint through the criminal Law, the civil Law of Tort (medical 
liability), through a parliamentary or health Ombudsman, and/or through a 
professional hearing (or that their complaint could initiate a professional action as 
well), and that this process might be started through an informal complain made to 
the health carer or the institution, or to other bodies (Austria, Hungary, Italy, 
Netherlands, Portugal and the UK). In other jurisdictions, the expert reports that there 
are no specific procedures for informed consent, but that the general Law applies, 
which could mean that all the above actions are available (Iceland, Latvia, Lithuania, 
Luxembourg, and Slovenia). In Germany, only the criminal liability was mentioned, 
whereas in other jurisdictions, the criminal Law was not mentioned, only the general 
civil Law (Belgium, Croatia, France, Norway, and Poland). It should be noted that 
there are variations within this civil liability. For example, the experts from Belgium 
and Sweden pointed to the difficulty in making a medical negligence claim for breach 
of informed consent regulations, and Estonia indicated that the burden of proof was on 
the patient. Some experts indicated the role of a National Agency for Patients’ Rights 
And Complaints (Denmark), an Office of Patient Rights (Greece), Malpractice 
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Commission (Romania), or Health Care Surveillance Authority (Slovakia). What was 
particularly interesting in the context of the survey being about Directive and cross-
border patient rights, no expert mentioned the role of the National Contact Points in 
this context. Further, no expert discussed how rules of which Law and which forum 
would apply in the international context. 
What is clear is that a patient coming from outside a Member State will have a 
complicated and culturally different (often almost opaque) system to consider. It is 
unclear how far this will act as a barrier to deciding to use rights to cross-border 
treatment under the Directive, but it certainly raises the question of how far 
harmonisation of processes, or at least a strengthening of the role of the National 
Contact Points. 
 
 
 
 
 
3.3 Task 3 Council of Europe activities 
The Council of Europe’s mandate concerns, in part, the protection of fundamental 
rights and freedoms of the citizens of Europe. Its 47 Member States (including all the 
European Union Member States) have taken direct and indirect steps to promote 
Patient Rights across Europe.  
The starting point for Council of Europe Activities is the 1950 Convention for the 
Protection of Human Rights and Fundamental Freedoms (The European Convention on 
Human Rights), with its enforcement through the European Court of Human Rights. 
The convention articulates the concept of human dignity. Given its origins a lot of the 
Convention concerns rights relating to the rule of Law and operation of justice. 
However, there are key foundational rights for patient rights. Article 1 establishes the 
right to life. . Article 8 gives a right to Private and Family Life,. Further, individuals 
have the right to freedom of thought conscience and religion (Article 9), and to 
freedom of expression (Article 10). These rights form the beginning of rights for 
patients. The ECtHR has interpreted the right to private and family life in a number of 
medical contexts. So, patient rights stand on a platform of dignity and the specific, 
long-standing principle of privacy in medicine from the Convention.  
The 1997 Convention for the protection of Human Rights and Dignity of the Human 
Being with regard to the Application of Biology and Medicine: Convention on Human 
Rights and Biomedicine contains the strongest statement of patient rights in the 
broader Europe. The duties flow from the Article 1 obligation that “Parties to this 
Convention shall protect the dignity and identity of all human beings and guarantee 
everyone, without discrimination, respect for their integrity and other rights and 
fundamental freedoms with regard to the application of biology and medicine”. What 
follows is not limited to patient rights – for example, Article 2 indicates the supremacy 
of human dignity over “the sole interests of society or science” – but it contains 
fundamental patient rights. Article 3 demands “equitable access to health care of 
Is the range of dispute resolution mechanisms fit for purpose? In particular, is a 
fault-based approach to complaint or redress for mistake appropriate for encouraging 
good medical practice? Does fault-based dispute resolution mitigate against 
explanation and apology? 
What is or should be the role of the National Contact Point in assisting the patient to 
negotiate the different dispute resolution mechanisms? 
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appropriate quality” but Parties do this “taking into account health needs and available 
resources”. Appropriate quality is, in part, considered in Article 4, which ties health 
care to “relevant professional obligations and standards”. Article 28 broadens the 
discussion about appropriate quality by requiring that the “fundamental questions 
raised by the developments of biology and medicine are the subject of appropriate 
public discussion in the light, in particular, of relevant medical, social, economic, 
ethical and legal implications, and that their possible application is made the subject of 
appropriate consultation”. 
Article 5 of the Convention on Human Rights and Biomedicine requires Parties to 
require a general principle that “an intervention in the health field may only be carried 
out after the person concerned has given free and informed consent to it”, where s/he 
is given “beforehand […] appropriate information as to the purpose and nature of the 
intervention as well as on its consequences and risks” and that s/he can “freely 
withdraw consent at any time”. Article 6 provides for those who are not legally 
competent to give consent, with provision for a guardian (be that person or other 
authority) to safeguard the person’s Article 5 rights in his or her place. Article 6 
includes the provision that “The opinion of the minor shall be taken into consideration 
as an increasingly determining factor in proportion to his or her age and degree of 
maturity”; the incompetent adult “shall as far as possible take part in the authorisation 
procedure”. What is not clear is how the guardian has to act in making decisions on 
behalf of another. Articles 7 and 8 address situations where consent is not required: 
the treatment of the mentally ill and those in emergency situations where consent is 
not possible, and in both instances a measure of serious harm occurring without the 
intervention is required. Article 9 requires that “previously expressed wishes relating 
to a medical intervention by a patient who is not, at the time of the intervention, in a 
state to express his or her wishes shall be taken into account”.  Article 10 establishes 
what again conforms to an international standard of privacy and rights to information: 
“1. Everyone has the right to respect for private life in relation to information about 
his or her health. 2. Everyone is entitled to know any information collected about his 
or her health. However, the wishes of individuals not to be so informed shall be 
observed. 3. In exceptional cases, restrictions may be placed by law on the exercise of 
the rights contained in paragraph 2 in the interests of the patient”.  Article 23 requires 
Parties to “provide appropriate judicial protection to prevent or to put a stop to an 
unlawful infringement of the rights and principles set forth in this Convention at short 
notice”; to compensate for “undue damage resulting from an intervention” (Article 
24); and that sanctions be in place for infringements of Convention provisions (Article 
25). 
These Articles are given in some detail to show that the agreement in this area of the 
Convention is in line with other international instruments, particularly the Helsinki 
Declaration, and could be said to be international ‘best practice’ to ensure patient 
autonomy and dignity.  
Whereas the Council of Europe has developed these landmark instruments in relation 
to biomedicine, they have not been universally accepted by the Member States. No 
Party has brought the Protocol on genetic testing into force, with only Moldova, 
Montenegro, Norway and Slovenia ratifying it. The ratification and entry into force for 
the other Protocols is somewhat better, but like the ratification and entry into force of 
the Convention itself, it is not universal amongst the Member States. There are a 
number of further lines of Council of Europe activity at the Treaty or Convention level 
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that have a bearing on Patient Rights. Data protection in Europe originates in the 
Council’s 1981 Convention for the Protection of Individuals with regard to Automatic 
Processing of Personal Data. Again, the acceptance by the Members is limited.  
The Country Correspondents’ responses to questions about the impact of Council of 
Europe Activities in their countries revealed very mixed responses. In some, the 
impact, especially of ECtHR cases, was reported to be significant. In Austria, Council 
activity was said to have inspired the patient safety strategy; in Belgium, professional 
hearings have been made public following ECtHR jurisprudence; the VO v France 
decision was said to have generated discussion in Germany; the Icelandic biobanking 
Law acknowledges Council of Europe influences; the Norwegian legislation on 
biomedicine is influenced by the Biomedicine Convention; in Poland decisions 
concerning blood transfusions and Jehovah’s Witnesses were influenced by Council 
activity; and in Slovenia Laws relating to assisted reproduction and transplantation of 
human body parts were also influenced by Council of Europe activity. Further, 
correspondents indicated that ECtHR decisions more generally were followed in their 
domestic Law (especially, as in The Netherlands, when the country was a party to the 
case). However, in other countries, the reported impact is quite thin. This poses the 
question, is this the case? 
 
 
 
 
4. Preliminary findings on patients ’rights in the cross-border situation 
This section highlights some of the specific issues related to the application of patients’ 
rights in the context of cross-border patients, e.g. informed consent and access to 
one’s medical record possibly impeded by language problems, choice of provider and 
information for cross-border patients, procedural rights and continuity of care.  
Self-determination & Confidentiality 
While in many member states no specific provisions exist for cross-border patients, 
the existing laws regarding informed consent, privacy or access to the medical record 
equally apply to all health care provided on their territory. However, for some country 
respondents it is clear that the cross-border situation may require some special 
attention. Some highlight the possibility to receive an e-copy of the medical file for 
cross-border patients (Estonia, Luxembourg, Romania, Slovenia). In France and 
Norway, mandatory translating services are covered by law with regard to cross-
border patients. Finally, the EXPAND cross-border project (among others in 
Luxembourg) aims to make cross-border patient data sharing more efficient. 
Quality and safety 
Many countries foresee as a general condition to grant prior authorization for cross-
border care that the service is part of the statutory benefit basket but cannot be 
provided within medically necessary time limits. Whereas in principle prior 
authorization cannot be granted on the basis of quality and patient safety reasons, 
Is the objection to the Convention specific to issues in relation to research and the 
pharmaceutical business, or does it also concern patient rights? 
Is the impact of Council of Europe activity really as varied (and in some cases 
limited) as correspondents indicate? 
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this seems to be a strong motivation for cross-border care. Although the Directive 
2011/24.EU provides for the possibility of member states to require and refuse prior 
authorization for treatment by providers who would raise quality and safety concerns, 
none of the countries seems to have actually implemented specific regulations in that 
respect. 
Choice 
As a principle Directive 2011/24/EU extends patients’ choice option to healthcare 
providers in another Member State irrespective of whether or not they are contracted 
by the statutory health system in that Member State. This raises two particular and 
related questions: (a) to what extent does this increase pressure on member states to 
extend choice options and also allow reimbursement for non-contracted providers 
domestically?; (b) to what extent member states are allowed to limit reimbursement 
for cross-border care to rates that are applicable to non-contracted providers?  In 
countries where health insurers are traditionally bound to also reimburse (to a lesser 
extent) non-contracted care (e.g. Austria, Netherlands), these questions may actually 
lead to reductions in choice domestically. 
Another issue is whether the absence of choice options domestically because the 
specific care or expertise is not available in the country (e.g. rare diseases) could 
justify to getting care and/or second opinion in another member state (see quality and 
safety section). Also the applicability of conditions that actually limit choice, such as 
referrals by a domestic provider or the requirement that first all domestic treatment 
options have to be exhausted, need to be questioned as to their conformity with EU 
rules. 
 
 
 
 
 
 
 
 
 
 
  
What specific requirements would be needed to guarantee self-determination and 
confidentiality to cross-border patients? How can continuity of care and good follow-
up for cross-border patients be guaranteed while respecting confidentiality and safe 
data sharing? 
How should patients’ right to safe and quality care in a timely manner be guaranteed 
in a EU context? Should next to the concept of “undue delay” a similar concept be 
needed to define a minimum standard for quality and safety? 
How should provider choice be defined in a cross-border setting? What conditions 
limiting choice may be justified or not? 
Is the information provided by the NCPs (and other relevant actors) sufficient to 
allow patients to make an informed choice of provider in another member state and 
to assess quality and patient safety aspects? 
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5. Next steps 
In addition to the full implementation and application of the Directive 2011/24/EU the 
question remains to what extent the development of a European Charter of patients’ 
rights can help to improve the position of cross-border patients and support the 
further development of patients’ rights at national level.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Is it feasible and desirable to define a minimum set of patients’ rights at EU 
level? 
If so, what form should this take and how would the various rights need to be 
termed?  
Should these rights apply specifically to cross-border patients or to all patients in 
the EU?  
Should the NCPs play a role in promoting patients’ rights at an EU level?  
How could the enforcement of patients’ rights be strengthened by the EU?  
Would there be any role for the European ombudsman?  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HOW TO OBTAIN EU PUBLICATIONS 
Free publications: 
• one copy: 
via EU Bookshop (http://bookshop.europa.eu); 
• more than one copy or posters/maps: 
from the European Union’s representations (http://ec.europa.eu/represent_en.htm);  
from the delegations in non-EU countries 
(http://eeas.europa.eu/delegations/index_en.htm);  
by contacting the Europe Direct service (http://europa.eu/europedirect/index_en.htm) 
or calling 00 800 6 7 8 9 10 11 (freephone number from anywhere in the EU) (*). 
 
(*) The information given is free, as are most calls (though some operators, phone boxes or hotels may 
charge you). 
Priced publications: 
• via EU Bookshop (http://bookshop.europa.eu). 
 
 
 
                doi: 10.2875/751285  
ISBN 9978-92-79-66960-6 
 
 
E
W
-0
1
-1
7
-2
4
4
-E
N
-N
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                               
 
 
 
 
[C
a
ta
lo
g
u
e
 n
u
m
b
e
r] 
